0001213900-24-033608.txt : 20240417 0001213900-24-033608.hdr.sgml : 20240417 20240417092626 ACCESSION NUMBER: 0001213900-24-033608 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 110 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240417 DATE AS OF CHANGE: 20240417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovative Payment Solutions, Inc. CENTRAL INDEX KEY: 0001591913 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-CATALOG & MAIL-ORDER HOUSES [5961] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-55648 FILM NUMBER: 24849485 BUSINESS ADDRESS: STREET 1: 56B 5TH AVENUE, LOT 1 #AT CITY: CARMEL BY THE SEA STATE: CA ZIP: 93921 BUSINESS PHONE: (866) 477-4729 MAIL ADDRESS: STREET 1: 56B 5TH AVENUE, LOT 1 #AT CITY: CARMEL BY THE SEA STATE: CA ZIP: 93921 FORMER COMPANY: FORMER CONFORMED NAME: QPAGOS DATE OF NAME CHANGE: 20160615 FORMER COMPANY: FORMER CONFORMED NAME: Asiya Pearls, Inc. DATE OF NAME CHANGE: 20131113 10-K/A 1 ea0203998-10ka1_innova.htm AMENDMENT NO. 1 TO FORM 10-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

FORM 10-K/A

(Amendment No. 1)

 

(Mark one) 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal period ended December 312023

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number – 000-55648

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   33 1230229
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)

 

56B 5th StreetLot 1, #AT

Carmel by the SeaCA 93921

(Address of principal executive offices) (Zip Code)

  

(866) 477-4729

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12 (g) of the Act: Common Stock, $0.0001 par value.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐  No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐  No ☒

 

Indicate by check mark whether the issuer: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes  No ☐

 

Indicate by check mark whether the registrant has submitted electronically every interactive data file required to be submitted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒  No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer, “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

 

  Large accelerated filer Accelerated filer  
  Non-accelerated filer Smaller reporting company  
    Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

  

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐ 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐  No 

 

As of June 30, 2023, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was approximately $4,628,228 (based upon the closing sale price of the registrant’s common stock reported on June 30, 2023 of $0.42 per share). This calculation excludes shares held by the registrant’s current directors and executive officers and stockholders that the registrant has concluded are affiliates of the registrant.

 

As of April 16, 2024, the issuer had 13,819,889 shares of common stock outstanding.

 

Documents incorporated by reference: None

 

 

 

 

 

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) to the Annual Report on Form 10-K of Innovative Payment Solutions, Inc. (the “Company”) for the fiscal year ended December 31, 2023, originally filed with the Securities and Exchange Commission (“SEC”) on March 29, 2024 (the “Original Filing”), is being filed solely to correct a typographical error as to the signing date of the Report of Independent Registered Public Accounting Firm contained therein, which read March 29, 2023 instead of March 29, 2024.

 

This Amendment No. 1 includes: Item 8 of Part II, “Financial Statements and Supplementary Data” in its entirety and without change from the Original Filing other than the correction of the signing date of the Report of Independent Registered Public Accounting Firm.

 

In addition, pursuant to the rules of the SEC, the exhibit list included herein reflects currently-dated certifications from the Company’s principal executive officer and principal accounting officer, which are filed as exhibits to this Amendment No. 1.

 

Except for the foregoing amended information, this Amendment No. 1 does not amend or update any other information contained in the Original Filing, or reflect any events that have occurred after the filing date of the Original Filing. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Filing.

 

 

 

PART II

 

Item 8. Financial Statements and Supplementary Data

 

    Page
Report of the Independent, Registered Public Accounting firm   F-2
Consolidated Balance Sheets as of December 31, 2023 and December 31, 2022   F-3
Consolidated Statements of Operations for the years ended December 31, 2023 and December 31, 2022   F-4
Consolidated Statements of Deficit for the years ended December 31, 2023 and December 31, 2022   F-5
Consolidated Statements of Cash Flows for the years ended December 31, 2023 and December 31, 2022   F-6
Notes to the Consolidated Financial Statements   F-7

 

F-1

 

 

805 Third Avenue
New York, NY 10022
Tel. 212.838.5100
Fax 212.838.2676
www.rbsmllp.com

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

Innovative Payment Solutions, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Innovative Payment Solutions, Inc. (the Company) as of December 31, 2023 and 2022, and the related consolidated statements of operations, changes in stockholders’ equity (deficit) and cash flows for each of the two years in the two-year period ended December 31, 2023, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the two years in the two-year period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America.

 

The Company’s Ability to Continue as a Going Concern

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 3 to the accompanying consolidated financial statements, the Company has suffered recurring losses from operations, generated negative cash flows from operating activities, has an accumulated deficit and has stated that substantial doubt exists about Company’s ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s plans in regarding these matters are also described in Note 3. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. Based on the previous year’s audits and the reviews performed by RBSM during year ended December 31, 2023, RBSM determined there were no CAM’s for the audit of the year ended December 31, 2023.

 

 

 

We have served as the Company’s auditor since 2014. PCAOB ID 587
New York, NY
March 29, 2024

  

F-2

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

CONSOLIDATED BALANCE SHEETS

 

   December 31,   December 31, 
   2023   2022 
Assets        
         
Current Assets        
Cash  $50,433   $373,822 
Other current assets   38,818    97,042 
Assets held for sale   
-
    807,263 
Total Current Assets   89,251    1,278,127 
           
Non-current assets          
Plant and equipment   7,027    40,362 
Intangible assets   
-
    1,401,491 
Security deposit   5,000    32,592 
Equity method investment   703,938    
-
 
Total Non-Current Assets   715,965    1,474,445 
Total Assets  $805,216   $2,752,572 
           
Liabilities and Equity (Deficit)          
           
Current Liabilities          
Accounts payable  $2,023,375   $727,922 
Liabilities held for sale   
-
    33,810 
Federal relief loans – current portion   9,369    
-
 
Notes payable   1,062,007    964,268 
Convertible debt, net of unamortized discount of $687,503 and $263,200, respectively   3,704,280    2,266,602 
Derivative liability   1,434,196    2,550,642 
Total Current Liabilities   8,233,227    6,543,244 
           
Non-Current Liabilities          
Federal relief loans   150,000    163,978 
Total Non-Current Liabilities   150,000    163,978 
           
Total Liabilities   8,383,227    6,707,222 
           
Equity (Deficit)          
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022.   
-
    
-
 
Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,819,889 and 12,563,426 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively.*   1,382    1,256 
Additional paid-in-capital*   50,656,225    48,442,355 
Accumulated deficit   (58,235,618)   (52,399,858)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders   (7,578,011)   (3,956,247)
Non-controlling interest   
-
    1,597 
Total Equity (Deficit)   (7,578,011)   (3,954,650)
Total Liabilities and Equity (Deficit)  $805,216   $2,752,572 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The accompanying notes are an integral part of these audited consolidated financial statements.

 

F-3

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   Twelve
months ended
   Twelve
months ended
 
   December   December 
   2023   2022 
Net Revenue  $410   $847 
           
Cost of Goods Sold   3,547    5,052 
           
Gross loss   (3,137)   (4,205)
           
General and administrative   3,576,352    5,452,579 
Depreciation   380,634    132,394 
Total Expense   3,956,986    5,584,973 
           
Loss from Operations   (3,960,123)   (5,589,178)
           
Investment impairment charge   
-
    (1)
Loss on debt conversion   (90,761)   
-
 
Loss on convertible notes   (73,562)   (4,602,709)
Loss on novation   (1,066,165)   
-
 
Fair value of warrants issued   (14,176)   
-
 
Interest expense, net   (424,117)   (199,788)
Amortization of debt discount   (770,372)   (263,200)
Derivative liability movements   1,501,446    411,752 
Loss before income taxes   (4,897,830)   (10,243,124)
           
Income taxes   
-
    
-
 
           
Net loss after income taxes   (4,897,830)   (10,243,124)
           
Net loss from equity method investments   (403,282)   
-
 
           
Net loss from continuing operations   (5,301,112)   (10,243,124)
           
Discontinued operations          
Operating loss from discontinued operations   (40,821)   (88,300)
Loss on disposal of subsidiary and investment   (495,424)   
-
 
Net loss from discontinued operations   (536,245)   (88,300)
           
Net loss   (5,837,357)   (10,331,424)
           
Net loss attributable to non-controlling interest   1,597    43,267 
           
Net loss attributable Innovative Payment Solutions, Inc. Stockholders’  $(5,835,760)  $(10,288,157)
           
Basic and diluted loss per share*          
Continuing operations*
  $(0.41)  $(0.83)
Discontinued operations*
   (0.04)   (0.00)
 
  $(0.45)  $(0.83)
           
Weighted Average Number of Shares Outstanding - Basic and diluted
   12,844,609    12,406,677 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The accompanying notes are an integral part of these audited consolidated financial statements.

 

F-4

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
FOR THE PERIOD JANUARY 1, 2022 TO DECEMBER 31, 2023

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount*   Additional
Paid-in
Capital*
   Accumulated
Deficit
   Non-controlling
shareholders
interest
   Total
Stockholders’
Equity
(Deficit)
 
Balance at December 31, 2021   
-
   $
-
    12,263,426   $1,226   $45,806,576   $(42,111,701)  $35,211   $3,731,312 
Fair value of warrants issued   -    
-
    -    
-
    708,063    
-
    
-
    708,063 
Shares issued for services   -    
-
    233,333    23    332,977    
-
    
-
    333,000 
Stock based option expense   -    
-
    -    
-
    1,233,682    
-
    
-
    1,233,682 
Restricted stock awards   -    
-
    66,667    7    361,057    
-
    
-
    361,064 
Proceeds from non-controlling shareholders   -    
-
    -    
-
    
-
    
-
    9,653    9,653 
Net loss   -    
-
    -    
-
    
-
    (10,288,157)   (43,267)   (10,331,424)
Balance at December 31, 2022   
-
   $
-
    12,563,426   $1,256   $48,442,355   $(52,399,858)  $1,597   $(3,954,650)
Conversion of convertible debt   -    
-
    1,253,625    126    523,135    
-
    
-
    523,261 
Additional shares issued on reverse stock split   -    
-
    2,838    
-
    
-
    
-
    
-
    - 
Fair value of warrants issued for services   -    
-
    -    
-
    159,004    
-
    
-
    159,004 
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    1,045,655    
-
    
-
    1,045,655 
Stock based compensation   -    
-
    -    
-
    377,856    
-
    
-
    377,856 
Fair value of warrants issued for equity method investments   -    
-
    -    
-
    108,220    
-
    
-
    108,220 
Net loss   -    
-
    -    
-
    
-
    (5,835,760)   (1,597)   (5,837,357)
Balance at December 31, 2023   
-
   $
-
    13,819,889   $1,382   $50,656,225   $(58,235,618)  $
-
   $(7,578,011)

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The accompanying notes are an integral part of these audited consolidated financial statements.

 

F-5

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

    Twelve
months ended
    Twelve
months ended
 
    December 31,     December 31,  
    2023     2022  
CASH FLOWS FROM OPERATING ACTIVITIES:            
Net loss   $ (5,837,357 )   $ (10,331,424 )
Net loss from discontinued operations     536,245       88,300  
Net loss from continuing operations     (5,301,112 )     (10,243,124 )
Adjustment to reconcile net loss to net cash used in operating activities:                
Derivative liability movements     (1,501,446 )     (411,752 )
Depreciation     380,634       132,394  
Amortization of debt discount     770,372       263,200  
Loss on novation     1,066,165      
-
 
Investment impairment charge    
-
      1  
Loss on conversion of debt to equity     90,761      
-
 
Loss on convertible notes     73,562       4,602,709  
Fair value of warrants issued for services     159,004       359,125  
Unrealized loss on equity method investments     403,282      
-
 
Shares issued for services    
-
      333,000  
Stock based compensation     377,856       1,594,746  
Changes in Assets and Liabilities                
Other current assets     58,224       (12,008 )
Accounts payable and accrued expenses     1,577,888       288,018  
Interest accruals     392,714       111,528  
Cash used in operating activities - continuing operations     (1,452,096 )     (2,982,163 )
Cash generated by operating activities - discontinued operations     35,287       (79,790 )
CASH USED IN OPERATING ACTIVITIES     (1,416,809 )     (3,061,953 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:                
Investment in equity method investment     (999,000 )    
-
 
Intangibles acquired     (44,405 )     (778,462 )
Investment in deposits    
-
      (12,792 )
Deposits refunded     14,800      
-
 
Plant and equipment purchased    
-
      (43,049 )
Net cash used in investing activities – continuing operations     (1,028,605 )     (834,303 )
Net cash used in investing activities – discontinued operations     (36,230 )     (41,320 )
NET CASH USED IN INVESTING ACTIVITIES     (1,064,835 )     (875,623 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from short term notes and convertible notes     2,461,666      
-
 
Repayment of convertible notes     (304,354 )     (1,147,063 )
Proceeds from non-controlling shareholders    
-
      9,653  
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES     2,157,312       (1,137,410 )
                 
NET DECREASE IN CASH     (324,332 )     (5,074,986 )
CASH AT BEGINNING OF YEAR     374,765       5,449,751  
CASH AT END OF YEAR   $ 50,433     $ 374,765  
                 
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS                
Cash   $ 373,822     $ 5,367,551  
Cash included in assets held for resale     943       82,200  
CASH AT BEGINNING OF THE YEAR   $ 374,765     $ 5,449,751  
                 
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS                
Cash   $ 50,433     $ 373,822  
Cash included in assets held for resale    
-
      943  
CASH AT END OF THE YEAR   $ 50,433     $ 374,765  
                 
CASH PAID FOR INTEREST AND TAXES:                
Cash paid for income taxes   $
-
    $
-
 
Cash paid for interest   $ (31,403 )   $ 88,260  
                 
NON-CASH INVESTING AND FINANCING ACTIVITIES                
Warrants issued for software development   $
-
    $ 348,938  
Fair value of warrants issued with convertible notes   $ 1,045,655     $
-
 
Conversion of convertible debt to equity   $ 432,500     $
-
 
Fair value of warrants issued for equity method investments   $ 108,220     $
-
 

 

The accompanying notes are an integral part of these audited consolidated financial statements.

 

F-6

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

  a) Organization

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

F-7

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

  b) Description of current business

 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express (as defined below), developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

IPSIPay Express

 

On April 28, 2023, the Company formed a new company called IPSIPay Express LLC (“IPSIPay Express”). This entity was formed as a Delaware limited liability company joint venture with OpenPath, Inc. (“OpenPath”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with OpenPath and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with OpenPath and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

 

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company is required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and OpenPath and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche was expected to be paid on or before November 30, 2023, subsequently, the Company’s management made a decision not to advance the third tranche to IPSIPay Express as the joint venture is not operational as yet. The need for any additional advances will be addressed with the joint venture partners once the joint venture becomes operational and begins generating revenue, our current shareholding in the joint venture remains at 22%.

 

Simultaneously with the funding of the initial Tranche, the Company issued to each of OpenPath and EfinityPay a five-year common stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. We are still obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. Simultaneously with the funding of the second Tranche, we are obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Should we decide to fund a third Tranche, we will be obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

 

Frictionless Financial Technologies

 

On June 21, 2021. the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

F-8

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

  b) Description of current business (continued)

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 1,000,000 (30,000,000 pre-split) shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below (see note 5), the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 has been impaired.

 

On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express joint venture. See note 5 for further information.

 

2 ACCOUNTING POLICIES AND ESTIMATES

 

  a) Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).

 

All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.

 

  b) Principles of Consolidation

 

The consolidated financial statements as of December 31, 2023, include the financial statements of the Company and its subsidiary, Beyond Fintech, in which it had a majority voting interest, until May 12, 2023, the date of disposal. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore, as of May 12, 2023 the Company has no subsidiaries. See note 4 for further information.

 

All significant inter-company accounts and transactions have been eliminated in the consolidated financial statements.

 

  c) Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

F-9

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  d) Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

  e) Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

  f) Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. The recent war in Ukraine and the global inflationary environment which has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

 

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

F-10

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  g) Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the year ended December 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s consolidated financial statements upon adoption.

 

  h) Reporting by Segment

 

No segmental information is required as the Company has only one operating segment.

 

  i) Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At December 31, 2023 and 2022, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At December 31, 2023 and 2022, the balance exceeds the federally insured limit by $0 and $120,580, respectively.

 

  j) Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended December 31, 2023 and 2022.

 

  k) Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

The Company recorded an impairment charge of $0 and $1 on its non-marketable equity securities for the years ended December 31, 2023 and 2022, respectively. The impairment charge was based on management’s determination that due to the lack of ability, to date, by Vivi Holdings (“Vivi”) to fulfill its capital raising requirements and implement its business strategy that there is a significant risk that Vivi may not be able to meet its obligations. 

 

F-11

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

  

  l) Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

  m) Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

  n) Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $410 and $847 during the years ended December 31, 2023 and 2022, respectively. 

 

F-12

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  o) Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Company’s common stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its common stock as quoted on the OTCQB, as an indicator of the fair value of its common stock in determining share- based payment arrangements.

 

  p) Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

  q) Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of December 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

 

F-13

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  r) Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

  s) Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the year ended December 31, 2023, the Company had a net loss of $5,837,357. In connection with preparing the consolidated financial statements for the year ended December 31, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the period ended December 31, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there is substantial doubt about their ability to continue as a going concern.

  

4 DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

 

On May 12, 2023, the Company entered into the May 2023 Frictionless Agreement to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 1,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18-mobnth period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

 

F-14

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

4 DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH (continued)

 

The assets and liabilities disposed of as of May 12, 2023 were as follows:

 

   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 

 

5 NOVATION  OF CERTAIN ASSETS AND LIABILITES

 

On September 5, 2023, the Company entered into a novation agreement with a third party whereby the third party assumed all of the Company’s debts, clients, and services and assumes all the rights and responsibilities of the Company under the SAAS Cloud Hosted Services Enablement Master Services Agreement, dated September 9, 2021 (the “SAAS Agreement”), including the information technology, supplier access, billing and rating technology, mobile wallet, debit card enablement, back-office support services, customer service, and consulting services related to the Company’s IPSIPay mobile application.

 

Pursuant to the novation agreement, Frictionless released the Company from all its obligations, debts, and liabilities under the SAAS Agreement as of September 5, 2023 and consented to the third party assuming these obligations. Each party agreed to indemnify the other party harmless for any damages, claims or expenses incurred by the other party.

 

The novation agreement also provided the third party a 30-day transition period in which the Company assisted the third party in transferring all the assets and obligations, including existing customers and wallets to the third party, thereafter the third party will no longer be permitted to operate the IPSIPay app under the brand name “IPSIPay”.

 

F-15

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

5 NOVATION  OF CERTAIN ASSETS AND LIABILITES (continued)

 

The assets and liabilities novated under the agreement as of September 5, 2023, were as follows:

 

   Amount 
Assets    
     
Current Assets    
Receivable on sale of subsidiary  $231,431 
      
Non-current assets     
Intangible assets   1,098,598 
Total assets   1,330,029 
      
Current Liabilities     
Accounts payable   263,864 
      
Net loss on novation  $1,066,165 

 

6 DISCONTINUED OPERATIONS

 

Effective May 12, 2023, the Company disposed of its investment in Beyond Fintech pursuant to the May 2023 Frictionless Agreement, as disclosed in note 4 above.

 

The following assets and liabilities are reported as discontinued operations:

 

   December 31, 
   2022 
Current assets    
Cash  $943 
Non-current assets     
Intangibles, net   291,320 
Investment   500,000 
Security deposit   15,000 
Assets held for sale  $807,263 
      
Current liabilities     
Accounts payable  $33,810 
Liabilities held for sale  $33,810 

 

The statement of operations from discontinued operations is as follows:

 

   Year ended December 31, 
   2023   2022 
         
Net Revenue  $
-
   $
-
 
           
Cost of Goods Sold   
-
    
-
 
           
Gross loss   
-
    
-
 
           
General and administrative   40,821    88,300 
Depreciation and amortization   
-
    
-
 
Total Expense   40,821    88,300 
           
Loss from operations before income taxes   (40,821)   (88,300)
           
Income Taxes   
-
    
-
 
Loss from discontinued operations, net of taxation  $(40,821)  $(88,300)

 

F-16

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

7 INTANGIBLES

 

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $41,320 and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless (see note 4 above).

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $1,127,400 and $44,405, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party (see note 5 above).

 

   December 31,
2023
   December 31,
2022
 
   Cost   Accumulated
amortization
   Net Book
Value
   Net book
value
 
Purchased Technology - IPSIPay  $
-
   $
-
   $
-
   $1,401,491 

 

Amortization expense was $347,298 and $100,909 for the years ended December 31, 2023 and 2022, respectively.

 

8 EQUITY METHOD INVESTMENT

 

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay (see note 1(b) above). As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of December 31, 2023, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

 

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended December 31, 2023 is as follow:

 

   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,000 
Fair value of warrants issued to third party joint venture partners   108,220 
    1,107,220 
Equity loss from joint venture   (403,282)
   $703,938 

    

9 INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

On May 12, 2023, the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless). refer Note 4 above.

  

10 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve-month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90-day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

F-17

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

10 LEASES (continued)

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Year ended December 31,
2023
   Year ended December 31,
2022
 
Operating lease expense  $40,704   $57,600 

 

Other lease information:

 

   Year ended December 31,
2023
   Year ended December 31,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(40,704)  $(57,600)
           
Remaining lease term – operating lease   -    Monthly 

 

11 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The company has accrued interest of $9,369 and $13,978 on this loan as of December 31, 2023 and 2022, respectively.

 

12 NOTES PAYABLE

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock at an exercise price of $0.24 per share.

 

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

Subsequent to year end, the maturity date of the notes was extended to April 30, 2024, all other terms remain the same as the previous notes. The Company will perform an analysis to determine whether the amendment meets the definition of a debt extinguishment or modification in terms of ASC 470.

 

F-18

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

12 NOTES PAYABLE (continued)

 

Notes payable consists of the following:

 

Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   December 31, Amount, net  

December 31,
2022
Amount,

net

 
Cavalry Fund I LP   10%  April 30, 2024   482,000    49,004    531,004    482,134 
Mercer Street Global Opportunity Fund, LLC   10%  April 30, 2024   482,000    49,003    531,003    482,134 
Total convertible notes payable          $964,000   $98,007   $1,062,007   $964,268 

    

Interest expense totaled $97,739 and $268 for the year ended December 31, 2023 and 2022, respectively.

  

13 CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 100,000 (3,000,000 pre-split) shares of Common Stock at an exercise price of $4.50 ($0.15 pre-split) per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

  (1) The conversion price of the Cavalry/Mercer Notes was reduced from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 100,000 (3,000,000 pre-split) shares of Common Stock underlying the Extension Warrants was increased to 1,304,348 (39,130,435 pre-split) shares;

 

  (2) The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 1,730,057 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

 

  (3) Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

 

  (4) Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $1.80 ($0.06 pre-split) per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $1.20 ($0.04 pre-split) per share; and

 

  (5) The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

F-19

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

13 CONVERTIBLE NOTES PAYABLE (continued)

 

December 2022 Note Amendment Transaction (continued)

 

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.345 ($0.0115 pre-split) per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

 

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (see note 11 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

 

Effective December 30, 2023 on February 27, 2024, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to April 30, 2024, other than the maturity date all other terms remained the same. The Company will perform an analysis to determine whether the amendment meets the definition of a debt extinguishment or modification in terms of ASC 470.

 

Convertible notes payable consists of the following:

 

Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    Unamortized
debt discount
    December 31,
2023
Amount,
net
    December  31,
2022
Amount,
net
 
Cavalry Fund I LP     10.00 %   April 30, 2024     898,980       10,238       -       909,218       1,133,301  
                                                     
Mercer Street Global 
Opportunity Fund, LLC
    10.00 %   April 30, 2024     991,754       148,010       -       1,139,764       1,133,301  
                                                     
Red Road Holdings Corporation     29.32 *%   June 15, 2024     101,679       1,393       (61,301 )     41,771       -  
      27.77 *%   July 30 2024     66,606       1,622       (49,545 )     18,683       -  
      32.04 *%   September 30, 2024     63,250       668       (60,809 )     3,109       -  
                                                     
2023 convertible notes      8.00 to 12.00 %   December 31, 2023 to September 14, 2024     2,026,666       80,916       (515,847 )     1,591,735       -  
                                                     
Total convertible notes payable               $ 4,148,935     $ 242,847     $ (687,502 )   $ 3,704,280     $ 2,266,602  

 

*The red Road Holdings Corporation interest rate is an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.

 

Interest expense totaled $319,543 and $193,886 for the years ended December 31, 2023 and 2022, respectively.

 

Amortization of debt discount totaled $770,372 and $263,200  for the years ended December 31, 2023 and 2022, respectively.

 

The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

F-20

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

13 CONVERTIBLE NOTES PAYABLE (continued)

 

Cavalry Fund LLP

 

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

Between August 24, 2023 and November 20, 2023, Cavalry converted $139,726 of interest and $192,774 of interest into 963,769 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $42,210.

 

Subsequent to year end, on February 27, 2024, the maturity date of the notes was extended to April 30, 2024, all other terms remain the same as the previous notes. Based on an analysis performed, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

The balance of the Cavalry Note plus accrued interest at December 31, 2023 was $909,218.

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

Between May 19, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of common stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

 

On February 27, 2024, Cavalry entered into a note amendment with the company extending the maturity date of the convertible note to April 30, 2024.

 

The balance of the Mercer Note plus accrued interest at December 31, 2023 was $1,139,764.

 

Quick Capital, LLC

 

On June 20, 2023, the Company closed a transaction with Quick Capital, LLC pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,857 in exchange for the issuance of a $62,857 Convertible Note, bearing interest at 8% per annum, which interest is earned on issuance of the note, and maturing on December 20, 2023. The Note is convertible into shares of Common Stock at an initial conversion price of $0.345 per share, in addition, the Company issued a warrant exercisable for 182,194 shares of Common Stock at an initial exercise price of $0.345 per share.

 

On December 20, 2023, the Company settled the outstanding principal of $62,857 and interest thereon of $2,514, of the Quick Capital note, thereby extinguishing the debt.

 

F-21

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

13 CONVERTIBLE NOTES PAYABLE (continued)

  

1800 Diagonal Street Lending LLC

 

On May 10, 2023, the Company closed a transaction with 1800 Diagonal Street Lending LLC (“1800 Diagonal”) pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $17,320 in exchange for the issuance of a $117,320 Convertible Note (the “May 1800 Diagonal Note”), bearing interest at 13% per annum, which interest is earned on issuance of the note, and maturing on May 10, 2024. The May 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

 

On June 13 2023, the Company closed a transaction with 1800 Diagonal, pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,700 in exchange for the issuance of a $62,700 Convertible Note (the “June 1800 Diagonal Note”), bearing interest at 17.33% per annum, which interest is earned on issuance of the note, and maturing on March 13, 2024. The June 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion. 

 

On August 3, 2023, the Company settled in full, the outstanding convertible notes owing to 1800 Diagonal, for $194,386, including the principal amount of $180,020, early settlement penalty of $9,306 and interest thereon of $5,060.

 

Red Road Holdings Corporation

 

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note (“RRH Note 1”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 29.3%, and maturing on June 15, 2024. The RRH Note 1 has mandatory monthly repayments of $18,444 which commenced on October 14, 2023. The RRH Note 1 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 1 plus accrued interest at December 31, 2023 was $41,772, net of unamortized debt discount of $61,301.

     
 

On October 19, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note (“RRH Note 2”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 27.8%, and maturing on July 30, 2024. The RRH Note 2 has mandatory monthly repayments of $9,222 which commenced on November 30, 2023. The RRH Note 2 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 2 plus accrued interest at December 31, 2023 was $18,683, net of unamortized debt discount of $49,545.

     
 

On December 20, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $13,250 in exchange for the issuance of a $63,250 Convertible Note (“RRH Note 3”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 32.0%, and maturing on September 30, 2024. The RRH Note 3 has mandatory monthly repayments of $8,082. The RRH Note 3 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 3 plus accrued interest at December 31, 2023 was $3,109, net of unamortized debt discount of $60,809.

 

F-22

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

13 CONVERTIBLE NOTES PAYABLE (continued)

 

2023 Convertible Notes

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors, pursuant to which the Company received an aggregate of $2,026,666 in gross proceeds in a private placement through the issuance of:

 

  Convertible Promissory Notes (the “2023 Notes” and each a “2023 Note”); and

 

  five-year warrants (the “2023 Warrants”) to purchase an aggregate 5,696,586 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The 2023 Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the 2023 Warrants for public resale.

 

The 2023 Notes and the 2023 Warrants contain conversion limitations providing that a holder thereof may not convert the 2023 Notes or exercise the 2023 Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

On December 14, 2023, two notes totaling $225,000 which matured on December 31, 2023 were rolled over for an additional 3 months to March 30, 2024. In exchange for the roll-over, the Company issued the note holders warrants exercisable for 292,463 shares of common stock at an exercise price of $0.345 per share.

 

The balance of the 2023 Notes plus accrued interest at December 31, 2023 was $1,591,734, net of unamortized debt discount of $515,847.

 

14 DERIVATIVE LIABILITY

 

The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described herein have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 12 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.

 

The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.

 

On May 10, 2023 and June 13, 2023, the Company entered into convertible note agreements with 1800 Diagonal which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $360,491 but limited to the cash value of the convertible notes of $150,000, using a Black-Scholes valuation model. These convertible notes were subsequently settled on August 3, 2023, resulting in the elimination of the derivative liability related to these notes.

 

F-23

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

14 DERIVATIVE LIABILITY (continued)

 
Between September 12, 2023 and December 20, 2023, the Company entered into a convertible note agreement with RRH which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $416,317 but limited to the cash value of the convertible notes of $235,000, using a Black-Scholes valuation model.

 

The net movement on the derivative liability for the year ended December 31, 2023 was a net mark-to-market credit of $1,501,446 determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Conversion price  $ 0.104 to $0.345     $ 0.345 to $4.50   
Risk free interest rate   3.60 to 5.55 %    0.79 to 4.73 %
Expected life of derivative liability   3.5 to 47 months     1.5 to 59 months  
Expected volatility of underlying stock    158.72 to 217.01 %   120.49 to 258.3 %
Expected dividend rate   0%   0%

 

The movement in derivative liability is as follows:

 

   December 31,
2023
   December 31,
2022
 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   385,000    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (1,501,446)   (411,752)
   $1,434,196   $2,550,642 

 

15 STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 13,819,889 and 12,563,426 shares of Common Stock issued and outstanding as of December 31, 2023 and December 31, 2022, respectively.

 

On July 8, 2022, the Company entered into a consulting agreement with a third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners.

 

The Company issued 66,667 (2,000,000 pre-split) shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant. In addition, the contractor will receive a monthly fee of $3,000 for the term of the Agreement, commencing on August 1, 2022.

 

On July 8, 2022, the Company entered into a second consulting agreement with a separate third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 66,667 (2,000,000 pre-split) shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant.

 

On July 11, 2022, the Board approved the issuance of  66,667 (2,000,000 pre-split) restricted shares of Common Stock to Richard Rosenblum, the Company’s President and Chief Financial Officer. These shares were valued at $110,000 at the date of grant.

 

On August 5, 2022, the Board approved the issuance of 100,000 (3,000,000 pre-split) shares of Common Stock to Samad Harake or his designees as compensation for the services rendered which were fully earned on the date of issue., Mr. Harake is the president and control person of Frictionless. These shares were valued at $165,000 at the date of grant.

 

F-24

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

15 STOCKHOLDERS’ EQUITY (continued)

 

  a. Common Stock (continued)

 

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.

 

On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.

 

On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt, refer Note 13 above.

 

On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.

 

On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt, refer note 13 above.

 

On November 8, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 289,855 shares of Common Stock for the conversion of $100,000 of convertible debt, refer note 13 above.

 

On November 20, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 500,000 shares of Common Stock for the conversion of $172,500 of convertible debt, refer note 13 above.

 

  b. Restricted stock awards

 

On December 15, 2020, in terms of an employment agreement entered into with an employee, the Company granted 83,333 (2,500,000 pre-split) restricted shares of which 33,333 (1,000,000 pre-split) vested on January 1, 2021 and the remaining 50,000 (1,500,000 pre-split) shares vest over a period of two years. The 50,000 (1,500,000 pre-split) shares of unvested restricted stock which was not physically issued to the employee were not earned due to the cessation of employment with the Company.

 

A summary of restricted stock activity during the period January 1, 2022 to December 31, 2023 is as follows:

 

   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2022   716,500   $1.47    341,583   $1.47    374,917   $1.47 
Granted and issued   66,667    1.65    -    -    66,667    1.65 
Forfeited/Cancelled   -    -    -    -    -    - 
Vested   -    -    (170,791)   (1.47)   170,791    1.47 
Outstanding December 31, 2022   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   -    -    -    -    -    - 
Forfeited/Cancelled   -    -    -    -    -    - 
Vested   -    -    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    -   $-    783,167   $1.50 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The restricted stock granted, issued and exercisable at December 31, 2023 is as follows:

 

    Restricted Stock
Granted and
Vested
 
Grant date Price   Number
Granted*
   Weighted Average Fair
Value per
Share*
 
$1.47    683,167   $1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The Company has recorded an expense of $0 and $361,064 for the years ended December 31, 2023 and 2022, respectively. 

 

F-25

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

15 STOCKHOLDERS’ EQUITY (continued)

    

  c. Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of December 31, 2023 and December 31, 2022.

 

  d. Warrants

 

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

 

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

 

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

 

On August 30, 2022, the Company extended the maturity date of the Cavalry/Mercer Notes and agreed to grant each note holder a warrant exercisable for 100,000 shares of Common Stock at an exercise price of $4.50 per share with an expiration date of August 30, 2027.

 

On December 30, 2022, the Company issued to Frictionless a 5-year warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $0.345 per share. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. On May 12, 2023, the Company entered into an agreement to cancel this warrant (see note 1(b)).

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred:

 

  The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above;

 

  The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.

 

  An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors, as disclosed in note 13 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 5,696,586 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

 

F-26

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

15 STOCKHOLDERS’ EQUITY (continued)

 

  d. Warrants (continued)

 

On August 11, 2023, the company issued an investor a five-year replacement warrant for a warrant that had expired on February 13, 2023 exercisable for 33,334 shares of common stock at an exercise price of $1.50 per share.

 

On December 14, 2023, two notes totaling $225,000 which matured on December 31, 2023 were rolled over for an additional 3 months to March 30, 2024. In exchange for the roll-over, the Company issued the note holders five-year warrants exercisable for 292,463 shares of common stock at an exercise price of $0.345 per share.

 

During the current year warrants exercisable for 33,334 shares expired as unexercised and a further warrants exercisable for 1,000,000 shares of common stock were forfeited on the disposal of frictionless and Beyond Fintech as disclosed in note 4 above.

 

The 2023 Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, OpenPath and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of OpenPath and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of OpenPath and EfinityPay an additional IPEX warrant to purchase 166,667 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above.

 

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Year ended
December 31,
2023
 
Exercise price  $ 0.345 to 0.45   
Risk free interest rate    3.77 to 4.86 %
Expected life    5 years   
Expected volatility of underlying stock    187.40 to 192.80 %
Expected dividend rate   0%

 

A summary of warrant activity during the period January 1, 2022 to December 31, 2023 is as follows:

 

   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,243,477   $ 1.50 – 5.625     $3.60 
Granted   1,700,000     0.345 – 1.035     0.5478 
Increase in warrants due to debt amendment full rachet trigger   2,408,696    0.345    0.345 
Cancelled on debt amendment   (165,797)   4.50    4.50 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625    $0.6265 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

F-27

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

15STOCKHOLDERS’ EQUITY (continued)

 

  d. Warrants (continued)

  

The warrants outstanding and exercisable at December 31, 2023 are as follows:

 

      Warrants Outstanding*     Warrants Exercisable*  
Exercise Price*     Number
Outstanding*
    Weighted
Average
Remaining
Contractual
life in years
    Weighted
Average
Exercise
Price*
    Number
Exercisable*
    Weighted
Average
Exercise
Price*
    Weighted
Average
Remaining
Contractual
life in years
 
$ 0.345       9,055,642       4.16               9,055,642               4.16  
$ 0.450       266,668       4.48               266,668               4.48  
$ 1.035       500,000       1.52               437,500               1.52  
$ 1.500       33,334       4.62               33,334               4.62  
$ 4.50       505,560       2.21               505,560               2.21  
$ 5.625       80,889       2.21               80,889               2.21  
          10,442,093       3.94     $ 0.6265       10,379,593     $ 0.6240       3.95  

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding have an intrinsic value of $0 and $0 as of December 31, 2023 and 2022, respectively.

 

  e. Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 26,667  shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

 

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

On July 11, 2022, the Board approved, granted and issued 500,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $4.50 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.

 

On September 13, 2022, the Company granted ten-year options exercisable for 6,667 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 26,668 shares of Common Stock at an exercise price of $1.20 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.

 

During the current financial year, the Company cancelled options exercisable for 23,891 (716,666 pre-split) shares of common stock due to the previous resignation or termination of employees and officers whose stock options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

 

F-28

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

15 STOCKHOLDERS’ EQUITY (continued)

 

e.Stock options (continued)

 

A summary of option activity during the period January 1, 2022 to December 31, 2023 is as follows:

 

   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,017,223   $4.50 to 12.00   $4.50 
Granted   526,668    1.20 – 4.50    4.20 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   1,543,891   $1.20 to 12.00   $4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (23,889)  $1.20 to 12.00    5.41 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   1,520,002   $1.20 to 12.00   $4.46 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The options outstanding and exercisable at December 31, 2023 are as follows:

 

    Options Outstanding*   Options Exercisable* 
Exercise  Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    20,001    5.86         20,001         5.86 
$4.50    1,500,001    7.94         1,388,890         7.96 
      1,520,002    7.91   $4.46    1,408,891   $4.45    7.93 

 

The options outstanding have an intrinsic value of $0 as of December 31, 2023 and 2022.

 

The option expense was $377,856 and $1,233,682 for the years ended December 31, 2023 and 2022, respectively.

 

16LOSS ON CONVERTIBLE NOTES

 

The loss on convertible notes consists of the following:

 

   December 31,
2023
   December 31,
2022
 
Penalty on cash settlement of convertible note  $9,306   $247,063 
Expense on extension of maturity date of convertible notes   64,256    836,414 
Fair value of warrants issued to convertible note holders on extension of maturity date   
-
    238,182 
Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders   
-
    2,360,658 
Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)   
-
    920,392 
   $73,562   $4,602,709 

 

Penalty on cash settlement of convertible note

 

On February 4, 2022, the Company cash settled the outstanding balance, including early settlement penalty thereon of $247,063, of a convertible note owing to Bellridge for gross proceeds of $1,235,313.

 

On August 3, 2023, the Company cash settled the outstanding balance of two convertible notes owing to 1800 Diagonal Street Lending LLC, including an early settlement penalty thereon of $9,306.

 

F-29

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

16LOSS ON CONVERTIBLE NOTES (continued)

 

Expense on extension of maturity date of convertible notes

 

On December 14, 2023, the Company extended the maturity date of two convertible notes to March 30, 2024, and issued the note holders additional warrants exercisable for 292,463 shares of common stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment, resulting in a charge of $64,256 for the year ended December 31, 2023.

 

In the prior year, The Company twice extended the maturity date of its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022, in terms of these extensions, the Company incurred penalties which increased the principle outstanding of these convertible notes in the aggregate amount of $836,414.

 

Fair value of warrants issued to convertible note holders on extension of maturity date

 

In addition to the penalty on extension of maturity date on its indebtedness to each of Cavalry and Mercer, in consideration for the second extension on August 30, 2022, the Company agreed to issue to each of Cavalry and Mercer a new five-year warrant to purchase an additional 100,000 (3,000,000 pre-split) shares of common stock at an exercise price of $4.50 ($0.15 pre-split) per share. The fair value of these warrants were determined as $238,182 on August 30, 2022, using a Black-Scholes valuation model.

 

Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders

 

On December 30, 2022, the Company again extended the maturity dates of each of the Notes to Cavalry and Mercer to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed that the conversion price of the Notes was reduced from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share and in addition, resulted in the 100,000 (3,000,000 pre-split) shares of common stock underlying the Extension Warrants increasing to 1,304,348 (39,130,435 pre-split) shares, in terms of the full-rachet provisions in those warrant agreements. The change in the conversion price and the increase in the number of warrant shares to be issued at the revised exercise price of $0.345 ($0.0115 pre-split) per share, resulted in a derivative liability on December 30, 2022 of $2,340,580, determined by using a Black-Scholes valuation model.

 

In addition to this, certain other warrants outstanding had their conversion price reduced from $1.50 ($0.05 pre-split) per share to $0.345 ($0.0115 pre-split) per share in terms of their warrant agreements, resulting in an additional derivative liability on December 30, 2022 of $20,079, determined by using a Black-Scholes valuation model.

 

Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)

 

On December 30, 2022, the Company also agreed to exchange the Original Warrants issued on February 16, 2021 to Cavalry and Mercer for 12-month non-convertible promissory notes in the amount of $482,000 each. This resulted in an additional charge of $964,000, less the fair value of the derivative liability of the Original warrants of $43,608, valued on December 30, 2022, using a Black-Scholes valuation model.

 

17INCOME TAXES

 

The Company’s operations are based in the US and currently enacted tax laws in the US are used in the calculation of income taxes.

 

Federal Income Tax - United States

 

On December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and changes to the deductibility of research and experimental expenditures that will be effective in the future). Notwithstanding the reduction in the corporate income tax rate, the overall impact of the new federal tax law is uncertain, including to what extent various states will conform to the newly enacted federal tax law.

 

F-30

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

17INCOME TAXES (continued)

 

Federal Income Tax - United States (continued)

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of December 31, 2022 and 2021, there have been no interest or penalties incurred on income taxes.

 

The provision for income taxes consists of the following:

 

   Year ended
December 31,
2023
   Year ended
December 31, 
2022
 
Current          
Federal  $
         
   $
           
 
State   
-
    
-
 
Foreign   
-
    
-
 
   $
-
   $
-
 
Deferred          
Federal  $
-
   $
-
 
State   
-
    
-
 
Foreign   
-
    
-
 
   $
-
   $
-
 

 

A reconciliation of the U.S. Federal statutory income tax to the effective income tax is as follows:

 

   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Continuing operations        
Tax expense at the federal statutory rate  $(1,225,845)  $(2,169,599)
State tax expense, net of federal tax effect   (170,564)   (324,289)
Permanent differences   712,951    1,194,446 
Prior year net operating loss true up   (228,714)   (3,277)
    (912,172)   (1,302,719)
Deferred income tax asset valuation allowance   912,172    1,302,719 
   $
-
   $
-
 

 

Significant components of the Company’s deferred income tax assets are as follows:

 

   December 31,
2023
   December 31,
2022
 
Other  $241,491   $241,491 
Capital loss   491,275    - 
Net operating losses   6,900,076    6,479,181 
Stock based compensation   511,142    511,142 
Valuation allowance   (8,143,986)   (7,231,814)
Net deferred income tax assets  $
-
   $
-
 

 

The valuation allowance for deferred income tax assets as of December 31, 2023 and December 31, 2022 was $8,143,986 and $7,231,814, respectively. The net change in the deferred income tax assets valuation allowance was an increase of $912,172 and is primarily attributable to tax operating losses and capital losses realized during the current year.

 

As of December 31, 2023, the prior three years remain open for examination by the federal or state regulatory agencies for purposes of an audit for tax purposes.

 

As of December 31, 2023, the Company had available for income tax purposes approximately $26.8 million in federal and $19.0 million in state net operating loss carry forwards, which may be available to offset future taxable income. $3.5 million of the net operating losses will begin to expire in 2034 and $23.3 million has an indefinite life. Due to the uncertainty of the utilization and recoverability of the loss carryforwards and other deferred tax assets, Management has determined a full valuation allowance for the deferred tax assets since it is more likely than not that the deferred tax assets will not be realizable.

F-31

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

17INCOME TAXES (continued)

 

Federal Income Tax - United States (continued)

 

The Company’s ability to utilize the previous Federal operating loss carryforwards may be adjusted if, pursuant to IRC Section 382/383 of the Internal Revenue Code of 1986, as amended, a change of ownership occurs. Management does not believe an ownership change has occurred under IRC Section 382/383. A future change in ownership may result in an adjustment to the loss carryforward.

 

The Company is subject to taxation in the U.S. and CA state. U.S. federal income tax returns for 2019 and after, remain open to examination. No income tax returns are currently under examination. As of December 31, 2023 and 2022, the Company does not have any unrecognized tax benefits, and continues to monitor its current and prior tax positions for any changes. The Company recognizes penalties and interest related to unrecognized tax benefits as income tax expense. For the years ended December 31, 2023 and 2022, there were no penalties or interest recorded in income tax expense. 

 

18EQUITY BASED COMPENSATION

 

Equity based compensation is made up of the following:

 

   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Incentive stock awards  $377,856   $1,594,746 
Securities issued for services rendered   144,828    333,000 
   $522,684   $1,927,746 

 

19NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus common stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the years ended December 31, 2023 and 2022 all warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the years ended December 31, 2023 and 2022 are as follows:

 

   Year ended
December 31, 
2023
(Shares)
   Year ended
December 31, 
2022
(Shares)
 
Convertible debt   13,363,993    6,569,863 
Stock options   1,520,002    1,543,891 
Warrants to purchase shares of common stock   10,442,093    5,186,375 
    25,326,088    13,300,129 

 

20RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share.

 

The option expense for Mr. Fuller was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.

 

Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.

 

William Corbett

 

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 500,000 shares of Common Stock at an exercise price of $4.50 per share.

 

F-32

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

20RELATED PARTY TRANSACTIONS (continued)

 

William Corbett (continued)

 

On June 21, 2023, Mr. Corbett advanced the company $50,000 to cover certain working capital expenses, the advance is short term in nature, bears no interest and has no fixed repayment terms. This advance was repaid on December 4, 2023.

 

The option expense for Mr. Corbett was $266,346 and $1,090,201 for the years ended December 31, 2023 and 2022, respectively.

 

Clifford Henry

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

 

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Henry was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.

 

Mr. Henry voluntary elected not to stand for re-election at the company’s annual general meeting, his tenure as a director ended on the date of the annual general meeting, November 30, 2023.

 

Madisson Butler

 

On September 13, 2022, the Company granted Ms. Butler (formerly known as Madisson Corbett), immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

  

The option expense for Ms. Butler was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.

 

David Rios

 

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Rios was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.

 

Richard Rosenblum

 

On July 11, 2022, the Company granted Mr. Rosenblum 66,667 restricted shares of Common Stock valued at $110,000, all of which are vested.

 

The option expense for Mr. Rosenblum was $111,510 for each of the years ended December 31, 2023 and 2022, respectively.

 

21COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under notes 12 and 13 above, which originally matured between December 30, 2023 and September 14, 2024, of which the notes that had maturity dates between December 30, 2023 and February 23, 2024 have been extended to dates between April 30, 2024 and August 23, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

 

22SUBSEQUENT EVENTS

 

Convertible note funding

  

Between February 6 and February 21, 2024, the Company entered into Securities Purchase Agreements pursuant to which the Company issued convertible promissory notes to four accredited investment entities for total gross proceeds of $308,335. The Notes are unsecured, mature 12 months from issuance date and bear interest at a rate of 8% per annum, and are convertible into shares of common stock of the Company at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, and similar events). The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale.

F-33

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

22 SUBSEQUENT EVENTS (continued)

  

Convertible note funding (continued)

 

On March 4, 2024, the Company entered into a Securities Purchase Agreement pursuant to which the Company issued a convertible promissory note and a warrant exercisable for shares of common stock to an accredited investor. The Company realized gross proceeds of $100,000 after an original issue discount of $14,286 and a once off interest charge of $9,143. The note matures on September 4, 2024. Principal and interest payments are due in four equal instalments of $30,871 commencing on May 3, 2024. The note is convertible into common stock at a fixed price of $0.345 per share, unless the note is in default, whereby the conversion price will be 70% of the lowest closing bid price for the 5 trading days prior to conversion. The note may be prepaid at any time for the full outstanding principal and outstanding interest.

  

Non-Binding Letter of Intent with Business Warrior

  

Overview and Cautionary Statement

  

On February 13, 2024, the Company signed an amended and restated non-binding letter of intent (the “LOI”) with Business Warrior Corporation, a Wyoming corporation (“BZWR”), pursuant to which the Company would acquire BZWR on the general terms described below (the “Proposed Transaction”).

  

Neither IPSI nor BZWR shall have any legal obligation of any kind with respect to the Proposed Transaction unless and until binding definitive agreements with respect to the Proposed Transaction are executed. Moreover, the Proposed Transaction, assuming definitive agreements are even executed, would be subject to the approval of the stockholders of both IPSI and BZWR and the satisfaction of other conditions to closing.

  

BZWR is a publicly listed, revenue generating fintech company that offers PayPlan, a comprehensive lending software platform that includes marketing services for lenders and businesses. The Company believes that a potential combination with a fintech company that generates some revenue monthly would complement the development and commercial launch of the Company’s IPSIPay ExpressTM products and potentially other product offerings.

  

In addition, the Company and BZWR have certain convertible note investors (the “Note Holders”) in common. Therefore, one purpose of the Proposed Transaction would be to convert the indebtedness of both the Company and BZWR held by the Note Holders into equity securities of the Company.

  

Outline of Proposed Terms

  

The principal terms of the Proposed Transaction are as follows:

  

1.Preliminary Structure. At the closing of the Proposed Transaction (the “Closing”), the Company would acquire 100% of the outstanding equity and equity equivalents of BZWR (including outstanding warrants and other securities that have the right to acquire or convert into equity securities of BZWR) on a cash-free, debt free basis by way of a merger of BZWR into a new subsidiary of the Company.

  

  2.

ConsiderationThe total consideration provided to or for the benefit of BZWR equity holders (including holders of warrants and other outstanding preferred stock or other convertible securities of BZWR), as applicable (the “Transaction Consideration”) would be in the form of newly-issued shares (the “Transaction Shares”) of Company common stock representing forty percent (40%) of the Common Stock immediately following the Closing.

  

  3. Note Exchange Transaction; Replacement Preferred. Prior to and as a condition to the Closing, the Note Holders of both IPSI and BZWR shall effect a note exchange transaction pursuant to which all of the outstanding convertible notes of IPSI and BZWR held by the Note Holders will be cancelled and exchanged for shares of newly-issued Series A Convertible Preferred Stock of IPSI (“Replacement Preferred”). The terms of the Replacement Preferred will be negotiated with the Note Holders.

  

  4. BZWR Capitalization Restructure. Prior to the Closing, BZWR shall cause all of its outstanding shares of preferred stock and warrants to be converted into shares of BZWR common stock, net exercised or cancelled, with the effect that only shares of BZWR common stock would be outstanding a Closing, the holders of which would be entitled to receive the Transaction Consideration.

  

  5. Board of Directors. The post-Closing Board of Directors of IPSI shall consist of a number of individuals to be agreed upon by IPSI and BZWR, provided that (i) the majority of the post-Closing Board of Directors will be appointed by IPSI and (ii) the majority of the post-Closing Board of Directors will be “independent” as defined under Nasdaq Stock Market rules.

  

Company Loan to BZWR

 

On February 12, 2024, and in connection with the LOI and the Proposed Transaction, the Company (utilizing a portion of the proceeds from the issuance of convertible Notes) loaned funds to BZWR in the principal amount of $226,190, which includes an original issue discount equal to $67,857, netting BZWR proceeds $158,333. The loan is memorialized by a secured promissory note (the “BZWR Note”). The BZWR Note does not accrued interest, except in the case of an event of default, which case interest accrues at 15% per annum. The BZWR Note matures on the earlier to occur of December 31, 2025 and the date that BZWR’s securities are listed on a national securities exchange. The BZWR Note may be prepaid at any time for an amount equal to 110% of the then principal and accrued interest. IPSI shall have the right to exchange the BZWR Note for securities issued by BZWR in any subsequent private placement by BZWR. The principal and accrued interest under BZWR Note is convertible into common stock of BZWR at a price equal to $0.0036 per share, subject to certain adjustments and potential resets. BZWR’s obligations under the BZWR Note are guaranteed by BZWR’s subsidiaries and secured by a lien on BZWR’s accounts receivable. The BZWR Note is one of several similar notes issued by BZWR. Keystone Capital Partners LLC is acting as collateral agent for the holders of such notes, include IPSI as the holder of the BZWR Note.

F-34

 

 

PART IV

 

Item 15. Exhibits and Financial Statement Schedules and Reports on Form 10-K

 

The following documents are filed as part of this amended report:

 

(a)(1)Financial Statements

 

For a list of the financial statements included herein, see Index to the Consolidated Financial Statements on page F-1 of this Annual Report on Form 10-K/A, incorporated into this Item by reference.

 

(a)(2)Financial Statement Schedules

 

None.

 

(a)(3)  The following exhibits are either filed as part of this Annual Report on Form 10-K/A:

 

EXHIBIT INDEX

 

Exhibit No.   Description 
31.1*   Certification of William Corbett, Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a)
31.2*   Certification of Richard Rosenblum, Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a)
32.1*   Certification of William Corbett, Chief Executive Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Richard Rosenblum, Chief Financial pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Inline Cover Page Interaction Data File (embedded within the Inline XBLR document)

 

* Filed herewith.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K/A (Amendment No. 1) to be signed on its behalf by the undersigned.

 

  Innovative Payment Solutions, Inc.
     
Date: April 17, 2024 By: /s/ William Corbett
    William Corbett
    Chief Executive Officer and Chairman
     
Date: April 17, 2024 By: /s/ Richard Rosenblum
    Richard Rosenblum
    Chief Financial Officer, President and Director

 

 

2

 

 

 

33-1230229 RBSM LLP 0.41 0.83 0.00 0.04 0.45 0.83 12406677 12844609 P3Y 2034 true FY 0001591913 true 0001591913 2023-01-01 2023-12-31 0001591913 2023-06-30 0001591913 2024-04-16 0001591913 2023-12-31 0001591913 2022-12-31 0001591913 2022-01-01 2022-12-31 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001591913 us-gaap:PreferredStockMember 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-12-31 0001591913 us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001591913 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001591913 us-gaap:PreferredStockMember 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001591913 us-gaap:RetainedEarningsMember 2023-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-12-31 0001591913 ipsi:InnovativePaymentSolutionsIncMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-12-31 0001591913 ipsi:QpagosCorporationsCapitalStockMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001591913 ipsi:QpagosCorporationsCapitalStockMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001591913 2019-11-01 2019-11-01 0001591913 srt:MaximumMember 2019-11-01 0001591913 srt:MinimumMember 2019-11-01 0001591913 ipsi:ViviHoldingsIncMember 2019-12-31 2019-12-31 0001591913 ipsi:StockPurchaseAgreementMember 2019-12-31 2019-12-31 0001591913 2019-12-31 0001591913 ipsi:GastonPereiraMember 2019-12-31 0001591913 ipsi:AndreyNovikovMember 2019-12-31 0001591913 ipsi:JosephAbramsMember 2019-12-31 0001591913 ipsi:ThreeTranchesMember 2023-01-01 2023-12-31 0001591913 ipsi:TrancheMember 2023-06-21 2023-06-21 0001591913 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-08-04 2023-08-04 0001591913 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-09-01 2023-09-01 0001591913 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-09-01 2023-09-01 0001591913 ipsi:IPEXWarrantMember 2023-01-01 2023-12-31 0001591913 ipsi:TrancheMember 2023-01-01 2023-12-31 0001591913 ipsi:SecondTrancheMember 2023-01-01 2023-12-31 0001591913 ipsi:ThirdTrancheMember 2023-01-01 2023-12-31 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-06-21 2021-06-21 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2023-12-31 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2023-01-01 2023-12-31 0001591913 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-12-31 0001591913 ipsi:BeyondFintechMember 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 ipsi:BeyondFintechMember 2022-12-30 2022-12-30 0001591913 2022-12-30 2022-12-30 0001591913 2023-05-12 2023-05-12 0001591913 ipsi:BeyondFintechIncMember 2023-12-31 0001591913 ipsi:LongTermInvestmentMember 2023-12-31 0001591913 ipsi:KiosksMember 2023-12-31 0001591913 us-gaap:ComputerEquipmentMember 2023-12-31 0001591913 us-gaap:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001591913 us-gaap:OfficeEquipmentMember 2023-12-31 0001591913 ipsi:OwnershipMember 2023-05-12 0001591913 2023-05-12 0001591913 ipsi:BeyondFintechMember 2023-05-12 0001591913 ipsi:FrictionlessAndBeyondFintechMember 2023-05-12 0001591913 ipsi:FrictionlessAndBeyondFintechMember 2023-05-12 2023-05-12 0001591913 ipsi:NovationMember 2023-09-05 0001591913 ipsi:NovationMember 2023-09-05 2023-09-05 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-12-31 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-12-31 0001591913 ipsi:BeyondFintechIncMember 2021-08-26 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-08-26 0001591913 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001591913 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-09-30 0001591913 2021-01-01 2021-12-31 0001591913 2023-01-01 2023-09-30 0001591913 ipsi:IPSIPayExpressMember 2023-01-01 2023-12-31 0001591913 ipsi:IPSIPayExpressMember 2023-12-31 0001591913 ipsi:InvestmentInFrictionlessFinancialTechnologiesIncMember 2023-05-12 0001591913 2023-01-01 2023-01-01 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2023-01-01 2023-12-31 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2022-01-01 2022-12-31 0001591913 ipsi:CavalryFundILPMember 2021-02-10 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-16 0001591913 us-gaap:WarrantMember 2021-02-16 0001591913 2021-02-16 0001591913 ipsi:AmendmentTransactionMember 2022-12-31 0001591913 ipsi:AmendmentTransactionMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 us-gaap:ConvertibleDebtMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2023-01-01 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2022-12-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-31 0001591913 ipsi:NotePayableMember 2023-12-31 0001591913 ipsi:NotePayableMember 2023-01-01 2023-12-31 0001591913 ipsi:NotePayableMember 2022-12-31 0001591913 2022-02-03 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 0001591913 us-gaap:WarrantMember 2022-02-03 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 2022-02-03 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2022-12-31 0001591913 us-gaap:WarrantMember ipsi:CavalryAndMercerMember 2022-12-31 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2022-12-31 0001591913 srt:MinimumMember 2022-12-31 0001591913 ipsi:CavalryAndMercerMember 2022-12-31 0001591913 us-gaap:WarrantMember us-gaap:CommonStockMember 2022-12-31 0001591913 2021-02-16 2021-02-16 0001591913 us-gaap:WarrantMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2022-12-30 2022-12-30 0001591913 2022-12-01 2022-12-28 0001591913 ipsi:CavalryAndMercerMember 2022-12-01 2022-12-28 0001591913 us-gaap:WarrantMember 2022-12-01 2022-12-28 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2023-12-31 0001591913 srt:MinimumMember 2023-12-31 0001591913 ipsi:CavalryAndMercerMember 2023-12-31 0001591913 srt:MinimumMember ipsi:CavalryMercerNoteMember 2023-12-31 0001591913 ipsi:CavalryMercerNoteMember 2023-01-01 2023-12-31 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2023-08-24 2023-08-24 0001591913 ipsi:CavalryFundLLPMember 2023-11-20 2023-11-20 0001591913 2023-08-24 2023-08-24 0001591913 2023-11-20 2023-11-20 0001591913 ipsi:CavalryFundLLPMember 2023-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 srt:MinimumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 ipsi:MercerConvertedMember 2023-05-19 2023-05-19 0001591913 ipsi:MercerConvertedMember 2023-08-30 2023-08-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:QuickCapitalLLCMember 2023-06-01 2023-06-20 0001591913 ipsi:QuickCapitalLLCMember 2023-06-20 0001591913 2023-12-01 2023-12-20 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-01 2023-05-10 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-10 0001591913 ipsi:CavalryAndMercerMember 2023-06-01 2023-06-13 0001591913 2023-06-01 2023-06-13 0001591913 2023-06-13 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-06-13 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-08-03 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-08-03 2023-08-03 0001591913 ipsi:ConvertibleNoteMember ipsi:DiagonalStreetLendingLLCMember 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-09-09 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-09-09 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-12-31 0001591913 ipsi:ConvertibleNoteMember ipsi:DiagonalStreetLendingLLCMember 2023-10-19 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-10-19 2023-10-19 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-10-19 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:ConvertibleNoteMember 2023-12-20 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-20 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-01 2023-12-20 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-20 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 2023-09-14 0001591913 srt:MaximumMember 2023-12-31 0001591913 ipsi:ConvertibleNoteMember 2023-12-31 0001591913 ipsi:NoteTwoMember 2023-12-14 0001591913 2023-12-14 0001591913 us-gaap:WarrantMember 2023-12-31 0001591913 ipsi:CavalryFundILPMember 2023-12-31 0001591913 ipsi:CavalryFundILPMember 2023-01-01 2023-12-31 0001591913 ipsi:CavalryFundILPMember 2022-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-01-01 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2023-01-01 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2023-01-01 2023-12-31 0001591913 srt:MinimumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-12-31 0001591913 srt:MaximumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-12-31 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-01-01 2023-12-31 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-12-31 0001591913 us-gaap:WarrantMember 2023-12-31 0001591913 2023-05-10 0001591913 2023-09-12 0001591913 ipsi:BlackScholesMember 2023-12-20 0001591913 srt:MinimumMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember 2023-01-01 2023-12-31 0001591913 srt:MinimumMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember 2022-01-01 2022-12-31 0001591913 2022-08-01 0001591913 us-gaap:CommonStockMember 2022-08-01 0001591913 2022-08-01 2022-08-01 0001591913 2022-07-08 0001591913 us-gaap:CommonStockMember 2022-07-08 0001591913 2022-07-11 2022-07-11 0001591913 ipsi:RichardRosenblumMember 2022-07-11 2022-07-11 0001591913 ipsi:SamadHarakeMember 2022-07-11 0001591913 2022-08-05 2022-08-05 0001591913 ipsi:SamadHarakeMember 2022-08-05 0001591913 2023-05-19 2023-05-19 0001591913 2023-08-01 2023-08-16 0001591913 2023-08-01 2023-08-24 0001591913 2023-08-01 2023-08-30 0001591913 2023-08-01 2023-08-31 0001591913 2023-11-08 2023-11-08 0001591913 2020-12-15 2020-12-15 0001591913 us-gaap:RestrictedStockMember 2020-12-15 2020-12-15 0001591913 us-gaap:RestrictedStockMember 2021-01-01 2021-01-01 0001591913 2021-01-01 2021-01-01 0001591913 us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2022-08-30 0001591913 2022-08-01 2022-08-30 0001591913 us-gaap:WarrantMember 2022-12-30 2022-12-30 0001591913 us-gaap:CommonStockMember 2022-12-30 0001591913 ipsi:DebtConversionNoticesMember 2023-01-01 2023-12-31 0001591913 2023-08-11 0001591913 2023-08-11 2023-08-11 0001591913 2023-12-14 2023-12-14 0001591913 ipsi:TwoThousandEighteenStockIncentivePlanMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2023-12-31 0001591913 ipsi:TwoThousandTwentyOnePlanMember 2021-10-22 2021-10-22 0001591913 ipsi:TwoThousandTwentyOnePlanMember srt:MaximumMember 2021-10-22 0001591913 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-11 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001591913 2022-09-13 2022-09-13 0001591913 us-gaap:CommonStockMember 2022-09-13 2022-09-13 0001591913 2022-09-13 0001591913 ipsi:TotalRestrictedSharesMember 2021-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointFourSevanMember 2023-01-01 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointFourSevanMember 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointFiveZeroMember 2023-01-01 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointFiveZeroMember 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointSixFiveMember 2023-01-01 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointSixFiveMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointThreeFourFiveMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointThreeFourFiveMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointFourFiveZeroMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointFourFiveZeroMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointZeroThreeFiveMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointZeroThreeFiveMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointFiveZeroZeroMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointFiveZeroZeroMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFourPointFiveZeroMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFourPointFiveZeroMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFivePointSixTwoFiveMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFivePointSixTwoFiveMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2021-12-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-12-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceOnePointTwoZeroMember 2023-12-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceOnePointTwoZeroMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceFourPointFiveZeroMember 2023-12-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceFourPointFiveZeroMember 2023-01-01 2023-12-31 0001591913 2022-02-04 2022-02-04 0001591913 2023-08-03 2023-08-03 0001591913 2022-08-30 2022-08-30 0001591913 ipsi:CavalryAndMercerMember 2022-08-30 2022-08-30 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2022-08-30 2022-08-30 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2022-08-30 2022-08-30 0001591913 us-gaap:WarrantMember 2022-08-30 0001591913 ipsi:NoteAmendmentLetterAgreementMember 2022-12-01 2022-12-30 0001591913 ipsi:CavalryAndMercerMember ipsi:WarrantAgreementMember 2022-12-30 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2022-12-30 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2022-12-30 0001591913 ipsi:CavalryAndMercerMember 2022-12-30 0001591913 ipsi:CavalryAndMercerMember 2022-12-01 2022-12-30 0001591913 us-gaap:CommonStockMember 2022-12-01 2022-12-30 0001591913 2022-12-01 2022-12-30 0001591913 ipsi:WarrantAgreementMember 2022-12-01 2022-12-30 0001591913 us-gaap:WarrantMember 2022-12-01 2022-12-30 0001591913 ipsi:BlackScholesValuationModelMember 2022-12-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-30 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-30 0001591913 srt:MaximumMember 2022-12-30 0001591913 us-gaap:WarrantMember 2022-12-30 0001591913 2022-12-30 0001591913 us-gaap:WarrantMember ipsi:BlackScholesValuationModelMember 2022-12-30 0001591913 2017-12-22 2017-12-22 0001591913 ipsi:OperatingLossCarryforwardMember 2023-12-31 0001591913 ipsi:IncentiveStockAwardsMember 2023-01-01 2023-12-31 0001591913 ipsi:IncentiveStockAwardsMember 2022-01-01 2022-12-31 0001591913 ipsi:SecuritiesIssuedForServicesRenderedMember 2023-01-01 2023-12-31 0001591913 ipsi:SecuritiesIssuedForServicesRenderedMember 2022-01-01 2022-12-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-12-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-12-31 0001591913 ipsi:StockOptionsMember 2023-01-01 2023-12-31 0001591913 ipsi:StockOptionsMember 2022-01-01 2022-12-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 ipsi:MrFullerMember 2022-09-13 0001591913 ipsi:MrFullerMember 2022-09-01 2022-09-13 0001591913 ipsi:JamesFullerMember 2023-01-01 2023-12-31 0001591913 ipsi:JamesFullerMember 2022-01-01 2022-12-31 0001591913 ipsi:WilliamCorbettMember 2022-07-11 0001591913 ipsi:WilliamCorbettMember 2022-07-01 2022-07-11 0001591913 ipsi:WilliamCorbettMember 2023-06-21 0001591913 ipsi:WilliamCorbettMember 2023-01-01 2023-12-31 0001591913 ipsi:WilliamCorbettMember 2022-01-01 2022-12-31 0001591913 ipsi:CliffordHenryMember 2023-01-01 2023-12-31 0001591913 ipsi:CliffordHenryMember 2022-09-13 0001591913 ipsi:CliffordHenryMember 2022-09-01 2022-09-13 0001591913 ipsi:CliffordHenryMember 2022-01-01 2022-12-31 0001591913 ipsi:MadissonButlerMember 2022-09-13 0001591913 ipsi:MadissonCorbettMember 2022-09-01 2022-09-13 0001591913 ipsi:MadissonCorbettMember 2022-09-13 0001591913 ipsi:MadissonButlerMember 2023-01-01 2023-12-31 0001591913 ipsi:MadissonButlerMember 2022-01-01 2022-12-31 0001591913 ipsi:DavidRiosMember 2022-09-13 0001591913 ipsi:DavidRiosMember 2022-09-01 2022-09-13 0001591913 ipsi:DavidRiosMember 2022-09-13 2022-09-13 0001591913 ipsi:DavidRiosMember 2023-01-01 2023-12-31 0001591913 ipsi:DavidRiosMember 2022-01-01 2022-12-31 0001591913 ipsi:MrRosenblumMember 2022-07-11 2022-07-11 0001591913 ipsi:RichardRosenblumMember 2023-01-01 2023-12-31 0001591913 ipsi:RichardRosenblumMember 2022-01-01 2022-12-31 0001591913 srt:ScenarioForecastMember 2024-02-06 2024-02-21 0001591913 srt:ScenarioForecastMember 2024-02-21 0001591913 srt:ScenarioForecastMember 2024-02-21 2024-02-21 0001591913 srt:ScenarioForecastMember 2024-03-04 2024-03-04 0001591913 srt:ScenarioForecastMember ipsi:SecuritiesPurchaseAgreementMember 2024-03-04 0001591913 srt:ScenarioForecastMember 2023-01-01 2024-03-04 0001591913 ipsi:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2023-01-01 2024-03-04 0001591913 srt:ScenarioForecastMember us-gaap:WarrantMember 2024-05-03 0001591913 ipsi:SecuritiesPurchaseAgreementMember 2023-12-31 0001591913 ipsi:SecuritiesPurchaseAgreementMember 2023-01-01 2023-12-31 0001591913 ipsi:BZWRMember 2023-12-31 0001591913 us-gaap:SubsequentEventMember 2024-02-12 0001591913 ipsi:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2024-02-12 0001591913 us-gaap:SubsequentEventMember 2024-02-12 2024-02-12 0001591913 ipsi:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2023-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure
EX-31.1 2 ea020399801ex31-1_innova.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, William Corbett, certify that:

 

1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Innovative Payment Solutions, Inc:

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 17, 2024 /s/ William Corbett
  William Corbett
  Chief Executive Officer
  (Principal Executive Officer)

 

EX-31.2 3 ea020399801ex31-2_innova.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard Rosenblum, certify that:

 

1.I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Innovative Payment Solutions, Inc.:

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 17, 2024 /s/ Richard Rosenblum
  Richard Rosenblum
  President and Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

EX-32.1 4 ea020399801ex32-1_innova.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-K/A for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, William Corbett, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: April 17, 2024 By: /s/ William Corbett
    William Corbett
    Chief Executive Officer
    (Principal Executive Officer)

 

 

EX-32.2 5 ea020399801ex32-2_innova.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-K/A for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Rosenblum, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: April 17, 2024 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President and Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

EX-101.SCH 6 ipsi-20231231.xsd XBRL SCHEMA FILE 001 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Statements of Operations (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Changes in Stockholders’ Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Organization and Description of Business link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Accounting Policies and Estimates link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Liquidity Matters and Going Concern link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Novation of Certain Assets and Liabilites link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Discontinued Operations link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Intangibles link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Equity Method Investment link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Investments link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Leases link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Federal Relief Loans link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Notes Payable link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Convertible Notes Payable link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Derivative Liability link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Stockholders’ Equity link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Loss on Convertible Notes link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Equity Based Compensation link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Net Loss Per Share link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 996000 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 996001 - Disclosure - Accounting Policies and Estimates (Tables) link:presentationLink link:definitionLink link:calculationLink 996002 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Tables) link:presentationLink link:definitionLink link:calculationLink 996003 - Disclosure - Novation of Certain Assets and Liabilites (Tables) link:presentationLink link:definitionLink link:calculationLink 996004 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:definitionLink link:calculationLink 996005 - Disclosure - Intangibles (Tables) link:presentationLink link:definitionLink link:calculationLink 996006 - Disclosure - Equity Method Investment (Tables) link:presentationLink link:definitionLink link:calculationLink 996007 - Disclosure - Leases (Tables) link:presentationLink link:definitionLink link:calculationLink 996008 - Disclosure - Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 996009 - Disclosure - Convertible Notes Payable (Tables) link:presentationLink link:definitionLink link:calculationLink 996010 - Disclosure - Derivative Liability (Tables) link:presentationLink link:definitionLink link:calculationLink 996011 - Disclosure - Stockholders’ Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 996012 - Disclosure - Loss on Convertible Notes (Tables) link:presentationLink link:definitionLink link:calculationLink 996013 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 996014 - Disclosure - Equity Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 996015 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 996016 - Disclosure - Organization and Description of Business (Details) link:presentationLink link:definitionLink link:calculationLink 996017 - Disclosure - Accounting Policies and Estimates (Details) link:presentationLink link:definitionLink link:calculationLink 996018 - Disclosure - Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets link:presentationLink link:definitionLink link:calculationLink 996019 - Disclosure - Liquidity Matters and Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 996020 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Details) link:presentationLink link:definitionLink link:calculationLink 996021 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities link:presentationLink link:definitionLink link:calculationLink 996022 - Disclosure - Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated link:presentationLink link:definitionLink link:calculationLink 996023 - Disclosure - Discontinued Operations (Details) - Schedule of Assets and Liabilities link:presentationLink link:definitionLink link:calculationLink 996024 - Disclosure - Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations link:presentationLink link:definitionLink link:calculationLink 996025 - Disclosure - Intangibles (Details) link:presentationLink link:definitionLink link:calculationLink 996026 - Disclosure - Intangibles (Details) - Schedule of Facilitate the Functioning of the IPSIPay Software link:presentationLink link:definitionLink link:calculationLink 996027 - Disclosure - Equity Method Investment (Details) link:presentationLink link:definitionLink link:calculationLink 996028 - Disclosure - Equity Method Investment (Details) - Schedule of Equity Method Investments link:presentationLink link:definitionLink link:calculationLink 996029 - Disclosure - Investments (Details) link:presentationLink link:definitionLink link:calculationLink 996030 - Disclosure - Leases (Details) link:presentationLink link:definitionLink link:calculationLink 996031 - Disclosure - Leases (Details) - Schedule of Total Lease Cost link:presentationLink link:definitionLink link:calculationLink 996032 - Disclosure - Leases (Details) - Schedule of Other Lease Information link:presentationLink link:definitionLink link:calculationLink 996033 - Disclosure - Federal Relief Loans (Details) link:presentationLink link:definitionLink link:calculationLink 996034 - Disclosure - Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 996035 - Disclosure - Notes Payable (Details) - Schedule of Notes Payable link:presentationLink link:definitionLink link:calculationLink 996036 - Disclosure - Convertible Notes Payable (Details) link:presentationLink link:definitionLink link:calculationLink 996037 - Disclosure - Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable link:presentationLink link:definitionLink link:calculationLink 996038 - Disclosure - Derivative Liability (Details) link:presentationLink link:definitionLink link:calculationLink 996039 - Disclosure - Derivative Liability (Details) - Schedule of Assumptions were used in the Black-Scholes Valuation Model link:presentationLink link:definitionLink link:calculationLink 996040 - Disclosure - Derivative Liability (Details) - Schedule of Movement in Derivative Liability link:presentationLink link:definitionLink link:calculationLink 996041 - Disclosure - Stockholders’ Equity (Details) link:presentationLink link:definitionLink link:calculationLink 996042 - Disclosure - Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity link:presentationLink link:definitionLink link:calculationLink 996043 - Disclosure - Stockholders’ Equity (Details) - Schedule of Restricted Stock Granted, Issued and Exercisable link:presentationLink link:definitionLink link:calculationLink 996044 - Disclosure - Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued link:presentationLink link:definitionLink link:calculationLink 996045 - Disclosure - Stockholders’ Equity (Details) - Schedule of Warrant Activity link:presentationLink link:definitionLink link:calculationLink 996046 - Disclosure - Stockholders’ Equity (Details) - Schedule of Warrants Outstanding and Exercisable link:presentationLink link:definitionLink link:calculationLink 996047 - Disclosure - Stockholders’ Equity (Details) - Schedule of Option Activity link:presentationLink link:definitionLink link:calculationLink 996048 - Disclosure - Stockholders’ Equity (Details) - Schedule of Options Outstanding and Exercisable link:presentationLink link:definitionLink link:calculationLink 996049 - Disclosure - Loss on Convertible Notes (Details) link:presentationLink link:definitionLink link:calculationLink 996050 - Disclosure - Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes link:presentationLink link:definitionLink link:calculationLink 996051 - Disclosure - Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 996052 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 996053 - Disclosure - Income Taxes (Details) - Schedule of Provision for Income Taxes link:presentationLink link:definitionLink link:calculationLink 996054 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of the U.S. Federal Statutory Income Tax link:presentationLink link:definitionLink link:calculationLink 996055 - Disclosure - Income Taxes (Details) - Schedule of Deferred Income Tax Assets link:presentationLink link:definitionLink link:calculationLink 996056 - Disclosure - Equity Based Compensation (Details) - Schedule of Equity Based Compensation link:presentationLink link:definitionLink link:calculationLink 996057 - Disclosure - Net Loss Per Share (Details) - Schedule of Anti-dilutive Shares link:presentationLink link:definitionLink link:calculationLink 996058 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 996059 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 996060 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 ipsi-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 ipsi-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 ipsi-20231231_lab.xml XBRL LABEL FILE EX-101.PRE 10 ipsi-20231231_pre.xml XBRL PRESENTATION FILE GRAPHIC 11 image_001.jpg GRAPHIC begin 644 image_001.jpg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end GRAPHIC 12 image_002.jpg GRAPHIC begin 644 image_002.jpg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end XML 14 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2023
Apr. 16, 2024
Jun. 30, 2023
Document Information Line Items      
Entity Registrant Name INNOVATIVE PAYMENT SOLUTIONS, INC.    
Document Type 10-K/A    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   13,819,889  
Entity Public Float     $ 4,628,228
Amendment Flag true    
Amendment Description This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) to the Annual Report on Form 10-K of Innovative Payment Solutions, Inc. (the “Company”) for the fiscal year ended December 31, 2023, originally filed with the Securities and Exchange Commission (“SEC”) on March 29, 2024 (the “Original Filing”), is being filed solely to correct a typographical error as to the signing date of the Report of Independent Registered Public Accounting Firm contained therein, which read March 29, 2023 instead of March 29, 2024.This Amendment No. 1 includes: Item 8 of Part II, “Financial Statements and Supplementary Data” in its entirety and without change from the Original Filing other than the correction of the signing date of the Report of Independent Registered Public Accounting Firm.In addition, pursuant to the rules of the SEC, the exhibit list included herein reflects currently-dated certifications from the Company’s principal executive officer and principal accounting officer, which are filed as exhibits to this Amendment No. 1.Except for the foregoing amended information, this Amendment No. 1 does not amend or update any other information contained in the Original Filing, or reflect any events that have occurred after the filing date of the Original Filing. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Filing.    
Entity Central Index Key 0001591913    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2023    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 000-55648    
Entity Incorporation, State or Country Code NV    
Entity Tax Identification Number 33-1230229    
Entity Address, Address Line One 56B 5th Street    
Entity Address, Address Line Two Lot 1, #AT    
Entity Address, City or Town Carmel by the Sea    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 93921    
City Area Code (866)    
Local Phone Number 477-4729    
Title of 12(g) Security Common Stock, $0.0001 par value.    
Entity Interactive Data Current Yes    
Document Financial Statement Error Correction [Flag] false    
Documents Incorporated by Reference [Text Block] None    
Auditor Name RBSM LLP    
Auditor Firm ID 587    
Auditor Location New York, NY    
No Trading Symbol Flag true    
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash $ 50,433 $ 373,822
Other current assets 38,818 97,042
Assets held for sale 807,263
Total Current Assets 89,251 1,278,127
Non-current assets    
Plant and equipment 7,027 40,362
Intangible assets 1,401,491
Security deposit 5,000 32,592
Equity method investment 703,938
Total Non-Current Assets 715,965 1,474,445
Total Assets 805,216 2,752,572
Current Liabilities    
Accounts payable 2,023,375 727,922
Liabilities held for sale 33,810
Federal relief loans – current portion 9,369
Notes payable 1,062,007 964,268
Convertible debt, net of unamortized discount of $687,503 and $263,200, respectively 3,704,280 2,266,602
Derivative liability 1,434,196 2,550,642
Total Current Liabilities 8,233,227 6,543,244
Non-Current Liabilities    
Federal relief loans 150,000 163,978
Total Non-Current Liabilities 150,000 163,978
Total Liabilities 8,383,227 6,707,222
Equity (Deficit)    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,819,889 and 12,563,426 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively. [1] 1,382 1,256
Additional paid-in-capital [1] 50,656,225 48,442,355
Accumulated deficit (58,235,618) (52,399,858)
Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders (7,578,011) (3,956,247)
Non-controlling interest 1,597
Total Equity (Deficit) (7,578,011) (3,954,650)
Total Liabilities and Equity (Deficit) $ 805,216 $ 2,752,572
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets (Parentheticals) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Convertible debt, net of unamortized discount (in Dollars) $ 687,503 $ 263,200
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in Dollars per share) [1] $ 0.0001 $ 0.0001
Common stock, shares authorized [1] 750,000,000 750,000,000
Common stock, shares issued [1] 13,819,889 12,563,426
Common stock, shares outstanding [1] 13,819,889 12,563,426
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Net Revenue $ 410 $ 847
Cost of Goods Sold 3,547 5,052
Gross loss (3,137) (4,205)
General and administrative 3,576,352 5,452,579
Depreciation 380,634 132,394
Total Expense 3,956,986 5,584,973
Loss from Operations (3,960,123) (5,589,178)
Investment impairment charge (1)
Loss on debt conversion (90,761)
Loss on convertible notes (73,562) (4,602,709)
Loss on novation (1,066,165)
Fair value of warrants issued (14,176)
Interest expense, net (424,117) (199,788)
Amortization of debt discount (770,372) (263,200)
Derivative liability movements 1,501,446 411,752
Loss before income taxes (4,897,830) (10,243,124)
Income taxes
Net loss after income taxes (4,897,830) (10,243,124)
Net loss from equity method investments (403,282)
Net loss from continuing operations (5,301,112) (10,243,124)
Discontinued operations    
Operating loss from discontinued operations (40,821) (88,300)
Loss on disposal of subsidiary and investment (495,424)
Net loss from discontinued operations (536,245) (88,300)
Net loss (5,837,357) (10,331,424)
Net loss attributable to non-controlling interest 1,597 43,267
Net loss attributable Innovative Payment Solutions, Inc. Stockholders’ $ (5,835,760) $ (10,288,157)
Basic and diluted loss per share*    
Continuing operations (in Dollars per share) [1] $ (0.41) $ (0.83)
Discontinued operations (in Dollars per share) [1] (0.04) 0
Basic and diluted loss per share total (in Dollars per share) $ (0.45) $ (0.83)
Weighted Average Number of Shares Outstanding – Basic (in Shares) 12,844,609 12,406,677
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations (Parentheticals) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Continuing operations diluted [1] $ (0.41) $ (0.83)
Discontinued operations diluted [1] (0.04) 0.00
Diluted loss per share $ (0.45) $ (0.83)
Weighted Average Number of Shares Outstanding – Diluted (in Shares) 12,844,609 12,406,677
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
[1]
Accumulated Deficit
Non-controlling shareholders interest
Total
Balance at Dec. 31, 2021 $ 1,226 [1] $ 45,806,576 $ (42,111,701) $ 35,211 $ 3,731,312
Balance (in Shares) at Dec. 31, 2021 12,263,426 [1]        
Fair value of warrants issued for services [1] 708,063 708,063
Shares issued for services $ 23 [1] 332,977 333,000
Shares issued for services (in Shares) [1]   233,333        
Stock based option expense [1] 1,233,682 1,233,682
Restricted stock awards $ 7 [1] 361,057 361,064
Restricted stock awards (in Shares) [1]   66,667        
Proceeds from non-controlling shareholders [1] 9,653 9,653
Net loss [1] (10,288,157) (43,267) (10,331,424)
Balance at Dec. 31, 2022 $ 1,256 [1] 48,442,355 (52,399,858) 1,597 (3,954,650)
Balance (in Shares) at Dec. 31, 2022 12,563,426 [1]        
Conversion of convertible debt $ 126 [1] 523,135 523,261
Conversion of convertible debt (in Shares) [1]   1,253,625        
Additional shares issued on reverse stock split [1]  
Additional shares issued on reverse stock split (in Shares) [1]   2,838        
Fair value of warrants issued for services [1] 159,004 159,004
Fair value of warrants issued to convertible debt holders [1] 1,045,655 1,045,655
Stock based compensation [1] 377,856 377,856
Fair value of warrants issued for equity method investments [1] 108,220 108,220
Net loss [1] (5,835,760) (1,597) (5,837,357)
Balance at Dec. 31, 2023 $ 1,382 [1] $ 50,656,225 $ (58,235,618) $ (7,578,011)
Balance (in Shares) at Dec. 31, 2023 13,819,889 [1]        
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,837,357) $ (10,331,424)
Net loss from discontinued operations 536,245 88,300
Net loss from continuing operations (5,301,112) (10,243,124)
Adjustment to reconcile net loss to net cash used in operating activities:    
Derivative liability movements (1,501,446) (411,752)
Depreciation 380,634 132,394
Amortization of debt discount 770,372 263,200
Loss on novation 1,066,165
Investment impairment charge 1
Loss on conversion of debt to equity 90,761
Loss on convertible notes 73,562 4,602,709
Fair value of warrants issued for services 159,004 359,125
Unrealized loss on equity method investments 403,282
Shares issued for services 333,000
Stock based compensation 377,856 1,594,746
Changes in Assets and Liabilities    
Other current assets 58,224 (12,008)
Accounts payable and accrued expenses 1,577,888 288,018
Interest accruals 392,714 111,528
Cash used in operating activities - continuing operations (1,452,096) (2,982,163)
Cash generated by operating activities - discontinued operations 35,287 (79,790)
CASH USED IN OPERATING ACTIVITIES (1,416,809) (3,061,953)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in equity method investment (999,000)
Intangibles acquired (44,405) (778,462)
Investment in deposits (12,792)
Deposits refunded 14,800
Plant and equipment purchased (43,049)
Net cash used in investing activities – continuing operations (1,028,605) (834,303)
Net cash used in investing activities – discontinued operations (36,230) (41,320)
NET CASH USED IN INVESTING ACTIVITIES (1,064,835) (875,623)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from short term notes and convertible notes 2,461,666
Repayment of convertible notes (304,354) (1,147,063)
Proceeds from non-controlling shareholders 9,653
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 2,157,312 (1,137,410)
NET DECREASE IN CASH (324,332) (5,074,986)
CASH AT BEGINNING OF YEAR 374,765 5,449,751
CASH AT END OF YEAR 50,433 374,765
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS    
Cash 373,822 5,367,551
Cash included in assets held for resale 943 82,200
CASH AT BEGINNING OF THE YEAR 374,765 5,449,751
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS    
Cash 50,433 373,822
Cash included in assets held for resale 943
CASH AT END OF THE YEAR 50,433 374,765
CASH PAID FOR INTEREST AND TAXES:    
Cash paid for income taxes
Cash paid for interest (31,403) 88,260
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Warrants issued for software development 348,938
Fair value of warrants issued with convertible notes 1,045,655
Conversion of convertible debt to equity 432,500
Fair value of warrants issued for equity method investments $ 108,220
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Description of Business
12 Months Ended
Dec. 31, 2023
Organization and Description of Business [Abstract]  
ORGANIZATION AND DESCRIPTION OF BUSINESS
1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

  a) Organization

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

 

  b) Description of current business

 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express (as defined below), developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

IPSIPay Express

 

On April 28, 2023, the Company formed a new company called IPSIPay Express LLC (“IPSIPay Express”). This entity was formed as a Delaware limited liability company joint venture with OpenPath, Inc. (“OpenPath”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with OpenPath and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with OpenPath and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

 

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company is required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and OpenPath and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche was expected to be paid on or before November 30, 2023, subsequently, the Company’s management made a decision not to advance the third tranche to IPSIPay Express as the joint venture is not operational as yet. The need for any additional advances will be addressed with the joint venture partners once the joint venture becomes operational and begins generating revenue, our current shareholding in the joint venture remains at 22%.

 

Simultaneously with the funding of the initial Tranche, the Company issued to each of OpenPath and EfinityPay a five-year common stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. We are still obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. Simultaneously with the funding of the second Tranche, we are obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Should we decide to fund a third Tranche, we will be obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

 

Frictionless Financial Technologies

 

On June 21, 2021. the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 1,000,000 (30,000,000 pre-split) shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below (see note 5), the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 has been impaired.

 

On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express joint venture. See note 5 for further information.

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounting Policies and Estimates
12 Months Ended
Dec. 31, 2023
Accounting Policies and Estimates [Abstract]  
ACCOUNTING POLICIES AND ESTIMATES
2 ACCOUNTING POLICIES AND ESTIMATES

 

  a) Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).

 

All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.

 

  b) Principles of Consolidation

 

The consolidated financial statements as of December 31, 2023, include the financial statements of the Company and its subsidiary, Beyond Fintech, in which it had a majority voting interest, until May 12, 2023, the date of disposal. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore, as of May 12, 2023 the Company has no subsidiaries. See note 4 for further information.

 

All significant inter-company accounts and transactions have been eliminated in the consolidated financial statements.

 

  c) Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

  d) Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

  e) Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

  f) Risks and Uncertainties

 

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. The recent war in Ukraine and the global inflationary environment which has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

 

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

  g) Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the year ended December 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s consolidated financial statements upon adoption.

 

  h) Reporting by Segment

 

No segmental information is required as the Company has only one operating segment.

 

  i) Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At December 31, 2023 and 2022, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At December 31, 2023 and 2022, the balance exceeds the federally insured limit by $0 and $120,580, respectively.

 

  j) Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended December 31, 2023 and 2022.

 

  k) Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

The Company recorded an impairment charge of $0 and $1 on its non-marketable equity securities for the years ended December 31, 2023 and 2022, respectively. The impairment charge was based on management’s determination that due to the lack of ability, to date, by Vivi Holdings (“Vivi”) to fulfill its capital raising requirements and implement its business strategy that there is a significant risk that Vivi may not be able to meet its obligations. 

 

  l) Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description   Estimated Useful Life
     
Kiosks   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

  m) Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

  n) Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $410 and $847 during the years ended December 31, 2023 and 2022, respectively. 

 

  o) Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Company’s common stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its common stock as quoted on the OTCQB, as an indicator of the fair value of its common stock in determining share- based payment arrangements.

 

  p) Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

  q) Income Taxes

 

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of December 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

 

  r) Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

  s) Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

XML 23 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Liquidity Matters and Going Concern
12 Months Ended
Dec. 31, 2023
Liquidity Matters and Going Concern [Abstract]  
LIQUIDITY MATTERS AND GOING CONCERN
3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the year ended December 31, 2023, the Company had a net loss of $5,837,357. In connection with preparing the consolidated financial statements for the year ended December 31, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the period ended December 31, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there is substantial doubt about their ability to continue as a going concern.

XML 24 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Disposal of Investment in Frictionless and Beyond Fintech
12 Months Ended
Dec. 31, 2023
Disposal of Investment in Frictionless and Beyond Fintech [Abstract]  
DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH
4 DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

 

On May 12, 2023, the Company entered into the May 2023 Frictionless Agreement to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 1,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18-mobnth period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

 

The assets and liabilities disposed of as of May 12, 2023 were as follows:

 

   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Novation of Certain Assets and Liabilites
12 Months Ended
Dec. 31, 2023
Novation of Certain Assets and Liabilites [Abstract]  
NOVATION OF CERTAIN ASSETS AND LIABILITES
5 NOVATION  OF CERTAIN ASSETS AND LIABILITES

 

On September 5, 2023, the Company entered into a novation agreement with a third party whereby the third party assumed all of the Company’s debts, clients, and services and assumes all the rights and responsibilities of the Company under the SAAS Cloud Hosted Services Enablement Master Services Agreement, dated September 9, 2021 (the “SAAS Agreement”), including the information technology, supplier access, billing and rating technology, mobile wallet, debit card enablement, back-office support services, customer service, and consulting services related to the Company’s IPSIPay mobile application.

 

Pursuant to the novation agreement, Frictionless released the Company from all its obligations, debts, and liabilities under the SAAS Agreement as of September 5, 2023 and consented to the third party assuming these obligations. Each party agreed to indemnify the other party harmless for any damages, claims or expenses incurred by the other party.

 

The novation agreement also provided the third party a 30-day transition period in which the Company assisted the third party in transferring all the assets and obligations, including existing customers and wallets to the third party, thereafter the third party will no longer be permitted to operate the IPSIPay app under the brand name “IPSIPay”.

 

The assets and liabilities novated under the agreement as of September 5, 2023, were as follows:

 

   Amount 
Assets    
     
Current Assets    
Receivable on sale of subsidiary  $231,431 
      
Non-current assets     
Intangible assets   1,098,598 
Total assets   1,330,029 
      
Current Liabilities     
Accounts payable   263,864 
      
Net loss on novation  $1,066,165 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations
12 Months Ended
Dec. 31, 2023
Discontinued Operations [Abstract]  
DISCONTINUED OPERATIONS
6 DISCONTINUED OPERATIONS

 

Effective May 12, 2023, the Company disposed of its investment in Beyond Fintech pursuant to the May 2023 Frictionless Agreement, as disclosed in note 4 above.

 

The following assets and liabilities are reported as discontinued operations:

 

   December 31, 
   2022 
Current assets    
Cash  $943 
Non-current assets     
Intangibles, net   291,320 
Investment   500,000 
Security deposit   15,000 
Assets held for sale  $807,263 
      
Current liabilities     
Accounts payable  $33,810 
Liabilities held for sale  $33,810 

 

The statement of operations from discontinued operations is as follows:

 

   Year ended December 31, 
   2023   2022 
         
Net Revenue  $
-
   $
-
 
           
Cost of Goods Sold   
-
    
-
 
           
Gross loss   
-
    
-
 
           
General and administrative   40,821    88,300 
Depreciation and amortization   
-
    
-
 
Total Expense   40,821    88,300 
           
Loss from operations before income taxes   (40,821)   (88,300)
           
Income Taxes   
-
    
-
 
Loss from discontinued operations, net of taxation  $(40,821)  $(88,300)
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangibles
12 Months Ended
Dec. 31, 2023
Intangibles [Abstract]  
INTANGIBLES
7 INTANGIBLES

 

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $41,320 and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless (see note 4 above).

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $1,127,400 and $44,405, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party (see note 5 above).

 

   December 31,
2023
   December 31,
2022
 
   Cost   Accumulated
amortization
   Net Book
Value
   Net book
value
 
Purchased Technology - IPSIPay  $
-
   $
-
   $
-
   $1,401,491 

 

Amortization expense was $347,298 and $100,909 for the years ended December 31, 2023 and 2022, respectively.

XML 28 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Method Investment
12 Months Ended
Dec. 31, 2023
Equity Method Investment [Abstract]  
EQUITY METHOD INVESTMENT
8 EQUITY METHOD INVESTMENT

 

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay (see note 1(b) above). As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of December 31, 2023, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

 

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended December 31, 2023 is as follow:

 

   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,000 
Fair value of warrants issued to third party joint venture partners   108,220 
    1,107,220 
Equity loss from joint venture   (403,282)
   $703,938 
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Investments
12 Months Ended
Dec. 31, 2023
Investments [Abstract]  
INVESTMENTS
9 INVESTMENTS

 

Investment in Frictionless Financial Technologies Inc.

 

On May 12, 2023, the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless). refer Note 4 above.

XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
LEASES
10 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve-month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90-day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Year ended December 31,
2023
   Year ended December 31,
2022
 
Operating lease expense  $40,704   $57,600 

 

Other lease information:

 

   Year ended December 31,
2023
   Year ended December 31,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(40,704)  $(57,600)
           
Remaining lease term – operating lease   -    Monthly 
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Federal Relief Loans
12 Months Ended
Dec. 31, 2023
Federal Relief Loans [Abstract]  
FEDERAL RELIEF LOANS
11 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The company has accrued interest of $9,369 and $13,978 on this loan as of December 31, 2023 and 2022, respectively.

XML 32 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Notes Payable
12 Months Ended
Dec. 31, 2023
Notes Payable [Abstract]  
NOTES PAYABLE
12 NOTES PAYABLE

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock at an exercise price of $0.24 per share.

 

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

Subsequent to year end, the maturity date of the notes was extended to April 30, 2024, all other terms remain the same as the previous notes. The Company will perform an analysis to determine whether the amendment meets the definition of a debt extinguishment or modification in terms of ASC 470.

 

Notes payable consists of the following:

 

Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   December 31, Amount, net  

December 31,
2022
Amount,

net

 
Cavalry Fund I LP   10%  April 30, 2024   482,000    49,004    531,004    482,134 
Mercer Street Global Opportunity Fund, LLC   10%  April 30, 2024   482,000    49,003    531,003    482,134 
Total convertible notes payable          $964,000   $98,007   $1,062,007   $964,268 

    

Interest expense totaled $97,739 and $268 for the year ended December 31, 2023 and 2022, respectively.

XML 33 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Convertible Notes Payable
12 Months Ended
Dec. 31, 2023
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE
13 CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 100,000 (3,000,000 pre-split) shares of Common Stock at an exercise price of $4.50 ($0.15 pre-split) per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

  (1) The conversion price of the Cavalry/Mercer Notes was reduced from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 100,000 (3,000,000 pre-split) shares of Common Stock underlying the Extension Warrants was increased to 1,304,348 (39,130,435 pre-split) shares;

 

  (2) The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 1,730,057 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

 

  (3) Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

 

  (4) Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $1.80 ($0.06 pre-split) per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $1.20 ($0.04 pre-split) per share; and

 

  (5) The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.345 ($0.0115 pre-split) per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

 

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (see note 11 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

 

Effective December 30, 2023 on February 27, 2024, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to April 30, 2024, other than the maturity date all other terms remained the same. The Company will perform an analysis to determine whether the amendment meets the definition of a debt extinguishment or modification in terms of ASC 470.

 

Convertible notes payable consists of the following:

 

Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    Unamortized
debt discount
    December 31,
2023
Amount,
net
    December  31,
2022
Amount,
net
 
Cavalry Fund I LP     10.00 %   April 30, 2024     898,980       10,238       -       909,218       1,133,301  
                                                     
Mercer Street Global 
Opportunity Fund, LLC
    10.00 %   April 30, 2024     991,754       148,010       -       1,139,764       1,133,301  
                                                     
Red Road Holdings Corporation     29.32 *%   June 15, 2024     101,679       1,393       (61,301 )     41,771       -  
      27.77 *%   July 30 2024     66,606       1,622       (49,545 )     18,683       -  
      32.04 *%   September 30, 2024     63,250       668       (60,809 )     3,109       -  
                                                     
2023 convertible notes      8.00 to 12.00 %   December 31, 2023 to September 14, 2024     2,026,666       80,916       (515,847 )     1,591,735       -  
                                                     
Total convertible notes payable               $ 4,148,935     $ 242,847     $ (687,502 )   $ 3,704,280     $ 2,266,602  

 

*The red Road Holdings Corporation interest rate is an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.

 

Interest expense totaled $319,543 and $193,886 for the years ended December 31, 2023 and 2022, respectively.

 

Amortization of debt discount totaled $770,372 and $263,200  for the years ended December 31, 2023 and 2022, respectively.

 

The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

Cavalry Fund LLP

 

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

Between August 24, 2023 and November 20, 2023, Cavalry converted $139,726 of interest and $192,774 of interest into 963,769 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $42,210.

 

The balance of the Cavalry Note plus accrued interest at December 31, 2023 was $909,218.

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

Between May 19, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of common stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

 

On February 27, 2024, Cavalry entered into a note amendment with the company extending the maturity date of the convertible note to April 30, 2024.

 

The balance of the Mercer Note plus accrued interest at December 31, 2023 was $1,139,764.

 

Quick Capital, LLC

 

On June 20, 2023, the Company closed a transaction with Quick Capital, LLC pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,857 in exchange for the issuance of a $62,857 Convertible Note, bearing interest at 8% per annum, which interest is earned on issuance of the note, and maturing on December 20, 2023. The Note is convertible into shares of Common Stock at an initial conversion price of $0.345 per share, in addition, the Company issued a warrant exercisable for 182,194 shares of Common Stock at an initial exercise price of $0.345 per share.

 

On December 20, 2023, the Company settled the outstanding principal of $62,857 and interest thereon of $2,514, of the Quick Capital note, thereby extinguishing the debt.

 

1800 Diagonal Street Lending LLC

 

On May 10, 2023, the Company closed a transaction with 1800 Diagonal Street Lending LLC (“1800 Diagonal”) pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $17,320 in exchange for the issuance of a $117,320 Convertible Note (the “May 1800 Diagonal Note”), bearing interest at 13% per annum, which interest is earned on issuance of the note, and maturing on May 10, 2024. The May 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

 

On June 13 2023, the Company closed a transaction with 1800 Diagonal, pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,700 in exchange for the issuance of a $62,700 Convertible Note (the “June 1800 Diagonal Note”), bearing interest at 17.33% per annum, which interest is earned on issuance of the note, and maturing on March 13, 2024. The June 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion. 

 

On August 3, 2023, the Company settled in full, the outstanding convertible notes owing to 1800 Diagonal, for $194,386, including the principal amount of $180,020, early settlement penalty of $9,306 and interest thereon of $5,060.

 

Red Road Holdings Corporation

 

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note (“RRH Note 1”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 29.3%, and maturing on June 15, 2024. The RRH Note 1 has mandatory monthly repayments of $18,444 which commenced on October 14, 2023. The RRH Note 1 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 1 plus accrued interest at December 31, 2023 was $41,772, net of unamortized debt discount of $61,301.

     
 

On October 19, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note (“RRH Note 2”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 27.8%, and maturing on July 30, 2024. The RRH Note 2 has mandatory monthly repayments of $9,222 which commenced on November 30, 2023. The RRH Note 2 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 2 plus accrued interest at December 31, 2023 was $18,683, net of unamortized debt discount of $49,545.

     
 

On December 20, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $13,250 in exchange for the issuance of a $63,250 Convertible Note (“RRH Note 3”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 32.0%, and maturing on September 30, 2024. The RRH Note 3 has mandatory monthly repayments of $8,082. The RRH Note 3 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 3 plus accrued interest at December 31, 2023 was $3,109, net of unamortized debt discount of $60,809.

 

2023 Convertible Notes

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors, pursuant to which the Company received an aggregate of $2,026,666 in gross proceeds in a private placement through the issuance of:

 

  Convertible Promissory Notes (the “2023 Notes” and each a “2023 Note”); and

 

  five-year warrants (the “2023 Warrants”) to purchase an aggregate 5,696,586 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The 2023 Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the 2023 Warrants for public resale.

 

The 2023 Notes and the 2023 Warrants contain conversion limitations providing that a holder thereof may not convert the 2023 Notes or exercise the 2023 Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

On December 14, 2023, two notes totaling $225,000 which matured on December 31, 2023 were rolled over for an additional 3 months to March 30, 2024. In exchange for the roll-over, the Company issued the note holders warrants exercisable for 292,463 shares of common stock at an exercise price of $0.345 per share.

 

The balance of the 2023 Notes plus accrued interest at December 31, 2023 was $1,591,734, net of unamortized debt discount of $515,847.

XML 34 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Liability
12 Months Ended
Dec. 31, 2023
Derivative Liability [Abstract]  
DERIVATIVE LIABILITY
14 DERIVATIVE LIABILITY

 

The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described herein have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 12 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.

 

The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.

 

On May 10, 2023 and June 13, 2023, the Company entered into convertible note agreements with 1800 Diagonal which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $360,491 but limited to the cash value of the convertible notes of $150,000, using a Black-Scholes valuation model. These convertible notes were subsequently settled on August 3, 2023, resulting in the elimination of the derivative liability related to these notes.

 

 
Between September 12, 2023 and December 20, 2023, the Company entered into a convertible note agreement with RRH which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $416,317 but limited to the cash value of the convertible notes of $235,000, using a Black-Scholes valuation model.

 

The net movement on the derivative liability for the year ended December 31, 2023 was a net mark-to-market credit of $1,501,446 determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Conversion price  $ 0.104 to $0.345     $ 0.345 to $4.50   
Risk free interest rate   3.60 to 5.55 %    0.79 to 4.73 %
Expected life of derivative liability   3.5 to 47 months     1.5 to 59 months  
Expected volatility of underlying stock    158.72 to 217.01 %   120.49 to 258.3 %
Expected dividend rate   0%   0%

 

The movement in derivative liability is as follows:

 

   December 31,
2023
   December 31,
2022
 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   385,000    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (1,501,446)   (411,752)
   $1,434,196   $2,550,642 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity
12 Months Ended
Dec. 31, 2023
Stockholders’ Equity [Abstract]  
STOCKHOLDERS’ EQUITY
15 STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 13,819,889 and 12,563,426 shares of Common Stock issued and outstanding as of December 31, 2023 and December 31, 2022, respectively.

 

On July 8, 2022, the Company entered into a consulting agreement with a third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners.

 

The Company issued 66,667 (2,000,000 pre-split) shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant. In addition, the contractor will receive a monthly fee of $3,000 for the term of the Agreement, commencing on August 1, 2022.

 

On July 8, 2022, the Company entered into a second consulting agreement with a separate third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 66,667 (2,000,000 pre-split) shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant.

 

On July 11, 2022, the Board approved the issuance of  66,667 (2,000,000 pre-split) restricted shares of Common Stock to Richard Rosenblum, the Company’s President and Chief Financial Officer. These shares were valued at $110,000 at the date of grant.

 

On August 5, 2022, the Board approved the issuance of 100,000 (3,000,000 pre-split) shares of Common Stock to Samad Harake or his designees as compensation for the services rendered which were fully earned on the date of issue., Mr. Harake is the president and control person of Frictionless. These shares were valued at $165,000 at the date of grant.

 

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.

 

On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.

 

On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt, refer Note 13 above.

 

On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.

 

On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt, refer note 13 above.

 

On November 8, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 289,855 shares of Common Stock for the conversion of $100,000 of convertible debt, refer note 13 above.

 

On November 20, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 500,000 shares of Common Stock for the conversion of $172,500 of convertible debt, refer note 13 above.

 

  b. Restricted stock awards

 

On December 15, 2020, in terms of an employment agreement entered into with an employee, the Company granted 83,333 (2,500,000 pre-split) restricted shares of which 33,333 (1,000,000 pre-split) vested on January 1, 2021 and the remaining 50,000 (1,500,000 pre-split) shares vest over a period of two years. The 50,000 (1,500,000 pre-split) shares of unvested restricted stock which was not physically issued to the employee were not earned due to the cessation of employment with the Company.

 

A summary of restricted stock activity during the period January 1, 2022 to December 31, 2023 is as follows:

 

   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2022   716,500   $1.47    341,583   $1.47    374,917   $1.47 
Granted and issued   66,667    1.65    -    -    66,667    1.65 
Forfeited/Cancelled   -    -    -    -    -    - 
Vested   -    -    (170,791)   (1.47)   170,791    1.47 
Outstanding December 31, 2022   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   -    -    -    -    -    - 
Forfeited/Cancelled   -    -    -    -    -    - 
Vested   -    -    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    -   $-    783,167   $1.50 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The restricted stock granted, issued and exercisable at December 31, 2023 is as follows:

 

    Restricted Stock
Granted and
Vested
 
Grant date Price   Number
Granted*
   Weighted Average Fair
Value per
Share*
 
$1.47    683,167   $1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The Company has recorded an expense of $0 and $361,064 for the years ended December 31, 2023 and 2022, respectively. 

 

  c. Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of December 31, 2023 and December 31, 2022.

 

  d. Warrants

 

Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.

 

The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.

 

As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.

 

On August 30, 2022, the Company extended the maturity date of the Cavalry/Mercer Notes and agreed to grant each note holder a warrant exercisable for 100,000 shares of Common Stock at an exercise price of $4.50 per share with an expiration date of August 30, 2027.

 

On December 30, 2022, the Company issued to Frictionless a 5-year warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $0.345 per share. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. On May 12, 2023, the Company entered into an agreement to cancel this warrant (see note 1(b)).

 

On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred:

 

  The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above;

 

  The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.

 

  An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors, as disclosed in note 13 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 5,696,586 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

 

On August 11, 2023, the company issued an investor a five-year replacement warrant for a warrant that had expired on February 13, 2023 exercisable for 33,334 shares of common stock at an exercise price of $1.50 per share.

 

On December 14, 2023, two notes totaling $225,000 which matured on December 31, 2023 were rolled over for an additional 3 months to March 30, 2024. In exchange for the roll-over, the Company issued the note holders five-year warrants exercisable for 292,463 shares of common stock at an exercise price of $0.345 per share.

 

During the current year warrants exercisable for 33,334 shares expired as unexercised and a further warrants exercisable for 1,000,000 shares of common stock were forfeited on the disposal of frictionless and Beyond Fintech as disclosed in note 4 above.

 

The 2023 Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, OpenPath and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of OpenPath and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of OpenPath and EfinityPay an additional IPEX warrant to purchase 166,667 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above.

 

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Year ended
December 31,
2023
 
Exercise price  $ 0.345 to 0.45   
Risk free interest rate    3.77 to 4.86 %
Expected life    5 years   
Expected volatility of underlying stock    187.40 to 192.80 %
Expected dividend rate   0%

 

A summary of warrant activity during the period January 1, 2022 to December 31, 2023 is as follows:

 

   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,243,477   $ 1.50 – 5.625     $3.60 
Granted   1,700,000     0.345 – 1.035     0.5478 
Increase in warrants due to debt amendment full rachet trigger   2,408,696    0.345    0.345 
Cancelled on debt amendment   (165,797)   4.50    4.50 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625    $0.6265 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding and exercisable at December 31, 2023 are as follows:

 

      Warrants Outstanding*     Warrants Exercisable*  
Exercise Price*     Number
Outstanding*
    Weighted
Average
Remaining
Contractual
life in years
    Weighted
Average
Exercise
Price*
    Number
Exercisable*
    Weighted
Average
Exercise
Price*
    Weighted
Average
Remaining
Contractual
life in years
 
$ 0.345       9,055,642       4.16               9,055,642               4.16  
$ 0.450       266,668       4.48               266,668               4.48  
$ 1.035       500,000       1.52               437,500               1.52  
$ 1.500       33,334       4.62               33,334               4.62  
$ 4.50       505,560       2.21               505,560               2.21  
$ 5.625       80,889       2.21               80,889               2.21  
          10,442,093       3.94     $ 0.6265       10,379,593     $ 0.6240       3.95  

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding have an intrinsic value of $0 and $0 as of December 31, 2023 and 2022, respectively.

 

  e. Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 26,667  shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

 

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

On July 11, 2022, the Board approved, granted and issued 500,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $4.50 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.

 

On September 13, 2022, the Company granted ten-year options exercisable for 6,667 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 26,668 shares of Common Stock at an exercise price of $1.20 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.

 

During the current financial year, the Company cancelled options exercisable for 23,891 (716,666 pre-split) shares of common stock due to the previous resignation or termination of employees and officers whose stock options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

 

A summary of option activity during the period January 1, 2022 to December 31, 2023 is as follows:

 

   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,017,223   $4.50 to 12.00   $4.50 
Granted   526,668    1.20 – 4.50    4.20 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   1,543,891   $1.20 to 12.00   $4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (23,889)  $1.20 to 12.00    5.41 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   1,520,002   $1.20 to 12.00   $4.46 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The options outstanding and exercisable at December 31, 2023 are as follows:

 

    Options Outstanding*   Options Exercisable* 
Exercise  Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    20,001    5.86         20,001         5.86 
$4.50    1,500,001    7.94         1,388,890         7.96 
      1,520,002    7.91   $4.46    1,408,891   $4.45    7.93 

 

The options outstanding have an intrinsic value of $0 as of December 31, 2023 and 2022.

 

The option expense was $377,856 and $1,233,682 for the years ended December 31, 2023 and 2022, respectively.

XML 36 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Loss on Convertible Notes
12 Months Ended
Dec. 31, 2023
Loss on Convertible Notes [Abstract]  
LOSS ON CONVERTIBLE NOTES
16LOSS ON CONVERTIBLE NOTES

 

The loss on convertible notes consists of the following:

 

   December 31,
2023
   December 31,
2022
 
Penalty on cash settlement of convertible note  $9,306   $247,063 
Expense on extension of maturity date of convertible notes   64,256    836,414 
Fair value of warrants issued to convertible note holders on extension of maturity date   
-
    238,182 
Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders   
-
    2,360,658 
Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)   
-
    920,392 
   $73,562   $4,602,709 

 

Penalty on cash settlement of convertible note

 

On February 4, 2022, the Company cash settled the outstanding balance, including early settlement penalty thereon of $247,063, of a convertible note owing to Bellridge for gross proceeds of $1,235,313.

 

On August 3, 2023, the Company cash settled the outstanding balance of two convertible notes owing to 1800 Diagonal Street Lending LLC, including an early settlement penalty thereon of $9,306.

 

Expense on extension of maturity date of convertible notes

 

On December 14, 2023, the Company extended the maturity date of two convertible notes to March 30, 2024, and issued the note holders additional warrants exercisable for 292,463 shares of common stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment, resulting in a charge of $64,256 for the year ended December 31, 2023.

 

In the prior year, The Company twice extended the maturity date of its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022, in terms of these extensions, the Company incurred penalties which increased the principle outstanding of these convertible notes in the aggregate amount of $836,414.

 

Fair value of warrants issued to convertible note holders on extension of maturity date

 

In addition to the penalty on extension of maturity date on its indebtedness to each of Cavalry and Mercer, in consideration for the second extension on August 30, 2022, the Company agreed to issue to each of Cavalry and Mercer a new five-year warrant to purchase an additional 100,000 (3,000,000 pre-split) shares of common stock at an exercise price of $4.50 ($0.15 pre-split) per share. The fair value of these warrants were determined as $238,182 on August 30, 2022, using a Black-Scholes valuation model.

 

Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders

 

On December 30, 2022, the Company again extended the maturity dates of each of the Notes to Cavalry and Mercer to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed that the conversion price of the Notes was reduced from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share and in addition, resulted in the 100,000 (3,000,000 pre-split) shares of common stock underlying the Extension Warrants increasing to 1,304,348 (39,130,435 pre-split) shares, in terms of the full-rachet provisions in those warrant agreements. The change in the conversion price and the increase in the number of warrant shares to be issued at the revised exercise price of $0.345 ($0.0115 pre-split) per share, resulted in a derivative liability on December 30, 2022 of $2,340,580, determined by using a Black-Scholes valuation model.

 

In addition to this, certain other warrants outstanding had their conversion price reduced from $1.50 ($0.05 pre-split) per share to $0.345 ($0.0115 pre-split) per share in terms of their warrant agreements, resulting in an additional derivative liability on December 30, 2022 of $20,079, determined by using a Black-Scholes valuation model.

 

Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)

 

On December 30, 2022, the Company also agreed to exchange the Original Warrants issued on February 16, 2021 to Cavalry and Mercer for 12-month non-convertible promissory notes in the amount of $482,000 each. This resulted in an additional charge of $964,000, less the fair value of the derivative liability of the Original warrants of $43,608, valued on December 30, 2022, using a Black-Scholes valuation model.

XML 37 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Taxes [Abstarct]  
INCOME TAXES
17INCOME TAXES

 

The Company’s operations are based in the US and currently enacted tax laws in the US are used in the calculation of income taxes.

 

Federal Income Tax - United States

 

On December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and changes to the deductibility of research and experimental expenditures that will be effective in the future). Notwithstanding the reduction in the corporate income tax rate, the overall impact of the new federal tax law is uncertain, including to what extent various states will conform to the newly enacted federal tax law.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of December 31, 2022 and 2021, there have been no interest or penalties incurred on income taxes.

 

The provision for income taxes consists of the following:

 

   Year ended
December 31,
2023
   Year ended
December 31, 
2022
 
Current          
Federal  $
         
   $
           
 
State   
-
    
-
 
Foreign   
-
    
-
 
   $
-
   $
-
 
Deferred          
Federal  $
-
   $
-
 
State   
-
    
-
 
Foreign   
-
    
-
 
   $
-
   $
-
 

 

A reconciliation of the U.S. Federal statutory income tax to the effective income tax is as follows:

 

   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Continuing operations        
Tax expense at the federal statutory rate  $(1,225,845)  $(2,169,599)
State tax expense, net of federal tax effect   (170,564)   (324,289)
Permanent differences   712,951    1,194,446 
Prior year net operating loss true up   (228,714)   (3,277)
    (912,172)   (1,302,719)
Deferred income tax asset valuation allowance   912,172    1,302,719 
   $
-
   $
-
 

 

Significant components of the Company’s deferred income tax assets are as follows:

 

   December 31,
2023
   December 31,
2022
 
Other  $241,491   $241,491 
Capital loss   491,275    - 
Net operating losses   6,900,076    6,479,181 
Stock based compensation   511,142    511,142 
Valuation allowance   (8,143,986)   (7,231,814)
Net deferred income tax assets  $
-
   $
-
 

 

The valuation allowance for deferred income tax assets as of December 31, 2023 and December 31, 2022 was $8,143,986 and $7,231,814, respectively. The net change in the deferred income tax assets valuation allowance was an increase of $912,172 and is primarily attributable to tax operating losses and capital losses realized during the current year.

 

As of December 31, 2023, the prior three years remain open for examination by the federal or state regulatory agencies for purposes of an audit for tax purposes.

 

As of December 31, 2023, the Company had available for income tax purposes approximately $26.8 million in federal and $19.0 million in state net operating loss carry forwards, which may be available to offset future taxable income. $3.5 million of the net operating losses will begin to expire in 2034 and $23.3 million has an indefinite life. Due to the uncertainty of the utilization and recoverability of the loss carryforwards and other deferred tax assets, Management has determined a full valuation allowance for the deferred tax assets since it is more likely than not that the deferred tax assets will not be realizable.

The Company’s ability to utilize the previous Federal operating loss carryforwards may be adjusted if, pursuant to IRC Section 382/383 of the Internal Revenue Code of 1986, as amended, a change of ownership occurs. Management does not believe an ownership change has occurred under IRC Section 382/383. A future change in ownership may result in an adjustment to the loss carryforward.

 

The Company is subject to taxation in the U.S. and CA state. U.S. federal income tax returns for 2019 and after, remain open to examination. No income tax returns are currently under examination. As of December 31, 2023 and 2022, the Company does not have any unrecognized tax benefits, and continues to monitor its current and prior tax positions for any changes. The Company recognizes penalties and interest related to unrecognized tax benefits as income tax expense. For the years ended December 31, 2023 and 2022, there were no penalties or interest recorded in income tax expense. 

XML 38 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Based Compensation
12 Months Ended
Dec. 31, 2023
Equity Based Compensation [Abstract]  
EQUITY BASED COMPENSATION
18EQUITY BASED COMPENSATION

 

Equity based compensation is made up of the following:

 

   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Incentive stock awards  $377,856   $1,594,746 
Securities issued for services rendered   144,828    333,000 
   $522,684   $1,927,746 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share
12 Months Ended
Dec. 31, 2023
Net Loss Per Share [Abstract]  
NET LOSS PER SHARE
19NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus common stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the years ended December 31, 2023 and 2022 all warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the years ended December 31, 2023 and 2022 are as follows:

 

   Year ended
December 31, 
2023
(Shares)
   Year ended
December 31, 
2022
(Shares)
 
Convertible debt   13,363,993    6,569,863 
Stock options   1,520,002    1,543,891 
Warrants to purchase shares of common stock   10,442,093    5,186,375 
    25,326,088    13,300,129 
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Transactions
12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
20RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties:

 

James Fuller

 

On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share.

 

The option expense for Mr. Fuller was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.

 

Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.

 

William Corbett

 

On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 500,000 shares of Common Stock at an exercise price of $4.50 per share.

 

On June 21, 2023, Mr. Corbett advanced the company $50,000 to cover certain working capital expenses, the advance is short term in nature, bears no interest and has no fixed repayment terms. This advance was repaid on December 4, 2023.

 

The option expense for Mr. Corbett was $266,346 and $1,090,201 for the years ended December 31, 2023 and 2022, respectively.

 

Clifford Henry

 

Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.

 

On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Henry was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.

 

Mr. Henry voluntary elected not to stand for re-election at the company’s annual general meeting, his tenure as a director ended on the date of the annual general meeting, November 30, 2023.

 

Madisson Butler

 

On September 13, 2022, the Company granted Ms. Butler (formerly known as Madisson Corbett), immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

  

The option expense for Ms. Butler was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.

 

David Rios

 

On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.

 

The option expense for Mr. Rios was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.

 

Richard Rosenblum

 

On July 11, 2022, the Company granted Mr. Rosenblum 66,667 restricted shares of Common Stock valued at $110,000, all of which are vested.

 

The option expense for Mr. Rosenblum was $111,510 for each of the years ended December 31, 2023 and 2022, respectively.

XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
12 Months Ended
Dec. 31, 2023
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES
21COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under notes 12 and 13 above, which originally matured between December 30, 2023 and September 14, 2024, of which the notes that had maturity dates between December 30, 2023 and February 23, 2024 have been extended to dates between April 30, 2024 and August 23, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

XML 42 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent Events
12 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
22SUBSEQUENT EVENTS

 

Convertible note funding

  

Between February 6 and February 21, 2024, the Company entered into Securities Purchase Agreements pursuant to which the Company issued convertible promissory notes to four accredited investment entities for total gross proceeds of $308,335. The Notes are unsecured, mature 12 months from issuance date and bear interest at a rate of 8% per annum, and are convertible into shares of common stock of the Company at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, and similar events). The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale.

On March 4, 2024, the Company entered into a Securities Purchase Agreement pursuant to which the Company issued a convertible promissory note and a warrant exercisable for shares of common stock to an accredited investor. The Company realized gross proceeds of $100,000 after an original issue discount of $14,286 and a once off interest charge of $9,143. The note matures on September 4, 2024. Principal and interest payments are due in four equal instalments of $30,871 commencing on May 3, 2024. The note is convertible into common stock at a fixed price of $0.345 per share, unless the note is in default, whereby the conversion price will be 70% of the lowest closing bid price for the 5 trading days prior to conversion. The note may be prepaid at any time for the full outstanding principal and outstanding interest.

  

Non-Binding Letter of Intent with Business Warrior

  

Overview and Cautionary Statement

  

On February 13, 2024, the Company signed an amended and restated non-binding letter of intent (the “LOI”) with Business Warrior Corporation, a Wyoming corporation (“BZWR”), pursuant to which the Company would acquire BZWR on the general terms described below (the “Proposed Transaction”).

  

Neither IPSI nor BZWR shall have any legal obligation of any kind with respect to the Proposed Transaction unless and until binding definitive agreements with respect to the Proposed Transaction are executed. Moreover, the Proposed Transaction, assuming definitive agreements are even executed, would be subject to the approval of the stockholders of both IPSI and BZWR and the satisfaction of other conditions to closing.

  

BZWR is a publicly listed, revenue generating fintech company that offers PayPlan, a comprehensive lending software platform that includes marketing services for lenders and businesses. The Company believes that a potential combination with a fintech company that generates some revenue monthly would complement the development and commercial launch of the Company’s IPSIPay ExpressTM products and potentially other product offerings.

  

In addition, the Company and BZWR have certain convertible note investors (the “Note Holders”) in common. Therefore, one purpose of the Proposed Transaction would be to convert the indebtedness of both the Company and BZWR held by the Note Holders into equity securities of the Company.

  

Outline of Proposed Terms

  

The principal terms of the Proposed Transaction are as follows:

  

1.Preliminary Structure. At the closing of the Proposed Transaction (the “Closing”), the Company would acquire 100% of the outstanding equity and equity equivalents of BZWR (including outstanding warrants and other securities that have the right to acquire or convert into equity securities of BZWR) on a cash-free, debt free basis by way of a merger of BZWR into a new subsidiary of the Company.

  

  2.

ConsiderationThe total consideration provided to or for the benefit of BZWR equity holders (including holders of warrants and other outstanding preferred stock or other convertible securities of BZWR), as applicable (the “Transaction Consideration”) would be in the form of newly-issued shares (the “Transaction Shares”) of Company common stock representing forty percent (40%) of the Common Stock immediately following the Closing.

  

  3. Note Exchange Transaction; Replacement Preferred. Prior to and as a condition to the Closing, the Note Holders of both IPSI and BZWR shall effect a note exchange transaction pursuant to which all of the outstanding convertible notes of IPSI and BZWR held by the Note Holders will be cancelled and exchanged for shares of newly-issued Series A Convertible Preferred Stock of IPSI (“Replacement Preferred”). The terms of the Replacement Preferred will be negotiated with the Note Holders.

  

  4. BZWR Capitalization Restructure. Prior to the Closing, BZWR shall cause all of its outstanding shares of preferred stock and warrants to be converted into shares of BZWR common stock, net exercised or cancelled, with the effect that only shares of BZWR common stock would be outstanding a Closing, the holders of which would be entitled to receive the Transaction Consideration.

  

  5. Board of Directors. The post-Closing Board of Directors of IPSI shall consist of a number of individuals to be agreed upon by IPSI and BZWR, provided that (i) the majority of the post-Closing Board of Directors will be appointed by IPSI and (ii) the majority of the post-Closing Board of Directors will be “independent” as defined under Nasdaq Stock Market rules.

  

Company Loan to BZWR

 

On February 12, 2024, and in connection with the LOI and the Proposed Transaction, the Company (utilizing a portion of the proceeds from the issuance of convertible Notes) loaned funds to BZWR in the principal amount of $226,190, which includes an original issue discount equal to $67,857, netting BZWR proceeds $158,333. The loan is memorialized by a secured promissory note (the “BZWR Note”). The BZWR Note does not accrued interest, except in the case of an event of default, which case interest accrues at 15% per annum. The BZWR Note matures on the earlier to occur of December 31, 2025 and the date that BZWR’s securities are listed on a national securities exchange. The BZWR Note may be prepaid at any time for an amount equal to 110% of the then principal and accrued interest. IPSI shall have the right to exchange the BZWR Note for securities issued by BZWR in any subsequent private placement by BZWR. The principal and accrued interest under BZWR Note is convertible into common stock of BZWR at a price equal to $0.0036 per share, subject to certain adjustments and potential resets. BZWR’s obligations under the BZWR Note are guaranteed by BZWR’s subsidiaries and secured by a lien on BZWR’s accounts receivable. The BZWR Note is one of several similar notes issued by BZWR. Keystone Capital Partners LLC is acting as collateral agent for the holders of such notes, include IPSI as the holder of the BZWR Note.

XML 43 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounting Policies, by Policy (Policies)
12 Months Ended
Dec. 31, 2023
Accounting Policies and Estimates [Abstract]  
Basis of Presentation
  a) Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).

All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Principles of Consolidation
  b) Principles of Consolidation

The consolidated financial statements as of December 31, 2023, include the financial statements of the Company and its subsidiary, Beyond Fintech, in which it had a majority voting interest, until May 12, 2023, the date of disposal. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore, as of May 12, 2023 the Company has no subsidiaries. See note 4 for further information.

All significant inter-company accounts and transactions have been eliminated in the consolidated financial statements.

Use of Estimates
  c) Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

Contingencies
  d) Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

Fair Value of Financial Instruments
  e) Fair Value of Financial Instruments

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

Risks and Uncertainties
  f) Risks and Uncertainties

The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. The recent war in Ukraine and the global inflationary environment which has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

Recent accounting pronouncements
  g) Recent accounting pronouncements

The Financial Accounting Standards Board (“FASB”) issued additional updates during the year ended December 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s consolidated financial statements upon adoption.

Reporting by Segment
  h) Reporting by Segment

No segmental information is required as the Company has only one operating segment.

Cash and Cash Equivalents
  i) Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At December 31, 2023 and 2022, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At December 31, 2023 and 2022, the balance exceeds the federally insured limit by $0 and $120,580, respectively.

Accounts Receivable and Allowance for Doubtful Accounts
  j) Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended December 31, 2023 and 2022.

Investments
  k) Investments

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

The Company recorded an impairment charge of $0 and $1 on its non-marketable equity securities for the years ended December 31, 2023 and 2022, respectively. The impairment charge was based on management’s determination that due to the lack of ability, to date, by Vivi Holdings (“Vivi”) to fulfill its capital raising requirements and implement its business strategy that there is a significant risk that Vivi may not be able to meet its obligations. 

 

Plant and Equipment
  l) Plant and Equipment

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

Description   Estimated Useful Life
     
Kiosks   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

Long-Term Assets
  m) Long-Term Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Revenue Recognition
  n) Revenue Recognition

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

  i. identify the contract with a customer;
  ii. identify the performance obligations in the contract;
  iii. determine the transaction price;
  iv. allocate the transaction price to performance obligations in the contract; and
  v. recognize revenue as the performance obligation is satisfied.

The Company had minimal revenues of $410 and $847 during the years ended December 31, 2023 and 2022, respectively. 

 

Share-Based Payment Arrangements
  o) Share-Based Payment Arrangements

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Company’s common stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its common stock as quoted on the OTCQB, as an indicator of the fair value of its common stock in determining share- based payment arrangements.

Derivative Liabilities
  p) Derivative Liabilities

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

Income Taxes
  q) Income Taxes

The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of December 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.

 

Comprehensive income
  r) Comprehensive income

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

Reclassification of prior year presentation
  s) Reclassification of prior year presentation

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounting Policies and Estimates (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies and Estimates [Abstract]  
Schedule of Estimated Useful Lives of the Assets Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:
Description   Estimated Useful Life
     
Kiosks   7 years
     
Computer equipment   3 years
     
Leasehold improvements   Lesser of estimated useful life or life of lease
     
Office equipment   10 years
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Disposal of Investment in Frictionless and Beyond Fintech (Tables)
12 Months Ended
Dec. 31, 2023
Disposal of Investment in Frictionless and Beyond Fintech [Abstract]  
Schedule of Assets and Liabilities The assets and liabilities disposed of as of May 12, 2023 were as follows:
   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Novation of Certain Assets and Liabilites (Tables)
12 Months Ended
Dec. 31, 2023
Novation of Certain Assets and Liabilites [Abstract]  
Schedule of Assets and liabilities Novated The assets and liabilities novated under the agreement as of September 5, 2023, were as follows:
   Amount 
Assets    
     
Current Assets    
Receivable on sale of subsidiary  $231,431 
      
Non-current assets     
Intangible assets   1,098,598 
Total assets   1,330,029 
      
Current Liabilities     
Accounts payable   263,864 
      
Net loss on novation  $1,066,165 
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations (Tables)
12 Months Ended
Dec. 31, 2023
Discontinued Operations [Abstract]  
Schedule of Assets and Liabilities The following assets and liabilities are reported as discontinued operations:
   December 31, 
   2022 
Current assets    
Cash  $943 
Non-current assets     
Intangibles, net   291,320 
Investment   500,000 
Security deposit   15,000 
Assets held for sale  $807,263 
      
Current liabilities     
Accounts payable  $33,810 
Liabilities held for sale  $33,810 
Schedule of Statement of Operations from Discontinued Operations The statement of operations from discontinued operations is as follows:
   Year ended December 31, 
   2023   2022 
         
Net Revenue  $
-
   $
-
 
           
Cost of Goods Sold   
-
    
-
 
           
Gross loss   
-
    
-
 
           
General and administrative   40,821    88,300 
Depreciation and amortization   
-
    
-
 
Total Expense   40,821    88,300 
           
Loss from operations before income taxes   (40,821)   (88,300)
           
Income Taxes   
-
    
-
 
Loss from discontinued operations, net of taxation  $(40,821)  $(88,300)
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangibles (Tables)
12 Months Ended
Dec. 31, 2023
Intangibles [Abstract]  
Schedule of Facilitate the Functioning of the IPSIPay Software On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party (see note 5 above).
   December 31,
2023
   December 31,
2022
 
   Cost   Accumulated
amortization
   Net Book
Value
   Net book
value
 
Purchased Technology - IPSIPay  $
-
   $
-
   $
-
   $1,401,491 
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Method Investment (Tables)
12 Months Ended
Dec. 31, 2023
Equity Method Investment [Abstract]  
Schedule of Equity Method Investments The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended December 31, 2023 is as follow:
   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,000 
Fair value of warrants issued to third party joint venture partners   108,220 
    1,107,220 
Equity loss from joint venture   (403,282)
   $703,938 
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases (Tables)
12 Months Ended
Dec. 31, 2023
Leases [Abstract]  
Schedule of Total Lease Cost Individual components of the total lease cost incurred by the Company is as follows:
   Year ended December 31,
2023
   Year ended December 31,
2022
 
Operating lease expense  $40,704   $57,600 
Schedule of Other Lease Information Other lease information:
   Year ended December 31,
2023
   Year ended December 31,
2022
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $(40,704)  $(57,600)
           
Remaining lease term – operating lease   -    Monthly 
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Notes Payable (Tables)
12 Months Ended
Dec. 31, 2023
Notes Payable [Abstract]  
Schedule of Notes Payable Notes payable consists of the following:
Description  Interest
Rate
   Maturity
date
  Principal   Accrued
Interest
   December 31, Amount, net  

December 31,
2022
Amount,

net

 
Cavalry Fund I LP   10%  April 30, 2024   482,000    49,004    531,004    482,134 
Mercer Street Global Opportunity Fund, LLC   10%  April 30, 2024   482,000    49,003    531,003    482,134 
Total convertible notes payable          $964,000   $98,007   $1,062,007   $964,268 
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Convertible Notes Payable (Tables)
12 Months Ended
Dec. 31, 2023
Convertible Notes Payable [Abstract]  
Schedule of Convertible Notes Payable Convertible notes payable consists of the following:
Description   Interest
Rate
    Maturity
date
  Principal     Accrued
Interest
    Unamortized
debt discount
    December 31,
2023
Amount,
net
    December  31,
2022
Amount,
net
 
Cavalry Fund I LP     10.00 %   April 30, 2024     898,980       10,238       -       909,218       1,133,301  
                                                     
Mercer Street Global 
Opportunity Fund, LLC
    10.00 %   April 30, 2024     991,754       148,010       -       1,139,764       1,133,301  
                                                     
Red Road Holdings Corporation     29.32 *%   June 15, 2024     101,679       1,393       (61,301 )     41,771       -  
      27.77 *%   July 30 2024     66,606       1,622       (49,545 )     18,683       -  
      32.04 *%   September 30, 2024     63,250       668       (60,809 )     3,109       -  
                                                     
2023 convertible notes      8.00 to 12.00 %   December 31, 2023 to September 14, 2024     2,026,666       80,916       (515,847 )     1,591,735       -  
                                                     
Total convertible notes payable               $ 4,148,935     $ 242,847     $ (687,502 )   $ 3,704,280     $ 2,266,602  
*The red Road Holdings Corporation interest rate is an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Liability (Tables)
12 Months Ended
Dec. 31, 2023
Derivative Liability [Abstract]  
Schedule of Assumptions were used in the Black-Scholes Valuation Model The following assumptions were used in the Black-Scholes valuation model:
   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Conversion price  $ 0.104 to $0.345     $ 0.345 to $4.50   
Risk free interest rate   3.60 to 5.55 %    0.79 to 4.73 %
Expected life of derivative liability   3.5 to 47 months     1.5 to 59 months  
Expected volatility of underlying stock    158.72 to 217.01 %   120.49 to 258.3 %
Expected dividend rate   0%   0%
Schedule of Movement in Derivative Liability The movement in derivative liability is as follows:
   December 31,
2023
   December 31,
2022
 
Opening balance  $2,550,642   $407,161 
Derivative financial liability arising from convertible note and warrants   385,000    238,182 
Derivative financial liability arising on note amendment included in loss on convertible notes   
-
    2,317,051 
Fair value adjustment to derivative liability   (1,501,446)   (411,752)
   $1,434,196   $2,550,642 
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2023
Stockholders’ Equity (Tables) [Line Items]  
Schedule of Restricted Stock Activity A summary of restricted stock activity during the period January 1, 2022 to December 31, 2023 is as follows:
   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2022   716,500   $1.47    341,583   $1.47    374,917   $1.47 
Granted and issued   66,667    1.65    -    -    66,667    1.65 
Forfeited/Cancelled   -    -    -    -    -    - 
Vested   -    -    (170,791)   (1.47)   170,791    1.47 
Outstanding December 31, 2022   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   -    -    -    -    -    - 
Forfeited/Cancelled   -    -    -    -    -    - 
Vested   -    -    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    -   $-    783,167   $1.50 
* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Restricted Stock Granted Issued and Exercisable The restricted stock granted, issued and exercisable at December 31, 2023 is as follows:
    Restricted Stock
Granted and
Vested
 
Grant date Price   Number
Granted*
   Weighted Average Fair
Value per
Share*
 
$1.47    683,167   $1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 
* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Fair Value of the Warrants Granted and Issued The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:
   Year ended
December 31,
2023
 
Exercise price  $ 0.345 to 0.45   
Risk free interest rate    3.77 to 4.86 %
Expected life    5 years   
Expected volatility of underlying stock    187.40 to 192.80 %
Expected dividend rate   0%
Options [Member]  
Stockholders’ Equity (Tables) [Line Items]  
Schedule of Warrant Activity A summary of option activity during the period January 1, 2022 to December 31, 2023 is as follows:
   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,017,223   $4.50 to 12.00   $4.50 
Granted   526,668    1.20 – 4.50    4.20 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   1,543,891   $1.20 to 12.00   $4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (23,889)  $1.20 to 12.00    5.41 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   1,520,002   $1.20 to 12.00   $4.46 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Warrants Outstanding and Exercisable The options outstanding and exercisable at December 31, 2023 are as follows:
    Options Outstanding*   Options Exercisable* 
Exercise  Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    20,001    5.86         20,001         5.86 
$4.50    1,500,001    7.94         1,388,890         7.96 
      1,520,002    7.91   $4.46    1,408,891   $4.45    7.93 
Warrant [Member]  
Stockholders’ Equity (Tables) [Line Items]  
Schedule of Warrant Activity A summary of warrant activity during the period January 1, 2022 to December 31, 2023 is as follows:
   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2022   1,243,477   $ 1.50 – 5.625     $3.60 
Granted   1,700,000     0.345 – 1.035     0.5478 
Increase in warrants due to debt amendment full rachet trigger   2,408,696    0.345    0.345 
Cancelled on debt amendment   (165,797)   4.50    4.50 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2022   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625    $0.6265 
* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

Schedule of Warrants Outstanding and Exercisable The warrants outstanding and exercisable at December 31, 2023 are as follows:
      Warrants Outstanding*     Warrants Exercisable*  
Exercise Price*     Number
Outstanding*
    Weighted
Average
Remaining
Contractual
life in years
    Weighted
Average
Exercise
Price*
    Number
Exercisable*
    Weighted
Average
Exercise
Price*
    Weighted
Average
Remaining
Contractual
life in years
 
$ 0.345       9,055,642       4.16               9,055,642               4.16  
$ 0.450       266,668       4.48               266,668               4.48  
$ 1.035       500,000       1.52               437,500               1.52  
$ 1.500       33,334       4.62               33,334               4.62  
$ 4.50       505,560       2.21               505,560               2.21  
$ 5.625       80,889       2.21               80,889               2.21  
          10,442,093       3.94     $ 0.6265       10,379,593     $ 0.6240       3.95  
* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Loss on Convertible Notes (Tables)
12 Months Ended
Dec. 31, 2023
Loss on Convertible Notes [Abstract]  
Schedule of the Loss on Convertible Notes The loss on convertible notes consists of the following:
   December 31,
2023
   December 31,
2022
 
Penalty on cash settlement of convertible note  $9,306   $247,063 
Expense on extension of maturity date of convertible notes   64,256    836,414 
Fair value of warrants issued to convertible note holders on extension of maturity date   
-
    238,182 
Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders   
-
    2,360,658 
Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)   
-
    920,392 
   $73,562   $4,602,709 
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes [Abstarct]  
Schedule of Provision for Income Taxes The provision for income taxes consists of the following:
   Year ended
December 31,
2023
   Year ended
December 31, 
2022
 
Current          
Federal  $
         
   $
           
 
State   
-
    
-
 
Foreign   
-
    
-
 
   $
-
   $
-
 
Deferred          
Federal  $
-
   $
-
 
State   
-
    
-
 
Foreign   
-
    
-
 
   $
-
   $
-
 
Schedule of Reconciliation of the U.S. Federal Statutory Income Tax A reconciliation of the U.S. Federal statutory income tax to the effective income tax is as follows:
   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Continuing operations        
Tax expense at the federal statutory rate  $(1,225,845)  $(2,169,599)
State tax expense, net of federal tax effect   (170,564)   (324,289)
Permanent differences   712,951    1,194,446 
Prior year net operating loss true up   (228,714)   (3,277)
    (912,172)   (1,302,719)
Deferred income tax asset valuation allowance   912,172    1,302,719 
   $
-
   $
-
 
Schedule of Deferred Income Tax Assets Significant components of the Company’s deferred income tax assets are as follows:
   December 31,
2023
   December 31,
2022
 
Other  $241,491   $241,491 
Capital loss   491,275    - 
Net operating losses   6,900,076    6,479,181 
Stock based compensation   511,142    511,142 
Valuation allowance   (8,143,986)   (7,231,814)
Net deferred income tax assets  $
-
   $
-
 
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Equity Based Compensation [Abstract]  
Schedule of Equity Based Compensation Equity based compensation is made up of the following:
   Year ended
December 31,
2023
   Year ended
December 31,
2022
 
Incentive stock awards  $377,856   $1,594,746 
Securities issued for services rendered   144,828    333,000 
   $522,684   $1,927,746 
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share (Tables)
12 Months Ended
Dec. 31, 2023
Net Loss Per Share [Abstract]  
Schedule of Dilutive Shares Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the years ended December 31, 2023 and 2022 are as follows:
   Year ended
December 31, 
2023
(Shares)
   Year ended
December 31, 
2022
(Shares)
 
Convertible debt   13,363,993    6,569,863 
Stock options   1,520,002    1,543,891 
Warrants to purchase shares of common stock   10,442,093    5,186,375 
    25,326,088    13,300,129 
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Description of Business (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 14, 2023
Sep. 01, 2023
Aug. 11, 2023
Aug. 04, 2023
Jun. 21, 2023
May 12, 2023
Dec. 30, 2022
Jun. 21, 2021
Dec. 31, 2019
Nov. 01, 2019
Dec. 28, 2022
Aug. 26, 2021
Dec. 31, 2023
Dec. 31, 2022
Organization and Description of Business [Line Items]                            
Common stock, par value (in Dollars per share) [1]                         $ 0.0001 $ 0.0001
Aggregate shares of common stock             30,000,000           621,920  
Aggregate of shares of common stock                         2,500  
Retained shares of common stock                         500,000  
Reverse stock split description                   the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders        
Shares percentage                 9.00%          
Capital contribution (in Dollars)                         $ 1,500,000  
Percentage of membership interest                         11.11%  
Joint venture percentage                         22.00%  
Shares of common stock                         1,333,334  
Exercise price per share (in Dollars per share) $ 0.345   $ 1.5       $ 1.2       $ 0.0115   $ 0.345  
Common stock outstanding percentage                         40.00%  
Percentage of remaining shares owned                       49.00%    
Beyond fintech shares (in Dollars)                         $ 250,000  
Proceeds from impairment (in Dollars)           $ 231,431                
Beyond Fintech [Member]                            
Organization and Description of Business [Line Items]                            
Aggregate shares of common stock             1,000,000              
Ownership percentage           51.00%           51.00%    
Stock Purchase Agreement [Member]                            
Organization and Description of Business [Line Items]                            
Stock purchase agreement                 2,250,000          
Maximum [Member]                            
Organization and Description of Business [Line Items]                            
Aggregate of shares of common stock                   320,477,867        
Minimum [Member]                            
Organization and Description of Business [Line Items]                            
Aggregate of shares of common stock                   32,047,817        
Share-Based Payment Arrangement, Tranche One [Member]                            
Organization and Description of Business [Line Items]                            
Payments (in Dollars)       $ 300,000                    
Share-Based Payment Arrangement, Tranche Two [Member]                            
Organization and Description of Business [Line Items]                            
Payments (in Dollars)   $ 500,000                        
Share-Based Payment Arrangement, Tranche Three [Member]                            
Organization and Description of Business [Line Items]                            
Payments (in Dollars)   $ 500,000                        
IPEX Warrant [Member]                            
Organization and Description of Business [Line Items]                            
Shares of common stock                         133,334  
Exercise price per share (in Dollars per share)                         $ 0.45  
Common Stock [Member]                            
Organization and Description of Business [Line Items]                            
Common stock, par value (in Dollars per share)                         $ 0.0001  
Common stock shares holder current                         500,000  
Common stock outstanding, percentage                         91.00%  
Innovative Payment Solutions, Inc [Member]                            
Organization and Description of Business [Line Items]                            
Date of incorporation                         May 12, 2016  
Three Tranches [Member]                            
Organization and Description of Business [Line Items]                            
Capital contribution (in Dollars)                         $ 500,000  
Tranche [Member]                            
Organization and Description of Business [Line Items]                            
Payments (in Dollars)         $ 200,000                  
Shares of common stock                         199,999  
Second Tranche [Member]                            
Organization and Description of Business [Line Items]                            
Shares of common stock                         166,667  
Third Tranche [Member]                            
Organization and Description of Business [Line Items]                            
Shares of common stock                         166,667  
Business Combination [Member]                            
Organization and Description of Business [Line Items]                            
Acquired interest                         1.00%  
Qpagos Corporation’s Capital Stock [Member]                            
Organization and Description of Business [Line Items]                            
Aggregate shares of common stock                         4,992,900  
Qpagos Corporation’s Capital Stock [Member] | Common Stock [Member]                            
Organization and Description of Business [Line Items]                            
Aggregate shares of common stock                         497,500  
Vivi Holdings, Inc [Member]                            
Organization and Description of Business [Line Items]                            
Exchange shares                 2,250,000          
Gaston Pereira [Member]                            
Organization and Description of Business [Line Items]                            
Shares percentage                 5.00%          
Andrey Novikov [Member]                            
Organization and Description of Business [Line Items]                            
Shares percentage                 2.50%          
Joseph Abrams [Member]                            
Organization and Description of Business [Line Items]                            
Shares percentage                 1.50%          
Frictionless Financial Technologies, Inc.[Member]                            
Organization and Description of Business [Line Items]                            
Variable interest entity ownership percentage               10.00%            
Common stock outstanding percentage                         41.00%  
Purchase price (in Dollars)                         $ 300,000  
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounting Policies and Estimates (Details)
12 Months Ended
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Accounting Policies and Estimates [Abstract]    
Operating segment 1  
Federally insured limit $ 0 $ 120,580
Impairment charge 1
Plant and equipment costs 1,000  
Revenues $ 410 $ 847
Beyond Fintech Inc. [Member]    
Accounting Policies and Estimates [Abstract]    
Ownership percentage 51.00%  
Long Term Investment [Member]    
Accounting Policies and Estimates [Abstract]    
Ownership percentage 20.00%  
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets
12 Months Ended
Dec. 31, 2023
Kiosks [Member]  
Property, Plant and Equipment [Line Items]  
Equipment, useful Life 7 years
Computer Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Equipment, useful Life 3 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Leasehold improvements Lesser of estimated useful life or life of lease
Office Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Equipment, useful Life 10 years
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Liquidity Matters and Going Concern (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Liquidity Matters and Going Concern [Abstract]    
Net loss $ (5,837,357) $ (10,331,424)
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Disposal of Investment in Frictionless and Beyond Fintech (Details) - USD ($)
May 12, 2023
Dec. 31, 2022
Aug. 26, 2021
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]      
Warrants to purchase of common stock (in Shares) 1,000,000 1,304,348  
Consideration received (in Dollars) $ 250,000    
Credit rate 20.00%    
Ownership [Member]      
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]      
Minority interest ownership percentage 10.00%    
Beyond Fintech [Member]      
Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]      
Minority interest ownership percentage 51.00%   51.00%
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities - Frictionless And Beyond Fintech [Member]
May 12, 2023
USD ($)
Current Assets  
Cash $ 339
Non-current assets  
Intangible assets 327,211
Security deposit 15,000
Investment 500,000
Total Non-Current Assets 842,211
Total assets 842,550
Current Liabilities  
Accounts payable 97,126
Net assets sold 745,424
Proceeds due on disposal (250,000)
Net loss on disposal $ 495,424
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated - Novation [Member]
Sep. 05, 2023
USD ($)
Current Assets  
Receivable on sale of subsidiary $ 231,431
Non-current assets  
Intangible assets 1,098,598
Total assets 1,330,029
Current Liabilities  
Accounts payable 263,864
Net loss on novation $ 1,066,165
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations (Details) - Schedule of Assets and Liabilities - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash   $ 943
Non-current assets    
Intangibles, net   291,320
Investment   500,000
Security deposit   15,000
Assets held for sale 807,263
Current liabilities    
Accounts payable   33,810
Liabilities held for sale $ 33,810
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations - Discontinued Operations [Member] - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Condensed Statement of Income Captions [Line Items]    
Net Revenue
Cost of Goods Sold
Gross loss
General and administrative 40,821 88,300
Depreciation and amortization
Total Expense 40,821 88,300
Loss from operations before income taxes (40,821) (88,300)
Income Taxes
Loss from discontinued operations, net of taxation $ (40,821) $ (88,300)
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangibles (Details) - USD ($)
1 Months Ended 9 Months Ended 12 Months Ended
Aug. 26, 2021
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Intangibles [Line Items]          
Gross proceeds $ 250,000       $ 375,000
Intangible assets        
IPSIPay software amount   $ 44,405   $ 1,127,400  
Amortization expense     $ 347,298 100,909  
Software [Member]          
Intangibles [Line Items]          
Intangible assets   $ 35,891   $ 41,320  
Beyond Fintech [Member]          
Intangibles [Line Items]          
Ownership percentage 51.00%        
Frictionless [Member]          
Intangibles [Line Items]          
Ownership percentage 49.00%        
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Intangibles (Details) - Schedule of Facilitate the Functioning of the IPSIPay Software - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Schedule of Facilitate the Functioning of the IPSIPay Software [Abstract]    
Cost  
Accumulated amortization  
Net Book Value $ 1,401,491
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Method Investment (Details)
Dec. 31, 2023
USD ($)
Equity Method Investment [Abstract]  
Capital contribution initial tranche amount $ 500,000
Capital contribution second tranche amount $ 500,000
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Method Investment (Details) - Schedule of Equity Method Investments - IPSIPay Express [Member]
12 Months Ended
Dec. 31, 2023
USD ($)
Schedule of Equity Method Investments [Line Items]  
Cash contribution to IPSIPay Express $ 999,000
Fair value of warrants issued to third party joint venture partners 108,220
Equity total 1,107,220
Equity loss from joint venture (403,282)
Joint venture total $ 703,938
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Investments (Details)
May 12, 2023
Investment in Frictionless Financial Technologies Inc. [Member]  
Investment [Line Items]  
Ownership interest 10.00%
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases (Details) - USD ($)
12 Months Ended
Jan. 01, 2023
Dec. 31, 2023
Leases [Abstract]    
Lease, description   The lease commenced on April 1, 2021 and is for a twelve-month period, terminating on April 1, 2022.
Operating lease payment   $ 4,800
Rent payments $ 5,088  
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases (Details) - Schedule of Total Lease Cost - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]    
Operating lease expense $ 40,704 $ 57,600
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases (Details) - Schedule of Other Lease Information - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases $ (40,704) $ (57,600)
Remaining lease term – operating lease Monthly
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Federal Relief Loans (Details) - Small Business Economic Injury Disaster Loan [Member] - USD ($)
12 Months Ended
Jul. 07, 2020
Dec. 31, 2023
Dec. 31, 2022
Federal Relief Loans [Line Items]      
Loan amount $ 150,000    
Interest rate 3.75%    
Loan monthly payment $ 731    
Aggregate principal amount interest   $ 9,369 $ 13,978
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Notes Payable (Details) - USD ($)
1 Months Ended 12 Months Ended
Feb. 16, 2021
Dec. 20, 2023
Dec. 31, 2023
Dec. 31, 2022
May 12, 2023
Sep. 13, 2022
Debt Instrument [Line Items]            
Warrants issued to purchase of common stock (in Shares)       1,304,348 1,000,000  
Exercise price (in Dollars per share) $ 0.24         $ 1.2
Non-convertible promissory notes $ 482,000          
Interest expense   $ 2,514 $ 97,739 $ 268    
Amendment Transaction [Member]            
Debt Instrument [Line Items]            
Interest rate     10.00%      
Non-convertible promissory notes       $ 482,000    
Notes issued     $ 964,000      
Maturity date     Dec. 30, 2023      
Conversion shares issued (in Shares)     51,901,711      
Warrant [Member]            
Debt Instrument [Line Items]            
Warrants issued to purchase of common stock (in Shares) 2,486,957          
Warrants     $ 43,608      
Cavalry and Mercer [Member]            
Debt Instrument [Line Items]            
Interest rate 12.50%          
Debt principal amount $ 572,000          
Convertible Debt [Member]            
Debt Instrument [Line Items]            
Convertible debt     $ 920,392      
Cavalry Fund I LP [Member]            
Debt Instrument [Line Items]            
Company received 500,500          
Mercer Street Global Opportunity Fund, LLC [Member]            
Debt Instrument [Line Items]            
Company received $ 500,500          
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Notes Payable (Details) - Schedule of Notes Payable - Note Payable [Member] - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Principal $ 964,000  
Accrued Interest 98,007  
Amount, net $ 1,062,007 $ 964,268
Cavalry Fund I LP [Member]    
Debt Instrument [Line Items]    
Interest Rate 10.00%  
Maturity date Apr. 30, 2024  
Principal $ 482,000  
Accrued Interest 49,004  
Amount, net $ 531,004 482,134
Mercer Street Global Opportunity Fund, LLC [Member]    
Debt Instrument [Line Items]    
Interest Rate 10.00%  
Maturity date Apr. 30, 2024  
Principal $ 482,000  
Accrued Interest 49,003  
Amount, net $ 531,003 $ 482,134
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Convertible Notes Payable (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 14, 2023
Nov. 20, 2023
Oct. 19, 2023
Sep. 09, 2023
Aug. 30, 2023
Aug. 24, 2023
Aug. 11, 2023
Aug. 03, 2023
Jun. 13, 2023
May 19, 2023
May 10, 2023
Dec. 30, 2022
Feb. 03, 2022
Feb. 16, 2021
Dec. 20, 2023
Jun. 20, 2023
Dec. 28, 2022
Nov. 16, 2022
Dec. 31, 2023
Dec. 31, 2022
Sep. 14, 2023
May 12, 2023
Jul. 08, 2022
Convertible Notes Payable [Line Items]                                              
Maturity date                         Aug. 16, 2022 Dec. 30, 2023                  
Interest rate percentage                           10.00%                  
Exercise price per share (in Dollars per share) $ 0.345           $ 1.5         $ 1.2         $ 0.0115   $ 0.345        
Shares of common stock (in Shares)                                       3,000,000     66,667
Warrant exercisable (in Shares)                                       1,304,348   1,000,000  
Non-convertible promissory notes                           $ 482,000                  
Common stock price per share (in Dollars per share)                       1.8                      
Aggregate amount                                 $ 2,264,784            
Convertible notes                                     $ 836,414        
Black-scholes valuation model                                     1,499,577        
Convertible note holders                                     $ 238,182        
Warrant share (in Shares)                                     (43,608)        
Value of notes                                     $ 964,000        
Holders amount                                     841,003        
Interest expense                                     319,543 $ 193,886      
Amortization of debt discount total                                     770,372 263,200      
Converted interest                                     432,500      
Common stock conversion price (in Shares)   963,769       963,769                                  
Loss on conversion           $ 42,210                                  
Outstanding principal amount                             $ 62,857                
Interest                             $ 2,514       97,739 268      
Issuance of convertible note                 $ 62,700                            
Bearing interest rate                 17.33%                            
Settlement penalty                                     (73,562) (4,602,709)      
Net of unamortized debt discount                                     $ 687,503 $ 263,200      
Aggregate of gross proceeds received                                         $ 2,026,666    
Purchase of aggregate shares (in Shares)                                     5,696,586        
Beneficially own of percentage                                     4.99%        
Limitation exceeds of percentage                                     9.99%        
Exercise price per share (in Dollars per share) $ 0.345                                            
Cavalry Fund I LP [Member]                                              
Convertible Notes Payable [Line Items]                                              
Interest rate percentage                           10.00%       20.00%          
Exercise price per share (in Dollars per share)                           $ 7.2       $ 4.5          
Warrant exercisable (in Shares)                           82,899                  
Purchase an additional shares (in Shares)                                   100,000          
Net proceeds                           $ 500,500                  
Original issue discount                           71,500                  
Senior secured convertible note                           $ 572,000                  
Initial conversion price per share (in Dollars per share)                           $ 0.23                  
Converted interest           $ 139,726                                  
Common stock conversion price (in Shares)   192,774                                          
Conversion price per share (in Dollars per share)   $ 0.345       $ 0.345                                  
Accrued interest                                     $ 909,218        
Mercer Street Global Opportunity Fund, LLC [Member]                                              
Convertible Notes Payable [Line Items]                                              
Interest rate percentage                                   20.00%          
Exercise price per share (in Dollars per share)                           $ 7.2       $ 4.5          
Warrant exercisable (in Shares)                           82,899                  
Purchase an additional shares (in Shares)                                   100,000          
Net proceeds                           $ 500,500                  
Original issue discount                           572,000                  
Senior secured convertible note                           $ 71,500                  
Accrued interest                                     1,139,764        
Original issue discount rate                           10.00%                  
Conversion price (in Dollars per share)                           $ 6.9                  
Mercer Converted [Member]                                              
Convertible Notes Payable [Line Items]                                              
Converted interest         $ 100,000         $ 100,000                          
Common stock conversion price (in Shares)         289,856         289,856                          
Conversion price per share (in Dollars per share)         $ 0.345         $ 0.345                          
Loss on conversion                   $ 48,551                          
Quick Capital, LLC [Member]                                              
Convertible Notes Payable [Line Items]                                              
Exercise price per share (in Dollars per share)                               $ 0.345              
Warrant exercisable (in Shares)                               182,194              
Net proceeds                               $ 50,000              
Original issue discount                               62,857              
Senior secured convertible note                               $ 12,857              
Original issue discount rate                               8.00%              
Conversion price (in Dollars per share)                               $ 0.345              
Diagonal Street Lending LLC [Member]                                              
Convertible Notes Payable [Line Items]                                              
Net proceeds                     $ 100,000                        
Original issue discount                     117,320                        
Senior secured convertible note                     $ 17,320                        
Accrued interest                                     41,772        
Original issue discount rate                     13.00%                        
Variable conversion rate percentage                 60.00%   60.00%                        
Convertible notes owing amount               $ 194,386                              
Principal amount               180,020                              
Settlement penalty               9,306                              
Interest thereon               $ 5,060                              
Net of unamortized debt discount                                     61,301        
Red Road Holdings Corporation [Member]                                              
Convertible Notes Payable [Line Items]                                              
Interest rate percentage     13.00% 13.00%                     15.00%                
Original issue discount     $ 73,450 $ 146,900                     $ 63,250                
Accrued interest                                     3,109        
Variable conversion rate percentage     60.00% 60.00%                     60.00%                
Net of unamortized debt discount                                     $ 60,809        
Effective interest rate     27.80% 29.30%                     32.00%                
Repayment debt     $ 9,222 $ 18,444                     $ 8,082                
Maximum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Interest rate percentage                                     12.00%        
Conversion price, per share (in Dollars per share)                       0.345                      
Minimum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Interest rate percentage                                     8.00%        
Conversion price, per share (in Dollars per share)                                     $ 0.15 $ 0.0115      
Warrant [Member]                                              
Convertible Notes Payable [Line Items]                                              
Additional shares of common stock (in Shares)                         100,000                    
Exercise price per share (in Dollars per share)                         $ 4.5       $ 0.345   [1] [1]      
Conversion price, per share (in Dollars per share)                       0.0115                      
Warrant exercisable (in Shares)                           2,486,957                  
Purchase an additional shares (in Shares)                           1,730,057                  
Accrued interest                                     $ 1,591,734        
Net of unamortized debt discount                                     $ 515,847        
Warrant [Member] | Maximum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                       1.5                      
Warrant [Member] | Minimum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                       0.05                      
Cavalry and Mercer [Member]                                              
Convertible Notes Payable [Line Items]                                              
Interest rate percentage                         20.00%                    
Additional shares of common stock (in Shares)                         3,000,000                    
Exercise price per share (in Dollars per share)                       0.04 $ 0.15                    
Conversion price, per share (in Dollars per share)                       0.0115             $ 0.345        
Shares of common stock (in Shares)                                       100,000      
Common stock price per share (in Dollars per share)                       0.06                      
Aggregate amount                                 $ 1,132,392            
Net proceeds                 $ 50,000                            
Original issue discount                 $ 12,700                            
Cavalry and Mercer [Member] | Maximum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                       0.345             $ 4.5 $ 4.5      
Cavalry and Mercer [Member] | Minimum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                       0.15               0.345      
Cavalry and Mercer [Member] | Warrant [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                                       $ 0.15      
Cavalry/Mercer Note [Member]                                              
Convertible Notes Payable [Line Items]                                              
Additional Charge                                     $ 920,392        
Cavalry/Mercer Note [Member] | Minimum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                                     $ 0.0115        
Cavalry Fund I LP [Member] | Maximum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price per share (in Dollars per share)                                   $ 4.5          
Cavalry Fund I LP [Member] | Minimum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price per share (in Dollars per share)                                   $ 0.345          
Mercer Street Global Opportunity Fund, LLC [Member] | Maximum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                       4.5                      
Mercer Street Global Opportunity Fund, LLC [Member] | Minimum [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                       $ 0.345                      
Convertible Note [Member]                                              
Convertible Notes Payable [Line Items]                                              
Conversion price, per share (in Dollars per share)                                     $ 0.345        
Accrued interest                             50,000                
Convertible Note [Member] | Diagonal Street Lending LLC [Member]                                              
Convertible Notes Payable [Line Items]                                              
Accrued interest     60,000 125,000                                      
Net of unamortized debt discount     $ 13,450 $ 21,900                                      
Convertible Note [Member] | Red Road Holdings Corporation [Member]                                              
Convertible Notes Payable [Line Items]                                              
Accrued interest                                     $ 18,683        
Net of unamortized debt discount                             $ 13,250       $ 49,545        
Common Stock [Member]                                              
Convertible Notes Payable [Line Items]                                              
Shares of common stock (in Shares)                                             2,000,000
Common Stock [Member] | Warrant [Member]                                              
Convertible Notes Payable [Line Items]                                              
Warrant exercisable (in Shares)                                       39,130,435      
Note Two [Member]                                              
Convertible Notes Payable [Line Items]                                              
Warrant exercisable (in Shares) 292,463                                            
Principal amount $ 225,000                                            
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Convertible Notes Payable [Line Items]    
Principal $ 4,148,935  
Accrued Interest 242,847  
Unamortized debt discount (687,502)  
Total convertible notes payable $ 3,704,280 $ 2,266,602
Cavalry Fund I LP [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date April 30, 2024  
Principal $ 898,980  
Accrued Interest 10,238  
Total convertible notes payable $ 909,218 1,133,301
Mercer Street Global Opportunity Fund, LLC [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date April 30, 2024  
Principal $ 991,754  
Accrued Interest 148,010  
Total convertible notes payable $ 1,139,764 $ 1,133,301
Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 29.32%  
Maturity date June 15, 2024  
Principal $ 101,679  
Accrued Interest 1,393  
Unamortized debt discount (61,301)  
Total convertible notes payable $ 41,771  
Red Road Holdings Corporation One [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 27.77%  
Maturity date July 30 2024  
Principal $ 66,606  
Accrued Interest 1,622  
Unamortized debt discount (49,545)  
Total convertible notes payable $ 18,683  
Red Road Holdings Corporation Two [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 32.04%  
Maturity date September 30, 2024  
Principal $ 63,250  
Accrued Interest 668  
Unamortized debt discount (60,809)  
Total convertible notes payable $ 3,109  
2023 convertible notes [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Maturity date December 31, 2023 to September 14, 2024  
Principal $ 2,026,666  
Accrued Interest 80,916  
Unamortized debt discount (515,847)  
Total convertible notes payable $ 1,591,735  
2023 convertible notes [Member] | Minimum [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 8.00%  
2023 convertible notes [Member] | Maximum [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 12.00%  
[1] The red Road Holdings Corporation interest rate is an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.
XML 81 R68.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Liability (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 20, 2023
Sep. 12, 2023
Jun. 13, 2023
May 10, 2023
Derivative Liability [Abstract]            
Rachet provision $ 474,614          
Convertible notes       $ 416,317 $ 150,000 $ 360,491
Net mark-to-market credit 1,501,446 $ 411,752        
Warrant [Member]            
Derivative Liability [Abstract]            
Derivative liability $ 2,317,051          
Black-Scholes [Member]            
Derivative Liability [Abstract]            
Convertible notes     $ 235,000      
XML 82 R69.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Liability (Details) - Schedule of Assumptions were used in the Black-Scholes Valuation Model - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected dividend rate 0.00% 0.00%
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Conversion price (in Dollars per share) $ 0.104 $ 0.345
Risk free interest rate 3.60% 0.79%
Expected life of derivative liability 3 months 15 days 1 month 15 days
Expected volatility of underlying stock 158.72% 120.49%
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Conversion price (in Dollars per share) $ 0.345 $ 4.5
Risk free interest rate 5.55% 4.73%
Expected life of derivative liability 47 months 59 months
Expected volatility of underlying stock 217.01% 258.30%
XML 83 R70.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Derivative Liability (Details) - Schedule of Movement in Derivative Liability - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Schedule of Movement in Derivative Liability [Abstract]    
Opening balance $ 2,550,642 $ 407,161
Derivative financial liability arising from convertible note and warrants 385,000 238,182
Derivative financial liability arising on note amendment included in loss on convertible notes 2,317,051
Fair value adjustment to derivative liability (1,501,446) (411,752)
Total $ 1,434,196 $ 2,550,642
XML 84 R71.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 14, 2023
Nov. 20, 2023
Nov. 08, 2023
Aug. 11, 2023
May 19, 2023
Dec. 30, 2022
Sep. 13, 2022
Aug. 05, 2022
Aug. 01, 2022
Jul. 11, 2022
Feb. 03, 2022
Oct. 22, 2021
Jan. 01, 2021
Dec. 15, 2020
Aug. 31, 2023
Aug. 30, 2023
Aug. 24, 2023
Aug. 16, 2023
Dec. 28, 2022
Aug. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Jul. 08, 2022
Dec. 31, 2021
Feb. 16, 2021
Stockholders’ Equity (Details) [Line Items]                                                  
Common stock authorized [1]                                         750,000,000 750,000,000      
Common stock par value (in Dollars per share) [1]                                         $ 0.0001 $ 0.0001      
Common stock issued                 66,667                       13,819,889 [1] 12,563,426 [1]      
Common stock outstanding [1]                                         13,819,889 12,563,426      
Value of grant date (in Dollars)                 $ 84,000                                
Agreement fee (in Dollars)                 $ 3,000                                
Common stock shares                                           3,000,000 66,667    
Restricted shares               100,000   66,667       83,333                      
Common stock conversion shares   500,000 289,855   72,464                   144,928 2,838 173,914 72,464              
Convertible debt (in Dollars)   $ 172,500 $ 100,000   $ 25,000                   $ 50,000   $ 60,000 $ 25,000              
Shares vested                         1,000,000                        
Remaining vested shares                                         50,000        
Vested years                                         2 years        
Shares underlying warrants, granted                                         50,000        
Expense (in Dollars)                                         $ 0 $ 361,064      
Preferred stock, authorized                                         25,000,000 25,000,000      
Preferred stock, par value (in Dollars per share)                                         $ 0.0001 $ 0.0001      
Description of compensation service                                         (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date.        
Exercise price (in Dollars per share)             $ 1.2                                   $ 0.24
Expiration date                                       Aug. 30, 2027          
Note amendment transaction description                                         the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred:   ● The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above;   ● The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.   ● An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number 292,463     33,334                                 33,334        
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share) $ 0.345     $ 1.5   $ 1.2                         $ 0.0115   $ 0.345        
Proceeds from Warrant Exercises (in Dollars) $ 225,000                                                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period                                         1,000,000        
Limitation exceeds percentage                                         9.99%        
Purchase an aggregate shares                                         133,334        
Preferred stock, per share amounts of preferred dividends in arrears (in Dollars per share)                                         $ 0.45        
Purchase shares of common stock                                         166,667        
Additional purchase shares of common stock                                         166,667        
Aggregate purchase of common stock                                         1,333,334        
Warrants outstanding an intrinsic value (in Dollars)                                         $ 0 $ 0      
Incentive stock options                   500,000                              
Amount of immediate expense (in Dollars)                                           31,970      
Options exercisable shares             6,667                           716,666        
Intrinsic value outstanding options (in Dollars)                                         $ 0 0      
Option expense (in Dollars)                                         $ 377,856 $ 1,233,682      
Maximum [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Warrants beneficially percentage                                         4.99%        
Shares of common stock                                         26,667        
Warrant [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Purchased shares           1,000,000                                      
Fair value of warrants (in Dollars)           $ 348,938                                      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)                     $ 4.5               $ 0.345   [2] [2]      
Purchase an aggregate shares                                         199,999        
Incentive stock options [2]                                         10,442,093 5,186,376   1,243,477  
Common Stock [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Common stock par value (in Dollars per share)                                         $ 0.0001        
Common stock issued                 2,000,000                                
Value of grant date (in Dollars)                                             $ 84,000    
Common stock shares                                             2,000,000    
Warrant exercisable                                       100,000          
Exercise price (in Dollars per share)           $ 0.345                           $ 4.5          
Options exercisable shares             26,668                           23,891        
Common Stock [Member] | Maximum [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Shares of common stock                                         100,000        
Chief Executive Officer [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Stock option exercise price (in Dollars per share)                   $ 4.5                              
Amount of immediate expense (in Dollars)                                           $ 823,854      
Debt Conversion Notices [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Aggregate shares of common stock                                         5,696,586        
Convertible debt amount (in Dollars)                                         $ 0.345        
2021 Stock Incentive Plan [Member] | Maximum [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Shares of common stock                       1,766,667                          
Restricted Stock [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Restricted shares                           2,500,000                      
Shares vested                         33,333                        
Remaining vested shares                                         1,500,000        
Shares underlying warrants, granted                                         1,500,000        
2018 Stock Incentive Plan [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Terminates period                                         10 years        
2021 Stock Incentive Plan [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Terminates period                       10 years                          
Richard Rosenblum [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Restricted shares                   2,000,000                              
Samad Harake [Member]                                                  
Stockholders’ Equity (Details) [Line Items]                                                  
Value of grant date (in Dollars)               $ 165,000   $ 110,000                              
Common stock shares               3,000,000                                  
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
[2] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 85 R72.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Total restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Total restricted shares, Outstanding at beginning [1] 783,167 716,500
Total restricted shares, Granted and issued [1] 66,667
Total restricted shares, Forfeited/Cancelled [1]
Total restricted shares, Vested [1]
Total restricted shares, Outstanding at ending [1] 783,167 783,167
Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.5 $ 1.47
Weighted average fair market value per share, Granted and issued [1] 1.65
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1]
Weighted average fair market value per share, Outstanding at ending [1] $ 1.5 $ 1.5
Total unvested restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Total unvested restricted shares, Outstanding at beginning [1] 170,792 341,583
Total unvested restricted shares, Granted and issued [1]
Total unvested restricted shares, Forfeited/Cancelled [1]
Total unvested restricted shares, Vested [1] (170,792) (170,791)
Total unvested restricted shares, Outstanding at ending [1] 170,792
Unvested restricted Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.47 $ 1.47
Weighted average fair market value per share, Granted and issued [1]
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1] (1.47) (1.47)
Weighted average fair market value per share, Outstanding at ending [1] $ 1.47
Total vested restricted shares [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Total unvested restricted shares, Outstanding at beginning [1] 612,375 374,917
Total unvested restricted shares, Granted and issued [1] 66,667
Total unvested restricted shares, Forfeited/Cancelled [1]
Total unvested restricted shares, Vested [1] 170,792 170,791
Total unvested restricted shares, Outstanding at ending [1] 783,167 612,375
Vested restricted Weighted average fair market value per share [Member]    
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.5 $ 1.47
Weighted average fair market value per share, Granted and issued [1] 1.65
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1] 1.47 1.47
Weighted average fair market value per share, Outstanding at ending [1] $ 1.5 $ 1.5
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 86 R73.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Details) - Schedule of Restricted Stock Granted, Issued and Exercisable
12 Months Ended
Dec. 31, 2023
$ / shares
shares
[1]
Restricted stock granted and Vested, number granted | shares 783,167
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.5
Grant Date Price 1.47 [Member]  
Restricted stock granted and Vested, number granted | shares 683,167
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.47
Grant Date Price 0.50 [Member]  
Restricted stock granted and Vested, number granted | shares 33,333
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.5
Grant Date Price 1.65 [Member]  
Restricted stock granted and Vested, number granted | shares 66,667
Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share) | $ / shares $ 1.65
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 87 R74.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued - Warrants [Member]
12 Months Ended
Dec. 31, 2023
$ / shares
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Expected life 5 years
Expected dividend rate 0.00%
Minimum [Member]  
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Exercise price (in Dollars per share) $ 0.345
Risk free interest rate 3.77%
Expected volatility of underlying stock 187.40%
Maximum [Member]  
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Exercise price (in Dollars per share) $ 0.45
Risk free interest rate 4.86%
Expected volatility of underlying stock 192.80%
XML 88 R75.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Details) - Schedule of Warrant Activity - Warrant [Member] - $ / shares
1 Months Ended 12 Months Ended
Feb. 03, 2022
Dec. 28, 2022
Dec. 31, 2023
Dec. 31, 2022
Schedule of Warrant Activity [Line Items]        
Shares Underlying, Outstanding (in Shares) [1]     5,186,376 1,243,477
Weighted average exercise price, Outstanding [1]     $ 0.9 $ 3.6
Shares Underlying, Granted (in Shares) [1]     6,289,051 1,700,000
Weighted average exercise price, Granted [1]     $ 0.3556 $ 0.5478
Shares Underlying, Forfeited (in Shares) [1]     (33,334)  
Exercise price per share, Forfeited [1]     $ 1.5  
Weighted average exercise price, Forfeited [1]     $ 1.5  
Shares Underlying, Increase in warrants due to debt amendment full rachet trigger (in Shares) [1]       2,408,696
IExercise price per share, ncrease in warrants due to debt amendment full rachet trigger [1]       $ 0.345
Weighted average exercise price, Increase in warrants due to debt amendment full rachet trigger [1]       $ 0.345
Shares Underlying, Cancelled on disposal of investment in Frictionless and Beyond Fintech (in Shares) [1]     (1,000,000) (165,797)
Exercise price per share, Cancelled on disposal of investment in Frictionless and Beyond Fintech [1]     $ 0.345 $ 4.5
Weighted average exercise price, Cancelled on disposal of investment in Frictionless and Beyond Fintech [1]     $ 0.345 $ 4.5
Shares Underlying, Exercised (in Shares) [1]    
Exercise price per share, Exercised [1]    
Weighted average exercise price, Exercised $ 4.5 $ 0.345 [1] [1]
Shares Underlying, Outstanding (in Shares) [1]     10,442,093 5,186,376
Weighted average exercise price, Outstanding [1]     $ 0.6265 $ 0.9
Minimum [Member]        
Schedule of Warrant Activity [Line Items]        
Exercise price per share, Outstanding [1]     0.345 1.5
Exercise price per share, Granted [1]     0.345 0.345
Exercise price per share, Outstanding [1]     0.345 0.345
Maximum [Member]        
Schedule of Warrant Activity [Line Items]        
Exercise price per share, Outstanding [1]     5.625 5.625
Exercise price per share, Granted [1]     1.5 1.035
Exercise price per share, Outstanding [1]     $ 5.625 $ 5.625
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 89 R76.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Details) - Schedule of Warrants Outstanding and Exercisable - Warrant [Member]
12 Months Ended
Dec. 31, 2023
$ / shares
shares
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 10,442,093 [1]
Weighted Average Remaining Contractual life in years 3 years 11 months 8 days
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 0.6265 [1]
Number Exercisable 10,379,593 [1]
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 0.624 [1]
Weighted Average Remaining Contractual life in years 3 years 11 months 12 days
Exercise Price 0.345 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 9,055,642 [1]
Weighted Average Remaining Contractual life in years 4 years 1 month 28 days
Number Exercisable 9,055,642 [1]
Weighted Average Remaining Contractual life in years 4 years 1 month 28 days
Exercise Price 0.450 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 266,668 [1]
Weighted Average Remaining Contractual life in years 4 years 5 months 23 days
Number Exercisable 266,668 [1]
Weighted Average Remaining Contractual life in years 4 years 5 months 23 days
Exercise Price 1.035 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 500,000 [1]
Weighted Average Remaining Contractual life in years 1 year 6 months 7 days
Number Exercisable 437,500 [1]
Weighted Average Remaining Contractual life in years 1 year 6 months 7 days
Exercise Price 1.500 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 33,334 [1]
Weighted Average Remaining Contractual life in years 4 years 7 months 13 days
Number Exercisable 33,334 [1]
Weighted Average Remaining Contractual life in years 4 years 7 months 13 days
Exercise Price 4.50 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 505,560 [1]
Weighted Average Remaining Contractual life in years 2 years 2 months 15 days
Number Exercisable 505,560 [1]
Weighted Average Remaining Contractual life in years 2 years 2 months 15 days
Exercise Price 5.625 [Member]  
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number Outstanding 80,889 [1]
Weighted Average Remaining Contractual life in years 2 years 2 months 15 days
Number Exercisable 80,889 [1]
Weighted Average Remaining Contractual life in years 2 years 2 months 15 days
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 90 R77.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Details) - Schedule of Option Activity - Stock Option [Member] - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Stockholders’ Equity (Details) - Schedule of Option Activity [Line Items]    
Shares Underlying, Outstanding (in Shares) [1] 1,543,891 1,017,223
Weighted average exercise price, Outstanding [1] $ 4.47 $ 4.5
Shares Underlying, Outstanding (in Shares) [1] 1,520,002 1,543,891
Weighted average exercise price, Outstanding [1] $ 4.46 $ 4.47
Shares Underlying, Granted (in Shares) [1] 526,668
Exercise price per share, Granted [1]  
Weighted average exercise price, Granted [1] $ 4.2
Shares Underlying, Forfeited/Cancelled (in Shares) [1] (23,889)
Exercise price per share, Forfeited/Cancelled [1]  
Weighted average exercise price, Forfeited/Cancelled [1] $ 5.41
Shares Underlying, Exercised (in Shares) [1]
Exercise price per share, Exercised [1]
Weighted average exercise price, Exercised [1]
Minimum [Member]    
Stockholders’ Equity (Details) - Schedule of Option Activity [Line Items]    
Exercise price per share, Outstanding [1] 1.2 4.5
Exercise price per share, Outstanding [1] 1.2 1.2
Exercise price per share, Granted [1]   1.2
Exercise price per share, Forfeited/Cancelled [1] 1.2  
Maximum [Member]    
Stockholders’ Equity (Details) - Schedule of Option Activity [Line Items]    
Exercise price per share, Outstanding [1] 12 12
Exercise price per share, Outstanding [1] 12 12
Exercise price per share, Granted [1]   $ 4.5
Exercise price per share, Forfeited/Cancelled [1] $ 12  
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
XML 91 R78.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stockholders’ Equity (Details) - Schedule of Options Outstanding and Exercisable - Option [Member]
12 Months Ended
Dec. 31, 2023
$ / shares
shares
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 1,520,002
Weighted Average Remaining Contractual life in years 7 years 10 months 28 days
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 4.46
Number Exercisable 1,408,891
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 4.45
Weighted Average Remaining Contractual life in years 7 years 11 months 4 days
Exercise Price One Point Two Zero [Member]  
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 20,001
Weighted Average Remaining Contractual life in years 5 years 10 months 9 days
Number Exercisable 20,001
Weighted Average Remaining Contractual life in years 5 years 10 months 9 days
Exercise Price Four Point Five Zero [Member]  
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 1,500,001
Weighted Average Remaining Contractual life in years 7 years 11 months 8 days
Number Exercisable 1,388,890
Weighted Average Remaining Contractual life in years 7 years 11 months 15 days
XML 92 R79.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Loss on Convertible Notes (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 14, 2023
Aug. 03, 2023
Aug. 30, 2022
Feb. 04, 2022
Dec. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]              
Settlement penalty payment       $ 247,063      
Gross proceeds       $ 1,235,313      
Penalty expenses   $ 9,306          
Purchased shares 292,463   100,000        
Debt extinguishment           $ 64,256  
Aggregate amount           $ 836,414  
Exercise price         $ 0.345    
Stock issued         1,304,348    
Derivative liability         $ 20,079    
Non-convertible promissory notes         482,000    
Additional charge         $ 964,000    
Maximum [Member]              
Debt Instrument [Line Items]              
Conversion price, per share         $ 0.345    
Minimum [Member]              
Debt Instrument [Line Items]              
Conversion price, per share           $ 0.15 $ 0.0115
Warrant [Member]              
Debt Instrument [Line Items]              
Exercise price         0.0115    
Fair value     $ 238,182        
Conversion price, per share         0.0115    
Derivative liability           $ 43,608  
Warrant [Member] | Maximum [Member]              
Debt Instrument [Line Items]              
Conversion price, per share         1.5    
Warrant [Member] | Minimum [Member]              
Debt Instrument [Line Items]              
Conversion price, per share         0.05    
Cavalry and Mercer [Member]              
Debt Instrument [Line Items]              
Purchased shares     3,000,000        
Conversion price, per share         $ 0.0115 $ 0.345  
Stock issued         100,000    
Cavalry and Mercer [Member] | Maximum [Member]              
Debt Instrument [Line Items]              
Exercise price     $ 4.5        
Conversion price, per share         $ 0.345 $ 4.5 4.5
Cavalry and Mercer [Member] | Minimum [Member]              
Debt Instrument [Line Items]              
Exercise price     $ 0.15        
Conversion price, per share         $ 0.15   0.345
Cavalry and Mercer [Member] | Warrant [Member]              
Debt Instrument [Line Items]              
Conversion price, per share             $ 0.15
Common Stock [Member]              
Debt Instrument [Line Items]              
Stock issued         3,000,000    
Warrant Agreement [Member] | Cavalry and Mercer [Member]              
Debt Instrument [Line Items]              
Conversion price, per share         $ 4.5    
Note Amendment Letter Agreement [Member]              
Debt Instrument [Line Items]              
Maturity date         Dec. 30, 2023    
Warrant Agreement [Member]              
Debt Instrument [Line Items]              
Stock issued         39,130,435    
Black Scholes Valuation Model [Member]              
Debt Instrument [Line Items]              
Derivative liability         $ 2,340,580    
Black Scholes Valuation Model [Member] | Warrant [Member]              
Debt Instrument [Line Items]              
Derivative liability         $ 43,608    
XML 93 R80.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of the Loss on Convertible Notes [Abstract]    
Penalty on cash settlement of convertible note $ 9,306 $ 247,063
Expense on extension of maturity date of convertible notes 64,256 836,414
Fair value of warrants issued to convertible note holders on extension of maturity date 238,182
Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders 2,360,658
Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608) 920,392
Loss on convertible notes $ 73,562 $ 4,602,709
XML 94 R81.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes (Parentheticals)
Dec. 31, 2023
USD ($)
Schedule of the Loss on Convertible Notes [Abstract]  
Net of the derivative liability value $ (43,608)
XML 95 R82.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details) - USD ($)
12 Months Ended
Dec. 22, 2017
Dec. 31, 2023
Dec. 31, 2022
Income Taxes (Details) [Line Items]      
Marginal rate 35.00%    
Flat rate 21.00%    
Income tax rate 30.00%    
Net operating losses percentage 80.00%    
Valuation allowance for deferred income tax assets   $ 8,143,986 $ 7,231,814
Deferred income tax assets valuation allowance   $ 912,172 1,302,719
Federal term   3 years  
Income tax purposes federal   $ 26,800,000  
Income tax purposes state   19,000,000  
Net operating losses   $ 6,900,076 $ 6,479,181
Operating loss Carryforwards expiration year   2034  
Indefinite life tax   $ 23,300,000  
Operating Loss Carryforward [Member]      
Income Taxes (Details) [Line Items]      
Net operating losses   $ 3,500,000  
XML 96 R83.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details) - Schedule of Provision for Income Taxes - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Current    
Federal
State
Foreign
Total current tax benefits
Deferred    
Federal
State
Foreign
Total deferred tax benefits
XML 97 R84.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details) - Schedule of Reconciliation of the U.S. Federal Statutory Income Tax - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Continuing operations    
Tax expense at the federal statutory rate $ (1,225,845) $ (2,169,599)
State tax expense, net of federal tax effect (170,564) (324,289)
Permanent differences 712,951 1,194,446
Prior year net operating loss true up (228,714) (3,277)
Total Continuing operations (912,172) (1,302,719)
Deferred income tax asset valuation allowance 912,172 1,302,719
Deferred tax assets, net
XML 98 R85.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details) - Schedule of Deferred Income Tax Assets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Schedule of Deferred Income Tax Assets [Line Items]    
Other $ 241,491 $ 241,491
Capital loss 491,275  
Net operating losses 6,900,076 6,479,181
Stock based compensation 511,142 511,142
Valuation allowance (8,143,986) (7,231,814)
Net deferred income tax assets
XML 99 R86.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Based Compensation (Details) - Schedule of Equity Based Compensation - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Equity Based Compensation [Abstract]    
Equity based compensation $ 522,684 $ 1,927,746
Incentive Stock Awards [Member]    
Schedule of Equity Based Compensation [Abstract]    
Equity based compensation 377,856 1,594,746
Securities Issued for Services Rendered [Member]    
Schedule of Equity Based Compensation [Abstract]    
Equity based compensation $ 144,828 $ 333,000
XML 100 R87.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Loss Per Share (Details) - Schedule of Anti-dilutive Shares - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Dilutive Shares [Line Items]    
Anti-dilutive shares 25,326,088 13,300,129
Convertible debt [Member]    
Schedule of Dilutive Shares [Line Items]    
Anti-dilutive shares 13,363,993 6,569,863
Stock options [Member]    
Schedule of Dilutive Shares [Line Items]    
Anti-dilutive shares 1,520,002 1,543,891
Warrants to purchase shares of common stock [Member]    
Schedule of Dilutive Shares [Line Items]    
Anti-dilutive shares 10,442,093 5,186,375
XML 101 R88.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Transactions (Details) - USD ($)
12 Months Ended
Sep. 13, 2022
Sep. 13, 2022
Jul. 11, 2022
Jul. 11, 2022
Dec. 31, 2023
Dec. 31, 2022
Jun. 21, 2023
Mr. Fuller [Member]              
Related Party Transaction [Line Items]              
Shares of options exercisable (in Shares) 6,667 6,667          
Exercise price (in Dollars per share)   $ 1.2          
James Fuller [Member]              
Related Party Transaction [Line Items]              
Option expense         $ 0 $ 7,993  
William Corbett [Member]              
Related Party Transaction [Line Items]              
Shares of options exercisable (in Shares)     500,000 500,000      
Exercise price (in Dollars per share)       $ 4.5      
Option expense         266,346 1,090,201  
Working capital expenses             $ 50,000
Clifford Henry [Member]              
Related Party Transaction [Line Items]              
Shares of options exercisable (in Shares) 6,667 6,667          
Exercise price (in Dollars per share)   $ 1.2          
Option expense         0 7,993  
Financial and capital markets advice         3,500    
Common Stock, Value, Issued $ 7,993 $ 7,993          
Madisson Butler [Member]              
Related Party Transaction [Line Items]              
Shares of options exercisable (in Shares) 6,667 6,667          
Option expense         0 7,993  
Madisson Corbett [Member]              
Related Party Transaction [Line Items]              
Exercise price (in Dollars per share)   $ 1.2          
Common Stock, Value, Issued $ 7,993 $ 7,993          
David Rios [Member]              
Related Party Transaction [Line Items]              
Shares of options exercisable (in Shares) 6,667 6,667          
Exercise price (in Dollars per share)   $ 1.2          
Option expense $ 7,993       0 7,993  
Mr. Rosenblum [Member]              
Related Party Transaction [Line Items]              
Restricted shares (in Shares)     66,667        
Restricted shares value     $ 110,000        
Richard Rosenblum [Member]              
Related Party Transaction [Line Items]              
Option expense         $ 111,510 $ 111,510  
XML 102 R89.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Details)
12 Months Ended
Dec. 31, 2023
Note Payable [Member]  
Loss Contingencies [Line Items]  
Notes payable and convertible notes payable description The Company has notes payable and convertible notes payable, disclosed under notes 12 and 13 above, which originally matured between December 30, 2023 and September 14, 2024, of which the notes that had maturity dates between December 30, 2023 and February 23, 2024 have been extended to dates between April 30, 2024 and August 23, 2024.
XML 103 R90.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent Events (Details) - USD ($)
1 Months Ended 12 Months Ended 14 Months Ended
Mar. 04, 2024
Feb. 21, 2024
Feb. 12, 2024
Feb. 21, 2024
Dec. 31, 2023
Mar. 04, 2024
May 03, 2024
Dec. 30, 2022
Subsequent Event [Line Items]                
Common stock outstanding percentage         40.00%      
Accrued interest percentage         110.00%      
BZWR [Member]                
Subsequent Event [Line Items]                
Ownership percentage         100.00%      
Warrant [Member]                
Subsequent Event [Line Items]                
Interest payments         $ 1,591,734      
Conversion price per share (in Dollars per share)               $ 0.0115
Securities Purchase Agreement [Member]                
Subsequent Event [Line Items]                
Conversion price per share (in Dollars per share)         $ 0.345      
Conversion rate         70.00%      
Interest accrued percentage         15.00%      
Common Stock [Member] | Securities Purchase Agreement [Member]                
Subsequent Event [Line Items]                
Conversion price per share (in Dollars per share)         $ 0.0036      
Subsequent Event [Member]                
Subsequent Event [Line Items]                
Gross proceeds     $ 158,333          
Principal amount     226,190          
Subsequent Event [Member] | Securities Purchase Agreement [Member]                
Subsequent Event [Line Items]                
Original issue amount     $ 67,857          
Maturity date           Sep. 04, 2024    
Forecast [Member]                
Subsequent Event [Line Items]                
Gross proceeds $ 100,000     $ 308,335        
Bears interest   8.00%   8.00%        
Conversion price (in Dollars per share)   $ 0.345            
Interest charge           $ 9,143    
Forecast [Member] | Warrant [Member]                
Subsequent Event [Line Items]                
Interest payments             $ 30,871  
Forecast [Member] | Securities Purchase Agreement [Member]                
Subsequent Event [Line Items]                
Original issue amount $ 14,286         $ 14,286    
EXCEL 104 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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Ƽ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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 106 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 108 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 403 491 1 true 114 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://ipsipay.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://ipsipay.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://ipsipay.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Operations (Parentheticals) Sheet http://ipsipay.com/role/ConsolidatedIncomeStatement_Parentheticals Consolidated Statements of Operations (Parentheticals) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Changes in Stockholders??? Equity (Deficit) Sheet http://ipsipay.com/role/ShareholdersEquityType2or3 Consolidated Statements of Changes in Stockholders??? Equity (Deficit) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://ipsipay.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 7 false false R8.htm 007 - Disclosure - Organization and Description of Business Sheet http://ipsipay.com/role/OrganizationandDescriptionofBusiness Organization and Description of Business Notes 8 false false R9.htm 008 - Disclosure - Accounting Policies and Estimates Sheet http://ipsipay.com/role/AccountingPoliciesandEstimates Accounting Policies and Estimates Notes 9 false false R10.htm 009 - Disclosure - Liquidity Matters and Going Concern Sheet http://ipsipay.com/role/LiquidityMattersandGoingConcern Liquidity Matters and Going Concern Notes 10 false false R11.htm 010 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech Sheet http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintech Disposal of Investment in Frictionless and Beyond Fintech Notes 11 false false R12.htm 011 - Disclosure - Novation of Certain Assets and Liabilites Sheet http://ipsipay.com/role/NovationofCertainAssetsandLiabilites Novation of Certain Assets and Liabilites Notes 12 false false R13.htm 012 - Disclosure - Discontinued Operations Sheet http://ipsipay.com/role/DiscontinuedOperations Discontinued Operations Notes 13 false false R14.htm 013 - Disclosure - Intangibles Sheet http://ipsipay.com/role/Intangibles Intangibles Notes 14 false false R15.htm 014 - Disclosure - Equity Method Investment Sheet http://ipsipay.com/role/EquityMethodInvestment Equity Method Investment Notes 15 false false R16.htm 015 - Disclosure - Investments Sheet http://ipsipay.com/role/Investments Investments Notes 16 false false R17.htm 016 - Disclosure - Leases Sheet http://ipsipay.com/role/Leases Leases Notes 17 false false R18.htm 017 - Disclosure - Federal Relief Loans Sheet http://ipsipay.com/role/FederalReliefLoans Federal Relief Loans Notes 18 false false R19.htm 018 - Disclosure - Notes Payable Notes http://ipsipay.com/role/NotesPayable Notes Payable Notes 19 false false R20.htm 019 - Disclosure - Convertible Notes Payable Notes http://ipsipay.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 20 false false R21.htm 020 - Disclosure - Derivative Liability Sheet http://ipsipay.com/role/DerivativeLiability Derivative Liability Notes 21 false false R22.htm 021 - Disclosure - Stockholders??? Equity Sheet http://ipsipay.com/role/StockholdersEquity Stockholders??? Equity Notes 22 false false R23.htm 022 - Disclosure - Loss on Convertible Notes Notes http://ipsipay.com/role/LossonConvertibleNotes Loss on Convertible Notes Notes 23 false false R24.htm 023 - Disclosure - Income Taxes Sheet http://ipsipay.com/role/IncomeTaxes Income Taxes Notes 24 false false R25.htm 024 - Disclosure - Equity Based Compensation Sheet http://ipsipay.com/role/EquityBasedCompensation Equity Based Compensation Notes 25 false false R26.htm 025 - Disclosure - Net Loss Per Share Sheet http://ipsipay.com/role/NetLossPerShare Net Loss Per Share Notes 26 false false R27.htm 026 - Disclosure - Related Party Transactions Sheet http://ipsipay.com/role/RelatedPartyTransactions Related Party Transactions Notes 27 false false R28.htm 027 - Disclosure - Commitments and Contingencies Sheet http://ipsipay.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 28 false false R29.htm 028 - Disclosure - Subsequent Events Sheet http://ipsipay.com/role/SubsequentEvents Subsequent Events Notes 29 false false R30.htm 996000 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://ipsipay.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://ipsipay.com/role/AccountingPoliciesandEstimates 30 false false R31.htm 996001 - Disclosure - Accounting Policies and Estimates (Tables) Sheet http://ipsipay.com/role/AccountingPoliciesandEstimatesTables Accounting Policies and Estimates (Tables) Tables http://ipsipay.com/role/AccountingPoliciesandEstimates 31 false false R32.htm 996002 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Tables) Sheet http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechTables Disposal of Investment in Frictionless and Beyond Fintech (Tables) Tables http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintech 32 false false R33.htm 996003 - Disclosure - Novation of Certain Assets and Liabilites (Tables) Sheet http://ipsipay.com/role/NovationofCertainAssetsandLiabilitesTables Novation of Certain Assets and Liabilites (Tables) Tables http://ipsipay.com/role/NovationofCertainAssetsandLiabilites 33 false false R34.htm 996004 - Disclosure - Discontinued Operations (Tables) Sheet http://ipsipay.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://ipsipay.com/role/DiscontinuedOperations 34 false false R35.htm 996005 - Disclosure - Intangibles (Tables) Sheet http://ipsipay.com/role/IntangiblesTables Intangibles (Tables) Tables http://ipsipay.com/role/Intangibles 35 false false R36.htm 996006 - Disclosure - Equity Method Investment (Tables) Sheet http://ipsipay.com/role/EquityMethodInvestmentTables Equity Method Investment (Tables) Tables http://ipsipay.com/role/EquityMethodInvestment 36 false false R37.htm 996007 - Disclosure - Leases (Tables) Sheet http://ipsipay.com/role/LeasesTables Leases (Tables) Tables http://ipsipay.com/role/Leases 37 false false R38.htm 996008 - Disclosure - Notes Payable (Tables) Notes http://ipsipay.com/role/NotesPayableTables Notes Payable (Tables) Tables http://ipsipay.com/role/NotesPayable 38 false false R39.htm 996009 - Disclosure - Convertible Notes Payable (Tables) Notes http://ipsipay.com/role/ConvertibleNotesPayableTables Convertible Notes Payable (Tables) Tables http://ipsipay.com/role/ConvertibleNotesPayable 39 false false R40.htm 996010 - Disclosure - Derivative Liability (Tables) Sheet http://ipsipay.com/role/DerivativeLiabilityTables Derivative Liability (Tables) Tables http://ipsipay.com/role/DerivativeLiability 40 false false R41.htm 996011 - Disclosure - Stockholders??? Equity (Tables) Sheet http://ipsipay.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://ipsipay.com/role/StockholdersEquity 41 false false R42.htm 996012 - Disclosure - Loss on Convertible Notes (Tables) Notes http://ipsipay.com/role/LossonConvertibleNotesTables Loss on Convertible Notes (Tables) Tables http://ipsipay.com/role/LossonConvertibleNotes 42 false false R43.htm 996013 - Disclosure - Income Taxes (Tables) Sheet http://ipsipay.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://ipsipay.com/role/IncomeTaxes 43 false false R44.htm 996014 - Disclosure - Equity Based Compensation (Tables) Sheet http://ipsipay.com/role/EquityBasedCompensationTables Equity Based Compensation (Tables) Tables http://ipsipay.com/role/EquityBasedCompensation 44 false false R45.htm 996015 - Disclosure - Net Loss Per Share (Tables) Sheet http://ipsipay.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://ipsipay.com/role/NetLossPerShare 45 false false R46.htm 996016 - Disclosure - Organization and Description of Business (Details) Sheet http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails Organization and Description of Business (Details) Details http://ipsipay.com/role/OrganizationandDescriptionofBusiness 46 false false R47.htm 996017 - Disclosure - Accounting Policies and Estimates (Details) Sheet http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails Accounting Policies and Estimates (Details) Details http://ipsipay.com/role/AccountingPoliciesandEstimatesTables 47 false false R48.htm 996018 - Disclosure - Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets Sheet http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets Details http://ipsipay.com/role/AccountingPoliciesandEstimatesTables 48 false false R49.htm 996019 - Disclosure - Liquidity Matters and Going Concern (Details) Sheet http://ipsipay.com/role/LiquidityMattersandGoingConcernDetails Liquidity Matters and Going Concern (Details) Details http://ipsipay.com/role/LiquidityMattersandGoingConcern 49 false false R50.htm 996020 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Details) Sheet http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails Disposal of Investment in Frictionless and Beyond Fintech (Details) Details http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechTables 50 false false R51.htm 996021 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities Sheet http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities Details http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechTables 51 false false R52.htm 996022 - Disclosure - Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated Sheet http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated Details http://ipsipay.com/role/NovationofCertainAssetsandLiabilitesTables 52 false false R53.htm 996023 - Disclosure - Discontinued Operations (Details) - Schedule of Assets and Liabilities Sheet http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0 Discontinued Operations (Details) - Schedule of Assets and Liabilities Details http://ipsipay.com/role/DiscontinuedOperationsTables 53 false false R54.htm 996024 - Disclosure - Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations Sheet http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations Details http://ipsipay.com/role/DiscontinuedOperationsTables 54 false false R55.htm 996025 - Disclosure - Intangibles (Details) Sheet http://ipsipay.com/role/IntangiblesDetails Intangibles (Details) Details http://ipsipay.com/role/IntangiblesTables 55 false false R56.htm 996026 - Disclosure - Intangibles (Details) - Schedule of Facilitate the Functioning of the IPSIPay Software Sheet http://ipsipay.com/role/ScheduleofFacilitatetheFunctioningoftheIPSIPaySoftwareTable Intangibles (Details) - Schedule of Facilitate the Functioning of the IPSIPay Software Details http://ipsipay.com/role/IntangiblesTables 56 false false R57.htm 996027 - Disclosure - Equity Method Investment (Details) Sheet http://ipsipay.com/role/EquityMethodInvestmentDetails Equity Method Investment (Details) Details http://ipsipay.com/role/EquityMethodInvestmentTables 57 false false R58.htm 996028 - Disclosure - Equity Method Investment (Details) - Schedule of Equity Method Investments Sheet http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable Equity Method Investment (Details) - Schedule of Equity Method Investments Details http://ipsipay.com/role/EquityMethodInvestmentTables 58 false false R59.htm 996029 - Disclosure - Investments (Details) Sheet http://ipsipay.com/role/InvestmentsDetails Investments (Details) Details http://ipsipay.com/role/Investments 59 false false R60.htm 996030 - Disclosure - Leases (Details) Sheet http://ipsipay.com/role/LeasesDetails Leases (Details) Details http://ipsipay.com/role/LeasesTables 60 false false R61.htm 996031 - Disclosure - Leases (Details) - Schedule of Total Lease Cost Sheet http://ipsipay.com/role/ScheduleofTotalLeaseCostTable Leases (Details) - Schedule of Total Lease Cost Details http://ipsipay.com/role/LeasesTables 61 false false R62.htm 996032 - Disclosure - Leases (Details) - Schedule of Other Lease Information Sheet http://ipsipay.com/role/ScheduleofOtherLeaseInformationTable Leases (Details) - Schedule of Other Lease Information Details http://ipsipay.com/role/LeasesTables 62 false false R63.htm 996033 - Disclosure - Federal Relief Loans (Details) Sheet http://ipsipay.com/role/FederalReliefLoansDetails Federal Relief Loans (Details) Details http://ipsipay.com/role/FederalReliefLoans 63 false false R64.htm 996034 - Disclosure - Notes Payable (Details) Notes http://ipsipay.com/role/NotesPayableDetails Notes Payable (Details) Details http://ipsipay.com/role/NotesPayableTables 64 false false R65.htm 996035 - Disclosure - Notes Payable (Details) - Schedule of Notes Payable Notes http://ipsipay.com/role/ScheduleofNotesPayableTable Notes Payable (Details) - Schedule of Notes Payable Details http://ipsipay.com/role/NotesPayableTables 65 false false R66.htm 996036 - Disclosure - Convertible Notes Payable (Details) Notes http://ipsipay.com/role/ConvertibleNotesPayableDetails Convertible Notes Payable (Details) Details http://ipsipay.com/role/ConvertibleNotesPayableTables 66 false false R67.htm 996037 - Disclosure - Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable Notes http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable Details http://ipsipay.com/role/ConvertibleNotesPayableTables 67 false false R68.htm 996038 - Disclosure - Derivative Liability (Details) Sheet http://ipsipay.com/role/DerivativeLiabilityDetails Derivative Liability (Details) Details http://ipsipay.com/role/DerivativeLiabilityTables 68 false false R69.htm 996039 - Disclosure - Derivative Liability (Details) - Schedule of Assumptions were used in the Black-Scholes Valuation Model Sheet http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable Derivative Liability (Details) - Schedule of Assumptions were used in the Black-Scholes Valuation Model Details http://ipsipay.com/role/DerivativeLiabilityTables 69 false false R70.htm 996040 - Disclosure - Derivative Liability (Details) - Schedule of Movement in Derivative Liability Sheet http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable Derivative Liability (Details) - Schedule of Movement in Derivative Liability Details http://ipsipay.com/role/DerivativeLiabilityTables 70 false false R71.htm 996041 - Disclosure - Stockholders??? Equity (Details) Sheet http://ipsipay.com/role/StockholdersEquityDetails Stockholders??? Equity (Details) Details http://ipsipay.com/role/StockholdersEquityTables 71 false false R72.htm 996042 - Disclosure - Stockholders??? Equity (Details) - Schedule of Restricted Stock Activity Sheet http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable Stockholders??? Equity (Details) - Schedule of Restricted Stock Activity Details http://ipsipay.com/role/StockholdersEquityTables 72 false false R73.htm 996043 - Disclosure - Stockholders??? Equity (Details) - Schedule of Restricted Stock Granted, Issued and Exercisable Sheet http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable Stockholders??? Equity (Details) - Schedule of Restricted Stock Granted, Issued and Exercisable Details http://ipsipay.com/role/StockholdersEquityTables 73 false false R74.htm 996044 - Disclosure - Stockholders??? Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Sheet http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable Stockholders??? Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued Details http://ipsipay.com/role/StockholdersEquityTables 74 false false R75.htm 996045 - Disclosure - Stockholders??? Equity (Details) - Schedule of Warrant Activity Sheet http://ipsipay.com/role/ScheduleofWarrantActivityTable Stockholders??? Equity (Details) - Schedule of Warrant Activity Details http://ipsipay.com/role/StockholdersEquityTables 75 false false R76.htm 996046 - Disclosure - Stockholders??? Equity (Details) - Schedule of Warrants Outstanding and Exercisable Sheet http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable Stockholders??? Equity (Details) - Schedule of Warrants Outstanding and Exercisable Details http://ipsipay.com/role/StockholdersEquityTables 76 false false R77.htm 996047 - Disclosure - Stockholders??? Equity (Details) - Schedule of Option Activity Sheet http://ipsipay.com/role/ScheduleofOptionActivityTable Stockholders??? Equity (Details) - Schedule of Option Activity Details http://ipsipay.com/role/StockholdersEquityTables 77 false false R78.htm 996048 - Disclosure - Stockholders??? Equity (Details) - Schedule of Options Outstanding and Exercisable Sheet http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable Stockholders??? Equity (Details) - Schedule of Options Outstanding and Exercisable Details http://ipsipay.com/role/StockholdersEquityTables 78 false false R79.htm 996049 - Disclosure - Loss on Convertible Notes (Details) Notes http://ipsipay.com/role/LossonConvertibleNotesDetails Loss on Convertible Notes (Details) Details http://ipsipay.com/role/LossonConvertibleNotesTables 79 false false R80.htm 996050 - Disclosure - Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes Notes http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes Details http://ipsipay.com/role/LossonConvertibleNotesTables 80 false false R81.htm 996051 - Disclosure - Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes (Parentheticals) Notes http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable_Parentheticals Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes (Parentheticals) Details http://ipsipay.com/role/LossonConvertibleNotesTables 81 false false R82.htm 996052 - Disclosure - Income Taxes (Details) Sheet http://ipsipay.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://ipsipay.com/role/IncomeTaxesTables 82 false false R83.htm 996053 - Disclosure - Income Taxes (Details) - Schedule of Provision for Income Taxes Sheet http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable Income Taxes (Details) - Schedule of Provision for Income Taxes Details http://ipsipay.com/role/IncomeTaxesTables 83 false false R84.htm 996054 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of the U.S. Federal Statutory Income Tax Sheet http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable Income Taxes (Details) - Schedule of Reconciliation of the U.S. Federal Statutory Income Tax Details http://ipsipay.com/role/IncomeTaxesTables 84 false false R85.htm 996055 - Disclosure - Income Taxes (Details) - Schedule of Deferred Income Tax Assets Sheet http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable Income Taxes (Details) - Schedule of Deferred Income Tax Assets Details http://ipsipay.com/role/IncomeTaxesTables 85 false false R86.htm 996056 - Disclosure - Equity Based Compensation (Details) - Schedule of Equity Based Compensation Sheet http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable Equity Based Compensation (Details) - Schedule of Equity Based Compensation Details http://ipsipay.com/role/EquityBasedCompensationTables 86 false false R87.htm 996057 - Disclosure - Net Loss Per Share (Details) - Schedule of Anti-dilutive Shares Sheet http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable Net Loss Per Share (Details) - Schedule of Anti-dilutive Shares Details http://ipsipay.com/role/NetLossPerShareTables 87 false false R88.htm 996058 - Disclosure - Related Party Transactions (Details) Sheet http://ipsipay.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://ipsipay.com/role/RelatedPartyTransactions 88 false false R89.htm 996059 - Disclosure - Commitments and Contingencies (Details) Sheet http://ipsipay.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://ipsipay.com/role/CommitmentsandContingencies 89 false false R90.htm 996060 - Disclosure - Subsequent Events (Details) Sheet http://ipsipay.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://ipsipay.com/role/SubsequentEvents 90 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 10 fact(s) appearing in ix:hidden were eligible for transformation: ipsi:FederalTerm, ipsi:OperatingLossCarryforwardsExpirationYear, us-gaap:EarningsPerShareDiluted, us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare, us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding - ea0203998-10ka1_innova.htm 6426, 6427, 6428, 6429, 6430, 6431, 6432, 6433, 6590, 6591 ea0203998-10ka1_innova.htm ipsi-20231231.xsd ipsi-20231231_cal.xml ipsi-20231231_def.xml ipsi-20231231_lab.xml ipsi-20231231_pre.xml image_001.jpg image_002.jpg http://fasb.org/srt/2023 http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 111 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea0203998-10ka1_innova.htm": { "nsprefix": "ipsi", "nsuri": "http://ipsipay.com/20231231", "dts": { "inline": { "local": [ "ea0203998-10ka1_innova.htm" ] }, "schema": { "local": [ "ipsi-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd" ] }, "calculationLink": { "local": [ "ipsi-20231231_cal.xml" ] }, "definitionLink": { "local": [ "ipsi-20231231_def.xml" ] }, "labelLink": { "local": [ "ipsi-20231231_lab.xml" ] }, "presentationLink": { "local": [ "ipsi-20231231_pre.xml" ] } }, "keyStandard": 401, "keyCustom": 90, "axisStandard": 32, "axisCustom": 0, "memberStandard": 24, "memberCustom": 78, "hidden": { "total": 188, "http://fasb.org/us-gaap/2023": 158, "http://ipsipay.com/20231231": 24, "http://xbrl.sec.gov/dei/2023": 6 }, "contextCount": 403, "entityCount": 1, "segmentCount": 114, "elementCount": 789, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 1054, "http://xbrl.sec.gov/dei/2023": 40, "http://fasb.org/srt/2023": 2 }, "report": { "R1": { "role": "http://ipsipay.com/role/DocumentAndEntityInformation", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R2": { "role": "http://ipsipay.com/role/ConsolidatedBalanceSheet", "longName": "001 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R3": { "role": "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals", "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)", "shortName": "Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:PreferredStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R4": { "role": "http://ipsipay.com/role/ConsolidatedIncomeStatement", "longName": "003 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R5": { "role": "http://ipsipay.com/role/ConsolidatedIncomeStatement_Parentheticals", "longName": "004 - Statement - Consolidated Statements of Operations (Parentheticals)", "shortName": "Consolidated Statements of Operations (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": null, "uniqueAnchor": null }, "R6": { "role": "http://ipsipay.com/role/ShareholdersEquityType2or3", "longName": "005 - Statement - Consolidated Statements of Changes in Stockholders\u2019 Equity (Deficit)", "shortName": "Consolidated Statements of Changes in Stockholders\u2019 Equity (Deficit)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c7", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c7", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R7": { "role": "http://ipsipay.com/role/ConsolidatedCashFlow", "longName": "006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:GainOrLossOnSaleOfStockInSubsidiary", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R8": { "role": "http://ipsipay.com/role/OrganizationandDescriptionofBusiness", "longName": "007 - Disclosure - Organization and Description of Business", "shortName": "Organization and Description of Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R9": { "role": "http://ipsipay.com/role/AccountingPoliciesandEstimates", "longName": "008 - Disclosure - Accounting Policies and Estimates", "shortName": "Accounting Policies and Estimates", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R10": { "role": "http://ipsipay.com/role/LiquidityMattersandGoingConcern", "longName": "009 - Disclosure - Liquidity Matters and Going Concern", "shortName": "Liquidity Matters and Going Concern", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R11": { "role": "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintech", "longName": "010 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech", "shortName": "Disposal of Investment in Frictionless and Beyond Fintech", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c0", "name": "ipsi:DisposalOfInvestmentInFrictionlessAndBeyondFintechTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ipsi:DisposalOfInvestmentInFrictionlessAndBeyondFintechTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R12": { "role": "http://ipsipay.com/role/NovationofCertainAssetsandLiabilites", "longName": "011 - Disclosure - Novation of Certain Assets and Liabilites", "shortName": "Novation of Certain Assets and Liabilites", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c0", "name": "ipsi:NovationofCertinAssetsandLiabilitesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ipsi:NovationofCertinAssetsandLiabilitesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R13": { "role": "http://ipsipay.com/role/DiscontinuedOperations", "longName": "012 - Disclosure - Discontinued Operations", "shortName": "Discontinued Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R14": { "role": "http://ipsipay.com/role/Intangibles", "longName": "013 - Disclosure - Intangibles", "shortName": "Intangibles", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R15": { "role": "http://ipsipay.com/role/EquityMethodInvestment", "longName": "014 - Disclosure - Equity Method Investment", "shortName": "Equity Method Investment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R16": { "role": "http://ipsipay.com/role/Investments", "longName": "015 - Disclosure - Investments", "shortName": "Investments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:InvestmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R17": { "role": "http://ipsipay.com/role/Leases", "longName": "016 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R18": { "role": "http://ipsipay.com/role/FederalReliefLoans", "longName": "017 - Disclosure - Federal Relief Loans", "shortName": "Federal Relief Loans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FederalHomeLoanBankAdvancesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FederalHomeLoanBankAdvancesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R19": { "role": "http://ipsipay.com/role/NotesPayable", "longName": "018 - Disclosure - Notes Payable", "shortName": "Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R20": { "role": "http://ipsipay.com/role/ConvertibleNotesPayable", "longName": "019 - Disclosure - Convertible Notes Payable", "shortName": "Convertible Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c0", "name": "ipsi:ConvertibleNotesPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ipsi:ConvertibleNotesPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R21": { "role": "http://ipsipay.com/role/DerivativeLiability", "longName": "020 - Disclosure - Derivative Liability", "shortName": "Derivative Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DerivativesAndFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DerivativesAndFairValueTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R22": { "role": "http://ipsipay.com/role/StockholdersEquity", "longName": "021 - Disclosure - Stockholders\u2019 Equity", "shortName": "Stockholders\u2019 Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R23": { "role": "http://ipsipay.com/role/LossonConvertibleNotes", "longName": "022 - Disclosure - Loss on Convertible Notes", "shortName": "Loss on Convertible Notes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c0", "name": "ipsi:LossOnConvertibleNotesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ipsi:LossOnConvertibleNotesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R24": { "role": "http://ipsipay.com/role/IncomeTaxes", "longName": "023 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R25": { "role": "http://ipsipay.com/role/EquityBasedCompensation", "longName": "024 - Disclosure - Equity Based Compensation", "shortName": "Equity Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R26": { "role": "http://ipsipay.com/role/NetLossPerShare", "longName": "025 - Disclosure - Net Loss Per Share", "shortName": "Net Loss Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R27": { "role": "http://ipsipay.com/role/RelatedPartyTransactions", "longName": "026 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R28": { "role": "http://ipsipay.com/role/CommitmentsandContingencies", "longName": "027 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R29": { "role": "http://ipsipay.com/role/SubsequentEvents", "longName": "028 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R30": { "role": "http://ipsipay.com/role/AccountingPoliciesByPolicy", "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)", "shortName": "Accounting Policies, by Policy (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "30", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R31": { "role": "http://ipsipay.com/role/AccountingPoliciesandEstimatesTables", "longName": "996001 - Disclosure - Accounting Policies and Estimates (Tables)", "shortName": "Accounting Policies and Estimates (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R32": { "role": "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechTables", "longName": "996002 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Tables)", "shortName": "Disposal of Investment in Frictionless and Beyond Fintech (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c0", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R33": { "role": "http://ipsipay.com/role/NovationofCertainAssetsandLiabilitesTables", "longName": "996003 - Disclosure - Novation of Certain Assets and Liabilites (Tables)", "shortName": "Novation of Certain Assets and Liabilites (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c0", "name": "ipsi:ScheduleOfAssetsAndLiabilitiesNovatedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ipsi:ScheduleOfAssetsAndLiabilitiesNovatedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R34": { "role": "http://ipsipay.com/role/DiscontinuedOperationsTables", "longName": "996004 - Disclosure - Discontinued Operations (Tables)", "shortName": "Discontinued Operations (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R35": { "role": "http://ipsipay.com/role/IntangiblesTables", "longName": "996005 - Disclosure - Intangibles (Tables)", "shortName": "Intangibles (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R36": { "role": "http://ipsipay.com/role/EquityMethodInvestmentTables", "longName": "996006 - Disclosure - Equity Method Investment (Tables)", "shortName": "Equity Method Investment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R37": { "role": "http://ipsipay.com/role/LeasesTables", "longName": "996007 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R38": { "role": "http://ipsipay.com/role/NotesPayableTables", "longName": "996008 - Disclosure - Notes Payable (Tables)", "shortName": "Notes Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R39": { "role": "http://ipsipay.com/role/ConvertibleNotesPayableTables", "longName": "996009 - Disclosure - Convertible Notes Payable (Tables)", "shortName": "Convertible Notes Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ConvertibleDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ConvertibleDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R40": { "role": "http://ipsipay.com/role/DerivativeLiabilityTables", "longName": "996010 - Disclosure - Derivative Liability (Tables)", "shortName": "Derivative Liability (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R41": { "role": "http://ipsipay.com/role/StockholdersEquityTables", "longName": "996011 - Disclosure - Stockholders\u2019 Equity (Tables)", "shortName": "Stockholders\u2019 Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R42": { "role": "http://ipsipay.com/role/LossonConvertibleNotesTables", "longName": "996012 - Disclosure - Loss on Convertible Notes (Tables)", "shortName": "Loss on Convertible Notes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDebtConversionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ipsi:LossOnConvertibleNotesTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDebtConversionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ipsi:LossOnConvertibleNotesTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R43": { "role": "http://ipsipay.com/role/IncomeTaxesTables", "longName": "996013 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R44": { "role": "http://ipsipay.com/role/EquityBasedCompensationTables", "longName": "996014 - Disclosure - Equity Based Compensation (Tables)", "shortName": "Equity Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R45": { "role": "http://ipsipay.com/role/NetLossPerShareTables", "longName": "996015 - Disclosure - Net Loss Per Share (Tables)", "shortName": "Net Loss Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R46": { "role": "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "longName": "996016 - Disclosure - Organization and Description of Business (Details)", "shortName": "Organization and Description of Business (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c62", "name": "us-gaap:StockIssuedDuringPeriodSharesOther", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R47": { "role": "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails", "longName": "996017 - Disclosure - Accounting Policies and Estimates (Details)", "shortName": "Accounting Policies and Estimates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R48": { "role": "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable", "longName": "996018 - Disclosure - Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets", "shortName": "Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c66", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c66", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R49": { "role": "http://ipsipay.com/role/LiquidityMattersandGoingConcernDetails", "longName": "996019 - Disclosure - Liquidity Matters and Going Concern (Details)", "shortName": "Liquidity Matters and Going Concern (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": null }, "R50": { "role": "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails", "longName": "996020 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Details)", "shortName": "Disposal of Investment in Frictionless and Beyond Fintech (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c71", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ipsi:DisposalOfInvestmentInFrictionlessAndBeyondFintechTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c63", "name": "us-gaap:SaleOfStockConsiderationReceivedPerTransaction", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ipsi:DisposalOfInvestmentInFrictionlessAndBeyondFintechTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R51": { "role": "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "longName": "996021 - Disclosure - Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities", "shortName": "Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c73", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c73", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R52": { "role": "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable", "longName": "996022 - Disclosure - Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated", "shortName": "Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c75", "name": "us-gaap:ReceivableInvestmentSale", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c75", "name": "us-gaap:ReceivableInvestmentSale", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R53": { "role": "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0", "longName": "996023 - Disclosure - Discontinued Operations (Details) - Schedule of Assets and Liabilities", "shortName": "Discontinued Operations (Details) - Schedule of Assets and Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R54": { "role": "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable", "longName": "996024 - Disclosure - Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations", "shortName": "Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c77", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c77", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R55": { "role": "http://ipsipay.com/role/IntangiblesDetails", "longName": "996025 - Disclosure - Intangibles (Details)", "shortName": "Intangibles (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c60", "name": "us-gaap:ProceedsFromSaleOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c60", "name": "us-gaap:ProceedsFromSaleOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R56": { "role": "http://ipsipay.com/role/ScheduleofFacilitatetheFunctioningoftheIPSIPaySoftwareTable", "longName": "996026 - Disclosure - Intangibles (Details) - Schedule of Facilitate the Functioning of the IPSIPay Software", "shortName": "Intangibles (Details) - Schedule of Facilitate the Functioning of the IPSIPay Software", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c4", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R57": { "role": "http://ipsipay.com/role/EquityMethodInvestmentDetails", "longName": "996027 - Disclosure - Equity Method Investment (Details)", "shortName": "Equity Method Investment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c3", "name": "ipsi:CapitalContributionInitialTrancheAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "ipsi:CapitalContributionInitialTrancheAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R58": { "role": "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable", "longName": "996028 - Disclosure - Equity Method Investment (Details) - Schedule of Equity Method Investments", "shortName": "Equity Method Investment (Details) - Schedule of Equity Method Investments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c85", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c85", "name": "us-gaap:PaymentsToAcquireEquityMethodInvestments", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R59": { "role": "http://ipsipay.com/role/InvestmentsDetails", "longName": "996029 - Disclosure - Investments (Details)", "shortName": "Investments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c87", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:InvestmentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c87", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:InvestmentTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R60": { "role": "http://ipsipay.com/role/LeasesDetails", "longName": "996030 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:LessorOperatingLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:LessorOperatingLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R61": { "role": "http://ipsipay.com/role/ScheduleofTotalLeaseCostTable", "longName": "996031 - Disclosure - Leases (Details) - Schedule of Total Lease Cost", "shortName": "Leases (Details) - Schedule of Total Lease Cost", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": null }, "R62": { "role": "http://ipsipay.com/role/ScheduleofOtherLeaseInformationTable", "longName": "996032 - Disclosure - Leases (Details) - Schedule of Other Lease Information", "shortName": "Leases (Details) - Schedule of Other Lease Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OperatingLeaseExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:LesseeOperatingLeaseDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R63": { "role": "http://ipsipay.com/role/FederalReliefLoansDetails", "longName": "996033 - Disclosure - Federal Relief Loans (Details)", "shortName": "Federal Relief Loans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c89", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:FederalHomeLoanBankAdvancesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c89", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:FederalHomeLoanBankAdvancesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R64": { "role": "http://ipsipay.com/role/NotesPayableDetails", "longName": "996034 - Disclosure - Notes Payable (Details)", "shortName": "Notes Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c4", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ipsi:ConvertibleNotesPayableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c100", "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R65": { "role": "http://ipsipay.com/role/ScheduleofNotesPayableTable", "longName": "996035 - Disclosure - Notes Payable (Details) - Schedule of Notes Payable", "shortName": "Notes Payable (Details) - Schedule of Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c109", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c109", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R66": { "role": "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "longName": "996036 - Disclosure - Convertible Notes Payable (Details)", "shortName": "Convertible Notes Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c112", "name": "us-gaap:DebtInstrumentMaturityDateRangeEnd1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ipsi:ConvertibleNotesPayableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c112", "name": "us-gaap:DebtInstrumentMaturityDateRangeEnd1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ipsi:ConvertibleNotesPayableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R67": { "role": "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "longName": "996037 - Disclosure - Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable", "shortName": "Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DebtInstrumentIssuedPrincipal", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DebtInstrumentIssuedPrincipal", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R68": { "role": "http://ipsipay.com/role/DerivativeLiabilityDetails", "longName": "996038 - Disclosure - Derivative Liability (Details)", "shortName": "Derivative Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c0", "name": "ipsi:RachetProvision", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DerivativesAndFairValueTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ipsi:RachetProvision", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:DerivativesAndFairValueTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R69": { "role": "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "longName": "996039 - Disclosure - Derivative Liability (Details) - Schedule of Assumptions were used in the Black-Scholes Valuation Model", "shortName": "Derivative Liability (Details) - Schedule of Assumptions were used in the Black-Scholes Valuation Model", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R70": { "role": "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable", "longName": "996040 - Disclosure - Derivative Liability (Details) - Schedule of Movement in Derivative Liability", "shortName": "Derivative Liability (Details) - Schedule of Movement in Derivative Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c3", "name": "ipsi:DerivativesLiabilityNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "ipsi:DerivativesLiabilityNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R71": { "role": "http://ipsipay.com/role/StockholdersEquityDetails", "longName": "996041 - Disclosure - Stockholders\u2019 Equity (Details)", "shortName": "Stockholders\u2019 Equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c207", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R72": { "role": "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable", "longName": "996042 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of Restricted Stock Activity", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of Restricted Stock Activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c258", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c246", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R73": { "role": "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable", "longName": "996043 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of Restricted Stock Granted, Issued and Exercisable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of Restricted Stock Granted, Issued and Exercisable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R74": { "role": "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable", "longName": "996044 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c101", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c101", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R75": { "role": "http://ipsipay.com/role/ScheduleofWarrantActivityTable", "longName": "996045 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of Warrant Activity", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of Warrant Activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c292", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c286", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R76": { "role": "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable", "longName": "996046 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of Warrants Outstanding and Exercisable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of Warrants Outstanding and Exercisable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c182", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c182", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R77": { "role": "http://ipsipay.com/role/ScheduleofOptionActivityTable", "longName": "996047 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of Option Activity", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of Option Activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c314", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c308", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R78": { "role": "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "longName": "996048 - Disclosure - Stockholders\u2019 Equity (Details) - Schedule of Options Outstanding and Exercisable", "shortName": "Stockholders\u2019 Equity (Details) - Schedule of Options Outstanding and Exercisable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c319", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c319", "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R79": { "role": "http://ipsipay.com/role/LossonConvertibleNotesDetails", "longName": "996049 - Disclosure - Loss on Convertible Notes (Details)", "shortName": "Loss on Convertible Notes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c326", "name": "ipsi:SettlementPenaltyPayment", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ipsi:LossOnConvertibleNotesTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c326", "name": "ipsi:SettlementPenaltyPayment", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ipsi:LossOnConvertibleNotesTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R80": { "role": "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable", "longName": "996050 - Disclosure - Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes", "shortName": "Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c0", "name": "ipsi:PenaltyOnCashSettlementOfConvertibleNote", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ipsi:LossOnConvertibleNotesTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "ipsi:PenaltyOnCashSettlementOfConvertibleNote", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ipsi:LossOnConvertibleNotesTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R81": { "role": "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable_Parentheticals", "longName": "996051 - Disclosure - Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes (Parentheticals)", "shortName": "Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes (Parentheticals)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ipsi:LossOnConvertibleNotesTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ipsi:LossOnConvertibleNotesTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R82": { "role": "http://ipsipay.com/role/IncomeTaxesDetails", "longName": "996052 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c350", "name": "ipsi:MarginalRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c350", "name": "ipsi:MarginalRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R83": { "role": "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable", "longName": "996053 - Disclosure - Income Taxes (Details) - Schedule of Provision for Income Taxes", "shortName": "Income Taxes (Details) - Schedule of Provision for Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": null, "uniqueAnchor": null }, "R84": { "role": "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable", "longName": "996054 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of the U.S. Federal Statutory Income Tax", "shortName": "Income Taxes (Details) - Schedule of Reconciliation of the U.S. Federal Statutory Income Tax", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R85": { "role": "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable", "longName": "996055 - Disclosure - Income Taxes (Details) - Schedule of Deferred Income Tax Assets", "shortName": "Income Taxes (Details) - Schedule of Deferred Income Tax Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c3", "name": "us-gaap:DeferredTaxAssetsOther", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c3", "name": "us-gaap:DeferredTaxAssetsOther", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R86": { "role": "http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable", "longName": "996056 - Disclosure - Equity Based Compensation (Details) - Schedule of Equity Based Compensation", "shortName": "Equity Based Compensation (Details) - Schedule of Equity Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R87": { "role": "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable", "longName": "996057 - Disclosure - Net Loss Per Share (Details) - Schedule of Anti-dilutive Shares", "shortName": "Net Loss Per Share (Details) - Schedule of Anti-dilutive Shares", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R88": { "role": "http://ipsipay.com/role/RelatedPartyTransactionsDetails", "longName": "996058 - Disclosure - Related Party Transactions (Details)", "shortName": "Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c362", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c363", "name": "us-gaap:StockOptionExercisePriceIncrease", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } }, "R89": { "role": "http://ipsipay.com/role/CommitmentsandContingenciesDetails", "longName": "996059 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c110", "name": "us-gaap:DebtInstrumentMaturityDateDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c110", "name": "us-gaap:DebtInstrumentMaturityDateDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true, "unique": true } }, "R90": { "role": "http://ipsipay.com/role/SubsequentEventsDetails", "longName": "996060 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c3", "name": "ipsi:CommonStockOutstandingPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "ea0203998-10ka1_innova.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies and Estimates [Abstract]" } } }, "auth_ref": [] }, "ipsi_AccountingPoliciesandEstimatesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AccountingPoliciesandEstimatesDetailsLineItems", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies and Estimates [Abstract]", "label": "Accounting Policiesand Estimates Details Line Items" } } }, "auth_ref": [] }, "ipsi_AccountingPoliciesandEstimatesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AccountingPoliciesandEstimatesDetailsTable", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails" ], "lang": { "en-us": { "role": { "label": "Accounting Policies and Estimates (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r25", "r798" ] }, "us-gaap_AccountsPayableInterestBearingInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableInterestBearingInterestRate", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bears interest", "label": "Accounts Payable, Interest-Bearing, Interest Rate", "documentation": "Reflects the effective interest rate as of the balance sheet date on interest-bearing trade payables." } } }, "auth_ref": [ "r100", "r101", "r103", "r104" ] }, "ipsi_AdditionalCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AdditionalCharge", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional charge", "documentation": "Additional charge.", "label": "Additional Charge" } } }, "auth_ref": [] }, "ipsi_AdditionalChargesOnConversionOfWarrant": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AdditionalChargesOnConversionOfWarrant", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Charge", "documentation": "Represent the amount of additional charges on conversion of warrant.", "label": "Additional Charges On Conversion Of Warrant" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in-capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r144", "r798", "r955" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r478", "r479", "r480", "r650", "r860", "r861", "r862", "r928", "r957" ] }, "ipsi_AdditionalPurchaseSharesOfCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AdditionalPurchaseSharesOfCommonStock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional purchase shares of common stock", "documentation": "Additional purchase shares of common stock.", "label": "Additional Purchase Shares Of Common Stock" } } }, "auth_ref": [] }, "us-gaap_AdjustmentOfWarrantsGrantedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentOfWarrantsGrantedForServices", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants", "label": "Adjustment of Warrants Granted for Services", "documentation": "Adjustment for noncash service expenses paid for by granting of warrants." } } }, "auth_ref": [ "r7" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants issued to convertible debt holders", "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature", "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature." } } }, "auth_ref": [ "r15", "r181", "r499" ] }, "ipsi_AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssuedForEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AdjustmentsToAdditionalPaidInCapitalFairValueOfWarrantsIssuedForEquityMethodInvestments", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants issued for equity method investments", "documentation": "Fair value of warrants issued for equity method investments.", "label": "Adjustments To Additional Paid In Capital Fair Value Of Warrants Issued For Equity Method Investments" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Stock based compensation", "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Stock based option expense", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration." } } }, "auth_ref": [ "r15", "r181" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants issued for services", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants." } } }, "auth_ref": [ "r15", "r63", "r181" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to reconcile net loss to net cash used in operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ipsi_AggregateAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AggregateAmount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "documentation": "Total Aggregate Amount means the sum of (i) the Purchase Price and (ii) the total consideration paid by Buyer's Affiliate to Seller under the Intellectual Property License Agreement.", "label": "Aggregate Amount" } } }, "auth_ref": [] }, "ipsi_AggregateOfGrossProceedsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AggregateOfGrossProceedsReceived", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate of gross proceeds received", "documentation": "Aggregate of gross proceeds received.", "label": "Aggregate Of Gross Proceeds Received" } } }, "auth_ref": [] }, "ipsi_AggregatePurchaseOfCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AggregatePurchaseOfCommonStock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate purchase of common stock", "documentation": "Aggregate purchase of common stock.", "label": "Aggregate Purchase Of Common Stock" } } }, "auth_ref": [] }, "ipsi_AgreementFee": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AgreementFee", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreement fee (in Dollars)", "documentation": "The amount of agreement fee.", "label": "Agreement Fee" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Equity based compensation", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r474", "r485" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Description", "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ipsi_AmendmentTransactionMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AmendmentTransactionMember", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Transaction [Member]", "label": "Amendment Transaction Member" } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt discount total", "label": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r7", "r102", "r159", "r420" ] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 3.0 }, "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt discount", "negatedLabel": "Amortization of debt discount", "label": "Amortization of Debt Issuance Costs and Discounts", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r420", "r540", "r789", "r790", "r854" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r7", "r54", "r58" ] }, "ipsi_AmountOfImmediateExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AmountOfImmediateExpense", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount of immediate expense (in Dollars)", "documentation": "Amount of immediate expense.", "label": "Amount Of Immediate Expense" } } }, "auth_ref": [] }, "ipsi_AndreyNovikovMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "AndreyNovikovMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Andrey Novikov [Member]", "label": "Andrey Novikov Member" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive shares", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r291" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r48" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Dilutive Shares [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r512" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails", "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Investment impairment charge", "terseLabel": "Impairment charge", "label": "Asset Impairment Charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r7", "r59" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total Assets", "terseLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r198", "r240", "r262", "r298", "r313", "r317", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r514", "r518", "r531", "r607", "r696", "r798", "r810", "r882", "r883", "r936" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r236", "r245", "r262", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r514", "r518", "r531", "r798", "r882", "r883", "r936" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Current Assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNet", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net assets sold", "label": "Net Assets", "documentation": "Amount of net assets (liabilities)." } } }, "auth_ref": [ "r12" ] }, "us-gaap_AssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrent", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Non-Current Assets", "label": "Assets, Noncurrent", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r262", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r514", "r518", "r531", "r882", "r883", "r936" ] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets", "label": "Assets, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable": { "parentTag": "us-gaap_AssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Disposal Group, Including Discontinued Operation, Assets", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r2", "r112", "r129", "r174", "r234", "r235" ] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Assets held for sale", "terseLabel": "Assets held for sale", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r112", "r129", "r172", "r174", "r234", "r235" ] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrentAbstract", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "label": "Schedule of Assets and Liabilities [Abstract]", "terseLabel": "Current assets" } } }, "auth_ref": [] }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrentAbstract", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets", "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Firm ID", "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r814", "r815", "r816" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Location", "label": "Auditor Location" } } }, "auth_ref": [ "r814", "r815", "r816" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Auditor Name", "label": "Auditor Name" } } }, "auth_ref": [ "r814", "r815", "r816" ] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateAxis", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardDateDomain", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Award Date [Domain]", "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r445", "r446", "r447", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r470", "r471", "r472", "r473" ] }, "ipsi_BZWRMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "BZWRMember", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "BZWR [Member]", "label": "BZWRMember" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimates" ], "lang": { "en-us": { "role": { "terseLabel": "ACCOUNTING POLICIES AND ESTIMATES", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r167" ] }, "ipsi_BeneficiallyOwnOfPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "BeneficiallyOwnOfPercentage", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Beneficially own of percentage", "documentation": "Percentage of beneficially own in excess.", "label": "Beneficially Own Of Percentage" } } }, "auth_ref": [] }, "ipsi_BeyondFintechIncMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "BeyondFintechIncMember", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails", "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Beyond Fintech Inc. [Member]", "verboseLabel": "Beyond Fintech [Member]", "label": "Beyond Fintech Inc Member" } } }, "auth_ref": [] }, "ipsi_BeyondFintechMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "BeyondFintechMember", "presentation": [ "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Beyond Fintech [Member]", "label": "Beyond Fintech Member" } } }, "auth_ref": [] }, "ipsi_BlackScholesMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "BlackScholesMember", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Black-Scholes [Member]", "label": "Black Scholes Member" } } }, "auth_ref": [] }, "ipsi_BlackScholesValuationModel": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "BlackScholesValuationModel", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Black-scholes valuation model", "documentation": "Black-Scholes valuation model.", "label": "Black Scholes Valuation Model" } } }, "auth_ref": [] }, "ipsi_BlackScholesValuationModelMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "BlackScholesValuationModelMember", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Black Scholes Valuation Model [Member]", "label": "Black Scholes Valuation Model Member" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r511", "r792", "r793" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r78", "r80", "r511", "r792", "r793" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired interest", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r79" ] }, "ipsi_CapitalContributionInitialTrancheAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CapitalContributionInitialTrancheAmount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/EquityMethodInvestmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital contribution initial tranche amount", "documentation": "Capital contribution initial tranche amount.", "label": "Capital Contribution Initial Tranche Amount" } } }, "auth_ref": [] }, "ipsi_CapitalContributionSecondTrancheAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CapitalContributionSecondTrancheAmount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/EquityMethodInvestmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital contribution second tranche amount", "documentation": "Capital contribution second tranche amount.", "label": "Capital Contribution Second Tranche Amount" } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash", "periodEndLabel": "Cash", "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r215", "r608", "r661", "r690", "r798", "r810", "r843" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r42" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "CASH AT BEGINNING OF YEAR", "periodEndLabel": "CASH AT END OF YEAR", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r41", "r164", "r260" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "CASH AT BEGINNING OF THE YEAR", "periodEndLabel": "CASH AT END OF THE YEAR", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r41", "r164", "r260" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "NET DECREASE IN CASH", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r1", "r164" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r843", "r949" ] }, "us-gaap_CashFDICInsuredAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFDICInsuredAmount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federally insured limit", "label": "Cash, FDIC Insured Amount", "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation." } } }, "auth_ref": [] }, "ipsi_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract", "presentation": [ "http://ipsipay.com/role/ScheduleofOtherLeaseInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities", "label": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities Abstract" } } }, "auth_ref": [] }, "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash used in investing activities \u2013 discontinued operations", "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations", "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r128", "r164" ] }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash generated by operating activities - discontinued operations", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r128", "r164" ] }, "ipsi_CavalryAndMercerMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CavalryAndMercerMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cavalry and Mercer [Member]", "verboseLabel": "Mercer Street Global Opportunity Fund, LLC [Member]", "label": "Cavalry And Mercer Member" } } }, "auth_ref": [] }, "ipsi_CavalryFundILPMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CavalryFundILPMember", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cavalry Fund I LP [Member]", "label": "Cavalry Fund ILPMember" } } }, "auth_ref": [] }, "ipsi_CavalryFundLLPMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CavalryFundLLPMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cavalry Fund LLP [Member]", "verboseLabel": "Cavalry Fund I LP [Member]", "label": "Cavalry Fund LLPMember" } } }, "auth_ref": [] }, "ipsi_CavalryMercerNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CavalryMercerNoteMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cavalry/Mercer Note [Member]", "label": "Cavalry Mercer Note Member" } } }, "auth_ref": [] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Executive Officer [Member]", "label": "Chief Executive Officer [Member]", "documentation": "Person with designation of chief executive officer." } } }, "auth_ref": [ "r866" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/StockholdersEquityDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r227", "r241", "r242", "r243", "r262", "r284", "r285", "r288", "r290", "r296", "r297", "r362", "r389", "r391", "r392", "r393", "r396", "r397", "r428", "r429", "r430", "r431", "r434", "r531", "r639", "r640", "r641", "r642", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r662", "r682", "r705", "r728", "r764", "r765", "r766", "r767", "r768", "r822", "r855", "r864" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable", "http://ipsipay.com/role/StockholdersEquityDetails", "http://ipsipay.com/role/StockholdersEquityTables", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r67" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/StockholdersEquityDetails", "http://ipsipay.com/role/StockholdersEquityTables", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price (in Dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r435" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails", "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants to purchase of common stock (in Shares)", "verboseLabel": "Warrants issued to purchase of common stock (in Shares)", "netLabel": "Warrant exercisable (in Shares)", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r435" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant exercisable", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "ipsi_CliffordHenryMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CliffordHenryMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Clifford Henry [Member]", "label": "Clifford Henry Member" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://ipsipay.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "COMMITMENTS AND CONTINGENCIES", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r176", "r381", "r382", "r770", "r878" ] }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Contingencies", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies." } } }, "auth_ref": [ "r61", "r771" ] }, "ipsi_CommitmentsandContingenciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CommitmentsandContingenciesDetailsTable", "presentation": [ "http://ipsipay.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonStockConvertibleConversionPriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockConvertibleConversionPriceIncrease", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price per share (in Dollars per share)", "verboseLabel": "Conversion price (in Dollars per share)", "label": "Common Stock, Convertible, Conversion Price, Increase", "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r435" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock price per share (in Dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r181" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ShareholdersEquityType2or3", "http://ipsipay.com/role/StockholdersEquityDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r860", "r861", "r928", "r953", "r957" ] }, "us-gaap_CommonStockOtherSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockOtherSharesOutstanding", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate of shares of common stock", "label": "Common Stock, Other Shares, Outstanding", "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized." } } }, "auth_ref": [] }, "ipsi_CommonStockOutstandingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CommonStockOutstandingPercentage", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock outstanding percentage", "documentation": "Common stock outstanding percentage.", "label": "Common Stock Outstanding Percentage" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Common stock par value (in Dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r143" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized", "verboseLabel": "Common stock authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r143", "r682" ] }, "ipsi_CommonStockSharesHolderCurrent": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "CommonStockSharesHolderCurrent", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock shares holder current", "documentation": "Number of common stock holder current.", "label": "Common Stock Shares Holder Current" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued", "verboseLabel": "Common stock issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r143" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding", "verboseLabel": "Common stock outstanding", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r15", "r143", "r682", "r702", "r957", "r958" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,819,889 and 12,563,426 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively.", "verboseLabel": "Common Stock, Value, Issued", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r143", "r610", "r798" ] }, "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Provision for Income Taxes [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive income", "label": "Comprehensive Income, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for comprehensive income." } } }, "auth_ref": [] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Computer Equipment [Member]", "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerSoftwareIntangibleAssetMember", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Software [Member]", "label": "Computer Software, Intangible Asset [Member]", "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks." } } }, "auth_ref": [ "r776", "r874", "r875" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Risks and Uncertainties", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r109", "r218" ] }, "srt_CondensedBalanceSheetStatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedBalanceSheetStatementTable", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "label": "Condensed Balance Sheet Statement [Table]", "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r229", "r266", "r825" ] }, "srt_CondensedBalanceSheetStatementsCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedBalanceSheetStatementsCaptionsLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "label": "Condensed Balance Sheet Statements, Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r230", "r266", "r825" ] }, "srt_CondensedStatementOfComprehensiveIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedStatementOfComprehensiveIncomeTable", "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "label": "Condensed Statement of Comprehensive Income [Table]", "documentation": "Disclosure of information about condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r229", "r266", "r825" ] }, "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock", "presentation": [ "http://ipsipay.com/role/DiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Statement of Operations from Discontinued Operations", "label": "Condensed Statement of Comprehensive Income [Table Text Block]", "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r838", "r859" ] }, "srt_CondensedStatementOfIncomeCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CondensedStatementOfIncomeCaptionsLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "label": "Condensed Statement of Income Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r230", "r266", "r825" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r231", "r266", "r514", "r515", "r518", "r519", "r554", "r772", "r839", "r840", "r841", "r881", "r884", "r885" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r231", "r266", "r514", "r515", "r518", "r519", "r554", "r772", "r839", "r840", "r841", "r881", "r884", "r885" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Principles of Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r84", "r778" ] }, "us-gaap_ContributionOfProperty": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContributionOfProperty", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital contribution (in Dollars)", "label": "Contribution of Property", "documentation": "Value of property contributed in noncash investing and financing activities." } } }, "auth_ref": [ "r44", "r45", "r46" ] }, "ipsi_ConversionOfConvertibleDebtToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ConversionOfConvertibleDebtToEquity", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible debt (in Dollars)", "documentation": "Amount of conversion of convertible debt to equity.", "label": "Conversion Of Convertible Debt To Equity" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockAmountConverted1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockAmountConverted1", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of convertible debt to equity", "verboseLabel": "Converted interest", "label": "Conversion of Stock, Amount Converted", "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r44", "r45", "r46" ] }, "us-gaap_ConversionOfStockAmountIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockAmountIssued1", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible notes", "label": "Conversion of Stock, Amount Issued", "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r44", "r45", "r46" ] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock conversion price (in Shares)", "label": "Conversion of Stock, Shares Converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r44", "r45", "r46" ] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible debt", "label": "Convertible Debt", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r23", "r200", "r948" ] }, "us-gaap_ConvertibleDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtCurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible debt, net of unamortized discount of $687,503 and $263,200, respectively", "label": "Convertible Debt, Current", "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r139" ] }, "us-gaap_ConvertibleDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtMember", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Debt [Member]", "label": "Convertible Debt [Member]", "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock." } } }, "auth_ref": [ "r178", "r399", "r400", "r410", "r411", "r412", "r416", "r417", "r418", "r419", "r420", "r786", "r787", "r788", "r789", "r790" ] }, "us-gaap_ConvertibleDebtSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtSecuritiesMember", "presentation": [ "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible debt [Member]", "label": "Convertible Debt Securities [Member]", "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder." } } }, "auth_ref": [ "r888" ] }, "us-gaap_ConvertibleDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtTableTextBlock", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Convertible Notes Payable", "label": "Convertible Debt [Table Text Block]", "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount." } } }, "auth_ref": [] }, "us-gaap_ConvertibleLongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleLongTermNotesPayable", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible notes", "label": "Convertible Notes Payable, Noncurrent", "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r33" ] }, "us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract", "lang": { "en-us": { "role": { "label": "Convertible Notes Payable [Abstract]" } } }, "auth_ref": [] }, "ipsi_ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ConvertibleNoteMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Note [Member]", "label": "Convertible Note Member" } } }, "auth_ref": [] }, "ipsi_ConvertibleNotesOwingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ConvertibleNotesOwingAmount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible notes owing amount", "documentation": "Represent the amount of convertible notes owing.", "label": "Convertible Notes Owing Amount" } } }, "auth_ref": [] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayable", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible note holders", "label": "Convertible Notes Payable", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r23", "r200", "r948" ] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total convertible notes payable", "label": "Convertible Notes Payable, Current", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r29" ] }, "ipsi_ConvertibleNotesPayableDetailsScheduleofConvertibleNotesPayableTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ConvertibleNotesPayableDetailsScheduleofConvertibleNotesPayableTable", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable [Table]" } } }, "auth_ref": [] }, "ipsi_ConvertibleNotesPayableDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ConvertibleNotesPayableDetailsTable", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable (Details) [Table]" } } }, "auth_ref": [] }, "ipsi_ConvertibleNotesPayableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ConvertibleNotesPayableTextBlock", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayable" ], "lang": { "en-us": { "role": { "terseLabel": "CONVERTIBLE NOTES PAYABLE", "documentation": "The entire disclosure for convertible notes payable.", "label": "Convertible Notes Payable Text Block" } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Goods Sold", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r155", "r589" ] }, "us-gaap_CreditDerivativeLiquidationProceedsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditDerivativeLiquidationProceedsPercentage", "presentation": [ "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit rate", "label": "Credit Derivative, Liquidation Proceeds, Percentage", "documentation": "Estimated percentage to which the maximum potential amount of future payments under the credit derivative would be covered by the proceeds from liquidation of assets held either as collateral or by third parties." } } }, "auth_ref": [ "r97" ] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Current", "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Current Federal Tax Expense (Benefit)", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r827", "r858", "r922" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentForeignTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Current Foreign Tax Expense (Benefit)", "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r827", "r858" ] }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total current tax benefits", "label": "Current Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations." } } }, "auth_ref": [ "r190", "r498", "r505", "r858" ] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable": { "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Current State and Local Tax Expense (Benefit)", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r827", "r858", "r922" ] }, "ipsi_DavidRiosMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DavidRiosMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "David Rios [Member]", "label": "David Rios Member" } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentRate", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion rate", "label": "Debt Conversion, Converted Instrument, Rate", "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments." } } }, "auth_ref": [ "r44", "r46" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion shares issued (in Shares)", "verboseLabel": "Aggregate shares of common stock", "label": "Debt Conversion, Converted Instrument, Shares Issued", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r44", "r46" ] }, "us-gaap_DebtConversionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable", "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Schedule of Convertible Notes Payable [Line Items]", "terseLabel": "Schedule of the Loss on Convertible Notes [Abstract]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ipsi_DebtConversionNoticesMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DebtConversionNoticesMember", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Conversion Notices [Member]", "label": "Debt Conversion Notices Member" } } }, "auth_ref": [] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible debt amount (in Dollars)", "label": "Debt Conversion, Original Debt, Amount", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r44", "r46" ] }, "us-gaap_DebtConversionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionTable", "presentation": [ "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable", "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Debt Conversion [Table]", "documentation": "A table that contains information on an original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r44", "r46" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://ipsipay.com/role/NotesPayable" ], "lang": { "en-us": { "role": { "terseLabel": "NOTES PAYABLE", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r177", "r261", "r398", "r404", "r405", "r406", "r407", "r408", "r409", "r414", "r421", "r422", "r424" ] }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAnnualPrincipalPayment", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount", "label": "Debt Instrument, Annual Principal Payment", "documentation": "Amount of the total principal payments made during the annual reporting period." } } }, "auth_ref": [ "r23" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://ipsipay.com/role/CommitmentsandContingenciesDetails", "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/FederalReliefLoansDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/ScheduleofNotesPayableTable", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r23", "r139", "r140", "r199", "r200", "r266", "r399", "r400", "r401", "r402", "r403", "r405", "r410", "r411", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r541", "r786", "r787", "r788", "r789", "r790", "r856" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price, per share (in Dollars per share)", "verboseLabel": "Conversion price, per share", "netLabel": "Conversion price per share (in Dollars per share)", "label": "Debt Instrument, Convertible, Conversion Price", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r179", "r401" ] }, "us-gaap_DebtInstrumentConvertibleConversionPriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleConversionPriceIncrease", "presentation": [ "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price (in Dollars per share)", "label": "Debt Instrument, Convertible, Conversion Price, Increase", "documentation": "Per share increase in conversion price of debt instrument. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r413", "r435" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/FederalReliefLoansDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/ScheduleofNotesPayableTable", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal", "verboseLabel": "Loan amount", "netLabel": "Debt principal amount", "label": "Original issue amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r103", "r105", "r399", "r541", "r787", "r788" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount", "label": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r412", "r530", "r787", "r788" ] }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentIncreaseAccruedInterest", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ScheduleofNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Interest", "label": "Debt Instrument, Increase, Accrued Interest", "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period." } } }, "auth_ref": [ "r856" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Debt Instrument, Interest Rate During Period", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r31", "r103", "r417" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective interest rate", "verboseLabel": "Interest accrued percentage", "label": "Debt Instrument, Interest Rate, Effective Percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r31", "r103", "r426", "r541" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/FederalReliefLoansDetails", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate", "verboseLabel": "Interest rate", "netLabel": "Variable conversion rate percentage", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r31", "r400" ] }, "us-gaap_DebtInstrumentIssuedPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentIssuedPrincipal", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Principal", "label": "Debt Instrument, Issued, Principal", "documentation": "Amount of principal of debt issued." } } }, "auth_ref": [ "r639" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/ScheduleofNotesPayableTable" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Convertible Notes Payable [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r266", "r399", "r400", "r401", "r402", "r403", "r405", "r410", "r411", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r423", "r541", "r786", "r787", "r788", "r789", "r790", "r856" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/ScheduleofNotesPayableTable", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maturity date", "label": "Debt Instrument, Maturity Date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r225", "r786", "r929" ] }, "us-gaap_DebtInstrumentMaturityDateDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDateDescription", "presentation": [ "http://ipsipay.com/role/CommitmentsandContingenciesDetails", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Maturity date", "verboseLabel": "Notes payable and convertible notes payable description", "label": "Debt Instrument, Maturity Date, Description", "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities." } } }, "auth_ref": [ "r32" ] }, "us-gaap_DebtInstrumentMaturityDateRangeEnd1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDateRangeEnd1", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maturity date", "label": "Debt Instrument, Maturity Date Range, End", "documentation": "Latest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r32" ] }, "us-gaap_DebtInstrumentMaturityDateRangeStart1": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDateRangeStart1", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maturity date", "label": "Debt Instrument, Maturity Date Range, Start", "documentation": "Earliest date the outstanding debt instruments are required to be repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r32" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r33", "r266", "r399", "r400", "r401", "r402", "r403", "r405", "r410", "r411", "r412", "r413", "r415", "r416", "r417", "r418", "r419", "r420", "r541", "r786", "r787", "r788", "r789", "r790", "r856" ] }, "ipsi_DebtInstrumentOriginalIssueDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DebtInstrumentOriginalIssueDiscount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original issue discount", "documentation": "The amount paid to debt instrument original issue discount.", "label": "Debt Instrument Original Issue Discount" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/FederalReliefLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan monthly payment", "label": "Debt Instrument, Periodic Payment", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r33", "r108" ] }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentPeriodicPaymentInterest", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/FederalReliefLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount interest", "label": "Debt Instrument, Periodic Payment, Interest", "documentation": "Amount of the required periodic payments applied to interest." } } }, "auth_ref": [ "r33" ] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible debt, net of unamortized discount (in Dollars)", "verboseLabel": "Net of unamortized debt discount", "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r102", "r105", "r887" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountCurrent", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Unamortized debt discount", "label": "Debt Instrument, Unamortized Discount, Current", "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer." } } }, "auth_ref": [ "r102", "r105" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Net of the derivative liability value", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r104", "r410", "r425", "r787", "r788" ] }, "ipsi_DebtInstrumentsConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DebtInstrumentsConvertibleConversionPrice1", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price (in Dollars per share)", "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instruments Convertible Conversion Price1" } } }, "auth_ref": [] }, "ipsi_DebtInstrumentsInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DebtInstrumentsInterestRateStatedPercentage", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instruments Interest Rate Stated Percentage" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r858", "r921", "r922" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred", "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredForeignIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign", "label": "Deferred Foreign Income Tax Expense (Benefit)", "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r190", "r858", "r921" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax benefits", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r7", "r190", "r223", "r504", "r505", "r858" ] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable": { "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofProvisionforIncomeTaxesTable" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r858", "r921", "r922" ] }, "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsCapitalLossCarryforwards", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Capital loss", "label": "Deferred Tax Assets, Capital Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards." } } }, "auth_ref": [ "r77", "r919" ] }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsLiabilitiesNet", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net deferred income tax assets", "label": "Deferred Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting." } } }, "auth_ref": [ "r918" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails", "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating losses", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r77", "r919" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax purposes federal", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards." } } }, "auth_ref": [ "r77", "r919" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax purposes state", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards." } } }, "auth_ref": [ "r77", "r919" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r77", "r919" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock based compensation", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs." } } }, "auth_ref": [ "r77", "r919" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails", "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "terseLabel": "Valuation allowance for deferred income tax assets", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r494" ] }, "us-gaap_DepositLiabilitiesAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepositLiabilitiesAccruedInterest", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest thereon", "label": "Deposit Liabilities, Accrued Interest", "documentation": "Amount of accrued but unpaid interest on deposit liabilities." } } }, "auth_ref": [ "r106" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 }, "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r7", "r60" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r670", "r673", "r687", "r688", "r689", "r692", "r693", "r694", "r695", "r697", "r698", "r699", "r700", "r716", "r717", "r718", "r719", "r722", "r723", "r724", "r725", "r750", "r752", "r755", "r757", "r800", "r802" ] }, "us-gaap_DerivativeFairValueOfDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeNet", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable": { "parentTag": "us-gaap_DerivativeLiabilitiesCurrent", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value adjustment to derivative liability", "label": "Derivative, Fair Value, Net", "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives." } } }, "auth_ref": [ "r530" ] }, "ipsi_DerivativeFinancialLiabilityArisingFromConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DerivativeFinancialLiabilityArisingFromConvertibleNote", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable": { "parentTag": "us-gaap_DerivativeLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial liability arising from convertible note and warrants", "documentation": "It represents as a derivative financial liability arising from convertible note.", "label": "Derivative Financial Liability Arising From Convertible Note" } } }, "auth_ref": [] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability movements", "verboseLabel": "Net mark-to-market credit", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r927" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r92", "r94", "r95", "r96", "r670", "r673", "r687", "r688", "r689", "r692", "r693", "r694", "r695", "r697", "r698", "r699", "r700", "r716", "r717", "r718", "r719", "r722", "r723", "r724", "r725", "r750", "r752", "r755", "r757", "r777", "r800", "r802" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Movement in Derivative Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Derivative Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 }, "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "terseLabel": "Derivative liability", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r246" ] }, "ipsi_DerivativeLiabilityDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DerivativeLiabilityDetailsTable", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivative Liability (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilityFairValueOfCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityFairValueOfCollateral", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability", "label": "Derivative Liability, Fair Value of Collateral", "documentation": "Fair value of securities pledged as collateral against derivative liabilities." } } }, "auth_ref": [ "r247" ] }, "us-gaap_DerivativeLiabilityNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNotionalAmount", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability", "label": "Derivative Liability, Notional Amount", "documentation": "Nominal or face amount used to calculate payments on the derivative liability." } } }, "auth_ref": [ "r751", "r753", "r754", "r756", "r924", "r925", "r926" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability [Abstract]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r526" ] }, "ipsi_Derivativefinancialliabilityarisingonnoteamendmentincludedinlossonconvertiblenotes": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "Derivativefinancialliabilityarisingonnoteamendmentincludedinlossonconvertiblenotes", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable": { "parentTag": "us-gaap_DerivativeLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial liability arising on note amendment included in loss on convertible notes", "documentation": "Derivative financial liability arising on note amendment included in loss on convertible notes.", "label": "Derivativefinancialliabilityarisingonnoteamendmentincludedinlossonconvertiblenotes" } } }, "auth_ref": [] }, "us-gaap_DerivativesAndFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesAndFairValueTextBlock", "presentation": [ "http://ipsipay.com/role/DerivativeLiability" ], "lang": { "en-us": { "role": { "terseLabel": "DERIVATIVE LIABILITY", "label": "Derivatives and Fair Value [Text Block]", "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities." } } }, "auth_ref": [ "r195", "r196" ] }, "ipsi_DerivativesLiabilityNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DerivativesLiabilityNotionalAmount", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable": { "parentTag": "us-gaap_DerivativeLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofMovementinDerivativeLiabilityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Opening balance", "documentation": "Nominal or face amount used to calculate payments on the derivative liability.", "label": "Derivatives Liability Notional Amount" } } }, "auth_ref": [] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liabilities", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r16", "r89", "r90", "r91", "r98", "r265" ] }, "ipsi_DiagonalStreetLendingLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DiagonalStreetLendingLLCMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "1800 Diagonal Street Lending LLC [Member]", "verboseLabel": "Diagonal Street Lending LLC [Member]", "label": "Diagonal Street Lending LLCMember" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://ipsipay.com/role/EquityBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "EQUITY BASED COMPENSATION", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r441", "r444", "r475", "r476", "r477", "r795" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Equity Based Compensation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0, "order": 1.0 }, "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss from discontinued operations", "verboseLabel": "Loss from operations before income taxes", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r116", "r117", "r118", "r119", "r120", "r126", "r151", "r950" ] }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0, "order": 2.0 }, "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on disposal of subsidiary and investment", "terseLabel": "Net loss on disposal", "verboseLabel": "Income Taxes", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r117", "r118", "r119", "r120", "r126", "r131", "r489", "r503", "r507" ] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "label": "Discontinued Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r234" ] }, "us-gaap_DisposalGroupDeferredGainOnDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupDeferredGainOnDisposal", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Proceeds due on disposal", "label": "Disposal Group, Deferred Gain on Disposal", "documentation": "The excess amount received or due over net assets in a transaction accounted for as a divestiture where a subsidiary, business or operating assets are \"sold\" by the entity to a newly formed, thinly capitalized, highly leveraged buyer. This gain is not yet recognized and is disclosed on the balance sheet as an offset against the carrying amount of the securities received." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrentAbstract", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0": { "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 1.0 }, "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable": { "parentTag": "us-gaap_AssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current", "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r112", "r129", "r172", "r174" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total Non-Current Assets", "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent", "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r3", "r112", "r129", "r174", "r234", "r235" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCash", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash included in assets held for resale", "periodEndLabel": "Cash included in assets held for resale", "label": "Disposal Group, Including Discontinued Operation, Cash", "documentation": "Amount of currency on hand, demand deposits with banks or financial institutions, and other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0, "order": 1.0 }, "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of." } } }, "auth_ref": [ "r2", "r112", "r129", "r174" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Goods Sold", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r127", "r235" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Disposal Group, Including Discontinued Operation, Depreciation and Amortization", "documentation": "Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r127" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r127" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Gross loss", "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r127", "r235" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 1.0 }, "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "verboseLabel": "Intangibles, net", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent", "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r3", "r112", "r129", "r174" ] }, "ipsi_DisposalGroupIncludingDiscontinuedOperationInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DisposalGroupIncludingDiscontinuedOperationInvestment", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 3.0 }, "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Investment", "documentation": "Amount classified as investments attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group Including Discontinued Operation Investment" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total Expense", "label": "Disposal Group, Including Discontinued Operation, Operating Expense", "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r127" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net Revenue", "label": "Disposal Group, Including Discontinued Operation, Revenue", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r127", "r235" ] }, "ipsi_DisposalGroupIncludingDiscontinuedOperationSecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DisposalGroupIncludingDiscontinuedOperationSecurityDeposit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent", "weight": 1.0, "order": 2.0 }, "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0": { "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Security deposit", "documentation": "Security deposit.", "label": "Disposal Group Including Discontinued Operation Security Deposit" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupNotDiscontinuedOperationIncomeStatementDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Statement of Operations From Discontinued Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://ipsipay.com/role/DiscontinuedOperations" ], "lang": { "en-us": { "role": { "terseLabel": "DISCONTINUED OPERATIONS", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r111", "r171" ] }, "ipsi_DisposalOfInvestmentInFrictionlessAndBeyondFintechAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DisposalOfInvestmentInFrictionlessAndBeyondFintechAbstract", "lang": { "en-us": { "role": { "label": "Disposal of Investment in Frictionless and Beyond Fintech [Abstract]" } } }, "auth_ref": [] }, "ipsi_DisposalOfInvestmentInFrictionlessAndBeyondFintechTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DisposalOfInvestmentInFrictionlessAndBeyondFintechTextBlock", "presentation": [ "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintech" ], "lang": { "en-us": { "role": { "terseLabel": "DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH", "documentation": "The disclosure for disposal of investment in frictionless and beyond fintech.", "label": "Disposal Of Investment In Frictionless And Beyond Fintech Text Block" } } }, "auth_ref": [] }, "ipsi_DisposalofInvestmentinFrictionlessandBeyondFintechDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DisposalofInvestmentinFrictionlessandBeyondFintechDetailsLineItems", "presentation": [ "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails" ], "lang": { "en-us": { "role": { "label": "Disposal of Investment in Frictionless and Beyond Fintech (Details) [Line Items]" } } }, "auth_ref": [] }, "ipsi_DisposalofInvestmentinFrictionlessandBeyondFintechDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DisposalofInvestmentinFrictionlessandBeyondFintechDetailsTable", "presentation": [ "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails" ], "lang": { "en-us": { "role": { "label": "Disposal of Investment in Frictionless and Beyond Fintech (Details) [Table]" } } }, "auth_ref": [] }, "ipsi_DocumentAndEntityInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "DocumentAndEntityInformationAbstract", "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Annual Report", "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r814", "r815", "r816" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Financial Statement Error Correction [Flag]", "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r814", "r815", "r816", "r818" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r817" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Documents Incorporated by Reference [Text Block]", "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r812" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "label": "Net Loss Per Share [Abstract]", "terseLabel": "Basic and diluted loss per share*" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Basic and diluted loss per share total (in Dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r256", "r272", "r273", "r274", "r275", "r276", "r282", "r284", "r288", "r289", "r290", "r294", "r528", "r529", "r604", "r622", "r780" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted loss per share", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r256", "r272", "r273", "r274", "r275", "r276", "r284", "r288", "r289", "r290", "r294", "r528", "r529", "r604", "r622", "r780" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://ipsipay.com/role/NetLossPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "NET LOSS PER SHARE", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r281", "r291", "r292", "r293" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r490" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating losses percentage", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments." } } }, "auth_ref": [ "r916", "r923" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r811" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r811" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r811" ] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Date of incorporation", "label": "Entity Incorporation, Date of Incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r819" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Public Float", "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r811" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r811" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r811" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r811" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Voluntary Filers", "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Well-known Seasoned Issuer", "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r820" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r15", "r232", "r251", "r252", "r253", "r267", "r268", "r269", "r271", "r277", "r279", "r295", "r364", "r365", "r436", "r478", "r479", "r480", "r500", "r501", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r532", "r533", "r534", "r535", "r536", "r537", "r547", "r627", "r628", "r629", "r650", "r728" ] }, "us-gaap_EquityFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityFairValueAdjustment", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants (in Dollars)", "label": "Equity, Fair Value Adjustment", "documentation": "Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties." } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r358", "r359", "r361" ] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership percentage", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r358" ] }, "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity loss from joint venture", "label": "Equity Method Investment, Realized Gain (Loss) on Disposal", "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment." } } }, "auth_ref": [ "r847", "r848", "r854" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment", "verboseLabel": "Joint venture total", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r304", "r356", "r844", "r872" ] }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "lang": { "en-us": { "role": { "label": "Equity Method Investment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsDisclosureTextBlock", "presentation": [ "http://ipsipay.com/role/EquityMethodInvestment" ], "lang": { "en-us": { "role": { "terseLabel": "EQUITY METHOD INVESTMENT", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group." } } }, "auth_ref": [ "r226", "r360", "r363", "r823" ] }, "us-gaap_EquityMethodInvestmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsTextBlock", "presentation": [ "http://ipsipay.com/role/EquityMethodInvestmentTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Method Investments", "label": "Equity Method Investments [Table Text Block]", "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information." } } }, "auth_ref": [ "r357" ] }, "us-gaap_ExcessStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExcessStockSharesIssued", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares of common stock", "label": "Excess Stock, Shares Issued", "documentation": "Number of excess stock shares of an entity that have been sold or granted to shareholders." } } }, "auth_ref": [] }, "ipsi_ExercisePriceFivePointSixTwoFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePriceFivePointSixTwoFiveMember", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price 5.625 [Member]", "label": "Exercise Price Five Point Six Two Five Member" } } }, "auth_ref": [] }, "ipsi_ExercisePriceFourPointFiveZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePriceFourPointFiveZeroMember", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price 4.50 [Member]", "verboseLabel": "Exercise Price Four Point Five Zero [Member]", "label": "Exercise Price Four Point Five Zero Member" } } }, "auth_ref": [] }, "ipsi_ExercisePriceOnePointFiveZeroZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePriceOnePointFiveZeroZeroMember", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price 1.500 [Member]", "label": "Exercise Price One Point Five Zero Zero Member" } } }, "auth_ref": [] }, "ipsi_ExercisePriceOnePointTwoZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePriceOnePointTwoZeroMember", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price One Point Two Zero [Member]", "label": "Exercise Price One Point Two Zero Member" } } }, "auth_ref": [] }, "ipsi_ExercisePriceOnePointZeroThreeFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePriceOnePointZeroThreeFiveMember", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price 1.035 [Member]", "label": "Exercise Price One Point Zero Three Five Member" } } }, "auth_ref": [] }, "ipsi_ExercisePricePerShareCancelledOnDisposalOfInvestmentInFrictionlessAndBeyondFintech": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePricePerShareCancelledOnDisposalOfInvestmentInFrictionlessAndBeyondFintech", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share, Cancelled on disposal of investment in Frictionless and Beyond Fintech", "documentation": "Exercise price per share, cancelled on disposal of investment in frictionless and beyond fintech.", "label": "Exercise Price Per Share Cancelled On Disposal Of Investment In Frictionless And Beyond Fintech" } } }, "auth_ref": [] }, "ipsi_ExercisePricePerShareExercised": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePricePerShareExercised", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share, Exercised", "documentation": "Exercise price per share, exercised.", "label": "Exercise Price Per Share Exercised" } } }, "auth_ref": [] }, "ipsi_ExercisePricePerShareForfeited": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePricePerShareForfeited", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share, Forfeited", "documentation": "Exercise price per share, forfeited.", "label": "Exercise Price Per Share Forfeited" } } }, "auth_ref": [] }, "ipsi_ExercisePricePerShareForfeitedCancelled": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePricePerShareForfeitedCancelled", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share, Forfeited/Cancelled", "documentation": "Exercise price per share, Forfeited/Cancelled.", "label": "Exercise Price Per Share Forfeited Cancelled" } } }, "auth_ref": [] }, "ipsi_ExercisePricePerShareGranted": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePricePerShareGranted", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share, Granted", "documentation": "Exercise price per share, granted.", "label": "Exercise Price Per Share Granted" } } }, "auth_ref": [] }, "ipsi_ExercisePricePerShareNcreaseInWarrantsDueToDebtAmendmentFullRachetTrigger": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePricePerShareNcreaseInWarrantsDueToDebtAmendmentFullRachetTrigger", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "IExercise price per share, ncrease in warrants due to debt amendment full rachet trigger", "documentation": "Exercise price per share, ncrease in warrants due to debt amendment full rachet trigger.", "label": "Exercise Price Per Share Ncrease In Warrants Due To Debt Amendment Full Rachet Trigger" } } }, "auth_ref": [] }, "ipsi_ExercisePriceZeroPointFourFiveZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePriceZeroPointFourFiveZeroMember", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price 0.450 [Member]", "label": "Exercise Price Zero Point Four Five Zero Member" } } }, "auth_ref": [] }, "ipsi_ExercisePriceZeroPointThreeFourFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExercisePriceZeroPointThreeFourFiveMember", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price 0.345 [Member]", "label": "Exercise Price Zero Point Three Four Five Member" } } }, "auth_ref": [] }, "ipsi_ExpirationDates": { "xbrltype": "dateItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ExpirationDates", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration date", "documentation": "Expiration date.", "label": "Expiration Dates" } } }, "auth_ref": [] }, "us-gaap_ExtinguishmentOfDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtAmount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt extinguishment", "label": "Extinguishment of Debt, Amount", "documentation": "Gross amount of debt extinguished." } } }, "auth_ref": [] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value of warrants issued", "label": "Fair Value Adjustment of Warrants", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r0", "r7" ] }, "ipsi_FairValueOfDerivativeLiabilityArisingOnTheAmendmentOfTheExercisePriceOfConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FairValueOfDerivativeLiabilityArisingOnTheAmendmentOfTheExercisePriceOfConvertibleNote", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable": { "parentTag": "ipsi_LossOnConvertibleNotes", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders", "documentation": "Fair value of derivative liability arising on the amendment of the exercise price of convertible note.", "label": "Fair Value Of Derivative Liability Arising On The Amendment Of The Exercise Price Of Convertible Note" } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r10", "r22" ] }, "ipsi_FairValueOfWarrantsIssuedForEquityMethodInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FairValueOfWarrantsIssuedForEquityMethodInvestment", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants issued for equity method investments", "documentation": "Amount of fair value of warrants issued for equity method investments.", "label": "Fair Value Of Warrants Issued For Equity Method Investment" } } }, "auth_ref": [] }, "ipsi_FairValueOfWarrantsIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FairValueOfWarrantsIssuedForServices", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants issued for services", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Of Warrants Issued For Services" } } }, "auth_ref": [] }, "ipsi_FairValueOfWarrantsIssuedToConvertibleNoteHoldersOnExtensionOfMaturityDate": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FairValueOfWarrantsIssuedToConvertibleNoteHoldersOnExtensionOfMaturityDate", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable": { "parentTag": "ipsi_LossOnConvertibleNotes", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants issued to convertible note holders on extension of maturity date", "documentation": "Fair value of warrants issued to convertible note holders on extension of maturity date.", "label": "Fair Value Of Warrants Issued To Convertible Note Holders On Extension Of Maturity Date" } } }, "auth_ref": [] }, "ipsi_FairValueOfWarrantsIssuedToThirdPartyJointVenturePartners": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FairValueOfWarrantsIssuedToThirdPartyJointVenturePartners", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable": { "parentTag": "us-gaap_IncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants issued to third party joint venture partners", "documentation": "Fair value of warrants issued to third party joint venture partners.", "label": "Fair Value Of Warrants Issued To Third Party Joint Venture Partners" } } }, "auth_ref": [] }, "ipsi_FairValueOfWarrantsIssuedWithConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FairValueOfWarrantsIssuedWithConvertibleNotes", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of warrants issued with convertible notes", "documentation": "Amount of fair value of warrants issued with convertible notes.", "label": "Fair Value Of Warrants Issued With Convertible Notes" } } }, "auth_ref": [] }, "us-gaap_FairValueOptionIneligibleItemsAggregateCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOptionIneligibleItemsAggregateCarryingAmount", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "label": "Fair Value, Option, Ineligible Items, Carrying Amount", "documentation": "Carrying amount of items included in each line item in the statement of financial position that are not eligible for the fair value option." } } }, "auth_ref": [ "r99" ] }, "us-gaap_FederalHomeLoanBankAdvancesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankAdvancesCurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Federal relief loans \u2013 current portion", "label": "Long-Term Federal Home Loan Bank Advances, Current", "documentation": "The current portion of Federal Home Loan Bank borrowings initially due beyond one year or beyond the normal operating cycle if longer." } } }, "auth_ref": [ "r9", "r62", "r139", "r199" ] }, "us-gaap_FederalHomeLoanBankAdvancesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankAdvancesLineItems", "presentation": [ "http://ipsipay.com/role/FederalReliefLoansDetails" ], "lang": { "en-us": { "role": { "label": "Federal Relief Loans [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FederalHomeLoanBankAdvancesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBankAdvancesTextBlock", "presentation": [ "http://ipsipay.com/role/FederalReliefLoans" ], "lang": { "en-us": { "role": { "terseLabel": "FEDERAL RELIEF LOANS", "label": "Federal Home Loan Bank, Advances [Text Block]", "documentation": "The entire disclosure of advances made and reported by Federal Home Loan Bank (FHLBank)." } } }, "auth_ref": [ "r197" ] }, "us-gaap_FederalHomeLoanBanksAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FederalHomeLoanBanksAbstract", "lang": { "en-us": { "role": { "label": "Federal Relief Loans [Abstract]" } } }, "auth_ref": [] }, "ipsi_FederalReliefLoansDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FederalReliefLoansDetailsTable", "presentation": [ "http://ipsipay.com/role/FederalReliefLoansDetails" ], "lang": { "en-us": { "role": { "label": "Federal Relief Loans (Details) [Table]" } } }, "auth_ref": [] }, "ipsi_FederalTerm": { "xbrltype": "durationItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FederalTerm", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal term", "documentation": "Federal term.", "label": "Federal Term" } } }, "auth_ref": [] }, "ipsi_FinancialAndCapitalMarketsAdvice": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FinancialAndCapitalMarketsAdvice", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial and capital markets advice", "documentation": "Amount of financial and capital markets advice.", "label": "Financial And Capital Markets Advice" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r423", "r433", "r526", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r621", "r785", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r868", "r869", "r870", "r871" ] }, "us-gaap_FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableModificationToTotalFinancingReceivablesExcludingAccruedInterestPercent", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest percentage", "label": "Financing Receivable, Excluding Accrued Interest, Modified in Period, to Total Financing Receivables, Percentage", "documentation": "Percentage, excluding accrued interest, of financing receivable modified during period for debtor experiencing financial difficulty to total financing receivables." } } }, "auth_ref": [ "r324" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ScheduleofFacilitatetheFunctioningoftheIPSIPaySoftwareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r239", "r377" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r375", "r376", "r377", "r378", "r590", "r591" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails", "http://ipsipay.com/role/ScheduleofFacilitatetheFunctioningoftheIPSIPaySoftwareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cost", "verboseLabel": "Intangible assets", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r169", "r591" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Intangibles [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r590" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r55", "r57" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofFacilitatetheFunctioningoftheIPSIPaySoftwareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net Book Value", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r169", "r590" ] }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNetAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Facilitate the Functioning of the IPSIPay Software [Abstract]" } } }, "auth_ref": [] }, "ipsi_FintechShares": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FintechShares", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Beyond fintech shares (in Dollars)", "documentation": "The amount of fintech shares.", "label": "Fintech Shares" } } }, "auth_ref": [] }, "ipsi_FlatRate": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FlatRate", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Flat rate", "documentation": "percentage of flat rate.", "label": "Flat Rate" } } }, "auth_ref": [] }, "ipsi_FrictionlessAndBeyondFintechMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FrictionlessAndBeyondFintechMember", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Frictionless And Beyond Fintech [Member]", "label": "Frictionless And Beyond Fintech Member" } } }, "auth_ref": [] }, "ipsi_FrictionlessFinancialTechnologiesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "FrictionlessFinancialTechnologiesIncMember", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Frictionless Financial Technologies, Inc.[Member]", "verboseLabel": "Frictionless [Member]", "label": "Frictionless Financial Technologies Inc Member" } } }, "auth_ref": [] }, "us-gaap_GainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestments", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on conversion", "label": "Gain (Loss) on Investments", "documentation": "Amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r158", "r821" ] }, "us-gaap_GainLossOnSaleOfOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfOtherAssets", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 4.0 }, "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on novation", "negatedLabel": "Loss on novation", "label": "Gain (Loss) on Disposition of Other Assets", "documentation": "Amount of gain (loss) on sale or disposal of other assets." } } }, "auth_ref": [ "r854" ] }, "us-gaap_GainOrLossOnSaleOfStockInSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainOrLossOnSaleOfStockInSubsidiary", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Derivative liability movements", "label": "Gain (Loss) on Disposition of Stock in Subsidiary", "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries." } } }, "auth_ref": [ "r847", "r848", "r854", "r944" ] }, "ipsi_GastonPereiraMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "GastonPereiraMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gaston Pereira [Member]", "label": "Gaston Pereira Member" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r156", "r707" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Intangibles [Abstract]" } } }, "auth_ref": [] }, "ipsi_GrantDatePriceOnePointFiveZeroMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "GrantDatePriceOnePointFiveZeroMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Grant Date Price 0.50 [Member]", "label": "Grant Date Price One Point Five Zero Member" } } }, "auth_ref": [] }, "ipsi_GrantDatePriceOnePointFourSevanMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "GrantDatePriceOnePointFourSevanMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Grant Date Price 1.47 [Member]", "label": "Grant Date Price One Point Four Sevan Member" } } }, "auth_ref": [] }, "ipsi_GrantDatePriceOnePointSixFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "GrantDatePriceOnePointSixFiveMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Grant Date Price 1.65 [Member]", "label": "Grant Date Price One Point Six Five Member" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Gross loss", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r153", "r262", "r298", "r312", "r316", "r318", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r531", "r782", "r882" ] }, "ipsi_HoldersAmounting": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "HoldersAmounting", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Holders amount", "documentation": "Holders amounting.", "label": "Holders Amounting" } } }, "auth_ref": [] }, "ipsi_IPEXWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IPEXWarrantMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IPEX Warrant [Member]", "label": "IPEXWarrant Member" } } }, "auth_ref": [] }, "ipsi_IPSIPayExpressMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IPSIPayExpressMember", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "IPSIPay Express [Member]", "label": "IPSIPay Express Member" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "ICFR Auditor Attestation Flag", "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r814", "r815", "r816" ] }, "ipsi_IncentiveStockAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IncentiveStockAwardsMember", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Incentive Stock Awards [Member]", "label": "Incentive Stock Awards Member" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 }, "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss from continuing operations", "terseLabel": "Net loss from continuing operations", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r83", "r154", "r166", "r272", "r273", "r274", "r275", "r287", "r290" ] }, "ipsi_IncomeLossFromContinuingOperationsAfterIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IncomeLossFromContinuingOperationsAfterIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss after income taxes", "documentation": "Net loss after income taxes.", "label": "Income Loss From Continuing Operations After Income Taxes Extraordinary Items Noncontrolling Interest" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r298", "r312", "r316", "r318", "r624", "r782" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations (in Dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r149", "r203", "r205", "r256", "r270", "r272", "r273", "r274", "r275", "r284", "r288", "r289", "r529", "r604", "r952" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations diluted", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r149", "r256", "r270", "r272", "r273", "r274", "r275", "r284", "r288", "r289", "r290", "r529", "r604", "r952" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 }, "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 }, "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss from discontinued operations", "negatedLabel": "Net loss from discontinued operations", "terseLabel": "Loss from discontinued operations, net of taxation", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r116", "r117", "r118", "r119", "r120", "r131", "r235", "r508", "r617" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations (in Dollars per share)", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r151", "r256", "r285", "r288", "r289", "r945", "r952" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations diluted", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r194", "r285", "r288", "r289" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0, "order": 2.0 }, "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Equity total", "terseLabel": "Net loss from equity method investments", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r7", "r150", "r204", "r302", "r356", "r616" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r792", "r793" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r379", "r380", "r712" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r380", "r712" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Taxes [Abstarct]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://ipsipay.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "INCOME TAXES", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r264", "r486", "r491", "r492", "r496", "r502", "r506", "r509", "r510", "r644" ] }, "us-gaap_IncomeTaxExaminationPenaltiesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExaminationPenaltiesExpense", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Penalty expenses", "label": "Income Tax Examination, Penalties Expense", "documentation": "The amount of estimated penalties recognized in the period arising from income tax examinations." } } }, "auth_ref": [ "r917" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0, "order": 3.0 }, "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred tax assets, net", "negatedLabel": "Income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r214", "r224", "r278", "r279", "r303", "r489", "r503", "r625" ] }, "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Statutory Income Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r250", "r487", "r488", "r492", "r493", "r495", "r497", "r638" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails", "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax asset valuation allowance", "verboseLabel": "Deferred income tax assets valuation allowance", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r916" ] }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable": { "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable" ], "lang": { "en-us": { "role": { "terseLabel": "Permanent differences", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)." } } }, "auth_ref": [ "r916" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable": { "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable" ], "lang": { "en-us": { "role": { "terseLabel": "Tax expense at the federal statutory rate", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r490" ] }, "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable": { "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable" ], "lang": { "en-us": { "role": { "terseLabel": "Prior year net operating loss true up", "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)." } } }, "auth_ref": [ "r916" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable": { "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable" ], "lang": { "en-us": { "role": { "terseLabel": "State tax expense, net of federal tax effect", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r916" ] }, "ipsi_IncomeTaxesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IncomeTaxesDetailsLineItems", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) [Line Items]" } } }, "auth_ref": [] }, "ipsi_IncomeTaxesDetailsScheduleofDeferredIncomeTaxAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IncomeTaxesDetailsScheduleofDeferredIncomeTaxAssetsTable", "presentation": [ "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Abstarct]", "label": "Income Taxes Details Scheduleof Deferred Income Tax Assets Table" } } }, "auth_ref": [] }, "ipsi_IncomeTaxesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IncomeTaxesDetailsTable", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for income taxes", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r43" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInterestPayableNet", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Interest accruals", "label": "Increase (Decrease) in Interest Payable, Net", "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInNotesPayableRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInNotesPayableRelatedParties", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable": { "parentTag": "ipsi_LossOnConvertibleNotes", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expense on extension of maturity date of convertible notes", "label": "Increase (Decrease) in Notes Payable, Related Parties", "documentation": "The increase (decrease) during the reporting period in the amount owed by the reporting entry in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r6" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in Assets and Liabilities", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r853" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Assets and liabilities Novated [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite life tax", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r170" ] }, "ipsi_InitialConversionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "InitialConversionPricePerShare", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial conversion price per share (in Dollars per share)", "documentation": "Amount of initial conversion price.", "label": "Initial Conversion Price Per Share" } } }, "auth_ref": [] }, "ipsi_InnovativePaymentSolutionsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "InnovativePaymentSolutionsIncMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Innovative Payment Solutions, Inc [Member]", "label": "Innovative Payment Solutions Inc Member" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://ipsipay.com/role/Intangibles" ], "lang": { "en-us": { "role": { "terseLabel": "INTANGIBLES", "label": "Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r374" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r53", "r56" ] }, "ipsi_IntangiblesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IntangiblesDetailsTable", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "label": "Intangibles (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r104", "r207", "r254", "r301", "r539", "r713", "r808", "r956" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "verboseLabel": "Interest", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r159", "r418", "r427", "r789", "r790" ] }, "us-gaap_InterestOnConvertibleDebtNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestOnConvertibleDebtNetOfTax", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest charge", "label": "Interest on Convertible Debt, Net of Tax", "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash." } } }, "auth_ref": [ "r283", "r286", "r290" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "verboseLabel": "Interest payments", "label": "Interest Payable", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r106", "r946" ] }, "ipsi_InterestsPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "InterestsPaidNet", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest", "documentation": "Cash paid for interest.", "label": "Interests Paid Net" } } }, "auth_ref": [] }, "ipsi_IntrinsicValueOutstandingOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "IntrinsicValueOutstandingOptions", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intrinsic value outstanding options (in Dollars)", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Intrinsic Value Outstanding Options" } } }, "auth_ref": [] }, "ipsi_InvestmentInFrictionlessFinancialTechnologiesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "InvestmentInFrictionlessFinancialTechnologiesIncMember", "presentation": [ "http://ipsipay.com/role/InvestmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment in Frictionless Financial Technologies Inc. [Member]", "label": "Investment In Frictionless Financial Technologies Inc Member" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeInvestmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInvestmentExpense", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense, net", "label": "Investment Income, Investment Expense", "documentation": "Amount of expenses related to the generation of investment income." } } }, "auth_ref": [ "r160", "r808", "r951" ] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value", "label": "Investment Owned, Fair Value", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r634", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r671", "r674", "r675", "r685", "r686", "r735", "r737", "r738", "r739", "r745", "r746", "r747", "r748", "r749", "r758", "r759", "r761", "r762", "r763", "r802", "r810", "r954" ] }, "us-gaap_InvestmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for investment in financial asset." } } }, "auth_ref": [ "r623", "r634", "r635", "r636", "r637", "r740", "r741" ] }, "us-gaap_InvestmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTextBlock", "presentation": [ "http://ipsipay.com/role/Investments" ], "lang": { "en-us": { "role": { "terseLabel": "INVESTMENTS", "label": "Investment [Text Block]", "documentation": "The entire disclosure for investment." } } }, "auth_ref": [ "r828", "r829", "r867" ] }, "us-gaap_InvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsAbstract", "lang": { "en-us": { "role": { "label": "Investments [Abstract]" } } }, "auth_ref": [] }, "ipsi_InvestmentsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "InvestmentsDetailsTable", "presentation": [ "http://ipsipay.com/role/InvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Investments (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued for services", "label": "Issuance of Stock and Warrants for Services or Claims", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [ "r7" ] }, "ipsi_JamesFullerMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "JamesFullerMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "James Fuller [Member]", "label": "James Fuller Member" } } }, "auth_ref": [] }, "ipsi_JosephAbramsMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "JosephAbramsMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Joseph Abrams [Member]", "label": "Joseph Abrams Member" } } }, "auth_ref": [] }, "ipsi_KiosksMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "KiosksMember", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Kiosks [Member]", "label": "Kiosks Member" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://ipsipay.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Total Lease Cost", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r932" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold Improvements [Member]", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r173" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseDescription", "presentation": [ "http://ipsipay.com/role/ScheduleofOtherLeaseInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining lease term \u2013 operating lease", "label": "Lessee, Operating Lease, Description", "documentation": "Description of lessee's operating lease." } } }, "auth_ref": [ "r544" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://ipsipay.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "LEASES", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r542" ] }, "us-gaap_LessorOperatingLeaseDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseDescription", "presentation": [ "http://ipsipay.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease, description", "label": "Lessor, Operating Lease, Description", "documentation": "Description of lessor's operating lease." } } }, "auth_ref": [ "r546" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r28", "r262", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r515", "r518", "r519", "r531", "r681", "r781", "r810", "r882", "r936", "r937" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Liabilities and Equity (Deficit)", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r148", "r202", "r613", "r798", "r857", "r873", "r930" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r30", "r237", "r262", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r515", "r518", "r519", "r531", "r798", "r882", "r936", "r937" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable", "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Current Liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total Non-Current Liabilities", "label": "Liabilities, Noncurrent", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r23", "r135", "r136", "r137", "r141", "r262", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r515", "r518", "r519", "r531", "r882", "r936", "r937" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Current Liabilities", "label": "Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofAssetsandLiabilitiesTable0" ], "lang": { "en-us": { "role": { "totalLabel": "Liabilities held for sale", "terseLabel": "Liabilities held for sale", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r2", "r112", "r129", "r172", "r174", "r234", "r235" ] }, "us-gaap_LiabilitiesSubjectToCompromiseDebtAndAccruedInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesSubjectToCompromiseDebtAndAccruedInterest", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Interest", "label": "Liabilities Subject to Compromise, Debt and Accrued Interest", "documentation": "The amount of debt and related accrued interest included in liabilities subject to compromise." } } }, "auth_ref": [ "r935" ] }, "ipsi_LimitationExceedsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LimitationExceedsPercentage", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Limitation exceeds of percentage", "documentation": "Limitation exceeds percentage.", "label": "Limitation Exceeds Percentage" } } }, "auth_ref": [] }, "ipsi_LiquidityMattersAndGoingConcernAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LiquidityMattersAndGoingConcernAbstract", "lang": { "en-us": { "role": { "label": "Liquidity Matters and Going Concern [Abstract]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtAverageAmountOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAverageAmountOutstanding", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding principal amount", "label": "Long-Term Debt, Average Amount Outstanding", "documentation": "Average amount outstanding of long-term debt." } } }, "auth_ref": [ "r227", "r228", "r713" ] }, "ipsi_LongTermInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LongTermInvestmentMember", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long Term Investment [Member]", "label": "Long Term Investment Member" } } }, "auth_ref": [] }, "ipsi_LongtermAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LongtermAssetsPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Assets", "documentation": "It represents long term assets policy.", "label": "Longterm Assets Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_LongtermConvertibleDebtCurrentAndNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermConvertibleDebtCurrentAndNoncurrentAbstract", "lang": { "en-us": { "role": { "label": "Loss on Convertible Notes [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LongtermFederalHomeLoanBankAdvancesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermFederalHomeLoanBankAdvancesNoncurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Federal relief loans", "label": "Long-Term Federal Home Loan Bank Advances, Noncurrent", "documentation": "The noncurrent portion of Federal Home Loan Bank borrowings initially due beyond one year or beyond the normal operating cycle if longer." } } }, "auth_ref": [ "r9", "r23", "r200" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://ipsipay.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r383", "r384", "r385", "r388", "r879", "r880" ] }, "ipsi_LossOnConversionOfDebtToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LossOnConversionOfDebtToEquity", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on conversion of debt to equity", "documentation": "Amount of loss on conversion of debt to equity.", "label": "Loss On Conversion Of Debt To Equity" } } }, "auth_ref": [] }, "ipsi_LossOnConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LossOnConvertibleNotes", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 6.0 }, "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Loss on convertible notes", "terseLabel": "Loss on convertible notes", "documentation": "Loss on convertible notes.", "label": "Loss On Convertible Notes" } } }, "auth_ref": [] }, "ipsi_LossOnConvertibleNotesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LossOnConvertibleNotesTableTextBlock", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotes" ], "lang": { "en-us": { "role": { "terseLabel": "LOSS ON CONVERTIBLE NOTES", "documentation": "The disclosure for loss on convertible notes.", "label": "Loss On Convertible Notes Table Text Block" } } }, "auth_ref": [] }, "ipsi_LossOnDebtConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LossOnDebtConversion", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on debt conversion", "documentation": "Loss on debt conversion.", "label": "Loss On Debt Conversion" } } }, "auth_ref": [] }, "ipsi_LossonConvertibleNotesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "LossonConvertibleNotesDetailsTable", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "label": "Loss on Convertible Notes (Details) [Table]" } } }, "auth_ref": [] }, "ipsi_MadissonButlerMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "MadissonButlerMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Madisson Butler [Member]", "label": "Madisson Butler Member" } } }, "auth_ref": [] }, "ipsi_MadissonCorbettMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "MadissonCorbettMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Madisson Corbett [Member]", "label": "Madisson Corbett Member" } } }, "auth_ref": [] }, "ipsi_MarginalRate": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "MarginalRate", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Marginal rate", "documentation": "Percentage of marginal rate.", "label": "Marginal Rate" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable", "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r439", "r588", "r626", "r672", "r673", "r736", "r742", "r743", "r744", "r760", "r773", "r774", "r784", "r791", "r794", "r799", "r886", "r938", "r939", "r940", "r941", "r942", "r943" ] }, "ipsi_MembershipInterest": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "MembershipInterest", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of membership interest", "documentation": "Percentage of membership interest.", "label": "Membership Interest" } } }, "auth_ref": [] }, "ipsi_MercerConvertedMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "MercerConvertedMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mercer Converted [Member]", "label": "Mercer Converted Member" } } }, "auth_ref": [] }, "ipsi_MercerStreetGlobalOpportunityFundLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "MercerStreetGlobalOpportunityFundLLCMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Mercer Street Global Opportunity Fund, LLC [Member]", "verboseLabel": "Cavalry Fund I LP [Member]", "label": "Mercer Street Global Opportunity Fund LLCMember" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable", "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r439", "r588", "r626", "r672", "r673", "r736", "r742", "r743", "r744", "r760", "r773", "r774", "r784", "r791", "r794", "r799", "r886", "r938", "r939", "r940", "r941", "r942", "r943" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r36", "r201", "r262", "r362", "r389", "r391", "r392", "r393", "r396", "r397", "r531", "r612", "r684" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails", "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails", "http://ipsipay.com/role/InvestmentsDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership percentage", "verboseLabel": "Minority interest ownership percentage", "netLabel": "Ownership interest", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ipsi_MrFullerMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "MrFullerMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mr. Fuller [Member]", "label": "Mr Fuller Member" } } }, "auth_ref": [] }, "ipsi_MrRosenblumMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "MrRosenblumMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mr. Rosenblum [Member]", "label": "Mr Rosenblum Member" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r259" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r259" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities \u2013 continuing operations", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations", "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r852" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "CASH USED IN OPERATING ACTIVITIES", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r164", "r165", "r166" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Cash used in operating activities - continuing operations", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r164", "r165", "r166" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable Innovative Payment Solutions, Inc. Stockholders\u2019", "terseLabel": "Net loss on novation", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r152", "r166", "r206", "r235", "r248", "r249", "r253", "r262", "r270", "r272", "r273", "r274", "r275", "r278", "r279", "r287", "r298", "r312", "r316", "r318", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r529", "r531", "r620", "r704", "r726", "r727", "r782", "r808", "r882" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "negatedLabel": "Net loss attributable to non-controlling interest", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r88", "r193", "r248", "r249", "r278", "r279", "r619", "r846" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Recent accounting pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "No Trading Symbol Flag", "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ipsi_NonConvertiblePromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NonConvertiblePromissoryNote", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-convertible promissory notes", "documentation": "The amount of non convertible promissory note.", "label": "Non Convertible Promissory Note" } } }, "auth_ref": [] }, "ipsi_NonConvertiblePromissoryNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NonConvertiblePromissoryNotes", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-convertible promissory notes", "documentation": "Non-convertible promissory notes.", "label": "Non Convertible Promissory Notes" } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "NON-CASH INVESTING AND FINANCING ACTIVITIES", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from non-controlling shareholders", "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders." } } }, "auth_ref": [ "r13", "r66", "r192" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling shareholders interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r81", "r436", "r860", "r861", "r862", "r957" ] }, "ipsi_NoteAmendmentLetterAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NoteAmendmentLetterAgreementMember", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note Amendment Letter Agreement [Member]", "label": "Note Amendment Letter Agreement Member" } } }, "auth_ref": [] }, "ipsi_NoteAmendmentTransactionDescription": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NoteAmendmentTransactionDescription", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note amendment transaction description", "documentation": "Note amendment transaction description.", "label": "Note Amendment Transaction Description" } } }, "auth_ref": [] }, "ipsi_NotePayableMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NotePayableMember", "presentation": [ "http://ipsipay.com/role/CommitmentsandContingenciesDetails", "http://ipsipay.com/role/ScheduleofNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable [Member]", "label": "Note Payable Member" } } }, "auth_ref": [] }, "ipsi_NoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NoteTwoMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note Two [Member]", "label": "Note Two Member" } } }, "auth_ref": [] }, "us-gaap_NotesIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesIssued1", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes issued", "label": "Notes Issued", "documentation": "The fair value of notes issued in noncash investing and financing activities." } } }, "auth_ref": [ "r44", "r45", "r46" ] }, "us-gaap_NotesPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableAbstract", "lang": { "en-us": { "role": { "label": "Notes Payable [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ScheduleofNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable", "verboseLabel": "Amount, net", "label": "Notes Payable, Current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r27" ] }, "ipsi_NotesPayableDetailsScheduleofNotesPayableTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NotesPayableDetailsScheduleofNotesPayableTable", "presentation": [ "http://ipsipay.com/role/ScheduleofNotesPayableTable" ], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) - Schedule of Notes Payable [Table]" } } }, "auth_ref": [] }, "ipsi_NotesPayableDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NotesPayableDetailsTable", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Notes Payable (Details) [Table]" } } }, "auth_ref": [] }, "ipsi_NovationMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NovationMember", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Novation [Member]", "label": "Novation Member" } } }, "auth_ref": [] }, "ipsi_NovationofCertainAssetsandLiabilitesDetailsScheduleofAssetsandliabilitiesNovatedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NovationofCertainAssetsandLiabilitesDetailsScheduleofAssetsandliabilitiesNovatedLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "label": "Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated [Line Items]" } } }, "auth_ref": [] }, "ipsi_NovationofCertainAssetsandLiabilitesDetailsScheduleofAssetsandliabilitiesNovatedTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NovationofCertainAssetsandLiabilitesDetailsScheduleofAssetsandliabilitiesNovatedTable", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "label": "Novation of Certain Assets and Liabilites (Details) - Schedule of Assets and liabilities Novated [Table]" } } }, "auth_ref": [] }, "ipsi_NovationofCertinAssetsandLiabilitesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NovationofCertinAssetsandLiabilitesAbstract", "lang": { "en-us": { "role": { "label": "Novation of Certain Assets and Liabilites [Abstract]" } } }, "auth_ref": [] }, "ipsi_NovationofCertinAssetsandLiabilitesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NovationofCertinAssetsandLiabilitesTextBlock", "presentation": [ "http://ipsipay.com/role/NovationofCertainAssetsandLiabilites" ], "lang": { "en-us": { "role": { "terseLabel": "NOVATION OF CERTAIN ASSETS AND LIABILITES", "documentation": "Novation of Certin Assets And Liabilites.", "label": "Novationof Certin Assetsand Liabilites Text Block" } } }, "auth_ref": [] }, "ipsi_NumberOfAdditionalSharesPurchase": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "NumberOfAdditionalSharesPurchase", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional shares of common stock (in Shares)", "documentation": "Represent the number of additional shares purchase.", "label": "Number Of Additional Shares Purchase" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating segment", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r865" ] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficeEquipmentMember", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Office Equipment [Member]", "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total Expense", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from Operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r298", "r312", "r316", "r318", "r782" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofOtherLeaseInformationTable", "http://ipsipay.com/role/ScheduleofTotalLeaseCostTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "negatedLabel": "Operating cash flows from operating leases", "label": "Operating Lease, Expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r931" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease payment", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r543", "r545" ] }, "ipsi_OperatingLossCarryforwardMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "OperatingLossCarryforwardMember", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss Carryforward [Member]", "label": "Operating Loss Carryforward Member" } } }, "auth_ref": [] }, "ipsi_OperatingLossCarryforwardsExpirationYear": { "xbrltype": "gYearItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "OperatingLossCarryforwardsExpirationYear", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss Carryforwards expiration year", "documentation": "Expiration year of each operating loss carryforward included in operating loss carryforward, in YYYY format.", "label": "Operating Loss Carryforwards Expiration Year" } } }, "auth_ref": [] }, "ipsi_OptionsExercisableShares": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "OptionsExercisableShares", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options exercisable shares", "documentation": "Options exercisable shares .", "label": "Options Exercisable Shares" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization and Description of Business [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r110", "r191", "r632", "r633" ] }, "ipsi_OrganizationandDescriptionofBusinessDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "OrganizationandDescriptionofBusinessDetailsLineItems", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Organization and Description of Business [Line Items]" } } }, "auth_ref": [] }, "ipsi_OrganizationandDescriptionofBusinessDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "OrganizationandDescriptionofBusinessDetailsTable", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Organization and Description of Business (Details) [Table]" } } }, "auth_ref": [] }, "ipsi_OriginalDiscountsRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "OriginalDiscountsRatePercentage", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original issue discount rate", "documentation": "The percentage of Original issue discount rate.", "label": "Original Discounts Rate Percentage" } } }, "auth_ref": [] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Investment impairment charge", "label": "Other Asset Impairment Charges", "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value." } } }, "auth_ref": [ "r854", "r876" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Other current assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r244", "r798" ] }, "us-gaap_OtherExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherExpenses", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments (in Dollars)", "label": "Other Expenses", "documentation": "Amount of expense classified as other." } } }, "auth_ref": [ "r157" ] }, "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeTaxExpenseBenefitContinuingOperations", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total Continuing operations", "label": "Other Income Tax Expense (Benefit), Continuing Operations", "documentation": "Amount of other current and other deferred income tax expense (benefit) attributable to continuing operations." } } }, "auth_ref": [ "r915" ] }, "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeTaxExpenseBenefitContinuingOperationsAbstract", "presentation": [ "http://ipsipay.com/role/ScheduleofReconciliationoftheUSFederalStatutoryIncomeTaxTable" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations", "label": "Other Income Tax Expense (Benefit), Continuing Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expense (in Dollars)", "label": "Other Tax Expense (Benefit)", "documentation": "Amount of other income tax expense (benefit)." } } }, "auth_ref": [ "r263", "r915", "r920" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails", "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails", "http://ipsipay.com/role/InvestmentsDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails", "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment." } } }, "auth_ref": [] }, "ipsi_OwnershipMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "OwnershipMember", "presentation": [ "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Member]", "label": "Ownership Member" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRent", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rent payments", "label": "Payments for Rent", "documentation": "Cash payments to lessor's for use of assets under operating leases." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PaymentsForSoftware": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForSoftware", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IPSIPay software amount", "label": "Payments for Software", "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization." } } }, "auth_ref": [ "r163" ] }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireEquityMethodInvestments", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable": { "parentTag": "us-gaap_IncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 }, "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Investment in equity method investment", "terseLabel": "Cash contribution to IPSIPay Express", "label": "Payments to Acquire Equity Method Investments", "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence." } } }, "auth_ref": [ "r37" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Intangibles acquired", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r163" ] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Investment in deposits", "label": "Payments to Acquire Investments", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r162" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Plant and equipment purchased", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r163" ] }, "ipsi_PenaltyOnCashSettlementOfConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "PenaltyOnCashSettlementOfConvertibleNote", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable": { "parentTag": "ipsi_LossOnConvertibleNotes", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Penalty on cash settlement of convertible note", "documentation": "Penalty on cash settlement of convertible note.", "label": "Penalty On Cash Settlement Of Convertible Note" } } }, "auth_ref": [] }, "ipsi_PenaltyOnConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "PenaltyOnConvertibleDebt", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on convertible notes", "verboseLabel": "Settlement penalty", "documentation": "Penalty on convertible debt.", "label": "Penalty On Convertible Debt" } } }, "auth_ref": [] }, "ipsi_PercentageOfRemainingSharesOwned": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "PercentageOfRemainingSharesOwned", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of remaining shares owned", "documentation": "Percentage of remaining shares owned.", "label": "Percentage Of Remaining Shares Owned" } } }, "auth_ref": [] }, "ipsi_PercentageOfSharesVivi": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "PercentageOfSharesVivi", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares percentage", "documentation": "Percentage of shares vivi.", "label": "Percentage Of Shares Vivi" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914" ] }, "us-gaap_PreferredStockConvertibleConversionPriceDecrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockConvertibleConversionPriceDecrease", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price per share (in Dollars per share)", "label": "Preferred Stock, Convertible, Conversion Price, Decrease", "documentation": "Per share decrease in conversion price of convertible preferred stock. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r432", "r435" ] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r800", "r801", "r804", "r805", "r806", "r807", "r953", "r957" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in Dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r142", "r428" ] }, "us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockPerShareAmountsOfPreferredDividendsInArrears", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, per share amounts of preferred dividends in arrears (in Dollars per share)", "label": "Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears", "documentation": "Per share amount of cumulative preferred dividends in arrears." } } }, "auth_ref": [ "r65" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock, authorized", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r142", "r682" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r142", "r428" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r142", "r682", "r702", "r957", "r958" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022.", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r142", "r609", "r798" ] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification of prior year presentation", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r842" ] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from short term notes and convertible notes", "label": "Proceeds from Convertible Debt", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r39" ] }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDebtNetOfIssuanceCosts", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Company received", "verboseLabel": "Gross proceeds", "label": "Proceeds from Debt, Net of Issuance Costs", "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination." } } }, "auth_ref": [ "r257" ] }, "ipsi_ProceedsFromDepositsRefunded": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ProceedsFromDepositsRefunded", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Deposits refunded", "documentation": "Deposits refunded.", "label": "Proceeds From Deposits Refunded" } } }, "auth_ref": [] }, "ipsi_ProceedsFromImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ProceedsFromImpairment", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from impairment (in Dollars)", "label": "Proceeds From Impairment" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfDebt", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds", "label": "Proceeds from Issuance of Debt", "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt." } } }, "auth_ref": [ "r850" ] }, "us-gaap_ProceedsFromMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromMinorityShareholders", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from non-controlling shareholders", "label": "Proceeds from Noncontrolling Interests", "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ProceedsFromSaleOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds", "label": "Proceeds from Sale of Intangible Assets", "documentation": "The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r161" ] }, "us-gaap_ProceedsFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromWarrantExercises", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from Warrant Exercises (in Dollars)", "label": "Proceeds from Warrant Exercises", "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants." } } }, "auth_ref": [ "r849" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow", "http://ipsipay.com/role/ConsolidatedIncomeStatement", "http://ipsipay.com/role/LiquidityMattersandGoingConcernDetails", "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r235", "r248", "r249", "r258", "r262", "r270", "r278", "r279", "r298", "r312", "r316", "r318", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r513", "r516", "r517", "r529", "r531", "r605", "r618", "r649", "r704", "r726", "r727", "r782", "r796", "r797", "r809", "r846", "r882" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plant and equipment costs", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r173", "r238", "r615" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Plant and equipment", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r8", "r606", "r615", "r798" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Plant and Equipment", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r8", "r219", "r222", "r614" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Estimated Useful Lives of the Assets", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r8" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment, useful Life", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "ipsi_PropertyPlantAndEquipmentsUsefulLife": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "PropertyPlantAndEquipmentsUsefulLife", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvements", "documentation": "Estimated useful live.", "label": "Property Plant And Equipments Useful Life" } } }, "auth_ref": [] }, "ipsi_PurchaseOfAggregateShares": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "PurchaseOfAggregateShares", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase of aggregate shares (in Shares)", "documentation": "Amount of purchase of aggregate shares.", "label": "Purchase Of Aggregate Shares" } } }, "auth_ref": [] }, "ipsi_PurchaseSharesOfCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "PurchaseSharesOfCommonStock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase shares of common stock", "documentation": "Number of purchase shares of common stock.", "label": "Purchase Shares Of Common Stock" } } }, "auth_ref": [] }, "ipsi_QpagosCorporationsCapitalStockMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "QpagosCorporationsCapitalStockMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Qpagos Corporation\u2019s Capital Stock [Member]", "label": "Qpagos Corporations Capital Stock Member" } } }, "auth_ref": [] }, "ipsi_QuickCapitalLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "QuickCapitalLLCMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quick Capital, LLC [Member]", "label": "Quick Capital LLCMember" } } }, "auth_ref": [] }, "ipsi_RachetProvision": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "RachetProvision", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rachet provision", "documentation": "A provision that provides an investor with down-round protection (i.e., where the company raises a subsequent round of financing, which can include IPO, at a lower price) by providing for the issuance of additional shares in the subsequent round.", "label": "Rachet Provision" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable", "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r437", "r439", "r470", "r471", "r472", "r564", "r588", "r626", "r672", "r673", "r736", "r742", "r743", "r744", "r760", "r773", "r774", "r784", "r791", "r794", "r799", "r802", "r877", "r886", "r939", "r940", "r941", "r942", "r943" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable", "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r384", "r385", "r386", "r387", "r437", "r439", "r470", "r471", "r472", "r564", "r588", "r626", "r672", "r673", "r736", "r742", "r743", "r744", "r760", "r773", "r774", "r784", "r791", "r794", "r799", "r802", "r877", "r886", "r939", "r940", "r941", "r942", "r943" ] }, "us-gaap_ReceivableInvestmentSale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivableInvestmentSale", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Receivable on sale of subsidiary", "label": "Receivable, Investment, Sale", "documentation": "Amount of receivable from sale of investment." } } }, "auth_ref": [ "r691", "r733", "r810" ] }, "ipsi_ReconciliationOfClosingCashWithinTheBalanceSheetToTheStatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ReconciliationOfClosingCashWithinTheBalanceSheetToTheStatementOfCashFlowsAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS", "label": "Reconciliation Of Closing Cash Within The Balance Sheet To The Statement Of Cash Flows Abstract" } } }, "auth_ref": [] }, "ipsi_ReconciliationOfOpeningCashWithinTheBalanceSheetToTheStatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ReconciliationOfOpeningCashWithinTheBalanceSheetToTheStatementOfCashFlowsAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS", "label": "Reconciliation Of Opening Cash Within The Balance Sheet To The Statement Of Cash Flows Abstract" } } }, "auth_ref": [] }, "ipsi_RedRoadHoldingsCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "RedRoadHoldingsCorporationMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Red Road Holdings Corporation [Member]", "label": "Red Road Holdings Corporation Member" } } }, "auth_ref": [] }, "ipsi_RedRoadHoldingsCorporationOneMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "RedRoadHoldingsCorporationOneMember", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Red Road Holdings Corporation One [Member]", "label": "Red Road Holdings Corporation One Member" } } }, "auth_ref": [] }, "ipsi_RedRoadHoldingsCorporationTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "RedRoadHoldingsCorporationTwoMember", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Red Road Holdings Corporation Two [Member]", "label": "Red Road Holdings Corporation Two Member" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofNotesPayableTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r438", "r551", "r552", "r676", "r677", "r678", "r679", "r680", "r701", "r703", "r734" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r551", "r552", "r934" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r708", "r709", "r712" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/RelatedPartyTransactionsDetails", "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable", "http://ipsipay.com/role/ScheduleofNotesPayableTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r438", "r551", "r552", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r676", "r677", "r678", "r679", "r680", "r701", "r703", "r734", "r934" ] }, "ipsi_RelatedPartyTransactionsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "RelatedPartyTransactionsDetailsTable", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "terseLabel": "RELATED PARTY TRANSACTIONS", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r548", "r549", "r550", "r552", "r553", "r645", "r646", "r647", "r710", "r711", "r712", "r731", "r732" ] }, "ipsi_RepaymentOfNotesPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "RepaymentOfNotesPayables", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of convertible note", "documentation": "Repayment of notes payables.", "label": "Repayment Of Notes Payables" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfConvertibleDebt", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of convertible notes", "label": "Repayments of Convertible Debt", "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r40" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfDebt", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayment debt", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r851" ] }, "us-gaap_RestrictedStockExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockExpense", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Option expense (in Dollars)", "label": "Restricted Stock or Unit Expense", "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock [Member]", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r48" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r145", "r181", "r611", "r630", "r631", "r643", "r683", "r798" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r232", "r267", "r268", "r269", "r271", "r277", "r279", "r364", "r365", "r478", "r479", "r480", "r500", "r501", "r520", "r522", "r523", "r525", "r527", "r627", "r629", "r650", "r957" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r706", "r775", "r779" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/AccountingPoliciesandEstimatesDetails", "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Net Revenue", "verboseLabel": "Revenues", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r255", "r262", "r299", "r300", "r311", "r314", "r315", "r319", "r320", "r321", "r362", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r531", "r605", "r882" ] }, "ipsi_RichardRosenblumMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "RichardRosenblumMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Richard Rosenblum [Member]", "label": "Richard Rosenblum Member" } } }, "auth_ref": [] }, "us-gaap_SaleLeasebackTransactionGrossProceedsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleLeasebackTransactionGrossProceedsInvestingActivities", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds", "label": "Sale Leaseback Transaction, Gross Proceeds, Investing Activities", "documentation": "Amount of cash inflow before closing and debt issuance costs received by a seller-lessee in a sale-leaseback recognized in investing activities." } } }, "auth_ref": [ "r211", "r212", "r213" ] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price (in Dollars)", "label": "Sale of Stock, Consideration Received on Transaction", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockConsiderationReceivedPerTransaction", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consideration received (in Dollars)", "label": "Sale of Stock, Consideration Received Per Transaction", "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockDescriptionOfTransaction", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Description of compensation service", "label": "Sale of Stock, Description of Transaction", "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination." } } }, "auth_ref": [ "r14", "r85", "r192" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockPercentageOfOwnershipBeforeTransaction", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Limitation exceeds percentage", "label": "Sale of Stock, Percentage of Ownership before Transaction", "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction." } } }, "auth_ref": [] }, "ipsi_SamadHarakeMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "SamadHarakeMember", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Samad Harake [Member]", "label": "Samad Harake Member" } } }, "auth_ref": [] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forecast [Member]", "label": "Forecast [Member]", "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact." } } }, "auth_ref": [ "r440", "r837", "r863" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable", "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable", "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable_Parentheticals", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r280", "r440", "r824", "r863" ] }, "ipsi_ScheduleOfAntiDilutiveSharesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfAntiDilutiveSharesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Anti Dilutive Shares Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://ipsipay.com/role/NetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Dilutive Shares", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r48" ] }, "ipsi_ScheduleOfAssetsAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfAssetsAndLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Assets And Liabilities Abstract" } } }, "auth_ref": [] }, "ipsi_ScheduleOfAssetsAndLiabilitiesNovatedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfAssetsAndLiabilitiesNovatedTableTextBlock", "presentation": [ "http://ipsipay.com/role/NovationofCertainAssetsandLiabilitesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets and liabilities Novated", "documentation": "Disclosure of schedule of assets and liabilities novated.", "label": "Schedule Of Assets And Liabilities Novated Table Text Block" } } }, "auth_ref": [] }, "ipsi_ScheduleOfAssumptionsWereUsedInTheBlackScholesValuationModelAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfAssumptionsWereUsedInTheBlackScholesValuationModelAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Assumptions Were Used In The Black Scholes Valuation Model Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://ipsipay.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Lease Information", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://ipsipay.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Provision for Income Taxes", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r189" ] }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "presentation": [ "http://ipsipay.com/role/DisposalofInvestmentinFrictionlessandBeyondFintechTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets and Liabilities", "label": "Condensed Balance Sheet [Table Text Block]", "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations." } } }, "auth_ref": [ "r838", "r859" ] }, "ipsi_ScheduleOfConvertibleNotesPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfConvertibleNotesPayableAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Convertible Notes Payable Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtConversionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtConversionsTextBlock", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of the Loss on Convertible Notes", "label": "Schedule of Debt Conversions [Table Text Block]", "documentation": "Tabular disclosure of information on an original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. The information may be presented entirely or partially in this block of text or in the associated elements." } } }, "auth_ref": [ "r44", "r45", "r46" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://ipsipay.com/role/NotesPayableTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Notes Payable", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "ipsi_ScheduleOfDeferredIncomeTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfDeferredIncomeTaxAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Deferred Income Tax Assets Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://ipsipay.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Income Tax Assets", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r188" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Movement in Derivative Liability", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position." } } }, "auth_ref": [ "r93" ] }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assumptions were used in the Black-Scholes Valuation Model", "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]", "documentation": "Tabular disclosure of derivative liabilities at fair value." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "presentation": [ "http://ipsipay.com/role/DiscontinuedOperationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets and Liabilities", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r11", "r21", "r24", "r112", "r121", "r122", "r123", "r124", "r125", "r130", "r132", "r133", "r175" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://ipsipay.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of the U.S. Federal Statutory Income Tax", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r187" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r75" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://ipsipay.com/role/EquityBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Equity Based Compensation", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r75" ] }, "ipsi_ScheduleOfEquityBasedCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfEquityBasedCompensationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Equity Based Compensation Abstract" } } }, "auth_ref": [] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://ipsipay.com/role/IntangiblesDetails", "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r358", "r359", "r361" ] }, "ipsi_ScheduleOfEquityMethodInvestmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfEquityMethodInvestmentsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Equity Method Investments Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r262", "r358", "r359", "r361", "r362", "r531" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityMethodInvestmentsTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r235", "r262", "r358", "r359", "r361", "r362", "r531" ] }, "ipsi_ScheduleOfEstimatedUsefulLivesOfTheAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfEstimatedUsefulLivesOfTheAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Estimated Useful Lives Of The Assets Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "presentation": [ "http://ipsipay.com/role/IntangiblesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Facilitate the Functioning of the IPSIPay Software", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class." } } }, "auth_ref": [ "r52" ] }, "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems", "presentation": [ "http://ipsipay.com/role/InvestmentsDetails" ], "lang": { "en-us": { "role": { "label": "Investment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r621" ] }, "ipsi_ScheduleOfNotesPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfNotesPayableAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Notes Payable Abstract" } } }, "auth_ref": [] }, "ipsi_ScheduleOfOptionActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfOptionActivityAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Option Activity Abstract" } } }, "auth_ref": [] }, "ipsi_ScheduleOfOptionsOutstandingAndExercisableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfOptionsOutstandingAndExercisableAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Options Outstanding And Exercisable Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://ipsipay.com/role/ScheduleofEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r8" ] }, "ipsi_ScheduleOfRestrictedStockGrantedIssuedAndExercisableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfRestrictedStockGrantedIssuedAndExercisableAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Restricted Stock Granted Issued And Exercisable Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Stock Activity", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r69" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]", "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r68" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Warrants Outstanding and Exercisable", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms." } } }, "auth_ref": [ "r68" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Warrant Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r19", "r20", "r69" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value of the Warrants Granted and Issued", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r186" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Stock Granted Issued and Exercisable", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "ipsi_ScheduleOfTheLossOnConvertibleNotesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfTheLossOnConvertibleNotesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of The Loss On Convertible Notes Abstract" } } }, "auth_ref": [] }, "ipsi_ScheduleOfWarrantActivityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfWarrantActivityAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Warrant Activity Abstract" } } }, "auth_ref": [] }, "ipsi_ScheduleOfWarrantsOutstandingAndExercisableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ScheduleOfWarrantsOutstandingAndExercisableAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Outstanding And Exercisable Abstract" } } }, "auth_ref": [] }, "ipsi_SecondTrancheMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "SecondTrancheMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Second Tranche [Member]", "label": "Second Tranche Member" } } }, "auth_ref": [] }, "us-gaap_SecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebt", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior secured convertible note", "label": "Secured Debt", "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower." } } }, "auth_ref": [ "r23", "r200", "r948" ] }, "ipsi_SecuritiesIssuedForServicesRenderedMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "SecuritiesIssuedForServicesRenderedMember", "presentation": [ "http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Securities Issued for Services Rendered [Member]", "label": "Securities Issued For Services Rendered Member" } } }, "auth_ref": [] }, "ipsi_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement Member" } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://ipsipay.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(g) Security", "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r813" ] }, "us-gaap_SecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecurityDeposit", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Security deposit", "label": "Security Deposit", "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease." } } }, "auth_ref": [ "r845" ] }, "us-gaap_SegmentDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDiscontinuedOperationsMember", "presentation": [ "http://ipsipay.com/role/ScheduleofStatementofOperationsfromDiscontinuedOperationsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued Operations [Member]", "label": "Discontinued Operations [Member]", "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale." } } }, "auth_ref": [ "r4", "r113", "r114", "r115" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Reporting by Segment", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r305", "r306", "r307", "r308", "r309", "r310", "r320", "r783" ] }, "us-gaap_SeniorNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorNotes", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of notes", "label": "Senior Notes", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders." } } }, "auth_ref": [ "r107", "r948" ] }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination [Member]", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period." } } }, "auth_ref": [ "r80" ] }, "ipsi_SettlementPenaltyPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "SettlementPenaltyPayment", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement penalty payment", "documentation": "Settlement penalty payment.", "label": "Settlement Penalty Payment" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Stock based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ShareBasedCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Restricted Stock Activity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total restricted shares, Forfeited/Cancelled", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r462" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average fair market value per share, Forfeited/Cancelled", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r462" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total restricted shares, Granted and issued", "verboseLabel": "Shares underlying warrants, granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r460" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average fair market value per share, Granted and issued", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r460" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Total restricted shares, Outstanding at beginning", "periodEndLabel": "Total restricted shares, Outstanding at ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r457", "r458" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average fair market value per share, Outstanding at beginning", "periodEndLabel": "Weighted average fair market value per share, Outstanding at ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r457", "r458" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total restricted shares, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r461" ] }, "ipsi_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Weighted average fair market value per share, Vested", "documentation": "Weighted average fair market value per share, Vested.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vesteds In Period Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "lang": { "en-us": { "role": { "label": "Schedule of Fair Value of the Warrants Granted and Issued [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "presentation": [ "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price (in Dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r471" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility of underlying stock", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r470" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Risk free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r472" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofEquityBasedCompensationTable" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Schedule of Equity Based Compensation [Abstract]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r442", "r443", "r445", "r446", "r447", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r470", "r471", "r472", "r473" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares Underlying, Forfeited/Cancelled (in Shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures", "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock granted and Vested, number granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r17" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase an additional shares (in Shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "verboseLabel": "Shares of options exercisable (in Shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r451" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Exercise price per share, Outstanding", "periodEndLabel": "Exercise price per share, Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r451" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements." } } }, "auth_ref": [ "r456" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares Underlying, Cancelled on disposal of investment in Frictionless and Beyond Fintech (in Shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r895" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Cancelled on disposal of investment in Frictionless and Beyond Fintech", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r895" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares Underlying, Forfeited (in Shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total unvested restricted shares, Granted and issued", "verboseLabel": "Shares Underlying, Granted (in Shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r453" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants outstanding an intrinsic value (in Dollars)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r68" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Shares Underlying, Outstanding (in Shares)", "periodEndLabel": "Shares Underlying, Outstanding (in Shares)", "terseLabel": "Incentive stock options", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r449", "r450" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, Outstanding", "periodEndLabel": "Weighted average exercise price, Outstanding", "terseLabel": "Restricted stock granted and Vested, weighted average fair value per share (in Dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r449", "r450" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock outstanding, percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum", "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r445", "r446", "r447", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r470", "r471", "r472", "r473" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Exercised", "verboseLabel": "Exercise price per share (in Dollars per share)", "netLabel": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price (in Dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r454" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Forfeited", "verboseLabel": "Weighted average exercise price, Forfeited/Cancelled", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Granted", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r453" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Tranche One [Member]", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheThreeMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Tranche Three [Member]", "label": "Share-Based Payment Arrangement, Tranche Three [Member]", "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Tranche Two [Member]", "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangements", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r441", "r448", "r467", "r468", "r469", "r470", "r473", "r481", "r482", "r483", "r484" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r73" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Domain]", "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r74" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Warrants Outstanding and Exercisable [Line Items]", "terseLabel": "Schedule of Options Outstanding and Exercisable [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number Exercisable", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied." } } }, "auth_ref": [ "r72" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number Outstanding", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices." } } }, "auth_ref": [ "r70" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected life of derivative liability", "verboseLabel": "Expected life", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r469" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Total unvested restricted shares, Outstanding at beginning", "periodEndLabel": "Total unvested restricted shares, Outstanding at ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total unvested restricted shares, Forfeited/Cancelled", "verboseLabel": "Remaining vested shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total unvested restricted shares, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Number of Shares, Period Increase (Decrease)", "documentation": "Number of increase (decrease) of non-vested options." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested years", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r466" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "documentation": "Number of options vested." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price (in Dollars per share)", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price", "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding." } } }, "auth_ref": [ "r71" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Contractual life in years", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r185" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price (in Dollars per share)", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices." } } }, "auth_ref": [ "r70" ] }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Contractual life in years", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r184" ] }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "presentation": [ "http://ipsipay.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "STOCKHOLDERS\u2019 EQUITY", "label": "Shareholders' Equity and Share-Based Payments [Text Block]", "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)." } } }, "auth_ref": [ "r180", "r183" ] }, "ipsi_ShareholdingJointVenturePercentage": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ShareholdingJointVenturePercentage", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Joint venture percentage", "documentation": "The Shareholding joint venture percentage.", "label": "Shareholding Joint Venture Percentage" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares of common stock (in Shares)", "verboseLabel": "Common stock shares", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r15" ] }, "us-gaap_SharesIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssuedPricePerShare", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price per share (in Dollars per share)", "label": "Shares Issued, Price Per Share", "documentation": "Per share or per unit amount of equity securities issued." } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance (in Shares)", "periodEndLabel": "Balance (in Shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "ipsi_SharesUnderlyingIncreaseInWarrantsDueToDebtAmendmentFullRachetTriggerinDollars": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "SharesUnderlyingIncreaseInWarrantsDueToDebtAmendmentFullRachetTriggerinDollars", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Shares Underlying, Increase in warrants due to debt amendment full rachet trigger (in Shares)", "documentation": "Shares Underlying, Increase in warrants due to debt amendment full rachet trigger.", "label": "Shares Underlying Increase In Warrants Due To Debt Amendment Full Rachet Triggerin Dollars" } } }, "auth_ref": [] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowings", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Working capital expenses", "label": "Short-Term Debt", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r138", "r199", "r798", "r947" ] }, "us-gaap_ShortTermDebtPercentageBearingFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtPercentageBearingFixedInterestRate", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bearing interest rate", "label": "Short-Term Debt, Percentage Bearing Fixed Interest Rate", "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/NotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r25" ] }, "ipsi_SmallBusinessEconomicInjuryDisasterLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "SmallBusinessEconomicInjuryDisasterLoanMember", "presentation": [ "http://ipsipay.com/role/FederalReliefLoansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Small Business Economic Injury Disaster Loan [Member]", "label": "Small Business Economic Injury Disaster Loan Member" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/StockholdersEquityDetails", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r227", "r241", "r242", "r243", "r262", "r284", "r285", "r288", "r290", "r296", "r297", "r362", "r389", "r391", "r392", "r393", "r396", "r397", "r428", "r429", "r430", "r431", "r434", "r531", "r639", "r640", "r641", "r642", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r662", "r682", "r705", "r728", "r764", "r765", "r766", "r767", "r768", "r822", "r855", "r864" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r15", "r35", "r232", "r251", "r252", "r253", "r267", "r268", "r269", "r271", "r277", "r279", "r295", "r364", "r365", "r436", "r478", "r479", "r480", "r500", "r501", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r532", "r533", "r534", "r535", "r536", "r537", "r547", "r627", "r628", "r629", "r650", "r728" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable", "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r267", "r268", "r269", "r295", "r589", "r634", "r662", "r674", "r676", "r677", "r678", "r679", "r680", "r682", "r685", "r686", "r687", "r688", "r689", "r692", "r693", "r694", "r695", "r697", "r698", "r699", "r700", "r701", "r703", "r706", "r707", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r728", "r803" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable", "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable", "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable_Parentheticals", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r280", "r440", "r824", "r826", "r863" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable", "http://ipsipay.com/role/ScheduleofAssumptionswereusedintheBlackScholesValuationModelTable", "http://ipsipay.com/role/ScheduleofRestrictedStockGrantedIssuedandExercisableTable", "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r267", "r268", "r269", "r295", "r589", "r634", "r662", "r674", "r676", "r677", "r678", "r679", "r680", "r682", "r685", "r686", "r687", "r688", "r689", "r692", "r693", "r694", "r695", "r697", "r698", "r699", "r700", "r701", "r703", "r706", "r707", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r728", "r803" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of convertible debt (in Shares)", "verboseLabel": "Common stock conversion shares", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r15", "r34", "r64", "r181", "r415" ] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued for services (in Shares)", "verboseLabel": "Exchange shares", "label": "Stock Issued During Period, Shares, Issued for Services", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesOther", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate shares of common stock", "label": "Stock Issued During Period, Shares, Other", "documentation": "Number of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock purchase agreement", "verboseLabel": "Purchased shares", "label": "Stock Issued During Period, Shares, Purchase of Assets", "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails", "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock awards (in Shares)", "verboseLabel": "Restricted shares (in Shares)", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards." } } }, "auth_ref": [ "r15", "r181" ] }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional shares issued on reverse stock split (in Shares)", "label": "Stock Issued During Period, Shares, Reverse Stock Splits", "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split." } } }, "auth_ref": [ "r15" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Shares Underlying, Exercised (in Shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r15", "r142", "r143", "r181", "r454" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockSplits", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock issued", "label": "Stock Issued During Period, Shares, Stock Splits", "documentation": "Number of shares issued during the period as a result of a stock split." } } }, "auth_ref": [ "r15", "r142", "r143", "r181" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of convertible debt", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r15", "r35", "r181" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued for services", "label": "Stock Issued During Period, Value, Issued for Services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueOther", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional shares issued on reverse stock split", "label": "Stock Issued During Period, Value, Other", "documentation": "Value of shares of stock issued attributable to transactions classified as other." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails", "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted stock awards", "verboseLabel": "Restricted shares value", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited." } } }, "auth_ref": [ "r15", "r181" ] }, "ipsi_StockOptionExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockOptionExercisePrice", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option exercise price (in Dollars per share)", "documentation": "Per share in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.", "label": "Stock Option Exercise Price" } } }, "auth_ref": [] }, "us-gaap_StockOptionExercisePriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionExercisePriceIncrease", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price (in Dollars per share)", "label": "Stock Option, Exercise Price, Increase", "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement." } } }, "auth_ref": [ "r435" ] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionMember", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable", "http://ipsipay.com/role/ScheduleofOptionsOutstandingandExercisableTable", "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Options [Member]", "verboseLabel": "Stock Option [Member]", "netLabel": "Option [Member]", "label": "Equity Option [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [ "r802" ] }, "us-gaap_StockOptionPlanExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionPlanExpense", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Option expense", "label": "Stock or Unit Option Plan Expense", "documentation": "Amount of noncash expense for option under share-based payment arrangement." } } }, "auth_ref": [ "r7" ] }, "ipsi_StockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockOptionsMember", "presentation": [ "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options [Member]", "documentation": "It represents stock options.", "label": "Stock Options Member" } } }, "auth_ref": [] }, "ipsi_StockPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockPurchaseAgreementMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Purchase Agreement [Member]", "label": "Stock Purchase Agreement Member" } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchased shares", "label": "Stock Repurchased and Retired During Period, Shares", "documentation": "Number of shares that have been repurchased and retired during the period." } } }, "auth_ref": [ "r15", "r142", "r143", "r181" ] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares of common stock", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r15", "r142", "r143", "r181", "r642", "r728", "r767" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity (deficit) attributable to Innovative Payment Solutions, Inc. Stockholders", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r143", "r146", "r147", "r168", "r684", "r702", "r729", "r730", "r798", "r810", "r857", "r873", "r930", "r957" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Equity (Deficit)", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsLineItems", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) [Line Items]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsScheduleofFairValueoftheWarrantsGrantedandIssuedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsScheduleofFairValueoftheWarrantsGrantedandIssuedLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued [Line Items]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsScheduleofFairValueoftheWarrantsGrantedandIssuedTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsScheduleofFairValueoftheWarrantsGrantedandIssuedTable", "presentation": [ "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued [Table]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsScheduleofOptionActivityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsScheduleofOptionActivityLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of Option Activity [Line Items]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsScheduleofOptionActivityTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsScheduleofOptionActivityTable", "presentation": [ "http://ipsipay.com/role/ScheduleofOptionActivityTable" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of Option Activity [Table]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsScheduleofRestrictedStockActivityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsScheduleofRestrictedStockActivityLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of Restricted Stock Activity [Line Items]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsScheduleofRestrictedStockActivityTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsScheduleofRestrictedStockActivityTable", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of Restricted Stock Activity [Table]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsScheduleofWarrantActivityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsScheduleofWarrantActivityLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Warrant Activity [Line Items]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsScheduleofWarrantActivityTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsScheduleofWarrantActivityTable", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) - Schedule of Warrant Activity [Table]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityDetailsTable", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedBalanceSheet", "http://ipsipay.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Total Equity (Deficit)", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r81", "r82", "r87", "r232", "r233", "r252", "r267", "r268", "r269", "r271", "r277", "r364", "r365", "r436", "r478", "r479", "r480", "r500", "r501", "r520", "r521", "r522", "r523", "r524", "r525", "r527", "r532", "r533", "r537", "r547", "r628", "r629", "r648", "r684", "r702", "r729", "r730", "r769", "r809", "r857", "r873", "r930", "r957" ] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityOtherShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityOtherShares", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retained shares of common stock", "label": "Stockholders' Equity, Other Shares", "documentation": "Number of increase (decrease) in shares of stock classified as other." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityReverseStockSplit": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityReverseStockSplit", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse stock split description", "label": "Stockholders' Equity, Reverse Stock Split", "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements." } } }, "auth_ref": [ "r182" ] }, "ipsi_StockholdersEquityTablesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityTablesLineItems", "presentation": [ "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Tables) [Line Items]" } } }, "auth_ref": [] }, "ipsi_StockholdersEquityTablesTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "StockholdersEquityTablesTable", "presentation": [ "http://ipsipay.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity (Tables) [Table]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r538", "r556" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Member]", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r538", "r556" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r538", "r556" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r538", "r556" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "ipsi_SubsequentEventsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "SubsequentEventsDetailsTable", "presentation": [ "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://ipsipay.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "SUBSEQUENT EVENTS", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r555", "r557" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://ipsipay.com/role/DerivativeLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://ipsipay.com/role/LiquidityMattersandGoingConcern" ], "lang": { "en-us": { "role": { "terseLabel": "LIQUIDITY MATTERS AND GOING CONCERN", "label": "Substantial Doubt about Going Concern [Text Block]", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r134" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH PAID FOR INTEREST AND TAXES:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardAxis", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward [Axis]", "documentation": "Information by specific tax credit related to an unused tax credit." } } }, "auth_ref": [ "r76" ] }, "us-gaap_TaxCreditCarryforwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardLineItems", "presentation": [ "http://ipsipay.com/role/ScheduleofDeferredIncomeTaxAssetsTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Income Tax Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_TaxCreditCarryforwardNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TaxCreditCarryforwardNameDomain", "presentation": [ "http://ipsipay.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Credit Carryforward, Name [Domain]", "documentation": "The name of the tax credit carryforward." } } }, "auth_ref": [ "r76" ] }, "ipsi_ThirdTrancheMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ThirdTrancheMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Third Tranche [Member]", "label": "Third Tranche Member" } } }, "auth_ref": [] }, "ipsi_ThreeTranchesMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ThreeTranchesMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Three Tranches [Member]", "label": "Three Tranches Member" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "documentation": "Information by title of individual or nature of relationship to individual or group of individuals." } } }, "auth_ref": [ "r866", "r933" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "documentation": "Title of individual, or nature of relationship to individual or group of individuals." } } }, "auth_ref": [] }, "ipsi_TotalRestrictedSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "TotalRestrictedSharesMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total restricted shares [Member]", "label": "Total Restricted Shares Member" } } }, "auth_ref": [] }, "ipsi_TotalUnvestedRestrictedSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "TotalUnvestedRestrictedSharesMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total unvested restricted shares [Member]", "label": "Total Unvested Restricted Shares Member" } } }, "auth_ref": [] }, "ipsi_TotalVestedRestrictedSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "TotalVestedRestrictedSharesMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total vested restricted shares [Member]", "label": "Total Vested Restricted Shares Member" } } }, "auth_ref": [] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r208", "r209", "r210", "r322", "r323", "r325" ] }, "ipsi_TrancheMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "TrancheMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tranche [Member]", "label": "Tranche Member" } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r423", "r433", "r526", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r621", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r868", "r869", "r870", "r871" ] }, "ipsi_TwoThousandAndTweentyThreeConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "TwoThousandAndTweentyThreeConvertibleNotesMember", "presentation": [ "http://ipsipay.com/role/ScheduleofConvertibleNotesPayableTable" ], "lang": { "en-us": { "role": { "terseLabel": "2023 convertible notes [Member]", "label": "Two Thousand And Tweenty Three Convertible Notes Member" } } }, "auth_ref": [] }, "ipsi_TwoThousandEighteenStockIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "TwoThousandEighteenStockIncentivePlanMember", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2018 Stock Incentive Plan [Member]", "label": "Two Thousand Eighteen Stock Incentive Plan Member" } } }, "auth_ref": [] }, "ipsi_TwoThousandTwentyOnePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "TwoThousandTwentyOnePlanMember", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2021 Stock Incentive Plan [Member]", "label": "Two Thousand Twenty One Plan Member" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://ipsipay.com/role/ScheduleofAssetsandliabilitiesNovatedTable", "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r512" ] }, "us-gaap_UnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrealizedGainLossOnInvestments", "crdr": "credit", "calculation": { "http://ipsipay.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized loss on equity method investments", "label": "Unrealized Gain (Loss) on Investments", "documentation": "Amount of unrealized gain (loss) on investment." } } }, "auth_ref": [ "r7" ] }, "ipsi_UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Unvested restricted Weighted average fair market value per share [Member]", "label": "Unvested Restricted Weighted Average Fair Market Value Per Share Member" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://ipsipay.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r49", "r50", "r51", "r216", "r217", "r220", "r221" ] }, "ipsi_ValueOfGrantDate": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ValueOfGrantDate", "crdr": "debit", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of grant date (in Dollars)", "documentation": "Value of grant date.", "label": "Value Of Grant Date" } } }, "auth_ref": [] }, "ipsi_ValueOfNotesExchangedForCertainWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ValueOfNotesExchangedForCertainWarrants", "crdr": "debit", "calculation": { "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable": { "parentTag": "ipsi_LossOnConvertibleNotes", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ipsipay.com/role/ScheduleoftheLossonConvertibleNotesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)", "documentation": "Value of notes exchanged for certain warrants.", "label": "Value Of Notes Exchanged For Certain Warrants" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityOwnershipPercentage", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable interest entity ownership percentage", "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage", "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)." } } }, "auth_ref": [ "r86" ] }, "ipsi_VestedRestrictedWeightedAverageFairMarketValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "VestedRestrictedWeightedAverageFairMarketValuePerShareMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Vested restricted Weighted average fair market value per share [Member]", "label": "Vested Restricted Weighted Average Fair Market Value Per Share Member" } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r889", "r890", "r891", "r892", "r893", "r894", "r895", "r896", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r905", "r906", "r907", "r908", "r909", "r910", "r911", "r912", "r913", "r914" ] }, "ipsi_ViviHoldingsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "ViviHoldingsIncMember", "presentation": [ "http://ipsipay.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vivi Holdings, Inc [Member]", "label": "Vivi Holdings Inc Member" } } }, "auth_ref": [] }, "ipsi_WarrantAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "WarrantAgreementMember", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant Agreement [Member]", "label": "Warrant Agreement Member" } } }, "auth_ref": [] }, "us-gaap_WarrantExercisePriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantExercisePriceIncrease", "presentation": [ "http://ipsipay.com/role/LossonConvertibleNotesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price", "label": "Warrant, Exercise Price, Increase", "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r435" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails", "http://ipsipay.com/role/DerivativeLiabilityDetails", "http://ipsipay.com/role/LossonConvertibleNotesDetails", "http://ipsipay.com/role/NotesPayableDetails", "http://ipsipay.com/role/ScheduleofAntidilutiveSharesTable", "http://ipsipay.com/role/ScheduleofFairValueoftheWarrantsGrantedandIssuedTable", "http://ipsipay.com/role/ScheduleofWarrantActivityTable", "http://ipsipay.com/role/ScheduleofWarrantsOutstandingandExercisableTable", "http://ipsipay.com/role/StockholdersEquityDetails", "http://ipsipay.com/role/StockholdersEquityTables", "http://ipsipay.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants [Member]", "verboseLabel": "Warrant [Member]", "netLabel": "Warrants to purchase shares of common stock [Member]", "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r800", "r801", "r804", "r805", "r806", "r807" ] }, "ipsi_WarrantsBeneficiallyPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "WarrantsBeneficiallyPercentage", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants beneficially percentage", "documentation": "Percentage of warrants beneficially own in excess.", "label": "Warrants Beneficially Percentage" } } }, "auth_ref": [] }, "ipsi_WarrantsExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "WarrantsExercisable", "presentation": [ "http://ipsipay.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant share (in Shares)", "documentation": "The shares warrants shares.", "label": "Warrants Exercisable" } } }, "auth_ref": [] }, "ipsi_WarrantsExercisableForSharesOfCommonStock": { "xbrltype": "sharesItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "WarrantsExercisableForSharesOfCommonStock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase an aggregate shares", "documentation": "Warrants exercisable for shares of common stock.", "label": "Warrants Exercisable For Shares Of Common Stock" } } }, "auth_ref": [] }, "ipsi_WarrantsIssuedForSoftwareDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "WarrantsIssuedForSoftwareDevelopment", "crdr": "credit", "presentation": [ "http://ipsipay.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants issued for software development", "documentation": "Warrants issued for software development.", "label": "Warrants Issued For Software Development" } } }, "auth_ref": [] }, "ipsi_WeightedAverageExercisesPriceIncreaseInWarrantsDueToDebtAmendmentFullRachetTrigger": { "xbrltype": "perShareItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "WeightedAverageExercisesPriceIncreaseInWarrantsDueToDebtAmendmentFullRachetTrigger", "presentation": [ "http://ipsipay.com/role/ScheduleofWarrantActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price, Increase in warrants due to debt amendment full rachet trigger", "documentation": "Weighted average exercise price, Increase in warrants due to debt amendment full rachet trigger.", "label": "Weighted Average Exercises Price Increase In Warrants Due To Debt Amendment Full Rachet Trigger" } } }, "auth_ref": [] }, "ipsi_WeightedAverageFairMarketValuePerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "WeightedAverageFairMarketValuePerShareMember", "presentation": [ "http://ipsipay.com/role/ScheduleofRestrictedStockActivityTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average fair market value per share [Member]", "label": "Weighted Average Fair Market Value Per Share Member" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Number of Shares Outstanding \u2013 Diluted (in Shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r283", "r290" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://ipsipay.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Number of Shares Outstanding \u2013 Basic (in Shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r282", "r290" ] }, "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesRestrictedStock", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted shares", "label": "Weighted Average Number of Shares, Restricted Stock", "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends." } } }, "auth_ref": [ "r47" ] }, "ipsi_WilliamCorbettMember": { "xbrltype": "domainItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "WilliamCorbettMember", "presentation": [ "http://ipsipay.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "William Corbett [Member]", "label": "William Corbett Member" } } }, "auth_ref": [] }, "ipsi_terminatesPeriod": { "xbrltype": "durationItemType", "nsuri": "http://ipsipay.com/20231231", "localname": "terminatesPeriod", "presentation": [ "http://ipsipay.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Terminates period", "documentation": "Terminates period.", "label": "terminates Period" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-11" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1D", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1D" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "205", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479910/205-30-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1B" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(1)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(3)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-13" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "460", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)-(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4K", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4K" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "25", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482981/835-30-25-12" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "25", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482981/835-30-25-13" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-20/tableOfContent" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1A" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1B" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-1C" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-3A" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4A" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-4B" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5A" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5D" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.13)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4,6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-9" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3A" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 5.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479836/810-10-S99-5" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//820/tableOfContent" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//942/tableOfContent" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-50" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "51", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-51" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-52" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "323", "Publisher": "FASB", "URI": "https://asc.fasb.org//323/tableOfContent" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "(a)", "Publisher": "SEC" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-12" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-42" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "51", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-51" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482551/740-270-45-3" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(f)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(5)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "12", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "450", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r776": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r777": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r821": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r822": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r823": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "323", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481543/323-740-50-2" }, "r824": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r825": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11" }, "r826": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r827": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r828": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "321", "Publisher": "FASB", "URI": "https://asc.fasb.org//321/tableOfContent" }, "r829": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "325", "Publisher": "FASB", "URI": "https://asc.fasb.org//325/tableOfContent" }, "r830": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r831": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r832": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r833": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r834": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r835": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r836": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r837": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "11", "Subsection": "03", "Publisher": "SEC" }, "r838": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "(a)", "Publisher": "SEC" }, "r839": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r840": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r841": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r842": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r843": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r844": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r845": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-2" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(g))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 112 0001213900-24-033608-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-033608-xbrl.zip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

&<5>7UO74H"K[7ZLTK;M,9%;7F&_[(' M1ANUCYY^"U3SC:I4KM:DHKR^8WNS'>"[4^\9N(R]&KF<8)QIU$,"UZP(.!\8 M$^J2+GTF]_9$LR3^A43ZU#'&'\E$ E>6HR_=T1Q\4E^V3/WRWPVFLZ! MP4"#VTU3K(VA#3^[4VWD?]X8U&=#]Q[QTN)/*X!:Y6EZ]I1=$.!>/+)XK90- M"S8KP&?%O$S7^(MRZ/*-?WQZC[]S B[+Z6 "S!B_<&T]MFW/LCT:#%;[T_\F M3WY,S _@> (N0 1\ZZ][>7,,M" /QA,>A$+'8SKRL/]!(S(KVE"+24WSV$O? MG#T 2' !]VBO@T5$X&N$O#7'6=EBK".#,7BD1!MA5:MFO2#>$5=N#CP. I0R MX.X'1S/)5',\+*;Q'BF@7P/1XK%B6(N%@#3\,#8LS1H9..O @R]85O/ZY.O[ M- PP/6R<'IH% /ZK4""W!C7U#^1.>P"]T:?_F5%K!)NB^I&P)#* 10H%<1]3 M9?S6B-;E,!5@[\/%"@I7\8TO<"OXW;I(7GXK?"0A( I/,0$%37I_=: MXV2[O-/M]GYK#CJ_MX@U^]]^3;H]+I]B72ZK>ML2(!AHP40];YT M;IJ#]@WI#^ _"&T_U[LEK6;_5W+[I?=[/QO +E'75;8=XI)5:-Q30WPL0TW( M4GB[J4U=P(G_5\R&RZ=*"RQ&_]EJ"@@@/-FRGQUMNM*C2;C^(UE((20_ @!' MVOV<5_*;/2Z)-&!0/%/SB7X:.N\;9 *W/+K\I=32J;YWX-_H^E-GG%X5:_FI M*_XJ59;> #L=;,U;L- JE*7(5ZY(6B<@;7W:.24&@QSG/,A+LKR;L4JFUZWL M;]T[2)R$!X=V#KF][WTEO;OV/=ANW5](LP4F7&?0:?<_Q(!?A[ZDW]-^M\ES M#EPZ*VR':N6GQ?C8?+)?+BYF^WD@)58QN^05\D^K1:!_U?)HZ));ZC]M$?P\ M045(;6U%R$8X>7<^R#Y!-5M]_4DY6V#[$(4W6Q:OK]^,_+QGW7"1%H;%QH!. MJ@$9VR/A ^[$1<^)I\V6U M(BFE);G:E IT(]2^0MKN(%8.1ULYWZC5)+6XI(9V'Z0]>C?-=I)'H!1C_$OD MSM9M6*LN/K3ZC[-.*UADR#B;,0PK%%6+LB3+2VIRUJ/F74;0NK<=N3M:57[V M9$F5Y+0&P(G+;;??=V&+(*8O'0HT&1DF)9:_'^%;_'NDN8]DAE-E#,O?D[ [ M$2=/;'!Z"A=H3WRTZZ.S"%L&Y;*?A+^ACO$$U'ZBQ#2TH6&R:03V$PV'$)Q> M>NP@E'_1#*OGH/3H67T0$KTQGVANA2?5IVEX+958:P4(XU)IR7R*-R&,]X7. M10F7&_H%"2J$0[@.@9E#[5/HHM)14$\#:Q6E"KJ MUCKTR,+[4%MB8\Q5L8 >SP/=D@ M^BZ#DR*KZXUO><&1]="R7<]M6OJ-6&>J80IX4GVU6I34ZM;"\)5LI;UBM9YO M*!554M(ZW(?;9EL.E5J^MU#_8K6A93^]#NV#9D74J.AYC]1INB[U-G/N\!!K M62I6*I)<21E"._UF2ENS/C&#HDM+\5R"%1[&S8YF=X]EBL%\V*+_MA"DNDJ.G MZN%\YH'-.SM241YV3+TH59>=I9>]'916%*BO41K'69H?],#*\%\/'[-%=7%- MJ?@7R%Q5I7+EK9KFN^*OE&^4I$I1D:K%)*$'ZB [<=4\0C$].!U?E5>=OQ,VCKV-_;DWK&)0#[ J+^L5?QU:[IOE M4+CQ+]BCIE!XJ\LJ2/.B*BG+AD1D;[NE->=* MIS+G]JZ4^K'SG4^CA-)BO?Q&_6F4SC@&2Z3/FI;NR^V(Q.XY+5,S)NDD=PTD MMZJ"/CQYM/.0DGOE^3RU+JCUJ%D/J"0LPJ/L1+-T\D44@!A'5!67-@D%UC ME,_&MM^M[!(L7)?>4/[?CL66V>*KW"*)A(?ZXDRE[:L#C\RGARR]W BU2S&J M@'Q5P#A9,J'JY-4^VU4XC'@V&GY\8:W=*$.UT.CZ[:MFYY\M/+ M?*(8WY= F,0EO\(6F+WN>!^+@A>[=/FXR2CG@7>OUA6I*J=4I)=NIL.+E2U) M60%1+8.P5E(*D:-W+QW%:UK7)4$*K[6W"?@$5W_GV$^&3O7/+]\ #6 .^DAH M!CC8N4$'#^^5I5(9[,7Z6RZU/R;*:V C2/6:(LD5]80F^GH#(=5^WK%-FFWS M!VHA*F&O#U^6[?5+!_6VO)V2L9/;;U,I+(R*EB6EEG*@PMLU/0XFO_9&X[7B M"\]KKM:E:GW?K=4G[O+<58[A:)MO_?8-Z703Y]J\&2X^BN&S&''H,5EV M,^U48>46U7I6AZNLX] ;P9/$H>/9PK3RFAL5TELYLYRF3J].9,WK$2M17%(I)3=3Z M:J)>0NV'5Q@@<::P%UX8;S8MO>US9BIQ [NRI$K%TF$"DYD/>W3G!R)R+W@N M_????ZLILOSQC27\.SXJ]IA]QI.^9:FHU*3*F_94CHAR//^TII8DM7A)]V^V MW5]_SO]@(B4E<^\A(8RCDG",NGJ8A/!;H/.>$_\'HK."8T0E5;DD_F,2K3T@ ML>1_4N+FS7#R48R@S=A6Y5/JP*57]WW0PT5"G9"N);"JJF6IHIQOZC]*@?02 MYTS2K5F&+?-N\7PUP&VGV^RV+M4 &6&!0Q[?X@>P^?$M[J/M>'"O,^&SX5CL M\_5,C(L<,!9$[2.CSW "8IHH&LXV4:12198JE;.9S) RQ%LO9KY2("UKW],I M#Y[B!+?3,?'!3-A@?6YOO T7XT0PD"IJ><>C8,-5NKN4;=:FR]_+N+/@"^PH\W=WW?NO49M(# MTZ8*.'OJ6SYO-LL$8D<"%ZLEJ5[;<33&N3F2S*QL#LCG]B^=;A=MR-XM^:/= MO']%UL9*CBZ=B*/3V)1U%6?0EJ1JVD.WWJY%N9+&LIQE(I=0^)1*=:E:3GF: MSUG[OJ5MQ%.[>[-2,"5 DO#>S=D.;B*Z/1N:5)SDL7JU^<;?#_+L-$RN9IG' MR\#C1:FD;AG<83R3"O\K"'SAD6PKN\J.RFXK)KGXW1>_^W Z+Y81;;=ZW5;G M2Z,2,/"L YO&N&'*9!':O(SEQSJ N+>BN.Z MPZ:\,=RI#;CZ!>@X[5@B4);8')":(^OY1KUTP/SL&Z#H+I)C_R0M%[%A39&4 MM"WP1X\\'*B7;:L@1"Q&BC;9)1R1/5OU+=.-<667'G9Z)D,:.&9%44ES= M++&1V8C&X<,_Y6)IG^&?LRNT>'N1C;3E^LJE7/_<8T/E8OG L:&3YW+V4;]P M"1IDLX;A$/Y=Y5+RD 66>DUQJ.IKK9"XQ [.U2'<_RB,NV;GAMSV[DFG.VC? MM_L#T@3E.6C^ZS(&(].AHWU;3N@O336#.T?@.-D32CSM!TW7T;RS6MN;#MO% M,U(W\XQ*._M%KP-MI7VC[32U$SOM%WX<\?D3?>\-8VQTO']\IN2W="/F,DVL??>.K:754A+5\XT::*K*EG4-!Q8)E\+A M;,.6>4NYV^L6F+4<&4$*5O+:21!91':683LOF_EWS7$TRW.)X;HX1QLM =<> M>\^:0T'V/E'3GBX<.G>>BB:M*5B^6-"'UL\^UW48T]W:3E^PW$W(<6ETMEP$ MLZI4D^IJ+9-*^SAV_*UF..1),V<4)^<]S^WH9\-[7#-.[_4QYK9&/J+R-\1D M;QSGT=\!BY%Y)03[B@5,6KF\YDS,3-OC^_#6&?>Y MR.IS\S%U.O2(9XL#8U\!1QQJWDN P=ZX[]FC[\T)4-03VYKJ9W+9 MY'R3KSE5:)?$O)-*G MCC'^2"::\V# J_#28OSM(XIQQ"1Q\^1NO#+3(>;V;AX5DZFX8?,$D MS_7)U_?)A87%@F*N\1?]0*K1/8+7-$X/Z@( _U4HD%N#FOH'Q+<)OC>PR#E/!LZ=PL8+;1'SC;YT*?K>N9#"_%3Z2 M$!"%IY@ #E=WA>CJ_75_)(.7*:RYZ6A#8_21=$&:<]QT;41#)7K3>_\NAB!$ M;H":9:@:.E3[7AA24"'PW"G#>13<2@*XB-(HAD7<..G M.YO *T8+)EM0E=8$4^W/GO.@6<9?O @XT"KPH6GI=P[H',MC'WOC6U_-] ,M M@S5NINW.'#J -WPVP3TKC(I_XAO^!,>,@M$VQ8WIS.B\7[?O]X:6H%+'".,G M9FH #DU3&"S,>,3/H'1&_N>-Z?5LZ-XC7EK\*;_&<0&AL^BYZ %O*G-.$HER3U_CWS/6,\4N*Q_;N?VEV._^/=W%A2NFFW6_==^[\KJ[/ MW_J=;KO?GW_[O"F7VYGGHVP,''P>9%MAXV]*8.W=@2@0NYPB-UE>+'SEV_P_Z4/Q+;03^! MB%]:W+<0/[XC5S9X@B!,3?.%+1Y/X+4 O5.0JD/J$$5E0*K@88-!FL,GX=K] MQS5=XT4C=X 64T#F/UDB3%.Q?B?/1O>E^>!0)JK9X59XC#KZ,%^I\P#ON8K M*+X*K@^ 91F0_PN&H.WF6N&R$1DWU-18JC,)'?P6$KDEA!)A$;^S]X;X37PD M7O[\:".Z[&>+ZCEW-G0-W="<%^&1$8'BX.UB.?W9T'_K->?[NYGCSC2+A7SQ MQOEU2TB***=([+()O^Q98\PLH#!9G@LD@ VE1_C1+:R9Y[KP1_( ,8$9(; ^7.[:<0''L"4IE#(V$L1 1B_[ZZO2C6 M7U3:,-^ ;V29ACO-Z3G,Z-29QW]''7;8S;)@)/S.5Q/3 .5\HWA=+!87AS]P MHDX!89PR5W'9#6#D&!R!*"%-L(CP5A3A@(ZU,F4M7T1EF ;$1IT #U_-)+GY M&'A:_@A>"_X+\.,SJ Q"?U!G9+C,ZL-8.F@*[0%6\ "W(QC:=.K8/XP)>YK8 M? =*-3%D\T#TSG-"$ MO1M%K2"0+I8?$:[DSDX*I%'%\V;]7Y"#J" MV!$0\.Q7!"\ID:$4T^T36&%N 1T.B[I*,;$]!K/7?D91$I4C*PP'YE X<70B M3Z9AIAU.&]G;QE-DV'A2O:Y(]4UE#==F#IWRL!4JQ V5EEJ)8D#9# ,(U&?- MI3JR+;5<'D5##?W S(#/+^$EPL5L@@9'3 '<% M)8(\L#MH#'5*OE%?-&]^\K=3U#2(,=^QK.CCVNR#T!1#0]AS*,O2,87M4"QF MH3EM!!O=-:(FF1 Z$A=+&EAW0],8@6E(P1X;^3^BB13F^S!_.$-'[8$)=V!! MVV&?@$13VZ4NF(PND_E)>SBY_ MNH[Q JR8B+\DM^XE>V68FCR?MSX1OR1XWX@Z(X@I@8;V@P/,HR[S W#J*D] M!VJ+97_Q0Q#-P/HR=DS2#'\)V,\/*W@@(UPACR*! %C'=?/Z[KIS#4*)M*Y_ MNYZ+KH"?]\,8V4&L!NEV3W7XC;1->)OSWW]32NI'"ZYQES^+WQ$Z-VWT4<52 M&'\8R%;H(T11@2-UNO83BUCE6+0*ON#P7(?!'?S(L"CB7("(*9Y=ZKK$/Z\Z MLGB75]!3Y\D84;P0#Q4$_65X3$RC0',9@J3H4L/'Y^#Q.IV:-K>Q;-;M3\EW MPW:_NWSCZP;.#QC./-N/DKQ.X=>SR#]G%A6<*F(_0QO4#9)6A\T_ A2XN?GX M6<3U_8Q7![SEAX>2H@-C ]43P4@M<(P((?7@!1C-5&6D^@T=\>"F*K].Z=$3 MKHV_)P3FZY((&85HR_FH-#PWB.&)$&\T^!8+K$4";HN1:C(7J?;OB802:M#]M7UAO,]EV_+P<+E(5[>QT/H/!'S[7L1OSSX(*+S@;2-*'H7H?!O8)I]F35$-'8?*@"\ M7BZ ;"G(14D\$]%NAZ+/)W-LYXCEB^B@63#$-.(91? 7!FBX\1C?S;( PNXG3UFT7H&1,.3""/)S&&> MF=!)&-< ,",E4"0X[7P^CX)'=4:T6;+I7R8)^*11#&7*#FF*\W93!'[!NPJ*L[;1#RG MX*+2H8*O89CHX_TKPV,FV@$7Q,RZ6[F -)!*H3RE] ;-]GPR[34JJ:FEL"^1"Q0,V3*(QED]0R) MDK)YD(5%LJ.!$KY ?'?*V$@MWZ@OAD;>,=4#NM(>^?XQ-XO<#^07#3C,(O!6 M:CA:;LVBU%,LJIYO+/;%_?1.(DU+=^@+6BG&=_MI'4%B 7?U.+"K16"RZV3H M4?C]TW;I])$TAXXV<=8<\M@GDQ-QFG#%VZ[WC59 MLHC7@"SH%<+T+"L!P7BB._8M,I""((1 F3DO8?;)Y6X>2^M.F:FFL3B.2<:: MX5CH==M3P_(K%%@D"".D3UPK);EV;)\+8R]FN\9SEI9-3-O"6,8C[B?X9CAS M#?%&?^9>&"%@KW]D1A^/[#-?Z-MU_SIRN41$G@P,V2$&3>%^CMF6!MZ^F?O\ MPI((?:I)I 5:&JAN&1JON#^B.S]O R]6 N^M+G4M5!M5T-=$U3PY;-7\GN'/7BV]D%1;%-.?1T%RUNO(R570 M=K!0[YS<'KA?U;6THF^[]@JQF%BMY*$;*A1N!1ZR8^-^O#(W $,-QLC8\HW-_@.6&%_I[V0]@^\ MVH]3R3!WW@Q?=4,Q'G&!YXQC( EE'7_.1*;N10'7.4F%T3Z4T6[!9! M,E[KY&/MD>6414#=]81:7)2P<"1F4WF2U'89Q.ZCY)<(8YJ5]PT$9$,_6E0T3.#7,8#J MDO_,C-%W4Y2Q4> :KY<1UJ(3\K%QPT%I]LSGXR&(&I.L"ZXC(VC8NS,I$S/ M(LVI8YA$J6$@#L4$VFB 6-*K3L-RQ5B M,6G_ZUC=1AOD&#P3P)-B,(??B\O#%)M?J01PF"9/3<*V9 E3_Q4+CXZUH&"H M*]4=#UH*-N *CP)Z\L3%"?P'\Q/>#EP?MG!L<1,;42,N MS(0(VL=.XW4B]:2-%F\G(U_$#OCB[X! J8F#-8!F8;8DFAA)^#W>8;:$89&[ MV.XR7W+"KF"Y1GST@PU:"PUKWI^ 6@H;6X(R+,'?_/FPWZ=8$0#/FY,"7#N' MR?UHQ7\"V#F0%''9=&'&?3'CG):,BF(1+H_1%+\08B4,-P>%D$!"SC&L56Z) MA1:8HZR5PW21RR-2+N=?($Z,@Q)_DPO9\, Y0)YE,=,.S##! MO2Z(,&UB(J2LRA+/LH$;V!>!2&625\A40G\ $QH8@W2E'%LW&TO#E\UD*4I2 M__(@WFZQQ/%:04KZV(@0P0/KO8RH$X>.J>/PTCTL464"A=K^EU]M=(!= M(&?;_MN9W^>;41/$C92+=8X$W32L'A+K&"DSXO$KX%!@A"%]U,SQ@AD$OP\I M87K7EY](O'#?""\C[#_1V'P_W$:S*=R>6]WJM]MD0;X4%BNY>#KNZWB&HA1 IIB<[*Z&NCEF"(;0/S4Z)0&JT<[3L5B..X37H2QR-0*8?B M8/3(!=%JW)4J)T&>NJY5Y0I+T+!I3:!OP%<4-BUCL2Z*#Y1>*+88Q[!"6_1; MD=] /1OPK8ON(LLTAJ+\LU^,^E6SM ?*:U$7=//OOJ ?S\#O'HMR([B2E<<) MB.*YR&<#/?18'9S?Z*JEZC_;O&F5)9.%;GHTIOX)"BD3R27@8OE:3NKNY+?J^]\DRX!HV[" K@D6/IB%L494BPC M=?RUYB8:6*>"N\/B6K0GN;+W SG!3V+#?"!7QKMU,J*ZO8Q@U8"P+FJYZ>8N MJ^5\0UDI&@0R?3/$9R8TV-B9. (+/E%MX64HLI1#D_DCK!B6C)>L6?8.59Z; M+[N2;Z@KESW43-_?6+E\6 :O$B,E[B.P!8L5@^EE S>L6?@.A:";+WQM=^_\ M"F'O1P>6P H9AU\93^]$A35NO-5++.]@,VR^Q-HF2T2;>^1QM3^D 4UAK_.\ M?EC^K19]OQF'DK!B <]\21RU ?(!%1TSOYFHT-CRV5!JR^:UA_H3XZ\0A<** M2/!;_5ZN>/ )Q#D^*ZBBT5BP^H5Z7*!9%"NL67L_:.2@/L?^Z,43V'^Z)OOU MF!8" [NE6L_ ?>H;DYGI:1;E!N9S:"HR*S&7+*7CQJ*8G($M(Z+M;5DD"A-< M3Y2-HXI7($_]0F$QCH/$78[VOW)BN'(0\<(N.'%3"GNTO&MY\#WUWY90(YRR M)KA4!"-55255+6TV#\&/6(CY(MC69W -ND8[R =LQ7:7]6+W6*+8;0M@W8[% M*ZLTGD%H/U/_]#M>RT1B:DHQC:$J+9:-S0VC \Z$L& -;!>? #&'K ML Y4X!W&LZE8UHK*>.;O"U;OOUNE2O+Q9RS[-@;(/.LV".LR H M:XSG\="+Q@GK=WO[\UL"9A4R(^1K/XK"G'V>#6;&_HN[?.Q.Q'U%OV5.,($[ MM%J@!?W%W( ,Y-DSYY2 1\AF/)+;$X_L,(MD?SR"L^'U# M(5_'1XSY UZT-/*YO+VI_9OF&%A?YH>\^6C>WK/%8ZR;.LNE"IX=DQ (=SVL M='L X1J).O.U1=F*)+/57 %.](ZP,3_VG##3IE,3).'\$#=,B^#W3."R1ONI M::!J#.?F3(/A#.)$4%9.)#IG22RS/'/]P'%07"FFE<3+)X-JFBLQN5%S8W$G M,@1!K?/*I:".,%(%&$Q=X1ET$5?Y9K&J#E:<+#+A0\?6= DLU)$Y8TJ']VV! M[VP_4#8:@*O%8%B+%I1]A$EWD6EP9P:OJ(!?]-G("^HBF>VBC;"21/-B,XN" M; -@E)> @N?CWVZ/QQ3%_T)=I['W6:3-F^'\L&@OZ6\V1C:# M@]2;0AJGI'<]WT@BMR_3HY;(T?L,S(6D[7!KD"J.T[QM2?]M$;*1Y6K_Z4QG>Z]$F>4^?L^?<2GIIG M4AEQ*SMH#]O7JFQG%!TH>B(*=)0*CY_,E6P(7R)L,PK/G!&SOC[3%XS,W_*N MQ[D(0_S'L&(2/&[NN>,PPF<+?+(TCDI]>T?EJV'9#CLLB?LB"9&9SR]W6NPH M@)7>21DGG">Y)^"#?J?B()M8* 76Z0^9Y#4;\"G%JBO;%FY$';%[_X5B&!X> M'Y1RG3B'/&%BU'42]46#5!!T8Q/;3! +3]@V-L(J)3Y:3,0P^/7?+4!-3G.) M>-COK'M3XBD=/H 1^V#MX;_]N9/1EH8GP_%FT=9:$541L/@UAFRHSA1HCM7] M&,-"CWN,@Z59,R=\PT,[;.@SG\?/NF0=@QZYS>K,JD] A(3G1"GJX@3 %8=Q M+6Z2V-E0>&@3EM3%KEALG(*GSBP@LLYZ!,3AY[:_P?F&='GX+Q8;1KZ-/OE1 M>Z)LRB!+"/+!G[Q<-<[EUV3A]*PD2',!I+RP-?9NUP4B\,!J/-[*AZLO#5[Q MD[_FZDHC9:3/6V4F*X>:O+?)B0=EUL507!+66C-WKK)K9<9>5J!B6&[I$L() MMN]6YN#ALB>#ESZ(LJRY,N(%IG'YE/51K!93X>=>83TC=@1_S(6EMZG8<$D5 M"7R.;X=$EHQ/T(Y=GXM/LOP8KY@5O8L1'#P@0W,8YY!PI;T+0MJ1%+V0 +&R M]NCJ)'(U?)<+QRJP32_&"HBTA?7@+NP\!N;H'39PL ),3F1J>]C1C4UR?(G1M,,P&"^OYX" L:?-X1L;WBR_&XHG$-:<>K;E04UBD2OR MV7/1\'(IWU@VI9,=.#$_9YK/#"*\E9]%QHC'F,CO M<_>;C\6J J/2YP!>O,#N7IO>J&Q+K3OL(J6Z>^O8DP[@PW FRX[3FB<;=E>H MLE12EQU%%S27&.S!\9#_JZD]V)\K%W8BE!.ZV(-DXEPW>])NP(8ID O?]9$HD,M5LN9'PV6*M"K'#[0VVRU>M^Z@T[W M%W+7^])I==I]%N]M]P>=K\U!^_@GJF_!E'-L\<+_W9;]UCPMRFBU8S':6C9+ M%S'>[\'ONT>*&<91^$:W?"+'A1'AN3'"QXZWK)ZFN"%#^C,2-^;CS$2(T=[$ M7F5F0O#2&C\43J.GH[E!Z)O'49C=!EH55#,_)(LW/+.V/F9LLX <;W_#RC'X M&:T7/7K(VQ2< HKF<,C9V=-E=G=P/.C.8 A?_^#EP%YO^P6T04]MEPZ<%I MO'5.>D-U%DLC;:G$5CTCHKKD8NGMJ*[%1.?NJNLN$#Y^J[\8NA_%_XE4V=*L M^$:Z+!4W^AHL)>MF1G(-TDBDW'SD5/;]9E[Q*V9O),FRN0,#??\VDAXE\YG1 M:-*35>G"PO_-LI*Y)UM,JN(.M4103Y@DEECAIR>)J6S^*4HIV" M MEIFDFT55(*A2&YL;W_#(JS:@$T]?<],:&/&[HB8%GECY5DR*T0%,BF]^,M:W)0(L M9]R../A>QXCE=-U)!DO8V;=0EG)[9F05^M+<)=:"VKFU3I/!T(#*A4UE#EQG M=(+]N7PX:"Z8J>./Z*,^*G@KD^O.)GRJ@\3-D!RZ8_1),V?&&*;Y QQ"&>&\N> MJ#D.6R1BER?X-';R( /;'YQM"-)$$0M7BCE +JM$HF*VDZ"$PVP/7(9N\%F" MS%KBF1.. ]>>.6S8?G/$ZJ+\I8Q8P[QNC%G1$U[O/8+I-\V,:Q MB*C!-&L![\+!6W"OQUZ;=.6SWZO-IO/SP@7!&'X]0>2,=1='6HTB,U*"PP , M9!4>YF <#"_4^5K94$%86@[8R!#G4$+A- '8G";%8RP""?-"P+-R&?\$I6?^NWSO41S/ M;8]S6GAZH00O\@0J&8NRNH68D!*]K#] ,F+$U(NYAJGDL= !T:7ZI2EL]L%X&,->D0TZ.4.VZ"W-:0G;<5[4X*#%C;1.CCO/@%X.PX&G2F%\88#6>>N)P-?K,M\R7'YO:#E8NG-3P_4BO) MK>&^#+%'(W!&,!^D&6P<'OOB.'F"9:N&]81,!$2MB=8 MK 5>GXOF^O(J."@1F[%0J 2!4!;UL.:"H^'ESRS^@5/H1R-G%D;;Y]EU?;[2 M'XL98B WMV MTB@47V8,2[RA)< +2DUV/-!"T(N=BA-%(5X*Z\?;8RC(!2BP M-"91PQ#6_%9[69B[9BV$U-AL:]8A[$??V"*,,=&I:,;"+_FACF*9#,](&)UW M[6.SUI?XTC%6'P;(1.N40R=8"#!\B0D,6$)8UHC+#9[JU[DEGCCI#H5^QW>RW@D[]FE+D M15-AKFX"J@.DOAC&R86?J<':0.(RI1J=%@?C_[+UK4^-(MC;Z7;]"A[W[C:H3@K'E>]<^ M1% 4U21;"CFUY^U5F9**4NR=34R.&+O:0IL*2\K M5Z[K\SS8H*[]V0-U%:8OW#2C,5J&2A$&&B[J<]6B9T3,W+!SVVVXZK( M=*^43+?(RK]",F>E>WQ)^TF7],HU3'P*[.R_5]Z2R-DH%TS-"I3/9;3/3*QL MQ$BF*@2>KX7?Q3+Y3^#Y,=MBR1G60LDFE_6URP(;%(]^*?%HD8/ Q$//)1Y4 M-V _PF;[654="0G24IX1"53B@4K* X4LQ@I!V%LTKJ9X!0C1&\;?%W[)FV+) M@T$&.FOAI2]2#0,Z#Y16Q5H('^QVSR? 8;!OHZ_Q<:!$&V]8H@>E)+K?-HGN MQ25:VD:^\>S&]:VY(TJ\6&D7I>D)PSST,I%,4BZP\K"$-[;=DDF!1(6R;NL2E^PPHJ5HU&Y%19Q1ZJU1576#0K?L)3P#=HC? 12 M(6K@LFH&!8DDF&/BCD4*9RTJVH[ C0!R<6A!IF:U**R/_I7^$6.*J")P(F2 M"-:QDJ[HSL&/A&)P*/'B >2"6F.UQ0N3E"ML:!&X'27FX M2S%T=@5C1DSQ@X'+S&IZW#%5SZ07GZA[ MZ39IS1MLB*=T/07'D'[XY=%#V!KCA*X3\I8'QQW.P)- M"1E$PAA?S,6V3[FGQ0H$ Z;!;=:B^>0YL&O@62%-PX/G,2@^;J2&8A1%#]-- M&R4N(A_DJDNZ SAW>.+W@@K;#WC_I3>CRU7OF4@.H^IWC-&39PZ*[QD)QOC MPM$0@P<1-I0UFV7X+L%'88$> LE%O!32U4K^ %+;B?KKE!+6)T8I\L)L.%-- MKS.EA01K#VY;R\><5;AP[&W$< M87Z,>?'$,W1R*[$+J>M/,D3Z2%T2V:HK43]S9#<155#@EH?%<-#7H_((QP9[ MSZ1,6>*U/FNHP438W,!B"**A-MR__-5B.>,872 G&+)":\%8,G\,&Y#HM9I M5L0/SNT?-%QDMU;X>&AU RLJ96?U&T3$[<)%AHV6,0S6B-]H-N.0@S-&U\<* M,@PGX,U,]I+JP+$99), K6,-CZ\ 8OW&?99] 375"(K M*EP*GG'$QSPN>.-18A6X!PR#YKS@EN@&$OU3^(95@$7RO,\GMNLXF*C%24&? M8J>]JA7*"_+HSU;K1-%GQ>U<+B78I$5-'@PAE;5-T)&\!YO,)XV"X-6\G)%Y M6? H 1CI&,_"FB,UR/KWD [L6%90"K?CN7?KA[U9(C&"[J'Q@_.W44\ M6)BP 9L7B&0U>7J/1?PWC;,L;1IQH2X,_="%D=*%T>TCZ'/E4-!$ M?S^AH/LF0D',_8X!/(J#D!P7:B?J-NBSG+ MJ"E!^%:"+;%9XF^Q@'5D%=IQM@+/%[DO5L)&'OB2J)C)X:>$ 4L$8N@''TD@ M_2Q5QES]J$ X=/65-+=]._C):H&OY^-HH4.>6QW?6M2O\%TD,BKIX%P/DQ1O MKS-Y/XKWH1'%*_)/TQ>5K_Z>A=U)O1:5PCIU:E[U"2YOP(;)8LFB;$6Q@R@K M;P0)O$$,E.: 8>QDTW4[#O'RC!A(D05<(& M8P%US[=A,*RS#4NU;(LW$_N6I3["G!Y8.3?E;UB&:@FSH38RSJ+'*ZBP0HW2 M8'S53I2S9=)X)\!<8N5^J!Q!SGC5CO!C^/?_O3($'Y=-%'9P/?LO MDD> Q4/VQ:9'DK& W'&M;.[R7?AUR^7YY?LC6=4'YJ+,6Q\=)I"JXBSW#S8 M_FL,%IR5KM[1!N/DD.-J89\=PCO?,"U0!423R8,$P?>P;K=8'V>NA\E&4O\= M 1+_JP$C2:PQ&V*TTFN&TYF FPSYP-D/7SCP)/\4?]B>651TH145X]9<:&*L MBD3VR J_>4FJ09"4COT?^A-OAG09IF0((QK$<$3#.GH!H&('$CP!*T; LO"H ME%_4PL.%(D!?1=T*N;OLT[%*>')V#56$]:CLEJKPL68643=%7S][WY,-J\I@ M =:Y+]=I!:E_1*&R6'($'QR^* %\F<&@*](W$5)F)F7?-.,D%HR &'\./7B^% MW[GPQP/P2L)XW#'[4G$2B]S&RF7H%Y:,XF0^0#9*!N\(R.VO!HR2:)'WS90H M*FTB()-'+EMC<:35/L(F'+,:8!)[7B8<6#,1;&',;U%4AG6!/K&JW <+ :7I MD:($$H'T!'-YJ]094J=@.]@M2LAP=LB.K7Z0N?1X$D"&"S .&UU"2N15E,QCSS%Y0&CF@4W")H!22U@DSP(T*VY.+W!9$1" F!*HIS02 M3+9+R$KO\I.[5")<1"PG9O68:"K(S\XQ"NDEH@[:9GPB@N(+;="_&(D#@\ R MW#QL8X,6L8T-.T>G>C*8\Y,FN@X(>5(PABT-UHH2KNN)^GM$.1(MIL8M=*2H M$,%F4W:;6(=?K%.7C%\Z_[&&:(6+K<288LS@K ;D*?PM#&63C&NBNQ+;,QX) MN2="* O (N9J.P!!U.1"#NEOT7A9YS,M@ (&K6EQG*#P+,N*6_Q!DAK80W!* M*#5M@6F[IM1!!Q)9'3W8%.Z>92;,9*:_6AA02X8<\I@';;STI?5VY3N-.5&X MM;%'8C;ZV/YQ_&";L'<_J^R_Q^B/'T\F1Z?_W>&;E2.,.R@?QCW#\W$9CO:< M!IN>\EZ+XP[!]DI2#/)\-^O]V6IK<& *G@*LBJ>E/2D$=.^R85^-H+HHHOP M!T.;+#2;:!V9ZH_@#*B! $- $; BW7 :HKW\ 0=-_17./34RB_HN_&U8WX46 MT\J98],?=6*QKBW5-VRZ8'F%0T3]!.-WF&T3:Y8*L.7'NG\)*5*8"C64]=Y! M]@$:F&@IPR8;7OGUB#H1'RS=KR?B"-;>V)+GU+>CH:6N?I;>H9\EK9^E>^AG MV=EY.O2Q'/I8#GTL^]''LLT\WBX*N8S2Y 6_Z]:8?IVM,;V"K3$W/F9PEB\W MR)T(K[L0S(DE@]MYGR?%NOO==Y2 =QJ(==-:KV7;PW7?Z^AW8>D4P? 28KT+ M>[F6DUG?F4P]C?HPKS]/SU-B?*OH=U&>F&H&,$"E\8+(V6Q%5)"$0;4 ]]^F M#3]1;Y*LK;QH#KZ-1*L6-M P/-+&JLDRE^@7WPOR>?@Z>/A:IY,,[?&3B0%K MYN!BM)R6+5P(+&OX(JT*+B/F,E:,YU9$F]'1Q3CPL8-0,SR,&@9:,YAQO8BT M0> (AI]4LC_),'E20*G76"O;4Y.?C(X5.D+;[OK"*J575A?MIC,T])^QD,%8 M!'"CB)^$09NP,;=YW.$+!N,\%'=?"'J=^MFV6;=BX#_%;N+BXTMS*?BS^]T\ M8[X(3]GO[.QM+3)A=NZ6!MNN^$PV6UDKGP,;>96S6S]AB,R=&ZEF+SHL#IWFS3 M.=/_?G0MOO*6C1K;LO[1:>\M;-D50J5ASA4CU;Z RZQEVS9MS%BLO[T([.S% M#])6O].-EEW)*4:+GYMP=D&TP+[$1:6LB MD#M1_\2*"LF,]ZTE=0ICE:<=+(A%S)MK41$!QP5,]= 4]@1$_^74#A)^-X>* M8QE=+-D@0&\J,T*MP*J,6-T65K6P*B%>'\2+= B_ 0$E:63V[L -ACW,:M3: MR8(*^)]7GGN/65/*%A=M]245OO$)LNX>#]]/Y.RQ@<@9+O3Q'18XL:7>LV 9 M"4(1D6N->COC##6D6K M@Z.I2Q4*6!9F86Q#D./Z,O#ES/9!76%]%"-;8C24 M806 ND8<054*7"?*N7]>TX[;BTT%_!]A.P+7H:QKERI,J0:2UU:)\D3L<,>E^"DYE:(9XKO3$,U1!6 M?<@;RU7^+**99&O*>4+E%1;\DU$%9S0G1;R!#1W^Q3HX,N8EQ8VDQM U+'HI M#-6^VJK<<=GOK"?I.ULV''#)5,G6!TF:?O">R";=1E!K:+'#'D6QY'NF\UEP6Z4#)K#/0CV;"\(]?6.PDGZY2@KMJ%;U/_0GCM\V$I"4L"W=&E M*.X,UJLJT>9!PPZ[=,/>6W:>Y3Z9QHE0=WD"^X5/X*ZJ(JH4+ZU?^Y6JG.R3 MFNN;PBYD?EB7F)+EI._A*?]4+-A57>H:$K!!80';%3A8>P2L60E;6#[%:ZEK M1=)V@G:%"^!;$;AA88$;O#^!JUWBXM=RHNGPK0C7J+!P[2H4VA[A>JI;MA 0 M8B9X!)/]K&#EY55Q&"=[(Y(X+BR)NR+Y:XTDUBZ(H2<1,5<%&ZY8JCJ$GP+L M/CW9M=R5SD\6D<$V.N,$/DD B-BT)SQ4<.@VEVEN0!W>5J;)5RQ?029<"/UN M*:2_"BVBA48(BF+<'V44C*Y!W&=V?&; A#;7N9@K=M6.UL7:N+CZA][%M-Y% M_="[N+L3=6A>/#0OMLV,/#0O-M6\^!J=B(,Z.Q'[!?N=;A$1YC-B4:!Y:;D! MO?=ZP=]^2=RN8-I@-5]0#!*XQ*.EW/NP\X[Z$[T&T_FR4-\8+0QDA MQ%_?QW38_D/U51%@D9^O=@A:XR3^PKC''61;=QSRG\@Q)-2G8P8XLV!"$$/3 M90!6G&GK'N1B2?ASP1*V&\N>V-_9'\CO8;_ Y&38.L>0TBBS&Q9H&4ODW++] M6$$2"UD9S\@'QO/*[-$,PR;"Q8DWUT5PP.RK+.^+K\/RUT>&1B@7;B%"TXEZ M&TU=F4E[*Y["N<[@\P@$9#TN'._%XJ@_8;K:1Q_03T!6+06567K-5?+K#$E( M2?EHO3J(J\M9"5I L50-3QCIMXV5X,F0RB'A_^$/DL&+$ MC18RHA%(8P@_O%^5&U7.>:\&7=&BZHX;W_9\),QTB'\S7L GQ%A(=Z@1CTNJL!&*\2:H*W'"$>$Z#6=N?6@,H(M)/0<& MCU5=NN'I0)&.7AB]25U_$R^2ISJ.8/5(.QG@>'BIJ(BQ:9%^B8I%-?$L8S:S M%C*H-B*9+JW9@POK?O^B(#0B53WCYB='N\>)[QUD#X^ M)DK5$Y<(-B482T,UG@S;(77S;LY[OX;SWJ+.EC\1GTWA\'8Q6%Q6F &FPK%C MN?=4MF?[)F'>VPQ#WJ.0,RMC(B&&^\M[=N.2BD@"(9[KVC$DC%SIR"G\>+#A M:/1XA!AUN7Y9H'*BJC W!)DU\/H+/ 8EO$3H]KEO,)XG#(JGVS@1KBRI$ZKZ M>@BKS_@**!'X[2J(F/W64(777\*74KSK_1R,00T'H_\6#D;87#7UX(\"6A4E MUO"Y$;TF?U;X)PEPV4)-ZQ(N1-CGA;D+GOY-0@TS9 J#1:^/;V3Q' MQK9[[/5P.6@)L[U]\A=BH)NT] *>.R)^^\2< G$+1TC-6=8"7(Z/GLO]E= , MB?#*(^,79LS?AVTM*_1]+-'[A[,+/BEQAX2C_LI[Q-^^-DH!?:N^8%![[;/X MAK7/BZ;>F+BPJYRVT&R[JJFL'0;MT0ZWJVE ^95E;;;R.O+W"D7X/^QB39C M!- J";$"7_CWREM&+O+UW?G_?M8XI0KOR/+\&'YSYM/6[VEVOZFQ6U0UI$C1 MV^$3^6(1AP&6>I=L),I^@AS%[+TC+MA% U',:)75*YMY5Z"8]RQB21HQE\2U M1O&=W9XKX^Z -S\BR21":]@F]3'@13Z#*QE>;U @#HRA.2)C::+?1[ICL4O! MGJ]\*G&#::*ZQ$7QN,$AC!Y05 _8%8\T3OXJA)]6>,^[ .)^)'@L'('@^6(M M&TQ&XH2=_#'"LUX;.+=?$DVM7(=_,#ZRBQG&[#W:,P7!N\$VA._"2LZ8<8"& M30CAA14BIDF-_.& HF%0]! ;8&<.\\7Q^S,'?!+G1:80D]^IIKQ3B;V3EDP4 M &KJARD;],/+U"HYS9<%&DUF.4K)JV$21)5 ML"AIHHL@:4=C"/!U:%<^-G36%4*GX M)T5F&"84?2&D6#VCQ4XO;E[_+6.BA_E$H4O7BUX4>X$ Q5+6AG929V%TBPJ? MBQ8V#PZ%S6F%S;U#87-])^)0N'PH7#X4+N]'X7(-AW@IWW6_ 78^M.3?9]LQCIP-00A9;X]W% MQJX(N-8(6HC')SF.$6(:L:(%=)=XO/U%Y?V+AF!L9M%UN:PAXD'F$(_DZ,=B MX-8/7AJLQ+ZY5ETJTV;3+QAA,#W/M#&#/EVQ+X(/P_ZV!K7D68S"ECP*_,TL M10S5#PAH^U$1/AF;&#IKI.3V.Y1)99@W-*/OEF#6GC'%30SGN+P284-^\IEB MSY5U:7=7G?0MT*5!(Z"'\07' \HJV@AT>2%=SONH8BN(;'M4+4B;8;N*M"TL MU",79OF61'6/VB?$-YR]1 DD4<^;V%N1=?37%BF@,@"MA5PT+YR^0DQ5/RYR)IXU+%_NV2@MZ" M^_OWD]L3]9>SLYN0 %Q*QF.-M7*/AP?/()X>WGC$CN3CPJ%G,06%,>OP1HM% MZ,$0-<._R %[/C(7H3P<>.8*2^7@,Z)'(680*@\2GP*"<@LJ _@L!NB7]%>> M$&<$"'"X[ 4-4?HX_LFU[EGJ/BKQE!"^N2W)),9%SOL.D$QTE,307=D!=/EL./.P1-N0A M*D*B)D1*7@;!BN$=D10$^^\+9%.HZJM&@_&+9M)TOB3=-JQ"FQEORZ4(/,\5[@ M*#$!&!,YU9NB]4@JV@0GG K;&,DD8QAP3252.UPIH2)W$)X7?&90O7;P@)HJ M1-H*L S^D537U$*WE[*1<,99D^=ORWC^H"&U,2HN'%:1R?!J5Y_N$7'RB_NH]8]%S[!3/#!<]>9Y!)6<>M\VG M@(*2 &FFW9M:2* ?P^0U I[?$B(<&U84OA%%"W37(EQ07X(*T-3Q47&=H6? M<'RJX;_($^92"2*"UP?U$,$E.L60J98Z.%ZO9;)>"L=X8;0[\)O5C/54!#/8 MYZSF [G%CH(ND34/GZ4]P\%LD[W5PF,=?$*.8331LCE\HRP>TPG@BIVQ?0SG MR^[*):U.)%2Q\22.<+JBE\^SZ='J"PFC'0_]/]Z?_8A=X;B4T8;8B3UO0:;:;%\6B@UZ(.$^ MR@1Q3;B*YRG"NYY=AM/(2+!Z;+!SD2#YSS<_6B^>: M7[&48?90C#.JPO-E[W2P#S"J.;W3?C/>Z9?+VYOKV[,K]?JK>OGMCXO;.TS' MPH_JU^^7YYA6OKJX92[KYXM_7,-_OEY^N[LX_[5YGS4M>=M24^W:5:)N)##$ MV2!C] E4T$-=?*QJ&3]/EIDLU>K9O6]9@L]HY8)AP.QWD9.@FQ)Y+AAUD-XB>@RXPL>5=EYT?E!^A$O0$O7+=_X39[?*.;ZZ85< MO]]L\*9AC2]YY=6U6.H;RT?9 XOL\\N-@4')T#<\UB6?< '60LPIG,B\E*$W M^).TB6&5%^R&O!X?/\':VA\5J5>1\(K!!H$[S7>H]61[J\!Y$!99):YXMT6I" MHJ/1KW=,=7Y*/Z 9>"1]+65HM:7 ,15?O$ M.D[LIX\\CD%X2)($$,@1TSEK(H"=1L:,]4U)_@I7I6)TP?KA8]T^U([.@F#4 M),."'J'M'R146-@8LUB B;A4#'#M#-]4'RV!L!3[."&X<+PA3+92P&X6I^") M=<9&Q;,DDP(SB/K)TQ9P7605L'DWQ\V&O?(ZXQ8D!I0#'H!S>1+?&560"6)V M%^6\\^ )@[2?ZH-T[2""J<*C7!@VG:_8"E.V/2#X8!$OQ0G!HN4X:_&U*';6 MSN&>MY=17^)5%,>]\3WB$XQ.7<[3UH/%2+M+9O0ND#ZBJ<6C]N01.A9*R[/G M_P6^C6NMKTV8]%^7K>[X^-&;NAB?Y'4.(;$2A2D=C\(=J[#@W?J!'738X^S- ME\\8; _QN>3B=*DM/S:0$^4NARF$?APCN$%/-]2;S,E&P C3>G2CO#"A"\!Y MI5)XXO!F\9,@],G#B? #%(,MD2+TH=+>-D+JC?-9D;YL"-9:F+TU2;M6MYUP M1AO$IJX+FGIXJ.!.J^#N'RJX=W9T#@7>>U3@73DN]E9KO=L6+FHM>'6Q4O : MHY\[X84HA%D]>[#,%=KQ8,*;V,EF?C8<=(]O'RQK>8=[DSN,&_C+GPL]4(K; MCCO]0CG2]*9&DW;),EE5!?ZO;)DQ!PPQ+\C"E>@YURRG6@.-E:"?2FY/8RJ- MFU:P(8ZQ"$!+B)\*:3MF*D0*3RY!E=05*:-G"]U__(YC?E+Y9"*#!:VZ=!XH M&!GN+GER0J2V&(:?U)17I@6DSZC"<7V\J8-+>69LO*$BS+]L# Z-S(0:V M;5W6UKWBL#8\K?F7;UB3:+R-KXMP('M8%6!SAK,=O)%S;?KBD MQ\NKBN,Z.OWO]<'D?MYD[7E\ES;'52O$O80I\ OLWN)20+_#;\.K]5J4 ^ B M@UV _[GX]\I^,AQ,Z.<*A<%UV.M-$N&?HEN6MM1U">R?[#Y.M3(WB>!DL?$0 M;;):DQ-(_USJ23XQ#3"G[#A@"NVXSMNFW_5G.3?!5;+Z'T M+MVEX=[;:!KM9,7:H(.B.;,+$,2&2TTN/30 /:2/-+V;3/RTZ5Q5$ J>WD0R M"%A3>[EO,A&KGLDA$&*^7]AT>5C$'C>,LM:@7T8LX4M4=^M8%:4RZT%-"R63M.MY M >',)8P3)HR#07%%J+^^(GS'#E_!D[IUD6+ W&]JI0YBU)#"S[=L(@CZ[@5L MXV59U'?@&% !,CQ@PN5@SM5ASO%%O6%K>I[?J!MWCDXG(ZVK#_?&IGO'2F^W MP5)+!$E1^LU]B_'$#5"83*[CT#TZ'?4'6E_OMR]L4Y\RIOT55;:JR9AQ3:YO M]EXC?]B-2O["09E_,6SWVA5_RB5E&XJV2VO=CZU1+Q7\Z6\A?$6V/.:H<:CL M:N>89][\:X''YE*%_4KBF[0=[HP?%X0%13YZ.6]\W#LZ[4_RJXIG!9T@!6-S44%WF@5(DV>4OX M5H-F2D)9N?+U-Y5M_O57]?SB^]W9Y3?U[/;VXHX5@UY=GGV^O+J\N[C=&=;5 MGJ&]7+O*+<).4;?8( T'*=9";*@N%VG5"-M0&+6J1*CZ@IQ&OL6[6.3?$_@+ M@L X3@;0AF):4R1;G3DV8_W% LNPNX>!.>$S6#.DU)S'P#S@BG,#.ZS&7$.) MB3J(;L_.;M5SQUN9ZJ]>0$!;XAT7A&"!,U-^,^!/?O2GL/5&4QF61K1V$UJ[ M;JS%D%X2?D?T%@JN6='>9+OLRJ'FNY!B7%.#%7$T^PCE00V","M' (!P.!KY M\X\>? [=QT'N=M@'6U$NS-Y\ATBF_P_&6XO!KO=T+D$?8K MMOS8(,BP8I5P)]8XSM;A4BYO;B_!>Q:#XB!EA*38",K2GAT[T?0N>$B3ITJ+ M-WWQEC(SWC^'.%=X#+ 7SYO"2$1S&C]$Z\7):_(?BJ;"*I43FB#P39 0A8U'XYZDTC'L MQP!)23C7B00L-TT\J#D8KY8*$U:CIZAEF7_.3&ZD!\N4!V&3*SX"G3?J*>=J6:J/CXEFI/S"+DZA=03A-BJP($7:.&>-,5]R M*8Y=.=B5ZWK@[KCWH#2GA$WV:"^YX#)\) ;T))03:"7I2$Q]@AI$"D&NO_GG MN.)N5U?E/K15C@YME6EME8-#6^7.SLZAK?)=M%5FN8MC660C[?T66R_;X6>_ M=L/ECF4GLUFS9"BI;=V9-)>H!9#-XBR:!3@5-%/++-:G2=&Q$L^5@V233@WM MFBY[BV0&2@9TNE.DM:V)LY@ 9S1ZUK#3AY;/0\OGH>7S3;=\UE^_Q*"Z&(2Q M2[#5J'01)M;K%PZ]DT:<"J+(!#"7L&'KJM;K=;2.OAU.8>?=-8=[]%7OT;??%K&S MB_2=]4)445[E&QQ&X!T,>]IX6+PTL07WYCO6:J_4TBN7((LJA4,)7['9/D.AUIW.#@4%S>>'BK)BQOKC @V=ZL%^%LX8BL_+5'2 M[V!/VEO)<@X; Y@]O_YV=_GM]XLOZO7-Q7?*>;:A:KAP6B*$ 5IF*$SVK1/N,=??- NI M'7;QW H201D6]LPUST+NDT@]Y6^?"!D^=C\T675.!D5RS!%M14:V&9DJ0FIX M+IYB\!*#XYM(*+^R5+W19'3NK'/.G+)@IV)/[76U8B.HGK!M?]H=.;M:F'0_ MSY][V9L$\Q9,X(T.8+',;86\;+6&T>9Q>\>3H]-)OUBE$9J\6>TM!_-R3_6L6CG/2S0_'V:9C MF6FK9 '[OLV,Q [DJ01R\$3/C1S%UV=^E:NQI"\15NM!+ G 72;I/>T>FX,]+TX7;#+J]S\CJ9N$-R;7T, MPI-SWFP%0(TW:CMR_"6T4SN-Z_*% ),^TL-HXQ2R^7=TK4I5.X>[M3&!EE:Y ML0MV4%6%;#_!K^\EB^83B-)*E'BSECKH( MJ9X_=Q2(MV N-$H%,8R7C#R1:@<[;T/L-9PUJKJ?[S/O,ZP_[?$/R_!5RT7L M&)$D4@_YH?3\4*^>_-">S/;5LF$%>SW+Y;KV,X>6DCVQENIWZ\F".Z.<-YFP M$M,,/@F6YCBP9L?VC^,'VP0-_K/*_GL\!ROJ&%3CT>DQKXHKY':^[JB[)4== M9ZZ@M?&25@VF)>&)>EE(1@'>Q9KUZU^R@ M>-Z6XLD55/C%Q_X*;+)H.IN<6ZS[.[KN&QCZX'#G'XZ>%=9'C8:I!5*_6*[E M8XLT(E*;C[9K!TL,RSPE(K\UE*^E+TX5;)'13K(+?)&H;E=>H@L&XYLK+CL\ M.NUWM+%>"(RDX!*V:V_&>[,WHZ/3\5CKY:BL>,UBP]S&^Q=KX<.Z[/C":S9JCQW?$'I(:B)4 @OABJ/-B<^RDE%'D^]N;ES^ M@WM?1(V/%J!O$!O^ I33_W(9UH#D??^(9_9 $8.EDGF MX1UBWB6G;D^NVIJ*G'W2]W-K2C*14^]D!?<.O*;Q MP=,LO&:3]GB:-4-*R39 1LD;]3P2K9_QXWU"235GG^2X'Q%P]7I>^&;42SN8 M10"G/AYDH38#JCE9Z)7V)DO(0C[HT3(4YBQM\93'RMO&!O"V-O&UX M(&_;OR.1MF 'VK9F1IT#47$:;G7:<,J#)JXC16S&1>R])5S$43.XB)??[LZ^ M_7+Y^6H7#.KI!>>15F@1N.&UJYZM[N$[JCYDQ-\Q8$.D,$::\S4$0R10G_U[ M92-[&#+SFJO94OW+]9Y=;./A'_Z3Z&\YMW.,X19;"^^IU N^.[,LD_C)_GNC M#3CLE+A"6W3"Y9&TWH MB;Q\>J'E0]BFYZT9YI8[Y-D2?B);1G2?.@D1,:W;KJ4^PN0? O[9B."OUQ$@I8:K&"'2X)8C-NZ6/V*P8Z!/ MKNPGRUP_6U34F>N C6#%T@&.V-;CU+=,07_E*8R/3GL#;3Q)RK>F^E:P8$BR MSHNF/H.FA']CGZ1+&QIX\^4S FN""IBO?%(FEON H)'T][A:%1K#F\\M%)P3 MMD0**/0X3.V:ZJ;7@J^);XGAS7X(+! J"5GV8S/0LNU!ELUU0;)CJ6PYEO%; M$ZXYVRQ\PXU[KW[#34!Z1^D(0VQSUH4&;W*$C>SUF@4?*?A I^_5N^]=3 M_EM@F,OLX/MLI^_&9U0 1YE:Y*?^WT[5M+;P\OW?S>,^BT$GNKL/'?[8U%FV MU&W_.OS/9K/5X\I!M_M-D8 M$X>EK;BTV8 $AZ7=*8#?AB A7#6YW.H>Q@/Z'?C_E"AAW=N["VB^ED;NSB1K M3[%8FPB%/S='6BKDF>0WEHO =?M'I[W^2--3R+SSAHJJL*E6GP#RD7A: 2@MFOCTE L3H$_1&1;P1G!_50-I$RFX]&G]985Q9/3<6-C;WGL.: MP7-68;AT;7ST,F^>5$ELY$(&'W6$V&4EXJ5"P&6Q0S!6^QN1NZ=7%YS;:-C>8Q(SO_2RV]V@*4*(N MF:N *PJF.K4>#&>.J[ N([L%$FZ17BB2<^>#2_Y SZ%_(],QSR"TA/OMM@W'MDW;.F9OD61S105%F9E%[!+GIEI8Q'H M,N?Z;!AS.4.NZ9>">)UGA_+)>FJ&J(#$O=%T4&OBKOG22"T.O8['J8$*I#&, MW2,IYR_3AR^/S50G[>.XAAJ(.^^,U7]F'+E<5_?XZ'0RF>3BL]H+U*6OANVS M% /:#,^&#\8,7B9!L&)Z6L[ _XL4_Q-3_/0[K#/<_^[/NB6/[$5<64I<7<__ MY,MZ2:MZY]WAFM[@DM)5RF_2&[Z>N>1P@B$+4 *X;-'9Y5)"E==KY;\/[_6.8OANVB ME%V[ ETHEU!A[5NGI^ECO3Z=4 ,TQG;S95M?<(&/%FXAKJ-?N+ .&M8M.?FT MCGYT.@(!F?22@?J<[;\5$S>OW/#+QRIWP-4?!(\V)V>--7W M)N+;A[ZW]=[84+@4VXV7M7^U7<.=49Q75-(@+Q[8+">Q5=S5E-;[3%NTD->N M$N\WD4.I1H P"E:RV02KF,'^>_3P!7"JT6&*?2!LDI(?]\%'7-O 0BUXKQIY M^L%&Y?O!?K-=#QF:+U&,05)2.L$^OX"C(?/R;>P(TS'SGS1164<8/5FQ^;O4 M-8G\>*+ZUMSRU6]2@\[NLJ'5(]1Y#Z4LY]'D"EPG\1CT%:R=985@D5>6$5C% M(]";GR+?2+W>V[F14%2;N)*N+LYN#UW8ZUW8OQG^[$'5];0F;!HZ93ZID<,' MUP;[RD >T6%$::20OX'MQ'-[9H$3.6/-(DMU,/RL#OXG6"U.EP^PWO!?M@*W M2]_"MJPK;ZG"Z_[K[$Y3SPW_T7+4SR_48GQK&?@KQX9GN[:1K^DF>7 \/WYP MOE B=X&:+:8<^RPGPZ:#=P/"D9B8AV-)9MYHQYJH68[#4)?/EO-D'5.+&$]W MP-)9_B-X.=$8#"(UUYX$) MT\94ZO,#B".8DYXX'&Q' M B%_YLJ/ !E(J8B^4Y ^9K+ZI!B(TE656AUC5MAN0(4VVGKM!.&:'$"XTD"X M1@<0KAV7=46 A#\9:L@XHM]>_DPGD M#7T0^8Q"@U59HVY#D<;V(+ 4"^7 PN"ZE -IR/BZ'+R9Z'EWZ](%X;/-%>P7 M>*H+SZ6*/.XO+HE$2/BQ%,M+!\6@^CN5U=\%#1?@U8"_L'T##D5US1;5_2,= M,Z?N^KH]7@HU&_VAQ;6&Q,R9"PWZ.NZ^"H>TY16'M06S\I,]#?410;6/.OV6 MTFW6N< 5JF?*+_#XZ'0PTH9-5&]NZ%9M)B^PJQ:+1,D[-__+(5EA,?)7,!YN M5PL!*NI$#8)!532K0H^7#"FJJ,R9^""40Q9AMUTFMK#/N^E&6-^%(A!499?^ M8"(=3*26+,6.+:0<[#J\O8*:\BCK\\C:LFRB@F2MG]0@!?H"3IE FV2FD&,; M4P08M+<0ZZ4L>P,WN=>NS, S'A*PUFM\2$1Z??K4?#=B,?&1/N80?NFCIK MNGM&-H(W(SSU".%)"KN_^EYO4KD4BM]^L/1>I@UD9?XC=5Z9#H!9:1O MJBS3]39_WWEO*@CJA#KQ.OL??#O$)).-51: M:35PL'AV!><<*C=WHGX2! M)Y*\_.2Q)X4<'YR]96HI*ZP2Q!C&L^?_Q?QJAD$$^[_PL/ 0ZV(=QWJRD1'! M$L?49L=T9M #1,+X^H_++\?=B0JO-"WXV([K0UMZKV#]YTR&_IK-_!6K.6;B ML/U 5& \VG@@A%[(=3#Z1Z<3K3?, DSF:[>C/6/2N#O#G[ MQ]GGJXMW9]9OJK7,:ZI^M:8^:PY)8Y548]TA 5S3/EZ"MW@14P!?%5#VZAGV MUS#SY@,^ >,X>N?3[4^HOC@5FA7B\6GK]$1<<>HZE75^?A8]A7HK?#C1ZL M#)=8=F %9@^IIKFR18771/Z%&H#HS!$?!^TC+-C*U?S3XRB1@PHL59,J+%7U MS&*T;1:4U1!"$HG .CT?8N_] !ET[ZT03\_FHP$Q^UG]8']4KWT;SA5(#*$1 MJ<0N#WY-#A=D$@NE]VIR01A9';O$<[H?8[BU]9,T]^/< EI'.GR'_.3QH/&T76>;,[\QAGU4 ]ZCD=$XPYZ!O)L);4SA*)$ML03[8 M("%S$*=CXKH+\<#D50P%2,!:16L6HH:M*S9);<%?%UQ3YI&Y4?G5/'? _PG1 MMZ[][Q@C!IL&C+?K>:2XS]&E,3^_B.GP#Z8?W> !_*5 7O=^Y^A4U_KCH389 MC#)6GGU+B?MA(4]N#%3 0(\0CC$LEAV0_,UR@-I.QN4Q U*7Z8(/X ;?'R&8 MB;7I9DGD#8("))8([#>XO).9QJA%D[Y4LXM8.X!GZZV82Y=Z?D.//_)5.IRE MDK 8SD"[F%2)@-C% =L,+0Y7_>CY2)&Y-&P'_TG?FZA3R_&>F5V44 /B^(-L M"E-*$::4^FPA-Z+O6T_>#$S0E_"B8A&'KLX[;$$Z8$Z1$E_ S6=C0_8+ 6@' M0B_GUL8E0H $W_?-D/ M2"(\9?O"-W_;AH"C55ZCT^HP%,5,#13;A-[1*?QO1B"66F2)US,&@HF_"2^^ MN)C"GP(QX1PSK1"I.3-1)Q"9=ZA\?\'_M4RD1+7\)]#+N:S+?A\$L:<-.\D8 MAZ90WP>&^K9-I4*T1CI&:-_D&O, ]DWO:+U)$LJ.V_4!V&UA'TL(>X! A&SP MH08QX9WMZ4W?K_L$HY5"-7%[^L%XLA#:P%BB^?2BFJ@/O/EVH TZ^++8X#>9 MUD=Y02@%,CJ/+7>S6?P;?_47^/YW'-GMTO"7W9C\#&4T9TZZG(ZB@?IT!@<, M-6L4A?79K&!1783HP.R(NKG,:$VO%3/!ZO2.^J-TQ*:/,?6.!I?C*+2;>'*H M?D)3IZLEJC?Z54312YZE8ULK7!*#E=LM6+157<$)C*2!G\.XS&C$\(M:.X?! M7^E^P'5DZB:PP_L;6:_$TMZ2;;KI!DFQ7K%IH*M-.EUMU,W*!446OFS-:Q@S M-DB5\QN$EIX,_6#AV$M8&^K* WN,4!L\JBT/[$?; ?=KYL'%3*)H(:1J0/LP M7\&5'<"^!'.^?IA-PBQ/1*FLP%&&YPC;(;DEZ@<^%K"O4-@-%:-'_&'!"K[F MDI]$_Z2IX:L1\1D!YM;?3E^07A\7-06,%#8>UX,[]QZ14,+/HF@@/)H/D QQ// NE6$^VMPK84TE$0B@4I,%&18MG'16Q M 8;J"X(.P>O "2'X&0L!4=AKR $0/LRCA3E._)UIS8GKADFE05<_CAPTZ,H. M'ECM-<(!F?;"9>-&H\NDF'T1YU:T5'JQ+%)3R,U@:%29=1%,%; ]3E@ MK*1@K(P/&"OM.74'*)8]@F)I;NC\">@6@[-L*'E(-D]NKVUX78DMUX.+ MLZK::)M\AERQ,>SFM4G)'5%$T1N, :R^J&1M+C N=P,U4MD%V-*!NW'A]ZS- MMD+O)P9GPC:+_6E.%7$9UHV*T9EV->;6/5\1:&/S-5/FV]Z]NA%Y^W9M49-3 M/F.EI&RW0EE]-]./U66RL@E-=:W:5Z#IZ:;-K2%<<;#:Q*JQX<=;[>DGOI+" M)%:;&PKME0AT%%WSW72BZUD$BU'YGHKE>PWT1&_$]"F#O]/M])I(6)3K*.E/ M4I,6A9JE?ZJVZNL/#25S8TZK7W].2UZ700?T>BST>G [BSW]4R5\#S*+O,?:9%NKT:E_GU:#O7*B"/)POID_@]V!E"-,C=9E#! M1-YLE.<5J!Q?SR=H;TURF]O-7'D]WC'*O0YU&>UC;G5UCOLWL[.6UFC9")LO\-F%=RL M"BQ;)3=KV,EO09;:K&:C7SE@OI.& #%S$S]$K!R;E93Q?-^VN6]C]R[%4KWQ M=:GRE._;U5]>V?C:0)R>(W!?F4L]%QQ\<7KU+8_-=^A?"0H($^%9'2@Y!2K7 MJAXV/673N[5A!U4PJH8Z2, 8!"#9''H0@!:?^K)7/1)F:YVA?MCQ5SGR%7KN MRNYXGZEX?9CLL&MJOW.03K2_'8%-*/F_.X=0S-E;S72^POEK&&>6M0U>I,(5 M)-[(@:?S-D\.L7ERI(UZ27 N=3L<2H7P>MGQ#H].T\X.AS[AS<1)11"X M&D3,;?RPK!4GT\1J0._"7O=_2AVZL@[,71U*#?/;'B*5AXY'@S<$Z-5KII[Z M_/K;'Q??[RZQFOHUP+WT4;R7HT6J6*I;4K:@6M0/R=OJ%L$R-.3+9X28"1O\ M;"(OP=8YRR0X7@%"D89 <1UA?:@]C>M@&4K,0"PT!@E$+TCV&H:H..SQ?^-I M1]:FNO1R-)9W]88:RR]<,]96/AP=G7+6>PYLHJ\GED[4,]!E*'F&@Y!<<+WR M;P@(EG14.2/"C&-MPJH1/D>)]V;20@:\=_:;]\3N0C&@$_72967TIL6AJL45 M&B!BJQE]/VNG$"7,Y@YO' 1+$; KJV6P!#E Y @4!W-%&+(I:$^L\3=S?Q$L M]AEF_9*WR[Y;HFB-KJ?X5@?5\[/#,9@M:7WV$9 6];RG@+A(L%NJH;IP\A.0 M6^H'_(Z&@A!"Q(AMYW@@,DJ,0-2*"TZ>=OMNB7(A!I##@;0B>6?-]0(&,6=W M_9 J_]*QLK<*0PECM?KH%[YU3%W^']P:B:5Y3ST8@X,'@'#%LBC_) M>06;$FPL.$(Q^+!"6&$C+-D[&:0)P[8%&;S-!=$1/*V;1#M,R%>$HT;P"PF% M0>MEV&X0M>:SAGU41PO?>[(# H^P76KIA[6#F1 F.?E4@6CD3R!):0B39(%E M@C>-:<_GH%JQ7=E>%^L8<,/[PWB?J1?9E%]3BC06^5K2I9T;C[;S\O.VF22>]*'[4?9P MMSC3C0X%->DLA!2*;N?,0X5H*7!&5C-$_$',[$C&=4U[#1D(>3P^O4)* M0L9/R^LDC4H[>!4Z6IZ_U^LE,SC8_7J^0M-W-_,;HZ4^T+EC)_5X._<2>\"D1IH^"] <[ M]2W8J7I%._4N)Y"VF@FDK>P*2+M$U6PM0-KC#3VPTJ6ZD)*KLV M:%Q]5QF,L5X$&%>I QBW##5!,Q'[<2\_,JY:#S)NE+JI 1E7K]!ANC7 F17? MS J5GZV6#YX/JBRO>37NHXDP J'K;.')6+>IRJ'H*I51=-6Z4'25&E!TU'FS3 -LN)_8VQX/QF7"#OK%5+A]4^#A3&'18*8 MJ&FG'FA'\NX(VAS4LC6?LU+6%!XGNO QYLED@D3%7"\BV!K2KK+_+4Z9CS'D M>))2G-.H)+5Y0<8DD\GFTVR9)#[ 0_RJQ8;BH&Y#4?8V,$C-_0N6M>SM8 M F)3X\62 886R']'FE]RT5Y4GF.2/A;Y7B<;L:W;=4AV1R!1Q[B+,4ET M#TP2:4P2DP.3Q*L+GI=0HGU7JC=BED#;5&9 MR]GLP2]_;M:)%2HT,>K<,RK8^=B>?<;F+5X2"T9SX*GP0==[!G/VGBQ:8[E. M70^FK\&0*Z),WK:0*YGW8>!!'_/ Z91_[V"AX)Y;+A*Q F\O6-!+]NN<29> MDA]W93Q!5G9]V-=&XZ3;JV'$9=MH2V!ZE1WMI(.YL6Y/W\!XBV[/)C+HRZCS MAR7,8@5G%@L7A91WL:I696M5JP97U,;0Y_+!]DU1J!TF3VT_I:\E'L04E7M+ M3]FV(:/RY9==& MRUL@VG1UALRA@>@D2:_CQQVTD!6>0F"")U2->$(U4;1QBJ4J(*NG6IROE"=H MMKU0D5XH.G=1].)$I5RTB=.4=0A;:\RFT0=.5#JU6$%&EH#E&L[R);K[P3# M:NCP U*AF)*3W;Y"$7%4)7X]IT/)+LI-K,SK]V7OZ'3<&VK];MK=ON6VR]'# MD:=O0R]1U]1L ?VD7[9O0Y^T;BZ#^OHV>IVV]6U,AJ7O_%ZW;7T;DU'F=:UD M7M<:SXSC%88P5_D#Z'1__FF9:32]>,T3;O3R;: M8)15M[8**('!8L3'_%7JDW@7*G++88I)5%]1P6!84Q?:PTK\AI#-B[S+5*%* M,,,=SK5,Z'#UQEIWG.7 Y%JD,$TCZ6M8*>%]K)MA2LHZP0K&0&8U[@CAV[$& M0T9(P"X<_SZ/\]K3R[J#X-NPD&TD^1J7)*"-T(N)<]5LWLDH-K>7:GD\'(]=VZ=G0K[QP/;#8 MN-D_NUT^/2P%^1B>A'"65+,*3WB [8S:]>7CP9/VIQ8WMKDVYHIYNH=*=8 MND_&==RLKMFS*L)/O \8CA>A5YIH*XCUK^@C1L31$(Q!R/:AL)>P*!4XT6[R MH:RVE7V /#K?>C10#$)8C'CA];.-C1^6CP)/MP>H\A=0M7%?[QE.Y0,/J(8R MJ#Q:UC+@;MG<=FWAR:6*&KIU,9<\(&@4H;R6[)GRG-<;'R*A&DZP@#'? MJ3E/^-NO38"=1QEMS,'D7&N>?,F],^^9%#L'#<(&8=K!#$WWYI;E M51BUHUH)595IKWMQVFO\AZ*&U-351M^.^;+WJ-EW6%@BOW5H\ZV-W;.) PZ/3\62L35*ZPII8H3:N?X6 MY95M3&V'VB)N5]-_6;/EG8=1#<+@(+_KS#6+4QJ-.@3IA-KY[>[*\9N927/R ME9$NRL^=,^J,CTXGG8FF=]^P*&W9@ J,*S5LP(15'O:T7J=;[Q94L@ W49QO M->Q2=BHOL^+6K4[9WZJ/+L;Z^&:G=QC;86Q5QM:PQUG6RV2I*C;.VZ5O63RN M\HOC34.*!G*_KQ<(M8*:FOFDFGIU=;ZS9=]R2PW;XVMV.X5\S6T.9E'UN]F% M'%5V(;O=0B[D*\I$?9SUQ5W#+E973+K::)!!J=TZO5;D@+7#S^LB8%Y_K'52 M4//:N<;I7MNK#ZNYK:_N 73[S .8:*/A&SE*):!*:US/06&/ZN!&'=RHO32Y M#V-[>V-KJ1OUW3+5[YYAJEA/"G\+U'..Z[I>+O.*%T\A3@UV9?RSW_TG@L V MXC2=ZI.37K)8/.?2_+\-^DF33G4_:71T^O>5:ZG=0:O=I$F%5KGJ;A)VKW2Z MVG"49 -OI]XJEI6.AML$2J%R#KX(S>6HMEK!>WM?;(:Q87]]"_[,$Y MVY?D9I%CU@Y[I-=%DR]G:>>KK^\V:Z3" M=IC?1T6-2.-NZ4CNBUQAIYU=KC M7@_Y?KOEE_&-&R.'W/$A=WP8VV%L[7%^4J#LT[H_,YJ2\RDN0JZ1B9,)GR-U M*6KJ_"W8:Y+C&>+RK8WWC@]G\V5> 8RX[@KA7O_H=)Q6(,PFLO1R3:A%)<\] M#.SI:3-2-Y$PY):W]);;X@*>O"LS(0XV.\+5RZA[0YGJNLLQJ9:>&GG'W7Z! M%MTF0$8*'?QBC\MG@+]F!7=OA!#]'7VH#8TFD0/2<-LC4F]G^))J>BO8Y:T8 MAFQ=_KN19^@9D8T'A.PA"%6J!IISPOGYTJO?U M\C[;03H*2$?ME!I-N/']WM'I<#S2!IV<5:)51"+=LW\?TK!CDIXB(M#'RH<1 M6GEY@14/>J$I2:A0 E>#) P832Z6Y>] ':0Y*8*T^V]K] *GBO)*O 8%" KT MY@@*V#2.E]Z"IA+^0JP[_2Y&5;"9]#UC)11I:P4+O.T>_>TTY?DFA[>)UO[Y_B-T?JCT?G9\? ];+2$EL@N4M08F9S;*3BC1?LA;FTY@CNSRXVA"0;&8A=:_-@*P!^EADL M=H!/>MIXG$S$,1% ;F*4Z!<0<)!RHF)*9LYQ7@@53W1Z"W;"G)>=TV/]SS04 MW.D.WYI+>,^864X'5P$M0!Q/@C^A>4F67W\]QUM+N :%:V:QG^H ,U9Q;_J =QKY%,FW,H:"&A("Q;$JHEX\9],GQ; ML%[%R)D#=2KXJPWY *F$PY"Q1VSYS8\8D'<]/19 M6S"[I;UW;F%)D:#AYERK,&,ULYQ#>>Y*M.,3N(Q]"W9NBFF,0_'];/ZHUQ#W[@K?7O%>X]N$/Z)Q5)AK%V4CT^YE\D M'RH+\\W#9= [\K?^)KY&*T0['FUL^EI-?7Q M#E/&BVLJKT[I.6XXZ6CG=R>FTB!K?7.ZK&3SADY/+[]]N_[C[.[R MCPOUYNP?OUU\NU-NKZ]^O[N\_G:KJ9??SD_$;?;:(_UV?7=QJ]Y=JW>_7JCG M,+SKJ\LO9W<77Y2OE]_.OIU?GEVIMW?P"YS$;3.CKL#1FK7E#84D"A CPGG* M)&UBMZD)?TLO= M18U8IVS%N'VJ$,?7%5)\B;5KP(XOOGTMLN:O725D:^X.R0OJQMF:9XZ'1KF! M5K<;<.^/+$S!I+98^6B=DFW)PF;R]\%0M<#4-)%.#PG,9Y9EYF!L[_8J)$MN M^&N^^M[C)3>=F7.9RYOL'IT..AUMD.)-:JHQA_M%@:7U?!OV TQGXEN/')9F MID:LZO&,X#4? %40"*\YUP3AQ(ZZJ?-CPDKTW+,'P[VW0LG_A'XPN)DP%G(V&2$Z3%3F:.>G7F<.+2X(^9>R M\P[KXJG!@^$S:O:X$[O$Z#N1G,-1B/Q717CK;"4+G8@"2WG)7GP>OO<&7POK M=XO#S9(?^#N;3FP1!T>GH%&3P5TV UQ*^I*&#.UH8.$?X[J2- 'JRF?#]U$C M6C]@)^V ##.84G&I*I@:=(P@N)[_R=Y^[7_'Q-RW%<:XKNXL.X>>7Z#,W+(5S!KMH7E.+67#!1PN']89B2W]2TA-L+) [ M.*?B[R1^Q<1N!,KX1,]27J'8U1R$W*?TT%F@F-3N-X7#]>CY<)96CO.B&E/O MR6(G\)&W!K( &8^VN4*9P:M9Q!?TV-GJ'MX>JCTM/,H&/A(^\ T>RAH%^4=( M=QKWANTJ\.8SP_5+>P#/!,,%Q@[0Q7 MVME94RPA&#T9IM!H5:64FY MP(MKX^&;U,;#SM%I_R0%'&I=&RLWX@@4@[55L MW;L;UQT.]K:9Q7KL>BV:F8YF92\%17)-I#XQ#2?T.!>/#\9'!>XQ5&W<)%?A MH@+G4T490NHX2?8H3@-#6MH.\U/5WPQ0A^%5Q?3H]"/(#69_\ G6$YXWE?+6 MW-V2<%1LC%,GESX0=]Z]X.\!I@W\GP&>@-S@L)^_IK M^%>DC^!TN8(/U ?+,16XXL0JX4T+GX?=8#$)&FEHZ-)3+X0GBV. ^P/7"W\_ MMQT^3#9J?HP#O+I0X>"<4#,%\Q=YQO_GO\9Z=_0I4&+?\J9@V="/)ZJPH78: M:VJEX?:9Y405;G/I?4D,0]M(Y\*IA9O*!7UKU42W5QEB/:"R Q++,S*OSL6[ MNWF"#T/D2D,2+3U99H-B'U:5;:^AZ/8K%($D)L.LB"V325%6&$B8Z-IHE$3* MC,T'0P)YC*I^9>C9&B8UV-:@W:^ D%W;*,&KG@Q[VFB8!DU7U*)+-1L*G:9B M5R@;P);[\](MIY7C'F?=^]L, ;B/0-W^AQ6A.![6EKKR?F[?R2JG M[A?PKJ8!E5 L,1!! MGJ^%A,%R.%S M[CK4F?CIL(H\7F-^HLH"W!:AR:H#J#$?W"^3#^ZU*!^,U8I3PQ&)*[+CN95) M;L?" =$50A!9:\N4VE 4S6UZMT+.4H3/XNT\9Z[YS6,BG2^W-^J &=&9@!I. M C W&D+>6GC32@^%I>A9&:O"B-I5QM&>18"7!YHK@MUQ*P#9 :ZB4H%\A MI5:ME="E!OT+I?<%$^ZCQJH$R^U1G7<3HU4H)^F5+"<1#+9FD1HN)*@BF[8327!Z'4J"?>&=29 M;B]3.S#N;4ML#NI,GI<:8C_;%L@, N4K#*AU^4NFW,=;"P-JW8&RHP0G61]/ MM/$@C5-AB]L\8]HS2"L,4/*::(-6)MC'6PL#XKO7FG&7+@S0JE<&5#EVI2L# MQE@9,-8&@^YN4U+MONKD?$F4M1?92$*D(%2Z.$R6^NT<\*B5 M,L%RKO^[LF=_*>?&PEX:SB$'O%6G_7WE6E)-;[[\+RVR*B]R0ZG@P:MUE4\H M%9QJ2FL*<[DW9(+)[[2L7%/<7>_U1$>"0K!,DSCC-:6$R^Q7G2GA">)F;YIA M;2G@^$QWG0*>('?FI@RP)A!1PPIP&1I5WE.1+]$22>/PLM3#A,>FI+%2,&FL M%DH:QX])/N>@R:3Q9) SV%.W8/P*Y)**_XT0NLY5*$A:6\JI1TS2%@%0HVKCSW M_L[R'XDUA(D$B_A=1X/)=>&-,R^\> 4UU5_GBSG4!WVD#%+02L6B.#%(V:)[OS&FJ<&99JG^BUJGF++UQUW.LH7V[C'HC*5]\A< M\6Q#T^'0G"'C71SPVHAVV'$OQK6S^0S_G_^:#$>33['C64DI7+LJ56!L".,J M*6%<%!5U@ZBH'[ (1N]\BGV0?M?]]+%,R%?)X7Y4P'6J%/*%.6:73_#NG[IB MOE5*3@O%?,>=+DQJI/4RZ\RKQWQ+;%B-,=]Q!Z/:&Z>X'O15/N DN6S3P8D= M!/R($/)D?%C-&1\N6UU=1WQXW"&@DYH#Q,IZ@%C2.7T6&TY?S,((I:GD'SY+ MCN=:_ I%RFMTOU6+V\<=,!&&*<7M"E]:QWNF^ PC2>'135[)+WYI&B^!RIQ' M:45.8J9EC*)L-^&^75SC6ZWT#1:ZQ&18VHY/N:N)4EYM:H7A+J><;+=7)"7+ MIHI'C_TDSE]3/;J#\:O=TH/LQ&R]EW2)*=9ZKPTI6SMJKH%W4 */BV;XW>*T MB==SV3W*4UTV[HPH8IT]K?7;6I5O:W8TZK^NA[%"NW[!9)'G+T4P/[H>/K.1 M?$6^2OD:R7EM("/@Z*17]R6>R/*RQH%N3[[&,U9YY_?XL-NB>WR2?H^KU>_Q MZ%)M[%;9P2O@XA)5_YLR;J"UL(E32Z3>U@L>0:187Y07%T6-E-T6U38L4;-' MJFT]\G.-8V"IN3S:K8L^Y*2O]5*(/+$28.:LPK+/9(/GUCNIS+32#\09Z _# MN1%#X"GL7%-$CW(,-W"*OZ6A^G'$9E/MZ\*"/4/2O^V3*UL\=,-><>U*FY?7 MG.B"]SC1>ITLWM622=1J&[7P GMYQ2G^;"LX8Z6L0HGEFA>"8VB=%(UUPA)! M(B:LUNJI0-59/2?NXB\UJ^F 'CER5R<8OS=_AC\1_;)E%/+DN MN*QZ5YLTY\D-2]3LU.FK=M%7[0\W3#'IU47"SG[1K>[$M0718MP=I<=?RSEL M63B7>;VH8?E"R&POZD*,J?#:(-K'Y"1U==:=4^:(#F3?-)(7]0'<45#UIK'T M_!<57,_E@X,ZD0C5)AB+=:&#A[ML LN[>;V M7=D#S&'GKUOT61;^1EFO]L9]]19")5[468!3V)#Y7R%[4]HW_405TIIJLCEZ'W._A.*F>:S'^JTRQ M%F.CA][-1!NDM(<>C/_7,/ZW]*&^AO4_>G4\FW%/WU$1UZ@"@$@]!Y(J<36] M.>M_]+HT#.,>%KANFN%VZ[]7W?IO"ROVN ?.4#>I?5_)^A^TROKO@6?4TT]2 M[+:D]1_E6#-<@%X=+D"9PU/%!>B!_S/6.N.D"Y"8W:ZM^Q(GJ"GKOC<^6/=- M6_>]NJW["GU;=5D5X!3VM&XG24]2CW%?88:UV!)]RGAIXY0)9AGWHMOWU6J5 MLL P&L3"J L*HW^ PDB#PM /4!B[JI)\;7R) Q+& 0GC@(2Q&UC8S;@6Q9$I M!JU#ID!+4ED/!@3-U%:7/X [J4S'?=X)*EDQ&H^()K(G<7F$B2@.>[X6PHQ! MGTN<+#>"D>M,T(4'+++9ZY#789GVDKZ&X/2>'T2MJLKF<&=!YI!1B8(<"@V= MB9=Q=1+;KZ$-M.,QJ,;%=]1Z?'\5P$3$4O=HG@\#, MC1DGJGF S;M_6 \1_BP?G=<].?MQ7TFYA4HW6TK6H89[3=:0(')(9>1Q_O,@ MU@M+!Y1^S<.G=%HM \Z-D?B,B+#2AS9=A^] @LHWMGQ24X1@>Z=+RM>2,C W M'FWGY>=M,\F;^]H@@8T.)\'.F"*T DDX[')9)W 4FC='X+($0PIK&N3ONYZ' M>OZ6@^WF@34>]S&%I0TG0VV0TNN9 ]BX**!QA4*>]L(9C_N]G'#&Z@@CRR?\V\QZGMTO3@=Z;MK%CNA-^6C"DNL$&T04 9)=[' MDX0ZC)3AF[=$\_.M1-<-R]-8ZI29C6KO9,"R+VQYNSK_%\OFQ4++F) (Q!?S MI"7T25L2>_T,S'V8MH*_4RG&WAFHO$(A=HW3Y!,&,DW3N GM^SW6HX$&-KR2> M#L..L<0Y(!Q+)D#H(3[9'$""CMR#YW 25]^"_4-!01)9?FRC%X2;)ZP.)?EN M$ O\)7&3+>D%FFK/>3G.O?V$KV7E"$29NJ*"53%,%A/@P^&DM3 @. GP@+GM MV*3XG[V58X(HN];2%*GKA;P/R!5E&3W MY)B,PN21>!1 '&W\&%-B;%S20W!_+3-H<'>OPI==L'<5WETLST[=78V?5JYX MPY6$K7.(C "UEQ!DSQ[# %( M67I+># ?J.C72P<5?-HQ/BN5:DB4EG&]$$0^ MND0]1,]J;KUWPCHT'G2PRUS7^L-DJ;>Z@7"WN%_>'5?@K64A!ZJY-,E8!:5% MORMDLPZZ63:KLE,ZH#TTR=;KHR)K2:FW/FK\^E77 T1*U@:3KC;JI5'MU% C M5666M=1(#1#WJCO0P%;;4B2UF:2GA<4 ;#:@*>%ULX3-%&,^^.<7B[)'8(T$ M(";AI99,$X/NLF!5%Q@I]O'66]^3S<^)EGXPQ,KG/?>/;04*[]8Z1(\YB0J)IGAHMG"[9OH2LW; 5N+$W)K@A<9O M8>TK*&H3!-ZWI_ U])K!:7DPP&@/RZ?IVC=C5=1D>"B4O 8'9XZ(KNK<\3#J M038"#OR$>;BMC1S5"IP%JZL SH>CH<[O!%-$K@GA;ZAO@/_(+6TZ3HK M)C\+J>YE$11]/B)Z&'TLC(? 'B,:[$MT*!41L43X&5TUIG!"T-5!Y%0&'\L( M_D(1"@4'E,'/Z@?[(WU M#-%X2TN5>AR":^)A6WA4CV696@1)MT5$B<-'LJ? MRK4*"357+$GIDUX4K*;_XH&:Y"+04S8]^@(C<:B!E' 2L%[/<)?B?X5B\/#0 M16>1'^24Q\G:)/8EX0U*_+[RAMKW]R0 AN);J,"H06<>/6K.M8880NV>QMXY M%4JJ>/*;()<,B>API&(INA1==70^C'"72-I@.G]9YO'2.Z:?EHHX&UW8':9-_&S_*?'K$"3+K,PL9,,3RF,3*GH5A"DJ4)94ECH&6<((-4 MA>KC5;-DH7 6>2Z6.B^",:D >Q'Y P*>^ 6F0*/*#Y(]0#Q,K=<=:9U! M$J2*'>K(!O"M&?9-F*CS*#Q#U++B(G"P<,YS8XE*)GM\/?CG DR5,AF>JQX8 M6BRC10'(2DJT5G^N'7C76RCWC/ )L7[=8W JSN-6=6]Q"]81G M3ZG98,W2D\LMAU;O5(FX1N\3O--R[7BN(XN=N\..UI]D'=CI:LGR/>@&>,PP M1R>#UB%[YCE0>EYYY@CEFHE5D,_30+LJ2)N]N.("ZJ):.B^*H$GPDFP*L5N: M,K6XWJRV0"QPZLW@6X[!MH5;:O3R)OBQ<]-C1X&L'9!CU]40.#@T!*8U!/8. M#8&'AL!#0^"A(;"=X?72O8!I/7A%$BOMZ>_BTC3U_W:J\%XO"5^EJTMF_Q:\ MJICI;VPP_B,0JVR+7TG$V%_-XE?BWG8K+/X*6')UV+UCQ,D>HIN^W>)7>%RI M%HL?I.YU9XY5/;TL9I)7S"WL650! Z%N2O0PU4<1T&?4.83'VLPHLS"H3 $# MDU&@4V7=I(T$ I.1KU\,V[WR@N#:C7[WS7WC2_I1JB[//E*HG)J,CY MF7N.PV@0C2!8/;)N+!8V6 51.FRCB$3]P6N.=X.58&MRDFI*U;!;C1G$W#.' M#7&,10 FIOBID*W,/,W(7(YAH4:V+EFRS]11A]]QS$\JGTSD[V)0(+US&4:& MVTL]14*DML05TMVIQ#".3O\1:F,R'F,JF?T&]?+Z?%('G_K\-[D>>CWK(5R3 M;>*5YD7Z]],/>J>OZ;VQI@\&'R41/%]KTA*#W=05+Z^.8\UAX?][?8[R1\B6 MK[.G>',ULM[I-=]$=LEK_@O5Y0ZI+K?;2:8"V6*#U;S-%.ZW=6IZ5LFQ*@1) M1PBJ:]T]FNVT7 MW>]V\)!K=JN)W[!U M!S&5J%6H_W1B?GL@O:8ON+Q?\C7/O\EL$( M>7L&XY,4FN"]M/\KK04XV7IW=)+"*%S83MH#&=\3Z[_2CA($6.>D7Z<'4#,F MX<[6 OQ;'4YZT@DH[. VZP3PQ--H^--&V]^T$9+'-6/AI+5G='_*@X+;37U1 M^HGD7YFL?44Y]3VHP8C!5]Z*3JSK^5=16G?C!=3;5AZHHN;72A4;(S1_ M\E=LA-5.MIO5I4Q=SU38$>Q3;48]N[AG)1N;8@VMJ5Y(>67:>$6U GOO6ROA MJ+P(K:[;R&<$7L/-BD$%#FK5@$V1R+A7,"=*G":YCM<<82>Z,M.XP&40HO=8[">%%\T]K!5 -WZ8Z MW;GO/:;T0TA@14T'0)H]:N$M'PK!&9OY5YCX&BM5+H$ 4Z W3J^R?^UDPFZ. M4^TKJF/?PECKIK +[RXTOOT**WW$& RQ#'MB2[! *4@0K..D:2F16EDQ9W)L M_SA^L$WP2W]6V7^/$4_KN-L%/^*8]Y:]"P$/]S+<2KZ3GHL;$VZCV$7;Q3WT M7&D':0-S"7]O$Z9(ZS)#F>8P^DZ\@XIQ"S 0)F]C*G^CP;K1^BA6&;U)O(H] MB0O@A[HOK62W3NB,RJYLSG:=<7]3NTY.=R&Y@!_?^+Z5T!PU[]L >Q>[VFBP M_28LNFO-WHWKH^DO,C=NVT=SB0Q\236]%6C:7.Y'H6:P0]C)Z%V/S. M'DY.K9#P^.ATQB+ET*AG.5T+@* 9XCGZ$ ML;&Y<:M")9XTK1O#O_89UR!9Y*4X2L83;#F Z64!"")Q<8R^3GDP\C KUKEU MC(@EY[9-.LT9MXF174>,87F'AP7!/6WP*Z$N";:Q!7!GS-]LUCT,H(P@PS\HD]@7%Y M<;@I0D-ZMIPG2Z+S0JAZWWJRK6=%>C.WY@)UBO@OR(FX< R8* '%&Z[AO/R' MI96,(,"_IGW51PZ^%2[?S L04)O MA&;:>YXSY\$\#P\$*;G>^8*F?VDFY4 MISGGT=Q !"TW]3U3Z\%PYFP=%A[21F+@G@8W6ZX,A^BUD$T+?L3U07+!-\A# M5:=1PPY]KN+;T:LIX?[1Z7"H#8=)9#!US]N MIFY'BM:H?C&$K0HL_\E&.E\?T4%0<4@8]L1PH5B&[S)@7P+! FN*"%)Q#B?L MG0PE6!A[EL2ALATLKH0P4+:&AUA_P0SU%R-?HG$R/#H=]U/7D1L1R]@<[_'A M*>#WDK+DR'XS"\F1#:8D037/K1Q&KMXI 6A/DS\3JORKE6_BHZ/3WH9Y"VE M%"\!@!>^0V/:T)WQ5":'=V;7MQY3B^_4N2MR(0<6R("Y\5X.++AS4 3+7-!* M[().O_UV<$$KL0M:W9EY"RY1+J5D#6+#/2R>O> M/.JFFT>I<.F46<>RE\ZDTRESZ1S?9D^0@G+SB 21:_6\'2M['+@^0_WUF;=+JE3=-NA7!- M$S/1"VD-/WR)FJ% X,[X;B,ICJE\]P++G3JK1RWUUKB!K]NF8"@[?["MN1H6 MJZG7\SGH&U^06I33'&6+BTII#@S*=-/7<=>J8_\L,FZF#HHJCRT",&C78<-" MGZRCMDUO#'=I34PZ ^Z#5+(F0!G<&H^&J?X*)O)?R.BF/MB!8L+!OWQ-0-&>B>@\3E 0-0_XK["6-PP)JNIG5*[%1YK8/E)4TYT M-PXMO?R*C#KR3/'*W M'^4]-:*_U%BT56$,*05>- A6Y%6:TZAZ[==![FJ0N\3LRY2E59"NVDK8*HPA MYH^\ECP7Y+II4-[781AJJM/5CSB@0_E"WUWP<)9=Y*V4QA/!8H9,*9;_2*ZP M("XC%@376R)A&$\^FJR1-X7:C"U>/"E5(#M2(5M/1X0%";ZL?%!]-Y2S8L&# M"$7]>BXUC=Y:,_@H5MGGC2N,CDY'NM8?9I$5A)$$)79R16! 6M'M&=LRJT&> M>,9L$6/^SF-RGL$0W/: MJ-6CSQ&@[ [;N/?2^= MD'@^M["4"1/?!IMS-RS&XV7P'9$B1RFS5$+<5BE)1D7QO'Z,4RE*B4S5B"H6 M#2>/1M"KU$#M1",03,:X-]ZL#Y:>:OVP@V4(4,X]1]5<$4$R[135,=9ODO\;37FHY:CWM$PQ?Z-J@I:>]:+E:DRK@D"YO,%T^;4&Z M_+M4X,\:@I =(V@#4,P;NMLVW5O_9^]=FQM%LH3A M[_P*UL_T$U43DEN@>]6\CE#9KF[-5MG>LKMGY_TR@:24S30"-2"[/+_^.>=D M@D!Z)8E>W:%O1Q4G4:C=7(*DE3(5WU!>?*9;W*$6HO =WAOZS,,BRPD@]NV@7O.U=2R8.=&(L),I>>O%,*Z%/\>^:N=+L5U'KK5"= M Y*\S1::3@,;L@_(VB^T;E"[PF.(WS];]ISIA0'82735;$697?)GZ@6$+F\J MG)&W"(;R3$$KX'#!DO40=TEJ^!@STO7% LV!F=60ULB<^0-=+?SH^CM6F#NH MCFRPZF\>_E^*JOR59FP.@1T"L[AP7RSYE6FVLUF20O5 &9CLKB149'(9-W0" M4Y-N@>;MAR?-%/"B>B)G;')+,2OZ] ]'0S6"PB"-B%*JX%:"E.6US):X/BWJ MV#0'34=Y^?3JH'5C>/X#C#$AS_:4-EY[AH^*>C<1&B,KFSFB; [C8VM]D!2_ M@*Y72=./-ZNG%YM"%X^X&VKA;X!I#J'K"!ND <(^(+O*W_:VW&4#77&'.+FP ML/D\DIS58H$J"""D';$DQ>* PNBXXD697,8(S44$U@/MY!#5HSWH:C#;KE(D MWY*D71'2^3GGFZ^O5.-:.K_/.0ZF 0;\!W/Y![P%,2.TS^U>G\ M"X=N[L^+Z<<(>$P@S8UYT5=ZL3DMVQ!J[U=]E#C\EUJA;\CEKF9$WNZAD'BS3=/J/U&V?.@&'ON)6-X&8':[('9BW9':70'T1R& M$\:^/68\+,*,^R=F?$+MHV#&W58Q9CRH#S/N=QI#Y82Q/P S[BI%F/'PQ(Q+ M1NU=W#+_X+G1:6'9'3?\"T^&YM-.* ]G UY54N&^>,H>B4XM)"&ZK3V37?:< ML*1I#QE 7<65GM Q%SJV"\B KG)09"Q'$/2BU;HGC*T,8S'ON:E_;S[ILQF# M9_B_342CIJ)T1<0@XTZ:IXLZT$7U3A=5EXLJ4084"_!TU7*E0"RO_\6VG'2# M]:1]'#'F%8G-=-LG[:,6MF=R2D#Q+?J%73]?8@LXP_@AS'CN*C! MZ:*.XZ*&IXLZBHM26Z>+.HZ+4DX7=1P7I1[#1540(2D[L9E7WN=)]ZTT?+D] M$Q),]6MO3PZ':*N4M3\N%W MR?$)I?9P%]78G-H,GK]B_-^@1PJG2P/!Q#A2E7ZKT1\J6?U2U9/#^Q,EU)P2 MND7NI66IWOEJME)3MOL^<0G8CD[1-)-<&UBM+S<;%(P5CWR&L4NID+TT]X6B?&V2M6_=5+R>W?<_475^_5 M$_H=&9OL%2GEZNT[C?]@I5PG/*T5FRQ6 M5+R3?>,YOL*6JCW:])"N?1H%\- MV&21:J?>OO.-WZ@V>2ISK3V/3X^CGZJTCN2B3E5:1W)1ITS^([FH4R;_D5S4 M*9/_."ZJ?129_*?JN.-#K%/EP9%IE,>[YO%D))<6R<,.6(,*;$FJ%>L MWJ%W'-5QF3.C3H4_)THH4O30.U7'G8CD+1')%AHI5FK0JW5U7(V$Q$EG.@8B M*%+CT#M5Q[W1ZKCHT-7.3F095S)'FVCS*9KMC+#>;1<%F0,L*L^LU<1@!^8- M21NIEC7T"U:4O*%2O$TT5 \K)-\2%20E9->) H5MOPP]7\GXCA2$9'NDRTI MB^V$'O7IU;YI$?6!>>/08\LTJJN?^0% MTC77(SV_RL^N!MAP07O%6]/-%4'T0I+^M@RN]4%66H ]J2M]E!>:_:C#AO'1 M%O_O>5SH_V$?Y![2\L8!E[C[C0,17OWK?OK$9BN# M"2870:1O@ &V/H7;OW>MZ1^_P>TZA#XCN,)G0* '!-<#'.:3 7]O3EO_PD7^ MI<)A")(R9H:+&R4$P=]A6U/O]]P@]4:AMEH_G5VD.<)<:TD/^(@EOMDZ5^$* MRH$V;OCLXJ]!5$I*+%O?,MS$W+)BN M# @T6CW"D>1VBWONSGT@!,X7H*XTVCIRTJI^]YQS@D("WYZ&Q0G2% 0O M/ /QX8E)MK\?@?>/O"B[(2JRJ3B;?6?V5'>(T6FN[]'VO=GPK*PY@$.&8;TX M'X(4LK[.LK!HS_+C $BGGL5*K:HPO#(1)G110#I#6SH =.^G#>F6)= 3".+ M6_#"4*4\VBAMOF!4A5%B'YB]LU03(A2GC=ERD)]/0<]F]@[[7:,Q[9-P^6\3 M^^<+.= R@G^0/\LY9ON'B5W&H_0.M[!K*P[:S@Q,'OD.H,]J!=3:T&GO?C0Q&J=UD_ENLMXUDW:DB4?,)4*_24K]8D>[F!JM^3KV^+M#"7AMS)Z M.TN>YWUC";=FQ.TI1$)ZB[U\WOT3SI;);=3^?M&U2*9\O^2V?,(%'\B6VW#" M7W/' R-]M.1,^+VA;[V;\.VC0R0/BVQ=YE1/7?U5;.$*@R)"+*6.;/]"K-UN MM-OM>K3?/*%?3O0KDI7?[]9>*+V%=K#;C;3J"P629%6&E7<78;UNG0HD3B5% M^7=2+?,:M(K(SI2JN@,8@+U&KWAVUPGO?TR\+U(NT._77FCW,L\:.+H*N8P= MB Z?KEDN'N=:_?"'?S.YJD>2GUU(?I=<];>;_#ZE9]<%Y>N?GEUD+$N_Y"*_ M@YK:=S+[CH3/9&LN_Z4\12PLBGAUC_;]FJ_UB9ELKKM) MDF.=8CT<]KIG%U'9P:\%!/1[&T\'D[P;L!U.4N&[)89K^<1E#P$0J:12)3B_S;3GY%R?L9_P[]4OW?< M46C)_VHVY<\Z,V8?Y#M09C[">_]<,7/*,-K_D2=UP4[D9E-\D116?^_>AODV MFB!CX&$5=13QB:>Y]/"S;2ZALT(@B":Y^:O3?EHQVR'V_[D9/+YW\(_RP^L2 MSCRRM8D^_2C? "5PX-Q8" :U&_S6S][7"$)TX>M[C8?5Q&;:'\T) \2'%R\) MZL']]F+VBS -0J?PF3T$3=QH\&QXZ/7-[PU+ WLL=>%X5$F4$W^;7(QO;FY_ M'SV,?[^6[T;__'I]\R#=WW[Y[6%\>W/?D,^=!ED2?=,%N\9! M!O]!7BV78*" 6DLGNKE]N+Z7'F[EAU^OY4LXQNV7\=7HX?I*_CR^&=U\]/MV9F%1Y2W'[**9/0HGK%.F53Z>Y-TKD34K>2]>Z@B@I7IG1# MU[ ERKY53OGOO7^XO?SO7V^_7%U_N_^__V>@*L#OK__GM_'#/^5W?D71^\VU M(^8AW<7>!%CP4%LP)?K?1%3>4E"%AN&398#L\6&<+8I=1!;AF67LWE3*;/]K* M?;)L -5,[#:S1RZ?#>&#GZ#/&WF,_+73?,9!3*TE6H _0<_G&XI]M $%Z@4L/%,Y:@3Z0&D$MWOK:_%0]+]<3 ML%49A#5^.%XXJX@7_D-#S[?K5,\$!==2LZC[]6&2U^0,U)^9]/>5\2H/.,;+ M[]!1@;J2VOKH/R)C!Q;Z4/GXOD&^#(^_DN(.=*:;Z%8TY6MS9MD.Q1ODT:/- M^$_$E>[8?YI?-1NL"G-ZW@ F=0D[!VYCZAIP)'MIV:2:2._$\N+YP+J6/%_! MX\X3;<%A]K,^Y6P0GM,M^8NU9/^1O>_3;]ZWS^6[E>VL "/P-?CUV)TVQ#M> M=,.0@.\@O]#\PSI+ZP_TS=@.^M:)CYJ,LU0Z(;YV:5L+"S^"$\Z(ML0:5,(? M6!-V'0"D4$\=>?GTZB YTO//NNVN-$-:99LM=-?% ML9CR9 5_@P?HKW%OMYF!_!E?-%M-7?Z@!\B2V=TVNA ?ZN:,X?L)I>M)*ZA0 MQ",VJ1?P:GL!]\FW[KX(J?1.?2]9>C,EG UW>1J/ IS. L PGZE;? ;!<2SYBA8Z@/^"%1$Z>!VQ9=[@"LEA@3!%TC@:R#D1 ]L+WOGRR M\ 5/EN6*W<>#'KYKD28#)W D"_VWF[!HP-^?F8EB8 ,LN*JW=YN!_N# *PFD M_,D7+CUT1"RO.0?]$38?(&*"UA1C::Y.O-2GJZW P\W,=41]@ +82[BC&5N8 M^ARH7_ /V(A@@O2SS]"(E/'Q)2/B(3"@FF2A5-?*.5-;I]#][?P!G6%<30XTK.FK8$N\T]]+(%\U$)I! MZ3-G9!H\/,%QY%_AK"C$'YZLE8.8]MOY_;E\A7U"@'N]^TN;&R/R;_=7P)O@ M +P'S;K7C RKR+=FX$TOL,AK\S.R.N^MTOJ%"K=PWLNK)1+4=S9=<78V3P/X M.SW#*G+,*G^N@/\Q&]0<3I82+H(,MR%/&*"8B?<"R^/'P];?G-7RPGT""H)_ M^27-M-? #48Y.:=5V!]L\+,^=U_CMM-M\=W@.6W ,]T"7BZP0[<=U!!,9,,. M\B\/$F&!(59Y[_$G)]04"'$92$![!) ]XN/P$H+-DX"7ZVWJ7;:G>Q#IY_6X2HD%-[2C?^P3"$N($WPQ4V M411R7DCLE*!V'Q*&W,3>Z\(0%!2=V%L3% CP9+Q^T M)5<\CT^@0C=?P2^$D_@0T**S6BRX5@H'U^#OYDQ#9 39YJYI#K[Z;!G/WLL] M=1&N@][EB=F@X&;/)#Y\;H-WIYO)V"\DH3BS1*DXP"!?\:@>03Z#K!7:!-*[ M@8J@!R6A6C2 K='GN!!Q..,5M\V=%<2Y '=TAROUG 4B$OAHR/\J-'64-7R? M:V9Y#[1LZZ1MC*:DY2K#=KM!BO2"8I_\*($5 U?E@4H<8ZD_/KXB+Q?;#RW/ M4:$B47=MJZFJO4,2P,+PW-<6[G M@O1O[6^(#H$LMJP.M^'9A9+1VY:-/^8Y\K:\)3YO'](6CD?))=$&/ I^VZS6J.@P?&[_9!,BZ3WC>)HA;$A=-9H;& M_%S[:Z&0".]; =TN1 +]31ER8A3(* )>SCA6(0F_*=#[9V'TD+S0Y"Z7X!ZQ MPP/+E3T% YAE(?3V#NE$1&YCVM<5B7 ^BTD,*Q.;N)V/'(>YJ9VS@_BB M5G M]K*70??M4(5.NVYTWT:_>[L3+;?Q"5_BVAY)[[FF!P(,@#\ "%\G1??[-F#L M@ X\ON@WA![-D 90"\F2K=7OG%VT.X/&L#U(..F,<3T-B&#R*J^XLXUG\C3O MIR#T "7PY)SG+:P9,SQ_30 J"(.IMM1!4\18A10@%R N-GTR@2X?7SVKPQ/% M)&//P6P _ZI\.46H$\/_^GV&O/\S< M82-C_ ]%E"^.UAJ-,'+(KA&&SJ;_1.EU&_WA0$Z0_>\&:F,P'-*C9 GA Y&W MH@.?H1/P.S!\\U&8]^Z+1=$AV(\%CYMD8J'>T(&7HGL-7TA4.=.=J6$Y,?28 MMXZE[ R/F+H6N,S MA#T7ETFM4A'Y-]:G:,O*('<=/*N96;X*:IK:Z+0&C=ZP)[]3&M@@!70\'C,# M&HTA4+%'C/OXD=@-C1Z^_1?2B .>3M)]$=T0'34CH/(B,$CSFZ%]\)=!!XV+ M=C;U442<'*\V8^:==>U?@RU:L TO0H7V&(8Q+#,020:.0?&I*,YY1B.3;)Y(O@^1'9A!].]T^2+/N&HV7-GO6K94#.N&:'W"2:67R_*I/< .V/GM$+R)9//*7NQ3V$$]N% D BD1Y*:(,W181 M(;JCUC283)=I/?.H3S>@%'%KI[_55@Z$)CROT3K XG"/9KLE:U.0.$ C]#6, M#%FV$U;+)%\M:PLS2=XPDQRV9;7P-@6QS?5G%O*R.4$W6RBVE\GGIA9WLEP! MXEX2(F/"!O\)(+)NA<"];]PK%^]JBG$R]-L[Y"SDSQ(V0Z J%U"&_P:,9R+" MB/#93#=6%)E#'$+GCR-13I>^T U )!YG?,\YY!K=1,#.M&1K N3*.1UQ:1[\ MX^I'O T4"!OB4T2*/%XD%#B!ZMH.2!&Y+[\BLI..[N6 MG;:+J3=[-7S725V*$K1MIV&CD7RDW$Q%KZMO0MIL"3J=J+\1D6#*$%VG<#QI M6,$PXSD\\"JXH*B5O9'5)6\QMG:HG]RU@]GU>J=\%E=6LW0@&M9'&[@$;* I MMX&^+8FOBO6"T=1IG6"JQ/GEML,&Z>"7PDW9SX.I@A[OE"':J/3BX[Q MB'!%:3>NV"WNH*LQ5QRH26Z_$UOK:MX*,<(=)D=R/,(-99!>ZO&XNET M&OIZ/9*<^;%YF^HEBP%LEU3>G0'F98#[])H59)VTA-] '51(SR/A ^>;,XH' M>=F:NK.T'! \\/@\E"5-T=!7"_[YC&6M(-MBTWDZ(FQTHOX"U(_5V*$0@U<% M+"*O5&%LZ O=*^CE158\7H$BRJM<01)@<(581@77DE!1)DKTJ(2&VTP-69_+ M&G96E2*=59T5W+GW(JY>B-5(:Z'"/AW+D>=SW="QBD%^L5;&3)Y0QTDLB3;@ MH1?J+P"*"V+51DE%@A1M%6CD0EFHWDD_!79PAS%_ .KC6N0UU0!]+5?8UR5 M75TL&QD.(X3U4ZC(_:OV75^L%M+Z]5[)NQ=$#_9J66L9D5"@OJ#2AFSB71]X]X&U[2462A76[7H(1IA+Y,, [0*FN+P.XQ.OY %=$@E!0>_1+ M^0C)B-)Y](WO)/ 2O%90J#-<:JMX;YY J? :VK?S6^]4GRCF$2HQ%-R3>=(*4P#6(184ETM>$!0H)5Z:K&P3 GD(5MX[KMS"#W[#BEE\L08^# M?.]5[6^#88[C.Y5P9!*UK>.[^S'(6QD$+-!368A$ZTX; QC&&N6^O1A*W-_EQA93H73)H88"^2+U %1:O)M\HC0M5S MCU"]/M:WDQ0&3NR$Y"UU+O#[6JRXK!;OL]D"%#&>O:MC9Q,J$)D^P97?@^0W M0+0SRB^4UFPH_ :'89<6[VLH1^_9TO4K6C;RNR9L"C<2AS\!9I7 D.!7*0&+ MB.#'R5R\!.Y1LV!$U>PMCA[PK=DAIV!&ZYG-Y/!X?JIQ M;A?03H#N1,FHC"6C57HKCEG[SE$INCF%)^+@(K@++]?O7O+Y"-C6@G^6,'<' MM!<&R+#$K )[Q2)68*FK!GI+#=KM//Z:2#;^VO7XR$>J$4EZ14#H-/-K4@GY M1+U12G&VG)2ZSY]R<1=^<:JV/N*'X&B;4)EJ=4U?BQ:EQLUS*@^3*LO5$;FF M4VR%M738!]G[*5<:#\^=7&?R!'-V LDUE#KS0D$<_(XQ^R@G#*F-R_F!G2$V MD('E(7:N,:]>@F!D&V<7_\08!?7A^=O$_ODB%.ODGZ""FW&N:.,P\36':B\ M;#E^K@&$]3Q^)\'I(*?.O8SB95GDDS#7-[K@-]T!K1B586J!BCWH;%#YBE%5 M/#.LE+2R1"4&.[27+Q7!$-B? =9C >IOFILQMC'LGEVTS_M))I1K98)#]_CA MT,,83TSAEIR9Q'ZJ4C@E+XM#W7":I6SH\R,EKU@C@YR7 41J.FSZ8;:R,1DB M%HDBLS^C2#3)QJTY0+&-IA+"D?[917=3D^8'X:VPZ\Z3?51YM@R $'9F1HLE M4//F\-$JQXA$=>?1'O!_]V&?@SL-SBZ40?^\D]3-[CZ(272I M%Z\6YM]@\%/?&&H?R4I8I#B5THGC#%5X8;7_%H-$=8Z:"* M-8>A%]K+BD5@D;=:<<-8$\$?!]@-)-K_P.WC]B(2&FWW(P;1).C]29K9#:\M M[#W,MU;08X@9Q1F;]$O4=YNW0??"+YI8(-C&>TD9@/+?-1-K5OB%*J*/'[6_ M P,XFE&N.\'>]0=P_^5IJE7NA:MGR3[$';#HR#R'*86"V:7# ?R,,4M&78]G M%SQ@R#V*O_F**__=BVO]M1PWXS& PW,M<0#P^"0P#OXK^9-^(&!XU0W\]"*& MRW]A43B5!)C]VOL^:^AU?HJ%2VQ]<*!QO"=/9#$&\!@43G70"RJ6]'\WK/[M$$T?D+S^"HVB>:CB'#8N*O4PF.$$3\ M"K5?;,M)G4L! K"?4)B6ST7^1AS2PU81WMT-7:48&!.@2"_M7:!K!@)-:]J7 M0Q0-V+6/A@/*F/3\\-E4<.,_+(FP)@+RP?WBZ\AZTHO!,XGD/P+X3O>P)\!?IR1MYX23.:#-Y/ M(,P,*\:)=Y5POF$U'H7/O.W""FY\9,YR=GZXX(-R@9:56-R7U/_WGS2 M9S,&C_!_FXA_3:6CG%TT1<_-;"&;K/M^PS!33S#+#;-VN3#;B].R2 C0RQKA MFVT'DTH.*J:&:C$5K1H_9[XP7[>A#'J-=G_?)FJF@J-TJ+>+6$O=F@>3RG)O M=HH IU=SX,1'VFJ/J&H!U^BPH&MT;X&RUOEP]]C(OC76NH;*-E*3LXN002U" M9;T&F&J-5E>IK9EYP-J-K,PWJ]]T[Z&R.E<6:R$<3)-N@ M\HR2 %-ZCR%*UNYV=U4B#Y0J)I8E$FD3@H%H936M4X47.6V[4:G8[:: VCD[VV79FZ M&]57<..1F$FARR[-9UMFMT$?:88UCY65Y?PM$F55E&HJ6*N.)$H)SN0?A>)R ML->L%H=231YJF7',GMK;;@060H'#M=@IVK-XAR8F^YDJOG6F>.$IX7\-$O_V MR> TKEEN=2/72![[U_>)V?R]X7QP=#PR*"4_G:_;?%1_+PL35:H17^[)=L, MQZ@QF0\#<):&[J+_3DRC%K-5V^?!SCG>;@)CR->X6#G:1;$]YI/@*/30D/** MMA>=AOY?S:;\66?&[(-\!^SC([SMSQ4SIW UZO"C3*V[8'VYV11?)&;M[]C; M)E^\"2@(#ZO(&L0G'L/HX6?;K)YB$]"#)_5:70?WTXK9#F'=YV;P^-[!/\H/ MKTLX\\C6)OKTHWP#G)L#Y\9",*C]X+=^]KY&$*)[7]]F/*PF-M/^:$YHV-D' M,&P0ZL']]F+VBS -0J?PF8,(&KO1X-GPT.N;KQHW$SA$+[AM?]I#E5OR )K< M'VUR,;ZYN?U]]##^_5J^&_WSZ_7-@W1_^^6WA_'MS7U#'M]< BN:U&"G0:#2 M-UTZRP=YM5R"L@!RCTYT<_MP?2\]W,H/OU[+EW",VR_CJ]'#]97\>7PS MNKD1<^9<3M2I2&IG(,8-T9XNV1.(1DH2]W&Z6;H, M!A10NJ%K378O;R5:_Y7W#[>7__WK[9>KZV_W9'?U/\K7__/;^.&?TCN_J=S[ MS64EDM:^L Z*R9I,-JP'E@40*&7CZ:X[4AL3^JBT,W5;P:>V(L+L/'+)\6\; M=G[**2'\-?P)22FH%;%*RD2NW;!G"PYMZ2_KEJ9]I=W*,P3)[X,0''*,V0[!Z>N:&].Q%/9\\):E^3AR MA?LHI6EJF2B9N:EJN71P;$U7 VTMX^1;I;'#ZD' MK%0-)M?JN*%^N-(HT ]7^N;-,N:_TDQ1;>JN-(-_@,-D,'F1!IO\>. )M566 M?AB:R,OPCO"XITO?-V>H..DGT,ZU/!#])8-[05&K[I L4@^V[R1C*]L2GZK\ M[%M*@;O%4I24//4]F4R:J$'#&>KM/*!@B.!O:N(2UGUV&[V.FEJ95W\,2'&O MJ,/>CB/="EY)]"HVDAU\IA=@=SC_30TX1%2E6R:"=\Z57J*OHU8WO=F>6=ST MGG>QTUYKSY?R]-K:D2\%E+RWR)?> K;6D8=&T:8(#VUWZL=#RZQHV9<.6K'> M255"Q:V>K)5<^^;._8+<.4]Q[7ZU1K77:_1Z<5VU]W=[J=QJ<,P:7W=SJM^. MW*HSR,*M*KJG'=[ZUN@Y3_'R?K6M&M#S'O&DCIRC'#VGOQD\WSOGJ,CM]B84 M'#$LY.TI.,5ZG"M*GH:%^U5PNHD='6JAX+1;K6-6< ;]5 MDWI3!WK.T^!GO^I-#>BY+OK-@3A'.?I-?W!HSG'RV6RL+/JG[5!@D+EH;(]!J# ;#4OGI ?$@E6$><\9W>UAJQG?9JM;AKKP$R7OB M5Q%^5=\<\#?%KXX3>>O(9$O12CM*J2GA>]=*4[QN>S-Q4E&K0ZC%V]7F1\S@ MMP_)5@MW)5?KF[R=VJN\(M9:-39LZZYTM,I@1RW5[]8^'W;VI@R&+WU/=O,Q ML9.L7;C5E,SQO6%KZ"N?V*-N(NI^T@R<\J3LTJK[2'E.W270'K-KS@)=&)&Q9E12I;GWE3\T%>R,I].N;&$D\)3B6'6+34= A2>;F'#+'GP M0VTZ0A8;#5%NJ\;3Z(C^,8V.J#$V5]^&-[BC_)UEG[1G)L,+=&!?NND YWW& M 1,X??[9H*1M;9&TES\O%\&J;OL,&]\'*TYV>:0W= M/8:>HE#E8OU_FURPK8W="TX.('9M<6SVM4!9#A]+.'L:J-=UO.>\;2!QX^\D MA$67^=1,5,MX$%6#; SIK/08'"G]AB:5BOC/&)[, JG97AI7THKM/LK:$URUM74-%PSLK_ZK-D-71]IDYM5:H7>,+%OP35"G@*):W#+7Q MQO:)N ;?A S*AOV8! 4C$R '#>,#BJ6B](Y?AG[QTZ@ 5ENSY'B66\RH^H)#+Z/JCE M*S2D_!>7?,7Y 'U$ @"O?J%]UQ>KA6R21Q$Y ]#A2D!<>]9T@_22,( !5T($ MGN#GZ@^*JZ'7WY&MD;SA5O/8<59LEN;>##$%%9NK-'J]?N(L5_PO_R:>&ACG M @Y "W(>%P,9[VDI^+103I'1Z[A[XE3P^E<93$7 M_BECLPS@5-O]PX&SC<[C^-8,J9 \46)65>P6E!;$,[1C0$XIV[0Q54G0QH0F M1D\44,%D4UMMY<1#LDMSG^@S:'-!]PXQ[1)5.VE#M9-/JMT1J'9! M[,FDD P/IY!T02%I]'MI*MY))=D%@R@V)871(BBR4'_5?''%Q[F!//H@O]/? M@V)K-O\$804TS68B@"(\EV0&*[W>O@XYE/"H8_$;MX]PULMV*O-_]2DZ"L_@E,CI$CQ*0MLJ;U+@1R+ MP,@5[J%7&P'10\K:,P.!XK%YO!R=B#\+S^FT:A':X DXF;E5+[FS'3\T:$1- M,@L3R*+!55U]L6 S4G1!MP-M]9&44'2@"K(4HW(=^?))TU%])/!>/NELCO/- MIBMZ]2W7Q'% (SSA"^FE+;3<]."2V@FU]% SW0$IAH%0=RC&O3V/) 3-OM<= M(!:42Z1P_!;JOJ &P=?!ND"[R:00H@]"]AUQ@$D9#JSF1SHZ\&@!Y.'>SL?> MHM=\S6RQL,'9Q4!M-P;=:*\1?E0,5"-I$>8P$_T/F^$QM4:LK=;R#IC6/5NZ M''A*.\BY/)'G*Z8>L0KB# T]A3O)Q,<*1*8)I00O"N3\W L2R53>*?^=PFX )P+56M_0]4IQ'+]/SKBKTZ&;+X0-!1L0:=N MY\+\]TRL>+OLZ1Z"$??4LPM@I\-^TF%/?+@\/GQ%[G(R/,!8M4$9DN>ZJ9E@ M!7#/>9@G3]%#9A@ \026(J?G!_4.Q4S:P$Q M@^5"$[)[U*W7$ !+F?'G;.+ MOH+\KQ?=,IAI3[^.DE"\T#*%(CM;,4]7A8>?=6M%_ !0A'N@D(2$WY!^ MG6]XB3WO,3JBG WM6'YA-A/1%,[C.(N93BU[1BY4DEZ(-[B&@^XHZX7-I+7O M8^D%).E5:"8R "P3^,5F0?*M&_%&,PO_-M.?+Z2__8S_\)^]7ZK?.FXHM.1_ M-9OR9YT9LP_RG?;(/L)[_UPQ .L'N=WZ*%-R&.Q$;C;%%RD-R-^[MV&^C:9K M+7$<'1K*XA,OA9L;S^&T[D\QTY0+@" ZH=-?G?;3BMD.Y2-];@:/[QW\H_SP MNH0SCVQMHD\_RC= I1PX-Q:"01T$O_6S]S6"$-WW^E[C836QF?9' M$M2#^^W%[!=A&H1.X3-[^)FXT>#9\-#KF]\92U.WEC!I->Q/V<3>_6TE+9MP M?]!?D;?=$'W M=%!T?9!72U 6IYK#SWES^W!]+SW7__WK M[9>KZV_WPK$E7__/;^.'?\KOO&CM[/VV%,^0+'SC*)&)FXD2#CI41D M^?DBZ4_A5QEL'EMPMS5'N-STX#0\D@B1*L*BW @37V^$JK;(PKC^H64X-R:H*I34SZ9W[&Q6SD9BF>6CN/G1%F-\!Q'_!N L># MU_(#*FD ?_)^RE6QP=EZ5(#'J;G!.LNT)T4MYPM5 MD.(2QNRC+,Z^MA70H(JO!H&#(-Z1QS*^U#9BD\4N&7<&[K#XV\3^^4*F^+3Q M"KOBOPN._M>*< [/CU,%XO!%?&:8.STYJ MSC!!3^N.D:$Y1DH6@VMEB(6VE581N+3SS!(X!%P4]7S+S+BC0_X< M;"KS->9I(5^(256!WH6OK\Q>XK_P3 YO+UE;-Z;A5.Y+5PH.1FKG:72=_=H) M),[8Y"G[O]B6LV5*0$(J1!IQWD#:*6H@8:HAB +-V 0+XL M?# YOX+\H@XG=*/D\ /MCKW]HDV.4@V,R3SS)\/$*R3BV)WYM4Q MJ);O4BIJJ_O9LN<,V/?LYTLOUZ-J) A$4K'.J:E_;S[ILQF#1_B_3;S0IM+I MGUTTA8.V)OB;>>N#X]WZL.#62]0@O!"L\ZIMM;C"'=R.S1R,KS/.]*>^M M8.>>A%M)<'QDW?<;AIER@EENF*GEPJQ:_]H6GYH7P^$;:@=#/(=5=#H%;9,\ MO6^K\YMU._&9E=5*NHA+H&RS)%="N'\E*6UCZ^'L239R,CK!>H7@4HV+]T!. ML -@<@X&DOE.JG'8ENG1ZD3K9@ZFA.[+C959-+>/UJ; KA3'NO7N 6=7*^7DU*K2V= [.6ARPRS9*7Z"61+,DKWQQ^#4BN:V=?!BXCQ= M?K;RMG-VBEQM)V%Z2^Z;37I1-N-W6%#AS#.[L$+OF8J=:M2M@<%5RV4G]4I&# ^'I>=6BB0WJG&NWP@E]V/0CXY6&5F1*C&IUVJ MGS#:)*$4!-@^(NLPM3WE5]]4.-_JT&62^6LA_YJK!C)F4M:@BDE94EF3LC9J M+?Y8G)O4P6/N.8QI@HL>_WC=I="/KLW2[6:TBJ_7$T(53F@PD1JTG8M MX#N"XP=4^9*.G]63DHZ0!0ZZ]K?R[ 5I77H,Z M"M:@^A-]^:^!N;[\ T.?TR +,67A!#$Y7 7](Q-3^4SR&"!P0HVCX#)[*7?/ M5]*I]N)K.KD7-/8K>RY&+;]P7E7SA3"R..(*3K?GK.MV'M !A+J7M7/IH'MV M03&-[;'VH[N_>%^"VHX=UH1T&GM7DY+N*GI'&XY4GZ,$>,D#LQ=J^,)P7L+Y MH!>UQ(_UMK9LIO;[/SIN$5!R\G*+_AOD%F\$_^K%[:(X5HS;#4KF=OM*"-VC5N^&K;.+_OFP MLXWA_6AWGN,8;Q@*1\<"BZN:0YRATV@/!HW!<'OWC1\-$4[D4%M!4)+F.U1) M$&S5?&N8 UU^]MX.-%"_U,&ZIEK76B,>MM]6^G7I2)"<.'7,VG"'F*"2EPG6 M[[YKER]\R,L/?>43>]1-Q(1/FH$%G#EG+0Z[5:84'S=/.![!L(.=T$/!T&D- M,G6UJ3\2_$B,8JNJ'/I*7L9 H[ [W3> $V]<62C+8AJ0LM"N1%FH2VU)32;1 M)J66/VG/C,87PSWII@,H]HPC++&_SN[:/?[C4$W9K PWFGI(\'+V+2**IG:;C=Z@ZBMSC$B.!;< M29@+OL;:!HY#7C(LBV/&ZWF&^;Y[FNE;;%I=D@1N;50Y(0_YUQ?+<6Y-D'SD MH@/A\_#W;ZY-#?S/OG(O2.F9KAOA(GTYPGV6&N M:U!["61?F\RM@OS),D=/%=#X2<\20 !5"T!P[T/@=KZA>F73I=MG%\-&N[7= MOWW\L[X*6"L5 !RT7K73;[1Z)BWH74C:HD'B4-TOMS!$A^;4YMI#@.63?^.3;*![K17U"N^,0/./+O3 MX*0)W68CV ):7@^X:XQYGG;,NC01W<$_4#XH>V<7@W:OT5$Z.\*R3O(RNM// MFFZOO:(OFDVCJF3=<8QF\0FBRGVZ:1:-1IE;M=8= +1T5 R1R\1>[4 MG?]#7.&8;O#!VI ZO_+;NS6OO;N[G7\5-W>E995*6'@#**G$.-3V1QP5B:(P M10"P]&<-/7VRH6L3W4 ,UVS=P?@"7!\:P7 /YLQ3*_$#;^ZT&.$=HVPZY$PD M"WIE&$T WA-S91=PY!%L%T0+>%K3S3P461>:ZR7/EWJC-'?E(\D7#T=&'$5N MS8M99/"4:U;][Y,EIB7V?/F'H M=H:7%R&=AFPRGS1CZ7D=%=PRH*"X@H+^I/4<@=_@CQ9 ^3]L=J4[4X"I>V>S MA;Y:C,P9/0K4CNE'EY;C.C?,#:*% _ !$DS##Y!ZG7:CUXHBQ_M-[#B^-.O, M?.@TLZU2!BB8'RG:UQX%?K;L2TY_GB*2B:,I(#.&:JO1'N9/IZT\Q[P416-; M8LY;R^LJZJ^*CPMF0R(@^'Z[T>V]A93LZF^H*-WOJ MU*C=PU$EQR/+B4-F"N_];0)(X7G&I:R>:;-9!WP'UD _FM M*7UF$WNEV:]RIR$R2% 7Q61%S7P-7@&W"8,Y;!.>A]Z0=7-JK.@CIMG&:_#. MEB+0 =^U&??&;,EO4WL%B7_MT!8X)+IS9R/_=K(WNX&[UH*X)Y%Q2]%E-'L_ M,<.P]=DC(R4?(.TX8%];4\9F3D4G]F/M<+(OZ%;$.WX K<;A2_R"F[@3>QC# MQ@%AS$?1+SNKIU'I\/RD;J.M1,%238;<#T%T7E-KGKV5G^3(9'R)^EN<-4XJ M@U9+OM*U1PMH0;YW;0:6YA?&7_/ERV6 :B78=!F$V]_)26XMV(/V_?J[MM!- M$H>;__5;,J?=6;, M/LAWVB-H5O?LSQ4#C/@@MY6/,MD]/&2H![<;R]FOPC3('0*GSF0&QF_T>#9 M\-#KF]\YL7-+TF' WW319T!.?4'>;5<,AO$#S\G M95=*#[?RPZ_7F'8)AQQ?C1ZNK^3/XYO1S>5X]$6^?X /$ 3WU5S=SKG%J7CG M(5W"KD\9O8?)Z)7>^8FI[].S>_E]E8MD_60LBS%ZMW,V,&D]/(N8JA50B=K? MY GQVV\.:7]Q2?>1W-,BV?6'.4X./X-0*J5M:3UQ*3TU\SGD8W(UVFN:B>1G MRRJ=."N)[FPF+*3(G<7;1F 5?=7LZ9,W3 A>C*%N+WS]M)%%@DP?:4 S)#_4 M'9P&@[9^JD4$AO,.ACT6$WUCRQ5L&,M'1^;L&W-UF\VNX*SF(Q\=?"_*>3.5 M@"M*[PST8;71B7%RR/QYCO&+A867!#O@4%]8,WT.X%K,AS:?LQ0 M#KE#CMMU: <\KWZTP(!G-DNSGYC1)@>+MI)JML[E>A+EFV @8U-"^"^!1FRZ M!=A.@'NX+YC\DLY#=,QL,1%7V&KYK M^##&X]7"2>1TN/O.Y='/D,R7AO1V6@;KELR M!6!)6IDFD].D-0#>FK%M[& M"+T)G#?6L^#"/6\-($].^GR_3N!K3G@'NCE= MV;B%I>?)P>N9/DFZ2(GD4(!+,J?ZT@A[NORW1_FX+G*;'N%DC[AOC:BVDMII MCUFL4VJH'G9L,D!8W-/890MGY&WE$KC>*SI:<_"107(Z9WU51>"!?/=2!/P#L,/I]) M@=6V<.6U'. :4^K"H >A*C77GUF35 F!G_@M3S$,,W1QD^E^^D'-M%+LX4P= MG*/-&Z0M66_JL%YG45MG%VT\2>QI0-2Q)DTV?<\O*E[GQCF3&)*)I.IND6[M M7(/"P\ 0*5&A#%"OE>V?_7LHG6N1-LA16YO M"11*+S@GY7(>RLXFY65M.+Z +@:'0\U)-U$KV]9&H]U6=PFG8<"7S)H7$^N[ M??4EDTJBMI.3Z/G1X]C*;(?=SZ3I9"?,, M:=V$<^*!9;]J0O["7)QK/O)L;/E%=Y]"('V'O_S?_S-05;2F@U^F#Y6/[U&5 MPY1Z5.LD,I"Y,LM+ GV-\0FT OQ\ZK=^6!/H^BK0VP:;74VQXL"V%ENE3*>X MS W?0" TL.Y.4: ?H:)V"RL0W?H=II=5FP#DVG:\4)Y8NQ;'Z^/QVC'-([=? M5BA=J%.+TPSP-)A$E$GYD^@5/(:P-L(\5S9Q#*3,+#99>U>;C-=41@T7^N,] M[CN[#9-BC\E;[+'VKO98B>=HEV*+K; UI_%*677 9?W:5-DK(O&\F3SO+LME M=W8(6I0.)#X]I-5IM#O1DJQMU]U1:G02L-O:PP9<>Z/3SD# _!41?W9(I5W: MUK-.GFU.RQ9U0.0^F+5?G<[IB)3V V7"*/4>-*FQ<\#YZ 7B0!Y, MF*H),H(*0U?LF^8R L M"[1X>PS.&E'+LUSI3B6?D:K@0,WP)?;T IK [V7P%K2[5/+;:36Z@RB?;02] M'I/7;5X"Z>0EV+??7(>=>(7)%J9[K\,@X8[%Q,!T.\K;\A@RN.^1+MSVT'K9WJT!\6%2?U,#U"<\Y@>XN(V=!?=CM%.-E-K M0O'_;0))RB.0=K!A2A5(H.S0\.5^M(XSIS0Z^:SW$X6G>Y;VWC1#&>P08RD7 M996TMA@GS_CA/>.&8X62N(2YA\_!ZJIO;&"*=]W_CZRU]5WL*Y^H,;Z M8#BN8#P!36C="5M+(4&5-1^T^%'7V767M%:VTV'7T5XG]G0-V:#4$A$:EH*A MX03!.P_CTUH/WW[L'1QOY7*R3B(G:W#&/(NU> O$C_^F*\.OC-")F/"+S-FSW7#$%P:8_YEAN1G57^]:!CQBB08T6A:O:4OI$UQ4YAJVPY.&HNMI/-BZ M[CTS6;FH'H,^M2"L$4G!Y)PDU[)0KV(W3[^3_U)#^2$N!70PFY=F9(GK=0OD M7Y+J^54L]BW8Y;:I!K2L)0CEL)K5/;N(B7+]A*?6Y#DPI+WL_#,LE&?76( 6 M'3[Z4X-?6KB^#&YEYMT=;DC2*1''(S>=\F):O).%I+[D. M1N/I/*F2%0*@1+6CML)//+'*QMF-COP.S$L&?"#H_7!@=P;@."C)6$KGO(^# M60A>W$W"-PCD@9-SB)H. [-OF"D_!>."-GR+<8;1#)D:.2FS0@]K96*@AZ0M MI#>ON4/^@(JJH'!D=8_,1 &#TAT!9W*H1&$$$MVV7Y&Q HO6Q RA)%CRAP$X M8*K-)$S^LE:$G[HM^)-ELJ:K!U@6WI4UGSM/%F@2_I4CO8HHBDV)=EA/9,_( M@L38\!.CR S\YY54$)LM-=?6L7=\8WT@>KM$+!K)A^,! YX:P"UG-?DWW ]M M7N"6O@"&Z"+/Y8B'^ SXI2\6;(9+K/'*">$D%B?H?JHQ:DF.R[09SSSUOD%5 M9S.VM %;^!8]\K6>\40 &UZ'2R*&$BW@"W ^!I(/?EF@^\7#^^!.2&4#H&$Q MQ[NU& B(#>J>9"_A WEFKQXEA G_!O]R^$GQZK4M#KR&4;TP/HR;MG4\)P@% M.@&\9D6!>LS,>]&1.N%"/>3W],/Y"I]Z?^[5T[F()%Y030H)J'7N0(* X@(< MP8:\ &X-\#]80\V\/: 6KRQSEX[*^6VK3-T5RK)7Y"W%TO$\D_K[J2>NCO%='<"47KJ M[G3XKD*1EF:UW./>.S<5Y O'U:-I'VW"^N$NYJ>&38?V3BC58&R,TV4@6B%BJW_+*&./:N>:8DV.&&)7(!DZT&ORY7>+L\PD61 M6[ ?N1&RCOXMP,2S9N> "C-NZ:4\A7DL^XYH)I M>%OBW&3KQ+O8N<5+K]%>G'-Y1$G8@= ?F>'4^%9W>%+V3"2'A,/@/E "T$#S MK.$?6M*>-=T@0<'P+=2_&C>+GD,TZZ;"=3A!PPP0X#\,KF3LXL*!? _K+ $ M57GZ2L:T 0L"FLB^FPH/M&Y]0O;=.CB K9 B#BTXT/H+XD, !P%[LX&0Z@U] M5QJ\2:_\I('9.<$;-*WUNT/O]%NR^+N1ZA6J2&(O^]E4L7G9B!.6B1Z0VWF@ MD3'=WB=FLKGNYIM"'QVDG7N)0."6IEYE#YSY-0]$7T&4/=B([4K0:UDGG9YYM4X/YV9E'L:G>GO+^-WY^VW%,%\\,G791Z)0(J0I8 M3"PJGUV0^5V;8:6=V@TKS;SU;L&M'X2!)0CPSSQT>OP3%C/?6N\TE3(WS/KE MPJQ"7I<,_+W?5+8)@N5=TN"X$7O?X$J>3+]WG-[.U&.LA2OA!JRAAEZKS>Q/ ML=JP"_+!((+^NR!W?U\CX,O==?+ Z-HI5#53H_OJT:K1_?8!;CT/89]T9_^J MDHVUHU Q#@*S9"NQAGK&6YR2GOFFLEN&;W5<>69093<(RQH:7L_X6FW#M5GJ M$W:-U^9?(Q"P58?]K ';D62'WNE%9K$$@%^*T+QE3.Y>N=A"() P(K*[@TGK M_M]T'-LD0KS.@0.\D=E[J:/W#HB4"1O-%''>"2^/+.0H&T^U"F-@N=5)D\7:W/F]U2K%Z]AOG!Z#J:U>:IOH8#J/ MB",[X"LX7$0TO5'4#@U[U\P\Q,@34HI&KI#7]QY\0L(@V($%2Z5!%TUKQ8*- MG!NJVFT,8KKDY0K'OJ_[#>TP:?. -]3%3G4-I3=L=(?19G5%;J@"ST]T+?+O MD9(HJ-MOR1:L#.1:9<6^M'W3+1U]9,Z^6 !2_YEP+ZP,]XY=M_NM1K<7G?FW MW=/W_J P+9_22H(I]O]605@-ME-2)>2S75I&E[UC #S,,@TFXE?M?MXOQ0A7 M<(A+7HG#NGK&KF+=]ME%7U$;PVZT>T1=O/K[)9IRP-I!#4$9=AJ=3G2,\<%C M#IL+)EHW=_ZL[UO6$531D"O.D[$UO#IH]&-FVQ9V^4=T MT3=VD>7SBA(NLH>S5-1^O_1KK$;B[H?E5T:0U!XGP0!);3Z4[3+[9Q=#$*9* M/SK>\0UKGQ4#=< 'Z:C [ ZD@.XJ1:^22DKC*C&/G@GO69A>4K.AL>D!&1X8 M48'J[QYL1QYHLZENP^Q$_,-E(.Q7O)9]M5BOF9V5G%(EZA7_SYYKW/FQ$R6R M9QEG %0=TB2.)DI=.'4BPN'0:[?N_+!KUD2NUP<2)MK#8=:$B7O=;S K3?T2 M;R]M8K.[0UJ3#9S\69?\B+IB6::\AZ)(=60I#T<7PC_E,:0"H0;U\WGB\V<7 M9/\>/HZ;WGAXERDF&VR$SIM-X09FHG:41F>X/;IP'/7=:3#N' ;&:@4PWDNT M^U);ZMCT%V,)AXPAE4D;XDQ?X$B7@0[6V48Z85, N,:&VM^>57*@8%QS?[&K M(F'?FYANXF\%M6Z]R4_/-QQP&R35H<8K#LO&D4RN)(:0B[E1*=&J..3! MN]6H#;C--"?#;.WZ)\5@KY>DI!B.U8@,U$,>=FGKQJNLN:ZM3U8\E(3UT#@W MS;.Z)3'HC::%!=R -)]-H^;P\FQE>UW]@R/H3AW5L[.WD2.E\RD^^&R)::SB M','WIDLR0 GWR69,')TNQ^%OL=D"Q]C!=?-FY^R[YL_1F[R&ZA4M5-6PZLEF MCSCN%RL7M4<&J,SXA+OEREY:WEP$(+,53IFC"06 4-X?3TA1%"F\J0<"%42@ M7G[29O)ZHD.X8?WZ2K3ETK:^ \6[P#WSR+-FMRKWW15L$L Q]=E:+XVMM<\N MU-[Y((&G+73#$.,#/73=+O/V=,Y0;5>VPV)-RO \.N4S=%@)1Z(2029-\)2] M+7@#C1?:*T[U6*,+<'L4TNX"4W^TY)DZ.%LYI#\&%$='IZD[-/]F@1-K#?T/9*(N#E7%F3DT_33I MVX1-^)0_30?IZWQS/&?(%A2#I++,Q&R?9F+&S<143C,Q=])@:C+]LO!N3G,N MJYASF3D)./' =0^S:T,VR,__-S*)-Q8A@58'!(6$T3B/HYE'&42?&)SBS/. MEZS/R,B'F-QS3Q=T+8EKBTPX0=@S3FN7O<9^<;:/KRYZ-L\,-X2>P7D#S6)G MI8&&".KI^-LE'(SKY.V!^G-[T/:4SS&R;Q,6^,:>&=R]=&G-R$FH# >]!OJ6 M0>_ !E_PLRP'BY^B0(1#0+H1:'@'7_KTS MFYI#C=PO. K0\[* [N^L)O^&"Q >4D%KIM]KDNR2RQ$WR<_Y1YXO(N"1L1E< MF.F0HT9M*4,^*G0.B(8>[K4SCDQ/WQ=W+MU8<6^AV:K^0%&.*<&O)0S.;'N# M,]6P+\E'3IJCB9^L3+3+'DWR\\+*TD3DD#2X1UAP10?WN[" 9:+_"

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end XML 114 ea0203998-10ka1_innova_htm.xml IDEA: XBRL DOCUMENT 0001591913 2023-01-01 2023-12-31 0001591913 2023-06-30 0001591913 2024-04-16 0001591913 2023-12-31 0001591913 2022-12-31 0001591913 2022-01-01 2022-12-31 0001591913 us-gaap:PreferredStockMember 2021-12-31 0001591913 us-gaap:CommonStockMember 2021-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001591913 us-gaap:RetainedEarningsMember 2021-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2021-12-31 0001591913 2021-12-31 0001591913 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-12-31 0001591913 us-gaap:PreferredStockMember 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-12-31 0001591913 us-gaap:PreferredStockMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001591913 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-12-31 0001591913 us-gaap:PreferredStockMember 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001591913 us-gaap:RetainedEarningsMember 2023-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-12-31 0001591913 ipsi:InnovativePaymentSolutionsIncMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-12-31 0001591913 ipsi:QpagosCorporationsCapitalStockMember us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001591913 ipsi:QpagosCorporationsCapitalStockMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001591913 2019-11-01 2019-11-01 0001591913 srt:MaximumMember 2019-11-01 0001591913 srt:MinimumMember 2019-11-01 0001591913 ipsi:ViviHoldingsIncMember 2019-12-31 2019-12-31 0001591913 ipsi:StockPurchaseAgreementMember 2019-12-31 2019-12-31 0001591913 2019-12-31 0001591913 ipsi:GastonPereiraMember 2019-12-31 0001591913 ipsi:AndreyNovikovMember 2019-12-31 0001591913 ipsi:JosephAbramsMember 2019-12-31 0001591913 ipsi:ThreeTranchesMember 2023-01-01 2023-12-31 0001591913 ipsi:TrancheMember 2023-06-21 2023-06-21 0001591913 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-08-04 2023-08-04 0001591913 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-09-01 2023-09-01 0001591913 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-09-01 2023-09-01 0001591913 ipsi:IPEXWarrantMember 2023-01-01 2023-12-31 0001591913 ipsi:TrancheMember 2023-01-01 2023-12-31 0001591913 ipsi:SecondTrancheMember 2023-01-01 2023-12-31 0001591913 ipsi:ThirdTrancheMember 2023-01-01 2023-12-31 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-06-21 2021-06-21 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2023-12-31 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2023-01-01 2023-12-31 0001591913 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-12-31 0001591913 ipsi:BeyondFintechMember 2021-08-26 0001591913 2021-08-01 2021-08-26 0001591913 ipsi:BeyondFintechMember 2022-12-30 2022-12-30 0001591913 2022-12-30 2022-12-30 0001591913 2023-05-12 2023-05-12 0001591913 ipsi:BeyondFintechIncMember 2023-12-31 0001591913 ipsi:LongTermInvestmentMember 2023-12-31 0001591913 ipsi:KiosksMember 2023-12-31 0001591913 us-gaap:ComputerEquipmentMember 2023-12-31 0001591913 us-gaap:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001591913 us-gaap:OfficeEquipmentMember 2023-12-31 0001591913 ipsi:OwnershipMember 2023-05-12 0001591913 2023-05-12 0001591913 ipsi:BeyondFintechMember 2023-05-12 0001591913 ipsi:FrictionlessAndBeyondFintechMember 2023-05-12 0001591913 ipsi:FrictionlessAndBeyondFintechMember 2023-05-12 2023-05-12 0001591913 ipsi:NovationMember 2023-09-05 0001591913 ipsi:NovationMember 2023-09-05 2023-09-05 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2023-01-01 2023-12-31 0001591913 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-12-31 0001591913 ipsi:BeyondFintechIncMember 2021-08-26 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-08-26 0001591913 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001591913 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-09-30 0001591913 2021-01-01 2021-12-31 0001591913 2023-01-01 2023-09-30 0001591913 ipsi:IPSIPayExpressMember 2023-01-01 2023-12-31 0001591913 ipsi:IPSIPayExpressMember 2023-12-31 0001591913 ipsi:InvestmentInFrictionlessFinancialTechnologiesIncMember 2023-05-12 0001591913 2023-01-01 2023-01-01 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2023-01-01 2023-12-31 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2022-01-01 2022-12-31 0001591913 ipsi:CavalryFundILPMember 2021-02-10 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-10 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-16 0001591913 us-gaap:WarrantMember 2021-02-16 0001591913 2021-02-16 0001591913 ipsi:AmendmentTransactionMember 2022-12-31 0001591913 ipsi:AmendmentTransactionMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 us-gaap:ConvertibleDebtMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2023-01-01 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2022-12-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-31 0001591913 ipsi:NotePayableMember 2023-12-31 0001591913 ipsi:NotePayableMember 2023-01-01 2023-12-31 0001591913 ipsi:NotePayableMember 2022-12-31 0001591913 2022-02-03 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 0001591913 us-gaap:WarrantMember 2022-02-03 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 2022-02-03 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2022-12-31 0001591913 us-gaap:WarrantMember ipsi:CavalryAndMercerMember 2022-12-31 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2022-12-31 0001591913 srt:MinimumMember 2022-12-31 0001591913 ipsi:CavalryAndMercerMember 2022-12-31 0001591913 us-gaap:WarrantMember us-gaap:CommonStockMember 2022-12-31 0001591913 2021-02-16 2021-02-16 0001591913 us-gaap:WarrantMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2022-12-30 2022-12-30 0001591913 2022-12-01 2022-12-28 0001591913 ipsi:CavalryAndMercerMember 2022-12-01 2022-12-28 0001591913 us-gaap:WarrantMember 2022-12-01 2022-12-28 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2023-12-31 0001591913 srt:MinimumMember 2023-12-31 0001591913 ipsi:CavalryAndMercerMember 2023-12-31 0001591913 srt:MinimumMember ipsi:CavalryMercerNoteMember 2023-12-31 0001591913 ipsi:CavalryMercerNoteMember 2023-01-01 2023-12-31 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2023-08-24 2023-08-24 0001591913 ipsi:CavalryFundLLPMember 2023-11-20 2023-11-20 0001591913 2023-08-24 2023-08-24 0001591913 2023-11-20 2023-11-20 0001591913 ipsi:CavalryFundLLPMember 2023-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 srt:MinimumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 ipsi:MercerConvertedMember 2023-05-19 2023-05-19 0001591913 ipsi:MercerConvertedMember 2023-08-30 2023-08-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:QuickCapitalLLCMember 2023-06-01 2023-06-20 0001591913 ipsi:QuickCapitalLLCMember 2023-06-20 0001591913 2023-12-01 2023-12-20 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-01 2023-05-10 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-05-10 0001591913 ipsi:CavalryAndMercerMember 2023-06-01 2023-06-13 0001591913 2023-06-01 2023-06-13 0001591913 2023-06-13 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-06-13 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-08-03 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-08-03 2023-08-03 0001591913 ipsi:ConvertibleNoteMember ipsi:DiagonalStreetLendingLLCMember 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-09-09 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-09-09 0001591913 ipsi:DiagonalStreetLendingLLCMember 2023-12-31 0001591913 ipsi:ConvertibleNoteMember ipsi:DiagonalStreetLendingLLCMember 2023-10-19 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-10-19 2023-10-19 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-10-19 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:ConvertibleNoteMember 2023-12-20 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-20 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-01 2023-12-20 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-20 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 2023-09-14 0001591913 srt:MaximumMember 2023-12-31 0001591913 ipsi:ConvertibleNoteMember 2023-12-31 0001591913 ipsi:NoteTwoMember 2023-12-14 0001591913 2023-12-14 0001591913 us-gaap:WarrantMember 2023-12-31 0001591913 ipsi:CavalryFundILPMember 2023-12-31 0001591913 ipsi:CavalryFundILPMember 2023-01-01 2023-12-31 0001591913 ipsi:CavalryFundILPMember 2022-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-01-01 2023-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-01-01 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2023-01-01 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2023-01-01 2023-12-31 0001591913 srt:MinimumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-12-31 0001591913 srt:MaximumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-12-31 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-01-01 2023-12-31 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-12-31 0001591913 us-gaap:WarrantMember 2023-12-31 0001591913 2023-05-10 0001591913 2023-09-12 0001591913 ipsi:BlackScholesMember 2023-12-20 0001591913 srt:MinimumMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember 2023-01-01 2023-12-31 0001591913 srt:MinimumMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember 2022-01-01 2022-12-31 0001591913 2022-08-01 0001591913 us-gaap:CommonStockMember 2022-08-01 0001591913 2022-08-01 2022-08-01 0001591913 2022-07-08 0001591913 us-gaap:CommonStockMember 2022-07-08 0001591913 2022-07-11 2022-07-11 0001591913 ipsi:RichardRosenblumMember 2022-07-11 2022-07-11 0001591913 ipsi:SamadHarakeMember 2022-07-11 0001591913 2022-08-05 2022-08-05 0001591913 ipsi:SamadHarakeMember 2022-08-05 0001591913 2023-05-19 2023-05-19 0001591913 2023-08-01 2023-08-16 0001591913 2023-08-01 2023-08-24 0001591913 2023-08-01 2023-08-30 0001591913 2023-08-01 2023-08-31 0001591913 2023-11-08 2023-11-08 0001591913 2020-12-15 2020-12-15 0001591913 us-gaap:RestrictedStockMember 2020-12-15 2020-12-15 0001591913 us-gaap:RestrictedStockMember 2021-01-01 2021-01-01 0001591913 2021-01-01 2021-01-01 0001591913 us-gaap:RestrictedStockMember 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2022-08-30 0001591913 2022-08-01 2022-08-30 0001591913 us-gaap:WarrantMember 2022-12-30 2022-12-30 0001591913 us-gaap:CommonStockMember 2022-12-30 0001591913 ipsi:DebtConversionNoticesMember 2023-01-01 2023-12-31 0001591913 2023-08-11 0001591913 2023-08-11 2023-08-11 0001591913 2023-12-14 2023-12-14 0001591913 ipsi:TwoThousandEighteenStockIncentivePlanMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2023-12-31 0001591913 ipsi:TwoThousandTwentyOnePlanMember 2021-10-22 2021-10-22 0001591913 ipsi:TwoThousandTwentyOnePlanMember srt:MaximumMember 2021-10-22 0001591913 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-07-11 2022-07-11 0001591913 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001591913 2022-09-13 2022-09-13 0001591913 us-gaap:CommonStockMember 2022-09-13 2022-09-13 0001591913 2022-09-13 0001591913 ipsi:TotalRestrictedSharesMember 2021-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2021-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2021-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2021-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-01-01 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-01-01 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointFourSevanMember 2023-01-01 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointFourSevanMember 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointFiveZeroMember 2023-01-01 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointFiveZeroMember 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointSixFiveMember 2023-01-01 2023-12-31 0001591913 ipsi:GrantDatePriceOnePointSixFiveMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2021-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointThreeFourFiveMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointThreeFourFiveMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointFourFiveZeroMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointFourFiveZeroMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointZeroThreeFiveMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointZeroThreeFiveMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointFiveZeroZeroMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointFiveZeroZeroMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFourPointFiveZeroMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFourPointFiveZeroMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFivePointSixTwoFiveMember 2023-12-31 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFivePointSixTwoFiveMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2021-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2021-12-31 0001591913 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001591913 us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-12-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceOnePointTwoZeroMember 2023-12-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceOnePointTwoZeroMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceFourPointFiveZeroMember 2023-12-31 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceFourPointFiveZeroMember 2023-01-01 2023-12-31 0001591913 2022-02-04 2022-02-04 0001591913 2023-08-03 2023-08-03 0001591913 2022-08-30 2022-08-30 0001591913 ipsi:CavalryAndMercerMember 2022-08-30 2022-08-30 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2022-08-30 2022-08-30 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2022-08-30 2022-08-30 0001591913 us-gaap:WarrantMember 2022-08-30 0001591913 ipsi:NoteAmendmentLetterAgreementMember 2022-12-01 2022-12-30 0001591913 ipsi:CavalryAndMercerMember ipsi:WarrantAgreementMember 2022-12-30 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2022-12-30 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2022-12-30 0001591913 ipsi:CavalryAndMercerMember 2022-12-30 0001591913 ipsi:CavalryAndMercerMember 2022-12-01 2022-12-30 0001591913 us-gaap:CommonStockMember 2022-12-01 2022-12-30 0001591913 2022-12-01 2022-12-30 0001591913 ipsi:WarrantAgreementMember 2022-12-01 2022-12-30 0001591913 us-gaap:WarrantMember 2022-12-01 2022-12-30 0001591913 ipsi:BlackScholesValuationModelMember 2022-12-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-30 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-30 0001591913 srt:MaximumMember 2022-12-30 0001591913 us-gaap:WarrantMember 2022-12-30 0001591913 2022-12-30 0001591913 us-gaap:WarrantMember ipsi:BlackScholesValuationModelMember 2022-12-30 0001591913 2017-12-22 2017-12-22 0001591913 ipsi:OperatingLossCarryforwardMember 2023-12-31 0001591913 ipsi:IncentiveStockAwardsMember 2023-01-01 2023-12-31 0001591913 ipsi:IncentiveStockAwardsMember 2022-01-01 2022-12-31 0001591913 ipsi:SecuritiesIssuedForServicesRenderedMember 2023-01-01 2023-12-31 0001591913 ipsi:SecuritiesIssuedForServicesRenderedMember 2022-01-01 2022-12-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-12-31 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-12-31 0001591913 ipsi:StockOptionsMember 2023-01-01 2023-12-31 0001591913 ipsi:StockOptionsMember 2022-01-01 2022-12-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001591913 ipsi:MrFullerMember 2022-09-13 0001591913 ipsi:MrFullerMember 2022-09-01 2022-09-13 0001591913 ipsi:JamesFullerMember 2023-01-01 2023-12-31 0001591913 ipsi:JamesFullerMember 2022-01-01 2022-12-31 0001591913 ipsi:WilliamCorbettMember 2022-07-11 0001591913 ipsi:WilliamCorbettMember 2022-07-01 2022-07-11 0001591913 ipsi:WilliamCorbettMember 2023-06-21 0001591913 ipsi:WilliamCorbettMember 2023-01-01 2023-12-31 0001591913 ipsi:WilliamCorbettMember 2022-01-01 2022-12-31 0001591913 ipsi:CliffordHenryMember 2023-01-01 2023-12-31 0001591913 ipsi:CliffordHenryMember 2022-09-13 0001591913 ipsi:CliffordHenryMember 2022-09-01 2022-09-13 0001591913 ipsi:CliffordHenryMember 2022-01-01 2022-12-31 0001591913 ipsi:MadissonButlerMember 2022-09-13 0001591913 ipsi:MadissonCorbettMember 2022-09-01 2022-09-13 0001591913 ipsi:MadissonCorbettMember 2022-09-13 0001591913 ipsi:MadissonButlerMember 2023-01-01 2023-12-31 0001591913 ipsi:MadissonButlerMember 2022-01-01 2022-12-31 0001591913 ipsi:DavidRiosMember 2022-09-13 0001591913 ipsi:DavidRiosMember 2022-09-01 2022-09-13 0001591913 ipsi:DavidRiosMember 2022-09-13 2022-09-13 0001591913 ipsi:DavidRiosMember 2023-01-01 2023-12-31 0001591913 ipsi:DavidRiosMember 2022-01-01 2022-12-31 0001591913 ipsi:MrRosenblumMember 2022-07-11 2022-07-11 0001591913 ipsi:RichardRosenblumMember 2023-01-01 2023-12-31 0001591913 ipsi:RichardRosenblumMember 2022-01-01 2022-12-31 0001591913 srt:ScenarioForecastMember 2024-02-06 2024-02-21 0001591913 srt:ScenarioForecastMember 2024-02-21 0001591913 srt:ScenarioForecastMember 2024-02-21 2024-02-21 0001591913 srt:ScenarioForecastMember 2024-03-04 2024-03-04 0001591913 srt:ScenarioForecastMember ipsi:SecuritiesPurchaseAgreementMember 2024-03-04 0001591913 srt:ScenarioForecastMember 2023-01-01 2024-03-04 0001591913 ipsi:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2023-01-01 2024-03-04 0001591913 srt:ScenarioForecastMember us-gaap:WarrantMember 2024-05-03 0001591913 ipsi:SecuritiesPurchaseAgreementMember 2023-12-31 0001591913 ipsi:SecuritiesPurchaseAgreementMember 2023-01-01 2023-12-31 0001591913 ipsi:BZWRMember 2023-12-31 0001591913 us-gaap:SubsequentEventMember 2024-02-12 0001591913 ipsi:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2024-02-12 0001591913 us-gaap:SubsequentEventMember 2024-02-12 2024-02-12 0001591913 ipsi:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2023-12-31 iso4217:USD shares iso4217:USD shares pure 10-K/A true 2023-12-31 --12-31 2023 false 000-55648 INNOVATIVE PAYMENT SOLUTIONS, INC. NV 56B 5th Street Lot 1, #AT Carmel by the Sea CA 93921 (866) 477-4729 Common Stock, $0.0001 par value. No No Yes Yes Non-accelerated Filer true false false false false 4628228 13819889 None This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) to the Annual Report on Form 10-K of Innovative Payment Solutions, Inc. (the “Company”) for the fiscal year ended December 31, 2023, originally filed with the Securities and Exchange Commission (“SEC”) on March 29, 2024 (the “Original Filing”), is being filed solely to correct a typographical error as to the signing date of the Report of Independent Registered Public Accounting Firm contained therein, which read March 29, 2023 instead of March 29, 2024.This Amendment No. 1 includes: Item 8 of Part II, “Financial Statements and Supplementary Data” in its entirety and without change from the Original Filing other than the correction of the signing date of the Report of Independent Registered Public Accounting Firm.In addition, pursuant to the rules of the SEC, the exhibit list included herein reflects currently-dated certifications from the Company’s principal executive officer and principal accounting officer, which are filed as exhibits to this Amendment No. 1.Except for the foregoing amended information, this Amendment No. 1 does not amend or update any other information contained in the Original Filing, or reflect any events that have occurred after the filing date of the Original Filing. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Filing. 587 New York, NY 50433 373822 38818 97042 807263 89251 1278127 7027 40362 1401491 5000 32592 703938 715965 1474445 805216 2752572 2023375 727922 33810 9369 1062007 964268 687503 263200 3704280 2266602 1434196 2550642 8233227 6543244 150000 163978 150000 163978 8383227 6707222 0.0001 0.0001 25000000 25000000 0 0 0 0 0.0001 0.0001 750000000 750000000 13819889 13819889 12563426 12563426 1382 1256 50656225 48442355 -58235618 -52399858 -7578011 -3956247 1597 -7578011 -3954650 805216 2752572 410 847 3547 5052 -3137 -4205 3576352 5452579 380634 132394 3956986 5584973 -3960123 -5589178 1 -90761 -73562 -4602709 -1066165 14176 424117 199788 770372 263200 1501446 411752 -4897830 -10243124 -4897830 -10243124 -403282 -5301112 -10243124 -40821 -88300 495424 -536245 -88300 -5837357 -10331424 -1597 -43267 -5835760 -10288157 -0.41 -0.83 -0.04 0 -0.45 -0.83 12844609 12406677 12263426 1226 45806576 -42111701 35211 3731312 708063 708063 233333 23 332977 333000 1233682 1233682 66667 7 361057 361064 9653 9653 -10288157 -43267 -10331424 12563426 1256 48442355 -52399858 1597 -3954650 1253625 126 523135 523261 2838 159004 159004 1045655 1045655 377856 377856 108220 108220 -5835760 -1597 -5837357 13819889 1382 50656225 -58235618 -7578011 -5837357 -10331424 -536245 -88300 -5301112 -10243124 1501446 411752 380634 132394 770372 263200 -1066165 1 90761 73562 4602709 159004 359125 -403282 333000 377856 1594746 -58224 12008 1577888 288018 392714 111528 -1452096 -2982163 35287 -79790 -1416809 -3061953 999000 44405 778462 12792 14800 43049 -1028605 -834303 -36230 -41320 -1064835 -875623 2461666 304354 1147063 9653 2157312 -1137410 -324332 -5074986 374765 5449751 50433 374765 373822 5367551 943 82200 374765 5449751 50433 373822 943 50433 374765 -31403 88260 348938 1045655 432500 108220 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>1</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>ORGANIZATION AND DESCRIPTION OF BUSINESS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>a)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Organization</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Pursuant to the Merger Agreement, upon consummation of the Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Merger. Prior to and as a condition to the closing of the Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other then stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.9in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>b)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Description of current business</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express (as defined below), developing a new account-to-account payment application called Instant Settlement in RealTime as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white"><i>IPSIPay Express</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">On April 28, 2023, the Company formed a new company called IPSIPay Express LLC (“IPSIPay Express”). This entity was formed as a Delaware limited liability company joint venture with OpenPath, Inc. (“OpenPath”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with OpenPath and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with OpenPath and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company is required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and OpenPath and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche was expected to be paid on or before November 30, 2023, subsequently, the Company’s management made a decision not to advance the third tranche to IPSIPay Express as the joint venture is not operational as yet. The need for any additional advances will be addressed with the joint venture partners once the joint venture becomes operational and begins generating revenue, our current shareholding in the joint venture remains at 22%. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">Simultaneously with the funding of the initial Tranche, the Company issued to each of OpenPath and EfinityPay a five-year common stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. We are still obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. Simultaneously with the funding of the second Tranche, we are obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Should we decide to fund a third Tranche, we will be obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="background-color: white"><i>Frictionless Financial Technologies</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On June 21, 2021. the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless agreed to deliver to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enables payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 1,000,000 (30,000,000 pre-split) shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below (see note 5), the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 has been impaired.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express joint venture. See note 5 for further information.</span></p> 2016-05-12 0.0001 621920 500000 497500 2500 500000 4992900 0.91 the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders 320477867 32047817 2250000 2250000 0.09 0.05 0.025 0.015 1500000 500000 0.1111 200000 300000 500000 500000 0.22 133334 0.45 199999 166667 166667 1333334 0.10 0.41 300000 0.01 0.51 0.49 1000000 30000000 250000 231431 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-size: 10pt"><b>2</b></span></td> <td style="width: 97%; text-align: justify"><span style="font-size: 10pt"><b>ACCOUNTING POLICIES AND ESTIMATES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>a)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Basis of Presentation</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>b)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Principles of Consolidation</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The consolidated financial statements as of December 31, 2023, include the financial statements of the Company and its subsidiary, Beyond Fintech, in which it had a majority voting interest, until May 12, 2023, the date of disposal. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore, as of May 12, 2023 the Company has no subsidiaries. See note 4 for further information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">All significant inter-company accounts and transactions have been eliminated in the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>c)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>d)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Contingencies</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>e)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">ASC 825-10 “<i>Financial Instruments</i>” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>f)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. The recent war in Ukraine and the global inflationary environment which has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>g)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Recent accounting pronouncements</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Financial Accounting Standards Board (“FASB”) issued additional updates during the year ended December 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s consolidated financial statements upon adoption.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>h)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Reporting by Segment</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">No segmental information is required as the Company has only one operating segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>i)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Cash and Cash Equivalents</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At December 31, 2023 and 2022, respectively, the Company had no cash equivalents.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At December 31, 2023 and 2022, the balance exceeds the federally insured limit by $0 and $120,580, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>j)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>k)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Investments</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company recorded an impairment charge of <span style="-sec-ix-hidden: hidden-fact-99">$0</span> and $1 on its non-marketable equity securities for the years ended December 31, 2023 and 2022, respectively. The impairment charge was based on management’s determination that due to the lack of ability, to date, by Vivi Holdings (“Vivi”) to fulfill its capital raising requirements and implement its business strategy that there is a significant risk that Vivi may not be able to meet its obligations. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>l)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Plant and Equipment</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1.5pt solid; width: 58%"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 41%"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">10 years</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>m)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Long-Term Assets</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>n)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Revenue Recognition</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">i.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the contract with a customer;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">ii.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">iii.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">determine the transaction price;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">iv.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">v.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company had minimal revenues of $410 and $847 during the years ended December 31, 2023 and 2022, respectively. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>o)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Share-Based Payment Arrangements</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Company’s common stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its common stock as quoted on the OTCQB, as an indicator of the fair value of its common stock in determining share- based payment arrangements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>p)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Derivative Liabilities</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>q)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Income Taxes</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of December 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>r)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Comprehensive income</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>s)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Reclassification of prior year presentation</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>a)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Basis of Presentation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>b)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Principles of Consolidation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The consolidated financial statements as of December 31, 2023, include the financial statements of the Company and its subsidiary, Beyond Fintech, in which it had a majority voting interest, until May 12, 2023, the date of disposal. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore, as of May 12, 2023 the Company has no subsidiaries. See note 4 for further information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">All significant inter-company accounts and transactions have been eliminated in the consolidated financial statements.</span></p> 0.51 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>c)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Use of Estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>d)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Contingencies</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>e)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Fair Value of Financial Instruments</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The carrying amounts reported in the balance sheets for cash, accounts receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">ASC 825-10 “<i>Financial Instruments</i>” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>f)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Risks and Uncertainties</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s operations are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. The recent war in Ukraine and the global inflationary environment which has resulted in significant interest rate increases in the U.S and abroad has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>g)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Recent accounting pronouncements</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Financial Accounting Standards Board (“FASB”) issued additional updates during the year ended December 31, 2023. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s consolidated financial statements upon adoption.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>h)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Reporting by Segment</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><span style="background-color: white">No segmental information is required as the Company has only one operating segment.</span></p> 1 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>i)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Cash and Cash Equivalents</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At December 31, 2023 and 2022, respectively, the Company had no cash equivalents.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At December 31, 2023 and 2022, the balance exceeds the federally insured limit by $0 and $120,580, respectively.</span></p> 0 120580 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>j)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended December 31, 2023 and 2022.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>k)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Investments</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on a balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company recorded an impairment charge of <span style="-sec-ix-hidden: hidden-fact-99">$0</span> and $1 on its non-marketable equity securities for the years ended December 31, 2023 and 2022, respectively. The impairment charge was based on management’s determination that due to the lack of ability, to date, by Vivi Holdings (“Vivi”) to fulfill its capital raising requirements and implement its business strategy that there is a significant risk that Vivi may not be able to meet its obligations. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 0.20 1 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>l)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Plant and Equipment</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1.5pt solid; width: 58%"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 41%"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">10 years</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.</span></p> <span style="background-color: white">Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1.5pt solid; width: 58%"><span style="font-size: 10pt"><b>Description</b></span></td> <td style="width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 41%"><span style="font-size: 10pt"><b>Estimated Useful Life</b></span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Kiosks</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">7 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Computer equipment</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">3 years</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Leasehold improvements</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">Lesser of estimated useful life or life of lease</span></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr style="background-color: #CCEEFF"> <td><span style="font-size: 10pt">Office equipment</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">10 years</span></td></tr> </table> 1000 P7Y P3Y Lesser of estimated useful life or life of lease P10Y <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>m)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Long-Term Assets</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>n)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Revenue Recognition</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">i.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the contract with a customer;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">ii.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">iii.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">determine the transaction price;</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">iv.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">v.</span></td> <td style="text-align: justify"><span style="font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company had minimal revenues of $410 and $847 during the years ended December 31, 2023 and 2022, respectively. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 410 847 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>o)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Share-Based Payment Arrangements</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining managements estimate of market value includes, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Where equity transactions with arms-length third parties, included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Company’s common stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its common stock as quoted on the OTCQB, as an indicator of the fair value of its common stock in determining share- based payment arrangements.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>p)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Derivative Liabilities</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>q)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Income Taxes</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company is based in the US and currently enacted US tax laws are used in the calculation of income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of December 31, 2023 and December 31, 2022, there have been no interest or penalties incurred on income taxes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>r)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Comprehensive income</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>s)</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Reclassification of prior year presentation</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>3</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>LIQUIDITY MATTERS AND GOING CONCERN</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the year ended December 31, 2023, the Company had a net loss of $5,837,357. In connection with preparing the consolidated financial statements for the year ended December 31, 2023, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The accompanying financial statements for the period ended December 31, 2023 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay, and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="background-color: white">The Company has determined that there is substantial doubt about their ability to continue as a going concern.</span></p> -5837357 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>4</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On May 12, 2023, the Company entered into the May 2023 Frictionless Agreement to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 1,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18-mobnth period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The assets and liabilities disposed of as of May 12, 2023 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Assets</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Current Assets</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Cash</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">339</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Non-current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">327,211</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Security deposit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Investment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">842,211</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total assets</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">842,550</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-indent: -9pt; padding-left: 9pt">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Current Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">97,126</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Net assets sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">745,424</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Proceeds due on disposal</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Net loss on disposal</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">495,424</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 0.10 1000000 0.51 250000 0.20 <span style="background-color: white">The assets and liabilities disposed of as of May 12, 2023 were as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Assets</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Current Assets</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Cash</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">339</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Non-current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">327,211</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 0.25in">Security deposit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Investment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">500,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 27pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">842,211</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total assets</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">842,550</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-indent: -9pt; padding-left: 9pt">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Current Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">97,126</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Net assets sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">745,424</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Proceeds due on disposal</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Net loss on disposal</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">495,424</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 339 327211 15000 500000 842211 842550 97126 745424 250000 495424 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>5</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>NOVATION  OF CERTAIN ASSETS AND LIABILITES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On September 5, 2023, the Company entered into a novation agreement with a third party whereby the third party assumed all of the Company’s debts, clients, and services and assumes all the rights and responsibilities of the Company under the SAAS Cloud Hosted Services Enablement Master Services Agreement, dated September 9, 2021 (the “SAAS Agreement”), including the information technology, supplier access, billing and rating technology, mobile wallet, debit card enablement, back-office support services, customer service, and consulting services related to the Company’s IPSIPay mobile application.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Pursuant to the novation agreement, Frictionless released the Company from all its obligations, debts, and liabilities under the SAAS Agreement as of September 5, 2023 and consented to the third party assuming these obligations. Each party agreed to indemnify the other party harmless for any damages, claims or expenses incurred by the other party.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The novation agreement also provided the third party a 30-day transition period in which the Company assisted the third party in transferring all the assets and obligations, including existing customers and wallets to the third party, thereafter the third party will no longer be permitted to operate the IPSIPay app under the brand name “IPSIPay”.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The assets and liabilities novated under the agreement as of September 5, 2023, were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 8pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Assets</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Current Assets</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Receivable on sale of subsidiary</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">231,431</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Non-current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,098,598</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total assets</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,330,029</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Current Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">263,864</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Net loss on novation</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,066,165</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <span style="background-color: white">The assets and liabilities novated under the agreement as of September 5, 2023, were as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Assets</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Current Assets</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Receivable on sale of subsidiary</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">231,431</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Non-current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,098,598</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total assets</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,330,029</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Current Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 0.25in">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">263,864</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Net loss on novation</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,066,165</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 231431 1098598 1330029 263864 1066165 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>6</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>DISCONTINUED OPERATIONS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 8pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Effective May 12, 2023, the Company disposed of its investment in Beyond Fintech pursuant to the May 2023 Frictionless Agreement, as disclosed in note 4 above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The following assets and liabilities are reported as discontinued operations:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 8pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Current assets</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Cash</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">943</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Non-current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intangibles, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">291,320</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Investment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Security deposit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Assets held for sale</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">807,263</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,810</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Liabilities held for sale</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">33,810</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 8pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The statement of operations from discontinued operations is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><span style="font-size: 8pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net Revenue</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Cost of Goods Sold</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Gross loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">General and administrative</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">40,821</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">88,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Total Expense</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">40,821</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">88,300</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Loss from operations before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(40,821</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(88,300</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income Taxes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Loss from discontinued operations, net of taxation</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(40,821</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(88,300</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table> <span style="background-color: white">The following assets and liabilities are reported as discontinued operations:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Current assets</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%">Cash</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">943</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Non-current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Intangibles, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">291,320</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Investment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Security deposit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Assets held for sale</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">807,263</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">33,810</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Liabilities held for sale</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">33,810</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 943 291320 500000 15000 807263 33810 33810 <span style="background-color: white">The statement of operations from discontinued operations is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net Revenue</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Cost of Goods Sold</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Gross loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">General and administrative</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">40,821</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">88,300</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Total Expense</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">40,821</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">88,300</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Loss from operations before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(40,821</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(88,300</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Income Taxes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Loss from discontinued operations, net of taxation</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(40,821</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(88,300</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr> </table> 40821 88300 40821 88300 -40821 -88300 -40821 -88300 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>7</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>INTANGIBLES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. During the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $41,320 and $35,891, respectively, was spent on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless (see note 4 above).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, and during the year ended December 31, 2022 and the nine months ended September 30, 2023, an additional $1,127,400 and $44,405, respectively, was incurred by the Company to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party (see note 5 above).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="10" style="font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated<br/> amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net Book<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net book<br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Purchased Technology - IPSIPay</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,401,491</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Amortization expense was $347,298 and $100,909 for the years ended December 31, 2023 and 2022, respectively.</span></p> 250000 0.51 0.49 41320 35891 375000 1127400 44405 On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party (see note 5 above).<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="10" style="font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Cost</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated<br/> amortization</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net Book<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net book<br/> value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Purchased Technology - IPSIPay</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,401,491</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 1401491 347298 100909 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>8</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>EQUITY METHOD INVESTMENT</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay (see note 1(b) above). As described in note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of December 31, 2023, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended December 31, 2023 is as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash contribution to IPSIPay Express</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">999,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Fair value of warrants issued to third party joint venture partners</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">108,220</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,107,220</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Equity loss from joint venture</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(403,282</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">703,938</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 500000 500000 <span style="background-color: white">The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended December 31, 2023 is as follow:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash contribution to IPSIPay Express</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">999,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Fair value of warrants issued to third party joint venture partners</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">108,220</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,107,220</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Equity loss from joint venture</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(403,282</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">703,938</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 999000 108220 1107220 403282 703938 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>9</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>INVESTMENTS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>Investment in Frictionless Financial Technologies Inc.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On May 12, 2023, the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless). refer Note 4 above.</span></p> 0.10 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>10</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>LEASES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5<sup>th</sup> Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve-month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90-day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>Total Lease Cost</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Individual components of the total lease cost incurred by the Company is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; text-align: left">Operating lease expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">40,704</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">57,600</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="background-color: white">Other lease information:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating cash flows from operating leases</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(40,704</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(57,600</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term – operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-113">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">Monthly</span></td><td style="text-align: left"> </td></tr> </table> The lease commenced on April 1, 2021 and is for a twelve-month period, terminating on April 1, 2022. 4800 5088 <span style="background-color: white">Individual components of the total lease cost incurred by the Company is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; text-align: left">Operating lease expense</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">40,704</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">57,600</td><td style="width: 1%; text-align: left"> </td></tr> </table> 40704 57600 <span style="background-color: white">Other lease information:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Cash paid for amounts included in the measurement of lease liabilities</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Operating cash flows from operating leases</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(40,704</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(57,600</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Remaining lease term – operating lease</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-113">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">Monthly</span></td><td style="text-align: left"> </td></tr> </table> 40704 57600 Monthly <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>11</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>FEDERAL RELIEF LOANS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>Small Business Administration Disaster Relief loan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The company has accrued interest of $9,369 and $13,978 on this loan as of December 31, 2023 and 2022, respectively.</span></p> 150000 0.0375 731 9369 13978 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>12</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>NOTES PAYABLE</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of the Company’s common stock at an exercise price of $0.24 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in Note 9 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of common stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">Subsequent to year end, the maturity date of the notes was extended to April 30, 2024, all other terms remain the same as the previous notes. The Company will perform an analysis to determine whether the amendment meets the definition of a debt extinguishment or modification in terms of ASC 470.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">Notes payable consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Interest<br/> Rate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity<br/> date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accrued<br/> Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, Amount, net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2022<br/> Amount,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>net</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Cavalry Fund I LP</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">April 30, 2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">482,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">49,004</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">531,004</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">482,134</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Mercer Street Global Opportunity Fund, LLC</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">10</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">April 30, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">482,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">49,003</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">531,003</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">482,134</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total convertible notes payable</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">964,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">98,007</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,062,007</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">964,268</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">    </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Interest expense totaled $97,739 and $268 for the year ended December 31, 2023 and 2022, respectively.</span></p> 500500 500500 0.125 572000 2486957 0.24 482000 964000 43608 920392 2023-12-30 0.10 51901711 <span style="background-color: white">Notes payable consists of the following:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Interest<br/> Rate</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity<br/> date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accrued<br/> Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, Amount, net</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2022<br/> Amount,</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>net</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Cavalry Fund I LP</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">10</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">April 30, 2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">482,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">49,004</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">531,004</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">482,134</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Mercer Street Global Opportunity Fund, LLC</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">10</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">April 30, 2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">482,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">49,003</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">531,003</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">482,134</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total convertible notes payable</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">964,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">98,007</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,062,007</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">964,268</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 0.10 2024-04-30 482000 49004 531004 482134 0.10 2024-04-30 482000 49003 531003 482134 964000 98007 1062007 964268 97739 268 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>13</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>CONVERTIBLE NOTES PAYABLE</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>December 2022 Note Amendment Transaction</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 100,000 (3,000,000 pre-split) shares of Common Stock at an exercise price of $4.50 ($0.15 pre-split) per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The conversion price of the Cavalry/Mercer Notes was reduced from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 100,000 (3,000,000 pre-split) shares of Common Stock underlying the Extension Warrants was increased to 1,304,348 (39,130,435 pre-split) shares;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify; font-size: 10pt">The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 1,730,057 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">(3)</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $1.80 ($0.06 pre-split) per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $1.20 ($0.04 pre-split) per share; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">(5)</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.345 ($0.0115 pre-split) per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, <i>Debt</i>, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $(43,608) and the value of the notes of $964,000 (see note 11 above) and the value of full rachet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003 (see note 14 below), the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">Effective December 30, 2023 on February 27, 2024, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to April 30, 2024, other than the maturity date all other terms remained the same. The Company will perform an analysis to determine whether the amendment meets the definition of a debt extinguishment or modification in terms of ASC 470.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Convertible notes payable consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Interest<br/> Rate</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity<br/> date</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accrued<br/> Interest</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unamortized<br/> debt discount</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31,<br/> 2023<br/> Amount,<br/> net</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December  31,<br/> 2022<br/> Amount, <br/> net</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 16%; text-align: left; text-indent: -9pt; padding-left: 9pt">Cavalry Fund I LP</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">10.00</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: center">April 30, 2024</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">898,980</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">10,238</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">909,218</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">1,133,301</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Mercer Street Global <br/> Opportunity Fund, LLC</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10.00</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: center">April 30, 2024</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">991,754</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">148,010</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,139,764</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,133,301</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Red Road Holdings Corporation</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">29.32</td> <td style="text-align: left">*%</td> <td> </td> <td style="text-align: center">June 15, 2024</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">101,679</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,393</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(61,301</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">41,771</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">27.77</td> <td style="text-align: left">*%</td> <td> </td> <td style="text-align: center">July 30 2024</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">66,606</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,622</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(49,545</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">18,683</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">32.04</td> <td style="text-align: left">*%</td> <td> </td> <td style="text-align: center">September 30, 2024</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">63,250</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">668</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(60,809</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,109</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">2023 convertible notes</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 8.00 to 12.00 </span></td> <td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">December 31, 2023 to September 14, 2024</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2,026,666</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">80,916</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(515,847</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,591,735</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total convertible notes payable</td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,148,935</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">242,847</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(687,502</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,704,280</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,266,602</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">The red Road Holdings Corporation interest rate is an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Interest expense totaled $319,543 and $193,886 for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Amortization of debt discount totaled $770,372 and $263,200  for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b><i>Cavalry Fund LLP</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Between August 24, 2023 and November 20, 2023, Cavalry converted $139,726 of interest and $192,774 of interest into 963,769 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $42,210.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The balance of the Cavalry Note plus accrued interest at December 31, 2023 was $909,218.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b><i>Mercer Street Global Opportunity Fund, LLC</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Between May 19, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of common stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On February 27, 2024, Cavalry entered into a note amendment with the company extending the maturity date of the convertible note to April 30, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The balance of the Mercer Note plus accrued interest at December 31, 2023 was $1,139,764.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b><i>Quick Capital, LLC</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On June 20, 2023, the Company closed a transaction with Quick Capital, LLC pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,857 in exchange for the issuance of a $62,857 Convertible Note, bearing interest at 8% per annum, which interest is earned on issuance of the note, and maturing on December 20, 2023. The Note is convertible into shares of Common Stock at an initial conversion price of $0.345 per share, in addition, the Company issued a warrant exercisable for 182,194 shares of Common Stock at an initial exercise price of $0.345 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On December 20, 2023, the Company settled the outstanding principal of $62,857 and interest thereon of $2,514, of the Quick Capital note, thereby extinguishing the debt.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b><i>1800 Diagonal Street Lending LLC</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-size: 10pt">On May 10, 2023, the Company closed a transaction with 1800 Diagonal Street Lending LLC (“1800 Diagonal”) pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $17,320 in exchange for the issuance of a $117,320 Convertible Note (the “May 1800 Diagonal Note”), bearing interest at 13% per annum, which interest is earned on issuance of the note, and maturing on May 10, 2024. The May 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 13 2023, the Company closed a transaction with 1800 Diagonal, pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $12,700 in exchange for the issuance of a $62,700 Convertible Note (the “June 1800 Diagonal Note”), bearing interest at 17.33% per annum, which interest is earned on issuance of the note, and maturing on March 13, 2024. The June 1800 Diagonal Note was convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 3, 2023, the Company settled in full, the outstanding convertible notes owing to 1800 Diagonal, for $194,386, including the principal amount of $180,020, early settlement penalty of $9,306 and interest thereon of $5,060.</p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b><i>Red Road Holdings Corporation</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i> </i></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note (“RRH Note 1”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 29.3%, and maturing on June 15, 2024. The RRH Note 1 has mandatory monthly repayments of $18,444 which commenced on October 14, 2023. The RRH Note 1 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The balance of the RRH Note 1 plus accrued interest at December 31, 2023 was $41,772, net of unamortized debt discount of $61,301.</span></p></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">●</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On October 19, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note (“RRH Note 2”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 27.8%, and maturing on July 30, 2024. The RRH Note 2 has mandatory monthly repayments of $9,222 which commenced on November 30, 2023. The RRH Note 2 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The balance of the RRH Note 2 plus accrued interest at December 31, 2023 was $18,683, net of unamortized debt discount of $49,545.</span></p></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-size: 10pt">●</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On December 20, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $13,250 in exchange for the issuance of a $63,250 Convertible Note (“RRH Note 3”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 32.0%, and maturing on September 30, 2024. The RRH Note 3 has mandatory monthly repayments of $8,082. The RRH Note 3 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The balance of the RRH Note 3 plus accrued interest at December 31, 2023 was $3,109, net of unamortized debt discount of $60,809.</span></p></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b><i> </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b><i>2023 Convertible Notes</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors, pursuant to which the Company received an aggregate of $2,026,666 in gross proceeds in a private placement through the issuance of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">Convertible Promissory Notes (the “2023 Notes” and each a “2023 Note”); and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">five-year warrants (the “2023 Warrants”) to purchase an aggregate 5,696,586 shares of Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The 2023 Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum, and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the 2023 Warrants for public resale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The 2023 Notes and the 2023 Warrants contain conversion limitations providing that a holder thereof may not convert the 2023 Notes or exercise the 2023 Warrants to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On December 14, 2023, two notes totaling $225,000 which matured on December 31, 2023 were rolled over for an additional 3 months to March 30, 2024. In exchange for the roll-over, the Company issued the note holders warrants exercisable for 292,463 shares of common stock at an exercise price of $0.345 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The balance of the 2023 Notes plus accrued interest at December 31, 2023 was $1,591,734, net of unamortized debt discount of $515,847.</span></p> 2022-08-16 0.20 100000 3000000 4.5 0.15 4.5 0.15 0.345 0.0115 100000 3000000 1304348 39130435 482000 2023-12-30 0.10 1730057 1.8 0.06 1.2 0.04 2264784 1132392 0.345 0.0115 836414 4.5 0.15 0.345 0.0115 1499577 238182 920392 -43608 964000 841003 <span style="background-color: white">Convertible notes payable consists of the following:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Description</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Interest<br/> Rate</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity<br/> date</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accrued<br/> Interest</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Unamortized<br/> debt discount</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December 31,<br/> 2023<br/> Amount,<br/> net</b></td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December  31,<br/> 2022<br/> Amount, <br/> net</b></td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 16%; text-align: left; text-indent: -9pt; padding-left: 9pt">Cavalry Fund I LP</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">10.00</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: center">April 30, 2024</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">898,980</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">10,238</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">909,218</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">1,133,301</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Mercer Street Global <br/> Opportunity Fund, LLC</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10.00</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: center">April 30, 2024</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">991,754</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">148,010</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,139,764</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,133,301</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Red Road Holdings Corporation</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">29.32</td> <td style="text-align: left">*%</td> <td> </td> <td style="text-align: center">June 15, 2024</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">101,679</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,393</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(61,301</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">41,771</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">27.77</td> <td style="text-align: left">*%</td> <td> </td> <td style="text-align: center">July 30 2024</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">66,606</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,622</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(49,545</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">18,683</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">32.04</td> <td style="text-align: left">*%</td> <td> </td> <td style="text-align: center">September 30, 2024</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">63,250</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">668</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(60,809</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,109</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">2023 convertible notes</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 8.00 to 12.00 </span></td> <td style="padding-bottom: 1.5pt; text-align: left">%</td> <td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">December 31, 2023 to September 14, 2024</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2,026,666</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">80,916</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(515,847</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,591,735</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 9pt"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total convertible notes payable</td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt; text-align: right"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,148,935</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">242,847</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(687,502</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,704,280</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,266,602</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">The red Road Holdings Corporation interest rate is an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.</td> </tr></table> 0.10 April 30, 2024 898980 10238 909218 1133301 0.10 April 30, 2024 991754 148010 1139764 1133301 0.2932 June 15, 2024 101679 1393 61301 41771 0.2777 July 30 2024 66606 1622 49545 18683 0.3204 September 30, 2024 63250 668 60809 3109 0.08 0.12 December 31, 2023 to September 14, 2024 2026666 80916 515847 1591735 4148935 242847 687502 3704280 2266602 319543 193886 770372 263200 500500 71500 572000 0.10 0.23 82899 7.2 0.20 100000 4.5 4.5 0.345 139726 192774 963769 963769 0.345 0.345 42210 909218 500500 71500 572000 0.10 6.9 82899 7.2 0.20 100000 4.5 4.5 0.345 100000 100000 289856 289856 0.345 0.345 48551 1139764 50000 12857 62857 0.08 0.345 182194 0.345 62857 2514 100000 17320 117320 0.13 0.60 50000 12700 62700 0.1733 0.60 194386 180020 9306 5060 125000 21900 146900 0.13 0.293 18444 0.60 41772 61301 60000 13450 73450 0.13 0.278 9222 0.60 18683 49545 50000 13250 63250 0.15 0.32 8082 0.60 3109 60809 2026666 5696586 0.345 0.08 0.12 0.345 0.0499 0.0999 225000 292463 0.345 1591734 515847 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>14</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>DERIVATIVE LIABILITY</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described herein have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On December 30, 2022, the Company entered into the December 2022 Note Amendment transaction (“the Note Amendment”) as fully described under note 12 above. Included in the derivative liability is: (i) the Original Warrants which were exchanged for non-convertible promissory notes, (ii) the Cavalry and Mercer convertible notes which were subject to the Note Amendment and (ii) the Cavalry and Mercer Extension Warrants as well as certain other warrants due to Cavalry and Mercer and certain other warrant holders. The Note Amendment triggered a repricing of certain of these warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The derivative liability on the Cavalry and Mercer convertible notes and the warrants affected by the note amendment were marked-to-market immediately prior to the Note Amendment resulting in a market to market movement on the original warrants, the convertible notes and the extension warrants and certain other warrants, which were subject to a full rachet provision, of $474,614. In addition, the Note and warrant Amendment gave rise to an additional derivative liability charge of $2,317,051 which was recorded as an expense in the loss on convertible notes charge in the statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On May 10, 2023 and June 13, 2023, the Company entered into convertible note agreements with 1800 Diagonal which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $360,491 but limited to the cash value of the convertible notes of $150,000, using a Black-Scholes valuation model. These convertible notes were subsequently settled on August 3, 2023, resulting in the elimination of the derivative liability related to these notes.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"> <br/> Between September 12, 2023 and December 20, 2023, the Company entered into a convertible note agreement with RRH which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $416,317 but limited to the cash value of the convertible notes of $235,000, using a Black-Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The net movement on the derivative liability for the year ended December 31, 2023 was a net mark-to-market credit of $1,501,446 determined by using a Black-Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The following assumptions were used in the Black-Scholes valuation model:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended<br/> December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Conversion price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.104 to $0.345  </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.345 to $4.50  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.60 to 5.55 </span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.79 to 4.73 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Expected life of derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5 to 47 months </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5 to 59 months </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility of underlying stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 158.72 to 217.01 </span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120.49 to 258.3 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Expected dividend rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The movement in derivative liability is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,550,642</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,161</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derivative financial liability arising from convertible note and warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">385,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">238,182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Derivative financial liability arising on note amendment included in loss on convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,317,051</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Fair value adjustment to derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,501,446</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(411,752</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,434,196</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,550,642</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 474614 2317051 360491 150000 416317 235000 1501446 <span style="background-color: white">The following assumptions were used in the Black-Scholes valuation model:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended<br/> December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Conversion price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.104 to $0.345  </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.345 to $4.50  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.60 to 5.55 </span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.79 to 4.73 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Expected life of derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5 to 47 months </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5 to 59 months </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility of underlying stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 158.72 to 217.01 </span></td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120.49 to 258.3 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Expected dividend rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> </table> 0.104 0.345 0.345 4.5 0.036 0.0555 0.0079 0.0473 P3M15D P47M P1M15D P59M 1.5872 2.1701 1.2049 2.583 0 0 <span style="background-color: white">The movement in derivative liability is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Opening balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,550,642</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">407,161</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Derivative financial liability arising from convertible note and warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">385,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">238,182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Derivative financial liability arising on note amendment included in loss on convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,317,051</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Fair value adjustment to derivative liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,501,446</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(411,752</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,434,196</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,550,642</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2550642 407161 385000 238182 2317051 1501446 411752 1434196 2550642 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt"><b>15</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>STOCKHOLDERS’ EQUITY</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Common Stock</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 13,819,889 and 12,563,426 shares of Common Stock issued and outstanding as of December 31, 2023 and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On July 8, 2022, the Company entered into a consulting agreement with a third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company issued 66,667 (2,000,000 pre-split) shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant. In addition, the contractor will receive a monthly fee of $3,000 for the term of the Agreement, commencing on August 1, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On July 8, 2022, the Company entered into a second consulting agreement with a separate third-party contractor for a period of twelve months to (i) review the Company’s business plan; (ii) analyze and assess the Company’s revenues, costs, and cash flow; and (iii) introduce the Company to and interface on the Company’s behalf with potential and actual commercial partners. The Company issued 66,667 (2,000,000 pre-split) shares of Common Stock as compensation for the services rendered which were fully earned on the date of issue. These shares were valued at $84,000 at the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On July 11, 2022, the Board approved the issuance of  66,667 (2,000,000 pre-split) restricted shares of Common Stock to Richard Rosenblum, the Company’s President and Chief Financial Officer. These shares were valued at $110,000 at the date of grant.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On August 5, 2022, the Board approved the issuance of 100,000 (3,000,000 pre-split) shares of Common Stock to Samad Harake or his designees as compensation for the services rendered which were fully earned on the date of issue., Mr. Harake is the president and control person of Frictionless. These shares were valued at $165,000 at the date of grant.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt, refer Note 13 above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt, refer Note 13 above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt, refer note 13 above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On November 8, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 289,855 shares of Common Stock for the conversion of $100,000 of convertible debt, refer note 13 above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">On November 20, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 500,000 shares of Common Stock for the conversion of $172,500 of convertible debt, refer note 13 above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted stock awards</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On December 15, 2020, in terms of an employment agreement entered into with an employee, the Company granted 83,333 (2,500,000 pre-split) restricted shares of which 33,333 (1,000,000 pre-split) vested on January 1, 2021 and the remaining 50,000 (1,500,000 pre-split) shares vest over a period of two years. The 50,000 (1,500,000 pre-split) shares of unvested restricted stock which was not physically issued to the employee were not earned due to the cessation of employment with the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A summary of restricted stock activity during the period January 1, 2022 to December 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total<br/> restricted<br/> shares*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> fair market<br/> value per<br/> share*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total<br/> unvested<br/> restricted<br/> shares*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> fair market<br/> value per<br/> share*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total vested<br/> restricted<br/> shares*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> fair market<br/> value per share*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Outstanding January 1, 2022</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">716,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">341,583</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">374,917</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted and issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,667</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.65</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-116; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,667</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.65</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-121; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-122; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-123; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-124; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(170,791</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,791</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">783,167</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,792</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">612,375</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted and issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-125; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-126; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-130; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-131; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-133; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-134; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-135; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-136; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-137; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-138; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(170,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">783,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-139; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-140; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">783,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The restricted stock granted, issued and exercisable at December 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Restricted Stock<br/> Granted and<br/> Vested</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Grant date Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number<br/> Granted*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Fair<br/> Value per<br/> Share*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 40%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">683,167</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 27%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,333</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.65</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.65</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">783,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; background-color: white">The Company has recorded an expense of $0 and $361,064 for the years ended December 31, 2023 and 2022, respectively. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>c.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Preferred Stock</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of December 31, 2023 and December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>d.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Warrants</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Effective July 8, 2022 (the “Effective Date”), the Company entered into an Endorsement Agreement with Pez-Mar, Inc., a California corporation (“Pez-Mar”), to furnish the services of Mario Lopez (“Lopez”). Pursuant to the Endorsement Agreement, Lopez will act as a Company spokesperson in connection with the promotion, advertisement and endorsement of the Company’s physical and virtual payment processing and money remittance business and the Company’s related products and services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Endorsement Agreement has a term of two (2) years from the Effective Date (the “Term”), which is subject to earlier termination on customary terms and conditions. The parties have agreed to certain deliverables of Lopez during the term of the agreement, including with respect to social media posts, television commercials, interviews and photo shoots. The Endorsement Agreement also contains other customary terms, covenants and conditions, including representations and warranties, restrictions on endorsements of competitive products during the term of the agreement, confidentiality, indemnification, and Pez-Mar and Lopez’s independent contractor status.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">As compensation for the services provided under the Endorsement Agreement, Lopez or their designees are entitled to the following payments: (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90<sup>th</sup> day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date. The right to exercise the Warrants shall be subject to vesting during the Term but shall vest in full upon the consummation of a fundamental transaction involving the Company or upon certain termination events provided for in the Endorsement Agreement. The Exercise Price may be payable via “cashless exercise”, unless the underlying Shares are registered under an effective registration statement under the Securities Act of 1933, as amended. The Shares are subject to certain “piggyback” registration rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On August 30, 2022, the Company extended the maturity date of the Cavalry/Mercer Notes and agreed to grant each note holder a warrant exercisable for 100,000 shares of Common Stock at an exercise price of $4.50 per share with an expiration date of August 30, 2027.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On December 30, 2022, the Company issued to Frictionless a 5-year warrant to purchase 1,000,000 shares of Common Stock at an exercise price of $0.345 per share. The fair value of these warrants was $348,938 determined by using a Black-Scholes valuation model, which fair value was capitalized to purchased technology on the date of grant. On May 12, 2023, the Company entered into an agreement to cancel this warrant (see note 1(b)).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On December 30, 2022, the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-size: 10pt">An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors, as disclosed in note 13 above. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 5,696,586 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">On August 11, 2023, the company issued an investor a five-year replacement warrant for a warrant that had expired on February 13, 2023 exercisable for 33,334 shares of common stock at an exercise price of $1.50 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">On December 14, 2023, two notes totaling $225,000 which matured on December 31, 2023 were rolled over for an additional 3 months to March 30, 2024. In exchange for the roll-over, the Company issued the note holders five-year warrants exercisable for 292,463 shares of common stock at an exercise price of $0.345 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">During the current year warrants exercisable for 33,334 shares expired as unexercised and a further warrants exercisable for 1,000,000 shares of common stock were forfeited on the disposal of frictionless and Beyond Fintech as disclosed in note 4 above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">The 2023 Warrants contain conversion limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61<sup>st </sup>day after such notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, OpenPath and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of OpenPath and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of OpenPath and EfinityPay an additional IPEX warrant to purchase 166,667 shares of common stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.345 to 0.45  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 3.77 to 4.86 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 5 years  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility of underlying stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 187.40 to 192.80 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Expected dividend rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"><span style="background-color: white">A summary of warrant activity during the period January 1, 2022 to December 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> Underlying<br/> Warrants*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise<br/> price per<br/> share*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> average<br/> exercise<br/> price*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 64%; font-weight: bold; vertical-align: top">Outstanding January 1, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,243,477</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 1.50 – 5.625  </span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3.60</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,700,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.345 – 1.035 </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.5478</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Increase in warrants due to debt amendment full rachet trigger</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,408,696</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.345</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left">Cancelled on debt amendment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(165,797</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: top">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; font-weight: bold; vertical-align: top">Outstanding December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,186,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.345 – 5.625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.9000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,289,051</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.345 – 1.50</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top">Forfeited</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(33,334</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.5000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Cancelled on disposal of investment in Frictionless and Beyond Fintech</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3450</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: top">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-145">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; font-weight: bold; padding-bottom: 4pt; vertical-align: top">Outstanding December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,442,093</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.345 – 5.625 </span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.6265</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The warrants outstanding and exercisable at December 31, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants Outstanding*</b></span></td> <td> </td> <td> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants Exercisable*</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<br/> Outstanding*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Exercise<br/> Price*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<br/> Exercisable*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Exercise<br/> Price*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.345</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,055,642</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,055,642</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.450</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,668</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.48</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,668</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.48</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.035</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.52</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437,500</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.52</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.500</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,334</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.62</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,334</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.62</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.50</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">505,560</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">505,560</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.625</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,889</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,889</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,442,093</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.94</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6265</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,379,593</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6240</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.95</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 6pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The warrants outstanding have an intrinsic value of $0 and $0 as of December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt"><b>e.</b></span></td> <td style="text-align: justify"><span style="font-size: 10pt"><b>Stock options</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The maximum number of securities available under the Plan is 26,667  shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt; background-color: white"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On July 11, 2022, the Board approved, granted and issued 500,000 ten-year incentive stock options, with immediate vesting, to the Company’s Chairman and Chief Executive Officer at an exercise price of $4.50 per share. This resulted in an immediate expense of $823,854 for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">On September 13, 2022, the Company granted ten-year options exercisable for 6,667 shares of Common Stock, with immediate vesting, to each of its four non-executive directors, totaling options exercisable for 26,668 shares of Common Stock at an exercise price of $1.20 per share. This resulted in an immediate expense of $31,970 for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">During the current financial year, the Company cancelled options exercisable for 23,891 (716,666 pre-split) shares of common stock due to the previous resignation or termination of employees and officers whose stock options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">A summary of option activity during the period January 1, 2022 to December 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> Underlying<br/> options*</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise<br/> price per<br/> share*</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> average<br/> exercise<br/> price*</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold">Outstanding January 1, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,017,223</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">4.50 to 12.00</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">526,668</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">1.20 – 4.50</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,543,891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-size: 10pt">1.20 to 12.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4.47</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-153">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-154">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-155">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(23,889</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-size: 10pt">1.20 to 12.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.41</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,520,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">1.20 to 12.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.46</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The options outstanding and exercisable at December 31, 2023 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Exercisable*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold">Exercise  Price*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number<br/> Outstanding*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number<br/> Exercisable*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 26%; text-align: right">1.20</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">5.86</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">5.86</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">4.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,500,001</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.94</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,388,890</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.96</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,520,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">7.91</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.46</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,408,891</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">7.93</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The options outstanding have an intrinsic value of $0 as of December 31, 2023 and 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="background-color: white">The option expense was $377,856 and $1,233,682 for the years ended December 31, 2023 and 2022, respectively.</span></p> 750000000 0.0001 13819889 13819889 12563426 12563426 66667 2000000 84000 3000 66667 2000000 84000 66667 2000000 110000 100000 3000000 165000 72464 25000 72464 25000 173914 60000 2838 144928 50000 289855 100000 500000 172500 83333 2500000 33333 1000000 50000 1500000 P2Y 50000 1500000 <span style="font-family: Times New Roman, Times, Serif">A summary of restricted stock activity during the period January 1, 2022 to December 31, 2023 is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total<br/> restricted<br/> shares*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> fair market<br/> value per<br/> share*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total<br/> unvested<br/> restricted<br/> shares*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> fair market<br/> value per<br/> share*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Total vested<br/> restricted<br/> shares*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> average<br/> fair market<br/> value per share*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Outstanding January 1, 2022</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">716,500</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">341,583</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">374,917</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted and issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,667</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.65</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-116; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,667</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.65</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-121; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-122; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-123; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-124; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(170,791</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,791</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2022</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">783,167</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,792</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">612,375</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted and issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-125; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-126; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-127; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-128; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-129; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-130; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-131; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-133; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-134; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-135; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-136; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-137; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-138; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(170,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">170,792</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding December 31, 2023</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">783,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-139; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-140; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">783,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td></tr> </table> 716500 1.47 341583 1.47 374917 1.47 66667 1.65 66667 1.65 -170791 1.47 170791 -1.47 783167 1.5 170792 1.47 612375 1.5 -170792 1.47 170792 -1.47 783167 1.5 783167 1.5 <span style="font-family: Times New Roman, Times, Serif; background-color: white">The restricted stock granted, issued and exercisable at December 31, 2023 is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Restricted Stock<br/> Granted and<br/> Vested</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Grant date Price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number<br/> Granted*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted Average Fair<br/> Value per<br/> Share*</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 40%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 25%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">683,167</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 27%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.47</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">33,333</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.65</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,667</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.65</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">783,167</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.50</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td></tr> </table> 683167 1.47 33333 1.5 66667 1.65 783167 1.5 0 361064 25000000 0.0001 (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Five hundred thousand (500,000) shares of the Common Stock at an exercise price of $1.035 per share. The Warrants shall have a three-year term commencing from the Effective Date. 100000 4.5 2027-08-30 1000000 0.345 348938 the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 11 above. In terms of the Note Amendment Transaction the following occurred:   ● The warrants issued to Cavalry and Mercer exercisable for 165,798 shares of Common Stock (82,899 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 11 above;   ● The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 2,408,696 (1,204,348 to each Cavalry and Mercer) and a reset of the exercise price to $0.345 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt.   ● An additional 457,895 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $1.50 to $4.50 per share to $0.345 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt. 5696586 0.345 33334 1.5 225000 292463 0.345 33334 1000000 0.0499 0.0999 133334 0.45 199999 166667 166667 1333334 <span style="background-color: white">The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.345 to 0.45  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 3.77 to 4.86 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 5 years  </span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected volatility of underlying stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 187.40 to 192.80 </span></td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Expected dividend rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">%</td></tr> </table> 0.345 0.45 0.0377 0.0486 P5Y 1.874 1.928 0 <span style="background-color: white">A summary of warrant activity during the period January 1, 2022 to December 31, 2023 is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> Underlying<br/> Warrants*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise<br/> price per<br/> share*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> average<br/> exercise<br/> price*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 64%; font-weight: bold; vertical-align: top">Outstanding January 1, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,243,477</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 1.50 – 5.625  </span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3.60</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,700,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.345 – 1.035 </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.5478</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Increase in warrants due to debt amendment full rachet trigger</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,408,696</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.345</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left">Cancelled on debt amendment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(165,797</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.50</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: top">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; font-weight: bold; vertical-align: top">Outstanding December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,186,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.345 – 5.625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.9000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top">Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,289,051</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 0.345 – 1.50</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3556</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top">Forfeited</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(33,334</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.5000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left">Cancelled on disposal of investment in Frictionless and Beyond Fintech</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,000,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.3450</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; vertical-align: top">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-145">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; font-weight: bold; padding-bottom: 4pt; vertical-align: top">Outstanding December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">10,442,093</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.345 – 5.625 </span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.6265</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 1243477 1.5 5.625 3.6 1700000 0.345 1.035 0.5478 2408696 0.345 0.345 165797 4.5 4.5 5186376 0.345 5.625 0.9 6289051 0.345 1.5 0.3556 33334 1.5 1.5 1000000 0.345 0.345 10442093 0.345 5.625 0.6265 <span style="background-color: white">The warrants outstanding and exercisable at December 31, 2023 are as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants Outstanding*</b></span></td> <td> </td> <td> </td> <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants Exercisable*</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<br/> Outstanding*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Exercise<br/> Price*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number<br/> Exercisable*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Exercise<br/> Price*</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.345</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,055,642</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,055,642</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.450</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,668</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.48</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,668</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.48</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.035</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.52</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">437,500</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.52</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.500</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,334</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.62</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,334</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.62</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.50</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">505,560</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">505,560</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.625</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,889</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,889</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"> </td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,442,093</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.94</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6265</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,379,593</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6240</span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.95</span></td> <td> </td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td></tr> </table> 9055642 P4Y1M28D 9055642 P4Y1M28D 266668 P4Y5M23D 266668 P4Y5M23D 500000 P1Y6M7D 437500 P1Y6M7D 33334 P4Y7M13D 33334 P4Y7M13D 505560 P2Y2M15D 505560 P2Y2M15D 80889 P2Y2M15D 80889 P2Y2M15D 10442093 P3Y11M8D 0.6265 10379593 0.624 P3Y11M12D 0 0 P10Y 26667 100000 P10Y 1766667 500000 4.5 823854 6667 26668 1.2 31970 23891 716666 <span style="background-color: white">A summary of option activity during the period January 1, 2022 to December 31, 2023 is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/> Underlying<br/> options*</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise<br/> price per<br/> share*</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> average<br/> exercise<br/> price*</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold">Outstanding January 1, 2022</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,017,223</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">4.50 to 12.00</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4.50</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">526,668</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt">1.20 – 4.50</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,543,891</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-size: 10pt">1.20 to 12.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4.47</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-153">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-154">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-155">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Forfeited/Cancelled</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(23,889</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="font-size: 10pt">1.20 to 12.00</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.41</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding December 31, 2023</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,520,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-size: 10pt">1.20 to 12.00</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.46</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">After giving effect to a 1 for 30 reverse stock split on August 30, 2023.</span></td> </tr></table> 1017223 4.5 12 4.5 526668 1.2 4.5 4.2 1543891 1.2 12 4.47 23889 1.2 12 5.41 1520002 1.2 12 4.46 <span style="background-color: white">The options outstanding and exercisable at December 31, 2023 are as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Outstanding*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Options Exercisable*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold">Exercise  Price*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number<br/> Outstanding*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number<br/> Exercisable*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual<br/> life in years</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 26%; text-align: right">1.20</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">5.86</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">20,001</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">5.86</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">4.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,500,001</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.94</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,388,890</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7.96</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,520,002</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">7.91</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.46</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,408,891</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4.45</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">7.93</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 20001 P5Y10M9D 20001 P5Y10M9D 1500001 P7Y11M8D 1388890 P7Y11M15D 1520002 P7Y10M28D 4.46 1408891 4.45 P7Y11M4D 0 0 377856 1233682 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>16</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>LOSS ON CONVERTIBLE NOTES</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in; background-color: white"><span style="background-color: white">The loss on convertible notes consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Penalty on cash settlement of convertible note</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,306</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">247,063</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expense on extension of maturity date of convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,256</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">836,414</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair value of warrants issued to convertible note holders on extension of maturity date</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">238,182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-160">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,360,658</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">920,392</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">73,562</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,602,709</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="background-color: white"><b><i>Penalty on cash settlement of convertible note</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">On February 4, 2022, the Company cash settled the outstanding balance, including early settlement penalty thereon of $247,063, of a convertible note owing to Bellridge for gross proceeds of $1,235,313.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">On August 3, 2023, the Company cash settled the outstanding balance of two convertible notes owing to 1800 Diagonal Street Lending LLC, including an early settlement penalty thereon of $9,306.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -9pt"><span style="background-color: white"><b><i>Expense on extension of maturity date of convertible notes</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">On December 14, 2023, the Company extended the maturity date of two convertible notes to March 30, 2024, and issued the note holders additional warrants exercisable for 292,463 shares of common stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment, resulting in a charge of $64,256 for the year ended December 31, 2023. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">In the prior year, The Company twice extended the maturity date of its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022, in terms of these extensions, the Company incurred penalties which increased the principle outstanding of these convertible notes in the aggregate amount of $836,414.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white"><b><i>Fair value of warrants issued to convertible note holders on extension of maturity date</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">In addition to the penalty on extension of maturity date on its indebtedness to each of Cavalry and Mercer, in consideration for the second extension on August 30, 2022, the Company agreed to issue to each of Cavalry and Mercer a new five-year warrant to purchase an additional 100,000 (3,000,000 pre-split) shares of common stock at an exercise price of $4.50 ($0.15 pre-split) per share. The fair value of these warrants were determined as $238,182 on August 30, 2022, using a Black-Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.15pt; text-align: justify; text-indent: -0.15pt"><span style="background-color: white"><b><i>Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">On December 30, 2022, the Company again extended the maturity dates of each of the Notes to Cavalry and Mercer to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed that the conversion price of the Notes was reduced from $4.50 ($0.15 pre-split) to $0.345 ($0.0115 pre-split) per share and in addition, resulted in the 100,000 (3,000,000 pre-split) shares of common stock underlying the Extension Warrants increasing to 1,304,348 (39,130,435 pre-split) shares, in terms of the full-rachet provisions in those warrant agreements. The change in the conversion price and the increase in the number of warrant shares to be issued at the revised exercise price of $0.345 ($0.0115 pre-split) per share, resulted in a derivative liability on December 30, 2022 of $2,340,580, determined by using a Black-Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">In addition to this, certain other warrants outstanding had their conversion price reduced from $1.50 ($0.05 pre-split) per share to $0.345 ($0.0115 pre-split) per share in terms of their warrant agreements, resulting in an additional derivative liability on December 30, 2022 of $20,079, determined by using a Black-Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white"><b><i>Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">On December 30, 2022, the Company also agreed to exchange the Original Warrants issued on February 16, 2021 to Cavalry and Mercer for 12-month non-convertible promissory notes in the amount of $482,000 each. This resulted in an additional charge of $964,000, less the fair value of the derivative liability of the Original warrants of $43,608, valued on December 30, 2022, using a Black-Scholes valuation model.</span></p> <span style="background-color: white">The loss on convertible notes consists of the following:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Penalty on cash settlement of convertible note</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,306</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">247,063</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Expense on extension of maturity date of convertible notes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,256</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">836,414</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair value of warrants issued to convertible note holders on extension of maturity date</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">238,182</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair value of derivative liability arising on the amendment of the exercise price of convertible notes and the full-rachet trigger on certain warrants issued to convertible note holders</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-160">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,360,658</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Value of notes exchanged for certain warrants, net of the derivative liability value of $(43,608)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">920,392</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">73,562</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,602,709</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 9306 247063 64256 836414 238182 2360658 -43608 920392 73562 4602709 247063 1235313 9306 292463 64256 836414 100000 3000000 4.5 0.15 238182 2023-12-30 4.5 0.15 0.345 0.0115 100000 3000000 1304348 39130435 0.345 0.0115 2340580 1.5 0.05 0.345 0.0115 20079 43608 482000 964000 43608 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>17</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>INCOME TAXES</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Company’s operations are based in the US and currently enacted tax laws in the US are used in the calculation of income taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>Federal Income Tax - United States</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 6pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On December 22, 2017, the Tax Cuts and Jobs Act (the TCJA), which significantly modified U.S. corporate income tax law, was signed into law by President Trump. The TCJA contains significant changes to corporate income taxation, including but not limited to the reduction of the corporate income tax rate from a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year taxable income and generally eliminating net operating loss carrybacks, allowing net operating losses to carryforward without expiration, one-time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits (including changes to the orphan drug tax credit and changes to the deductibility of research and experimental expenditures that will be effective in the future). Notwithstanding the reduction in the corporate income tax rate, the overall impact of the new federal tax law is uncertain, including to what extent various states will conform to the newly enacted federal tax law.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 6pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of December 31, 2022 and 2021, there have been no interest or penalties incurred on income taxes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 7.5pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The provision for income taxes consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 7.5pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 76%">Federal</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">         </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">           </div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in">State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Deferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in">Federal</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 7.5pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">A reconciliation of the U.S. Federal statutory income tax to the effective income tax is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><span style="font-size: 7.5pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Continuing operations</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Tax expense at the federal statutory rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,225,845</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,169,599</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State tax expense, net of federal tax effect</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(170,564</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(324,289</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Permanent differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">712,951</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,194,446</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Prior year net operating loss true up</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(228,714</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,277</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(912,172</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,302,719</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred income tax asset valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">912,172</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,302,719</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><span style="font-size: 7.5pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Significant components of the Company’s deferred income tax assets are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 7.5pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Other</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">241,491</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">241,491</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Capital loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">491,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net operating losses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,076</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,479,181</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">511,142</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">511,142</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,143,986</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,231,814</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 4pt">Net deferred income tax assets</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 7.5pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The valuation allowance for deferred income tax assets as of December 31, 2023 and December 31, 2022 was $8,143,986 and $7,231,814, respectively. The net change in the deferred income tax assets valuation allowance was an increase of $912,172 and is primarily attributable to tax operating losses and capital losses realized during the current year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 7.5pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">As of December 31, 2023, the prior <span style="-sec-ix-hidden: hidden-fact-182">three</span> years remain open for examination by the federal or state regulatory agencies for purposes of an audit for tax purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 7.5pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">As of December 31, 2023, the Company had available for income tax purposes approximately $26.8 million in federal and $19.0 million in state net operating loss carry forwards, which may be available to offset future taxable income. $3.5 million of the net operating losses will begin to expire in <span style="-sec-ix-hidden: hidden-fact-183">2034</span> and $23.3 million has an indefinite life. Due to the uncertainty of the utilization and recoverability of the loss carryforwards and other deferred tax assets, Management has determined a full valuation allowance for the deferred tax assets since it is more likely than not that the deferred tax assets will not be realizable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Company’s ability to utilize the previous Federal operating loss carryforwards may be adjusted if, pursuant to IRC Section 382/383 of the Internal Revenue Code of 1986, as amended, a change of ownership occurs. Management does not believe an ownership change has occurred under IRC Section 382/383. A future change in ownership may result in an adjustment to the loss carryforward.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Company is subject to taxation in the U.S. and CA state. U.S. federal income tax returns for 2019 and after, remain open to examination. No income tax returns are currently under examination. As of December 31, 2023 and 2022, the Company does not have any unrecognized tax benefits, and continues to monitor its current and prior tax positions for any changes. The Company recognizes penalties and interest related to unrecognized tax benefits as income tax expense. For the years ended December 31, 2023 and 2022, there were no penalties or interest recorded in income tax expense. </span></p> 0.35 0.21 0.30 0.80 <span style="background-color: white">The provision for income taxes consists of the following:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 76%">Federal</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">         </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">           </div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in">State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Deferred</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in">Federal</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">State</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.125in; padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span style="background-color: white">A reconciliation of the U.S. Federal statutory income tax to the effective income tax is as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Continuing operations</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Tax expense at the federal statutory rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,225,845</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,169,599</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">State tax expense, net of federal tax effect</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(170,564</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(324,289</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Permanent differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">712,951</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,194,446</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Prior year net operating loss true up</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(228,714</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,277</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(912,172</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,302,719</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred income tax asset valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">912,172</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,302,719</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> -1225845 -2169599 -170564 -324289 712951 1194446 -228714 -3277 -912172 -1302719 912172 1302719 <span style="background-color: white">Significant components of the Company’s deferred income tax assets are as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Other</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">241,491</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">241,491</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Capital loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">491,275</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net operating losses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,076</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,479,181</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">511,142</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">511,142</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(8,143,986</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,231,814</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 4pt">Net deferred income tax assets</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 241491 241491 491275 6900076 6479181 511142 511142 8143986 7231814 8143986 7231814 912172 26800000 19000000 3500000 23300000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>18</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>EQUITY BASED COMPENSATION</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="background-color: white">Equity based compensation is made up of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Incentive stock awards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">377,856</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,594,746</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Securities issued for services rendered</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">144,828</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">333,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">522,684</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,927,746</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span style="background-color: white">Equity based compensation is made up of the following:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Incentive stock awards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">377,856</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,594,746</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Securities issued for services rendered</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">144,828</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">333,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">522,684</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,927,746</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 377856 1594746 144828 333000 522684 1927746 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>19</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>NET LOSS PER SHARE</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Basic loss per share is based on the weighted-average number of common shares outstanding during each period. Diluted loss per share is based on basic shares as determined above plus common stock equivalents. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the years ended December 31, 2023 and 2022 all warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the years ended December 31, 2023 and 2022 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31, <br/> 2023<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31, <br/> 2022<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible debt</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13,363,993</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">6,569,863</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,520,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,543,891</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase shares of common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,442,093</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,186,375</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">25,326,088</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">13,300,129</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span style="background-color: white">Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the years ended December 31, 2023 and 2022 are as follows:</span><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31, <br/> 2023<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31, <br/> 2022<br/> (Shares)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Convertible debt</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13,363,993</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">6,569,863</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,520,002</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,543,891</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants to purchase shares of common stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,442,093</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,186,375</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">25,326,088</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">13,300,129</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 13363993 6569863 1520002 1543891 10442093 5186375 25326088 13300129 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>20</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>RELATED PARTY TRANSACTIONS</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The following transactions were entered into with related parties:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>James Fuller</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On September 13, 2022, the Company granted Mr. Fuller ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The option expense for Mr. Fuller was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Mr. Fuller voluntarily resigned as a member of the Board of Directors effective as of our 2022 annual meeting of shareholders which occurred on November 3, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>William Corbett</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On July 11, 2022, the Company granted Mr. Corbett ten-year options exercisable for 500,000 shares of Common Stock at an exercise price of $4.50 per share.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On June 21, 2023, Mr. Corbett advanced the company $50,000 to cover certain working capital expenses, the advance is short term in nature, bears no interest and has no fixed repayment terms. This advance was repaid on December 4, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The option expense for Mr. Corbett was $266,346 and $1,090,201 for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>Clifford Henry</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Mr. Henry has an oral consulting arrangement with the Company whereby he is paid $3,500 per month for financial and capital markets advice. This consulting agreement commenced in May, 2021 and was approved and ratified by the Board in March 2022. This consulting agreement and related payments were terminated in September 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On September 13, 2022, the Company granted Mr. Henry, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The option expense for Mr. Henry was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">Mr. Henry voluntary elected not to stand for re-election at the company’s annual general meeting, his tenure as a director ended on the date of the annual general meeting, November 30, 2023. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>Madisson Butler</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On September 13, 2022, the Company granted Ms. Butler (formerly known as Madisson Corbett), immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The option expense for Ms. Butler was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>David Rios</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On September 13, 2022, the Company granted Mr. Rios, immediately vesting, ten-year options exercisable for 6,667 shares of Common Stock at an exercise price of $1.20 per share, valued at $7,993 using a Black Scholes valuation model.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The option expense for Mr. Rios was $0 and $7,993 for the years ended December 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>Richard Rosenblum</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">On July 11, 2022, the Company granted Mr. Rosenblum 66,667 restricted shares of Common Stock valued at $110,000, all of which are vested.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The option expense for Mr. Rosenblum was $111,510 for each of the years ended December 31, 2023 and 2022, respectively.</span></p> 6667 1.2 0 7993 500000 4.5 50000 266346 1090201 3500 6667 1.2 7993 0 7993 6667 1.2 7993 0 7993 6667 1.2 7993 0 7993 66667 110000 111510 111510 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>21</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>COMMITMENTS AND CONTINGENCIES</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white">The Company has notes payable and convertible notes payable, disclosed under notes 12 and 13 above, which originally matured between December 30, 2023 and September 14, 2024, of which the notes that had maturity dates between December 30, 2023 and February 23, 2024 have been extended to dates between April 30, 2024 and August 23, 2024. The Company may settle the notes payable, at its option by the issue of common shares and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.</span></p> The Company has notes payable and convertible notes payable, disclosed under notes 12 and 13 above, which originally matured between December 30, 2023 and September 14, 2024, of which the notes that had maturity dates between December 30, 2023 and February 23, 2024 have been extended to dates between April 30, 2024 and August 23, 2024. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><b>22</b></span></td><td style="text-align: justify"><span style="font-size: 10pt"><b>SUBSEQUENT EVENTS</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 8pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="background-color: white"><b>Convertible note funding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">Between February 6 and February 21, 2024, the Company entered into Securities Purchase Agreements pursuant to which the Company issued convertible promissory notes to four accredited investment entities for total gross proceeds of $308,335. The Notes are unsecured, mature 12 months from issuance date and bear interest at a rate of 8% per annum, and are convertible into shares of common stock of the Company at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, and similar events). The Notes may be prepaid at any time without penalty. The Note contains customary events of default. The Company is under no obligation to register the shares of Common Stock underlying the Notes for public resale.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">On March 4, 2024, the Company entered into a Securities Purchase Agreement pursuant to which the Company issued a convertible promissory note and a warrant exercisable for shares of common stock to an accredited investor. The Company realized gross proceeds of $100,000 after an original issue discount of $14,286 and a once off interest charge of $9,143. The note matures on September 4, 2024. Principal and interest payments are due in four equal instalments of $30,871 commencing on May 3, 2024. The note is convertible into common stock at a fixed price of $0.345 per share, unless the note is in default, whereby the conversion price will be 70% of the lowest closing bid price for the 5 trading days prior to conversion. The note may be prepaid at any time for the full outstanding principal and outstanding interest.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><b>Non-Binding Letter of Intent with Business Warrior</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><i>Overview and Cautionary Statement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">On February 13, 2024, the Company signed an amended and restated non-binding letter of intent (the “LOI”) with Business Warrior Corporation, a Wyoming corporation (“BZWR”), pursuant to which the Company would acquire BZWR on the general terms described below (the “Proposed Transaction”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">Neither IPSI nor BZWR shall have any legal obligation of any kind with respect to the Proposed Transaction unless and until binding definitive agreements with respect to the Proposed Transaction are executed. Moreover, the Proposed Transaction, assuming definitive agreements are even executed, would be subject to the approval of the stockholders of both IPSI and BZWR and the satisfaction of other conditions to closing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">BZWR is a publicly listed, revenue generating fintech company that offers <span style="background-color: white">PayPlan, a comprehensive lending software platform that includes marketing services for lenders and businesses. The Company believes that a potential combination with a fintech company that generates some revenue monthly would complement the development and commercial launch of the Company’s IPSIPay Express<sup>TM</sup> products and potentially other product offerings. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">In addition, the Company and BZWR have certain convertible note investors (the “<b>Note Holders</b>”) in common. Therefore, one purpose of the Proposed Transaction would be to convert the indebtedness of both the Company and BZWR held by the Note Holders into equity securities of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white"><i>Outline of Proposed Terms</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="background-color: white">The principal terms of the Proposed Transaction are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 8pt"> <b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">1.</span></td><td style="text-align: justify"><span style="font-size: 10pt; background-color: white"><span style="text-decoration:underline">Preliminary Structure</span>. At the closing of the Proposed Transaction (the “Closing”), the Company would acquire </span><span style="font-size: 10pt">100% of the outstanding equity and equity equivalents of BZWR (including outstanding warrants and other securities that have the right to acquire or convert into equity securities of BZWR) on a cash-free, debt free basis by way of a merger of BZWR into a new subsidiary of the Company.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; background-color: white"><span style="font-size: 7pt"> <b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">2.</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><span style="text-decoration:underline">Consideration</span>. </span>The total consideration provided to or for the benefit of BZWR equity holders (including holders of warrants and other outstanding preferred stock or other convertible securities of BZWR), as applicable (the “Transaction Consideration”) would be in the form of newly-issued shares (the “Transaction Shares”) of Company common stock representing forty percent (40%) of the Common Stock immediately following the Closing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-size: 7pt"> </span><span style="font-size: 8pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span style="text-decoration:underline">Note Exchange Transaction; Replacement Preferred</span>. Prior to and as a condition to the Closing, the Note Holders of both IPSI and BZWR shall effect a note exchange transaction pursuant to which all of the outstanding convertible notes of IPSI and BZWR held by the Note Holders will be cancelled and exchanged for shares of newly-issued Series A Convertible Preferred Stock of IPSI (“Replacement Preferred”). The terms of the Replacement Preferred will be negotiated with the Note Holders.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-size: 7pt"> <b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">4.</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span style="text-decoration:underline">BZWR Capitalization Restructure</span>. Prior to the Closing, BZWR shall cause all of its outstanding shares of preferred stock and warrants to be converted into shares of BZWR common stock, net exercised or cancelled, with the effect that only shares of BZWR common stock would be outstanding a Closing, the holders of which would be entitled to receive the Transaction Consideration.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-size: 7pt"> <b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in"><span style="font-size: 10pt">5.</span></td> <td style="text-align: justify"><span style="font-size: 10pt"><span style="text-decoration:underline">Board of Directors</span>. The post-Closing Board of Directors of IPSI shall consist of a number of individuals to be agreed upon by IPSI and BZWR, provided that (i) the majority of the post-Closing Board of Directors will be appointed by IPSI and (ii) the majority of the post-Closing Board of Directors will be “independent” as defined under Nasdaq Stock Market rules.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; background-color: white"><span style="font-size: 7pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><b>Company Loan to BZWR</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-size: 7pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white">On February 12, 2024, and in connection with the LOI and the Proposed Transaction, the Company (utilizing a portion of the proceeds from the issuance of convertible Notes) loaned funds to BZWR in the principal amount of $226,190, which includes an original issue discount equal to $67,857, netting BZWR proceeds $158,333. The loan is memorialized by a secured promissory note (the “BZWR Note”). The BZWR Note does not accrued interest, except in the case of an event of default, which case interest accrues at 15% per annum. The BZWR Note matures on the earlier to occur of December 31, 2025 and the date that BZWR’s securities are listed on a national securities exchange. The BZWR Note may be prepaid at any time for an amount equal to 110% of the then principal and accrued interest. IPSI shall have the right to exchange the BZWR Note for securities issued by BZWR in any subsequent private placement by BZWR. The principal and accrued interest under BZWR Note is convertible into common stock of BZWR at a price equal to $0.0036 per share, subject to certain adjustments and potential resets. BZWR’s obligations under the BZWR Note are guaranteed by BZWR’s subsidiaries and secured by a lien on BZWR’s accounts receivable. The BZWR Note is one of several similar notes issued by BZWR. Keystone Capital Partners LLC is acting as collateral agent for the holders of such notes, include IPSI as the holder of the BZWR Note.</p> 308335 0.08 0.345 100000 14286 9143 2024-09-04 30871 0.345 0.70 1 0.40 226190 67857 158333 0.15 1.10 0.0036 33-1230229 RBSM LLP -0.41 -0.83 0.00 -0.04 -0.45 -0.83 12406677 12844609 P3Y 2034 true FY 0001591913 true After giving effect to a 1 for 30 reverse stock split on August 30, 2023. After giving effect to a 1 for 30 reverse stock split on August 30, 2023. After giving effect to a 1 for 30 reverse stock split on August 30, 2023. The red Road Holdings Corporation interest rate is an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made. After giving effect to a 1 for 30 reverse stock split on August 30, 2023. After giving effect to a 1 for 30 reverse stock split on August 30, 2023. After giving effect to a 1 for 30 reverse stock split on August 30, 2023. After giving effect to a 1 for 30 reverse stock split on August 30, 2023. After giving effect to a 1 for 30 reverse stock split on August 30, 2023.